PARADIGM pathway analysis of mRNA expression and copy number data
Breast Invasive Carcinoma (Primary solid tumor)
17 October 2014  |  analyses__2014_10_17
Maintainer Information
Citation Information
doi:10.7908/C1B856ZV
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): PARADIGM pathway analysis of mRNA expression and copy number data. Broad Institute of MIT and Harvard. doi:10.7908/C1B856ZV
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 55 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Signaling mediated by p38-alpha and p38-beta 248
Signaling events mediated by Stem cell factor receptor (c-Kit) 225
EGFR-dependent Endothelin signaling events 146
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 145
Endothelins 144
Class IB PI3K non-lipid kinase events 126
IGF1 pathway 119
FOXM1 transcription factor network 105
Arf6 signaling events 102
Nongenotropic Androgen signaling 95
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 526 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 526 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Signaling mediated by p38-alpha and p38-beta 0.4715 248 10918 44 -0.61 0.034 1000 -1000 -0.008 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.4278 225 17608 78 -1 0.32 1000 -1000 -0.017 -1000
EGFR-dependent Endothelin signaling events 0.2776 146 3082 21 -0.31 0.048 1000 -1000 -0.034 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.2757 145 9924 68 -0.88 0.45 1000 -1000 -0.037 -1000
Endothelins 0.2738 144 13902 96 -0.81 0.17 1000 -1000 -0.033 -1000
Class IB PI3K non-lipid kinase events 0.2395 126 378 3 -0.11 -1000 1000 -1000 -0.025 -1000
IGF1 pathway 0.2262 119 6815 57 -0.26 0.11 1000 -1000 -0.028 -1000
FOXM1 transcription factor network 0.1996 105 5370 51 -0.14 0.68 1000 -1000 0.011 -1000
Arf6 signaling events 0.1939 102 6339 62 -0.31 0.082 1000 -1000 -0.008 -1000
Nongenotropic Androgen signaling 0.1806 95 4970 52 -0.57 0.3 1000 -1000 -0.023 -1000
Glucocorticoid receptor regulatory network 0.1483 78 8986 114 -0.95 0.29 1000 -1000 -0.047 -1000
S1P1 pathway 0.1483 78 2812 36 -0.62 0.046 1000 -1000 -0.02 -1000
Signaling events mediated by PTP1B 0.1407 74 5658 76 -0.37 0.19 1000 -1000 -0.017 -1000
Calcium signaling in the CD4+ TCR pathway 0.1388 73 2289 31 -0.35 0.041 1000 -1000 -0.041 -1000
PDGFR-alpha signaling pathway 0.1331 70 3106 44 -0.7 0.063 1000 -1000 -0.022 -1000
HIF-1-alpha transcription factor network 0.1312 69 5266 76 -0.4 0.065 1000 -1000 -0.024 -1000
BMP receptor signaling 0.1293 68 5561 81 -0.4 0.11 1000 -1000 -0.025 -1000
Ephrin B reverse signaling 0.1293 68 3296 48 -0.18 0.06 1000 -1000 -0.038 -1000
Ras signaling in the CD4+ TCR pathway 0.1255 66 1134 17 -0.2 0.033 1000 -1000 -0.001 -1000
Plasma membrane estrogen receptor signaling 0.1084 57 4916 86 -0.25 0.18 1000 -1000 -0.048 -1000
FAS signaling pathway (CD95) 0.1046 55 2597 47 -0.88 0.06 1000 -1000 -0.023 -1000
IL6-mediated signaling events 0.0989 52 3915 75 -0.37 0.073 1000 -1000 -0.026 -1000
Integrins in angiogenesis 0.0951 50 4204 84 -0.39 0.13 1000 -1000 -0.029 -1000
EPHB forward signaling 0.0951 50 4267 85 -0.18 0.14 1000 -1000 -0.058 -1000
IL4-mediated signaling events 0.0932 49 4482 91 -0.51 0.14 1000 -1000 -0.099 -1000
Visual signal transduction: Rods 0.0932 49 2578 52 -0.43 0.074 1000 -1000 -0.007 -1000
Fc-epsilon receptor I signaling in mast cells 0.0894 47 4589 97 -0.35 0.041 1000 -1000 -0.056 -1000
PLK1 signaling events 0.0875 46 3933 85 -0.035 0.17 1000 -1000 -0.02 -1000
IL23-mediated signaling events 0.0875 46 2801 60 -0.79 0.065 1000 -1000 -0.003 -1000
E-cadherin signaling in keratinocytes 0.0875 46 1982 43 -0.27 0.036 1000 -1000 -0.02 -1000
Aurora B signaling 0.0856 45 3027 67 -0.38 0.24 1000 -1000 -0.021 -1000
IL12-mediated signaling events 0.0779 41 3587 87 -0.83 0.088 1000 -1000 -0.03 -1000
Glypican 1 network 0.0779 41 1980 48 -0.39 0.07 1000 -1000 -0.027 -1000
Signaling events mediated by the Hedgehog family 0.0741 39 2033 52 -0.14 0.068 1000 -1000 -0.015 -1000
Nectin adhesion pathway 0.0741 39 2477 63 -0.077 0.054 1000 -1000 -0.027 -1000
S1P5 pathway 0.0741 39 667 17 -0.17 0.066 1000 -1000 -0.003 -1000
TCGA08_retinoblastoma 0.0741 39 318 8 -0.022 0.058 1000 -1000 -0.01 -1000
Insulin Pathway 0.0741 39 2937 74 -0.28 0.091 1000 -1000 -0.027 -1000
p75(NTR)-mediated signaling 0.0722 38 4793 125 -0.13 0.094 1000 -1000 -0.04 -1000
Presenilin action in Notch and Wnt signaling 0.0684 36 2231 61 -0.38 0.11 1000 -1000 -0.037 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0684 36 2722 74 -0.27 0.074 1000 -1000 -0.06 -1000
Syndecan-3-mediated signaling events 0.0665 35 1233 35 -0.36 0.076 1000 -1000 -0.01 -1000
ErbB4 signaling events 0.0646 34 2406 69 -0.36 0.14 1000 -1000 -0.011 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0627 33 2861 85 -0.54 0.043 1000 -1000 -0.037 -1000
TCGA08_p53 0.0608 32 224 7 -0.009 0.029 1000 -1000 -0.008 -1000
LPA receptor mediated events 0.0608 32 3320 102 -0.35 0.095 1000 -1000 -0.04 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0608 32 3877 120 -0.25 0.12 1000 -1000 -0.04 -1000
S1P4 pathway 0.0608 32 821 25 -0.17 0.045 1000 -1000 -0.013 -1000
Signaling events regulated by Ret tyrosine kinase 0.0570 30 2463 82 -0.1 0.12 1000 -1000 -0.049 -1000
TCR signaling in naïve CD8+ T cells 0.0570 30 2822 93 -0.039 0.081 1000 -1000 -0.04 -1000
IL27-mediated signaling events 0.0570 30 1572 51 -0.37 0.068 1000 -1000 -0.032 -1000
ErbB2/ErbB3 signaling events 0.0551 29 1915 65 -0.35 0.047 1000 -1000 -0.048 -1000
TCGA08_rtk_signaling 0.0551 29 766 26 -0.27 0.042 1000 -1000 -0.026 -1000
Syndecan-2-mediated signaling events 0.0532 28 1990 69 -0.32 0.13 1000 -1000 -0.009 -1000
Canonical Wnt signaling pathway 0.0513 27 1413 51 -0.38 0.16 1000 -1000 -0.033 -1000
Regulation of nuclear SMAD2/3 signaling 0.0494 26 3606 136 -0.37 0.075 1000 -1000 -0.043 -1000
FOXA2 and FOXA3 transcription factor networks 0.0475 25 1182 46 -0.75 0.051 1000 -1000 -0.016 -1000
amb2 Integrin signaling 0.0475 25 2129 82 -0.52 0.13 1000 -1000 -0.018 -1000
mTOR signaling pathway 0.0456 24 1304 53 -0.051 0.044 1000 -1000 -0.031 -1000
Reelin signaling pathway 0.0456 24 1354 56 -0.055 0.083 1000 -1000 -0.014 -1000
IL1-mediated signaling events 0.0456 24 1500 62 -0.049 0.068 1000 -1000 -0.021 -1000
Angiopoietin receptor Tie2-mediated signaling 0.0456 24 2112 88 -0.39 0.13 1000 -1000 -0.061 -1000
Thromboxane A2 receptor signaling 0.0437 23 2419 105 -0.27 0.067 1000 -1000 -0.034 -1000
Ceramide signaling pathway 0.0437 23 1780 76 -0.25 0.083 1000 -1000 -0.026 -1000
HIF-2-alpha transcription factor network 0.0437 23 1015 43 -0.23 0.26 1000 -1000 -0.097 -1000
S1P3 pathway 0.0437 23 971 42 -0.17 0.063 1000 -1000 -0.016 -1000
Coregulation of Androgen receptor activity 0.0399 21 1645 76 -0.23 0.054 1000 -1000 -0.011 -1000
Osteopontin-mediated events 0.0399 21 799 38 -0.35 0.13 1000 -1000 -0.014 -1000
Syndecan-4-mediated signaling events 0.0399 21 1436 67 -0.39 0.15 1000 -1000 -0.025 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.0380 20 1078 52 -0.38 0.11 1000 -1000 -0.018 -1000
Regulation of p38-alpha and p38-beta 0.0380 20 1109 54 -0.31 0.072 1000 -1000 -0.043 -1000
Regulation of Telomerase 0.0380 20 2119 102 -0.35 0.087 1000 -1000 -0.014 -1000
Regulation of Androgen receptor activity 0.0380 20 1457 70 -0.43 0.079 1000 -1000 -0.034 -1000
E-cadherin signaling in the nascent adherens junction 0.0342 18 1372 76 -0.038 0.06 1000 -1000 -0.045 -1000
E-cadherin signaling events 0.0342 18 93 5 0.007 0.035 1000 -1000 0.02 -1000
IL2 signaling events mediated by PI3K 0.0323 17 1029 58 -0.12 0.049 1000 -1000 -0.027 -1000
Noncanonical Wnt signaling pathway 0.0304 16 429 26 -0.015 0.041 1000 -1000 -0.028 -1000
Signaling events mediated by PRL 0.0304 16 547 34 -0.31 0.052 1000 -1000 -0.023 -1000
Caspase cascade in apoptosis 0.0285 15 1175 74 -0.15 0.049 1000 -1000 -0.025 -1000
Syndecan-1-mediated signaling events 0.0285 15 522 34 -0.041 0.11 1000 -1000 -0.017 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0285 15 679 45 -0.005 0.06 1000 -1000 -0.027 -1000
Hedgehog signaling events mediated by Gli proteins 0.0266 14 966 65 -0.17 0.078 1000 -1000 -0.032 -1000
ceramide signaling pathway 0.0247 13 642 49 -0.069 0.053 1000 -1000 -0.017 -1000
Wnt signaling 0.0247 13 92 7 -0.015 0.041 1000 -1000 -0.016 -1000
BCR signaling pathway 0.0247 13 1302 99 -0.15 0.092 1000 -1000 -0.045 -1000
JNK signaling in the CD4+ TCR pathway 0.0228 12 215 17 -0.04 0.09 1000 -1000 -0.016 -1000
Cellular roles of Anthrax toxin 0.0228 12 500 39 -0.063 0.038 1000 -1000 -0.016 -1000
IFN-gamma pathway 0.0228 12 862 68 -0.02 0.1 1000 -1000 -0.036 -1000
PLK2 and PLK4 events 0.0209 11 33 3 0.016 0.055 1000 -1000 0.003 -1000
FoxO family signaling 0.0209 11 743 64 0 0.15 1000 -1000 -0.019 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0209 11 1396 125 -0.38 0.075 1000 -1000 -0.033 -1000
VEGFR1 specific signals 0.0209 11 626 56 -0.38 0.076 1000 -1000 -0.03 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0190 10 282 28 -0.17 0.054 1000 -1000 -0.009 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.0190 10 566 54 -0.04 0.083 1000 -1000 -0.023 -1000
EPO signaling pathway 0.0190 10 591 55 -0.089 0.069 1000 -1000 -0.013 -1000
Class I PI3K signaling events mediated by Akt 0.0190 10 717 68 -0.15 0.062 1000 -1000 -0.026 -1000
Signaling events mediated by HDAC Class III 0.0152 8 326 40 -0.062 0.062 1000 -1000 -0.039 -1000
TRAIL signaling pathway 0.0152 8 419 48 -0.001 0.047 1000 -1000 -0.02 -1000
Signaling mediated by p38-gamma and p38-delta 0.0152 8 127 15 -0.006 0.035 1000 -1000 -0.022 -1000
Signaling events mediated by HDAC Class II 0.0133 7 558 75 -0.059 0.067 1000 -1000 -0.02 -1000
Circadian rhythm pathway 0.0133 7 171 22 -0.021 0.11 1000 -1000 -0.024 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0133 7 585 83 -0.069 0.066 1000 -1000 -0.015 -1000
p38 MAPK signaling pathway 0.0133 7 310 44 -0.016 0.067 1000 -1000 -0.009 -1000
Visual signal transduction: Cones 0.0114 6 228 38 0 0.07 1000 -1000 0 -1000
Retinoic acid receptors-mediated signaling 0.0114 6 388 58 -0.052 0.08 1000 -1000 -0.012 -1000
Paxillin-dependent events mediated by a4b1 0.0114 6 234 36 -0.071 0.076 1000 -1000 -0.027 -1000
Arf6 trafficking events 0.0114 6 481 71 -0.25 0.056 1000 -1000 -0.022 -1000
Canonical NF-kappaB pathway 0.0095 5 199 39 0 0.073 1000 -1000 -0.009 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0095 5 202 37 -0.02 0.085 1000 -1000 -0.02 -1000
Class I PI3K signaling events 0.0095 5 397 73 -0.008 0.059 1000 -1000 -0.025 -1000
PDGFR-beta signaling pathway 0.0095 5 559 97 -0.033 0.081 1000 -1000 -0.038 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0076 4 163 34 -0.048 0.083 1000 -1000 -0.024 -1000
Aurora C signaling 0.0076 4 31 7 0 0.079 1000 -1000 -0.01 -1000
Insulin-mediated glucose transport 0.0076 4 158 32 -0.099 0.053 1000 -1000 -0.013 -1000
Signaling events mediated by HDAC Class I 0.0076 4 459 104 -0.21 0.082 1000 -1000 -0.034 -1000
Atypical NF-kappaB pathway 0.0076 4 141 31 -0.02 0.049 1000 -1000 -0.005 -1000
IL2 signaling events mediated by STAT5 0.0076 4 103 22 -0.019 0.082 1000 -1000 -0.02 -1000
Aurora A signaling 0.0057 3 203 60 0 0.12 1000 -1000 -0.007 -1000
Arf6 downstream pathway 0.0057 3 140 43 -0.091 0.093 1000 -1000 -0.029 -1000
Effects of Botulinum toxin 0.0057 3 85 26 0 0.07 1000 -1000 -0.003 -1000
LPA4-mediated signaling events 0.0038 2 28 12 -0.01 0.036 1000 -1000 -0.018 -1000
Ephrin A reverse signaling 0.0019 1 7 7 0 0.044 1000 -1000 0 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0019 1 65 33 0 0.076 1000 -1000 -0.027 -1000
Rapid glucocorticoid signaling 0.0019 1 25 20 0 0.044 1000 -1000 -0.001 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0000 0 17 23 -0.007 0.066 1000 -1000 -0.013 -1000
BARD1 signaling events 0.0000 0 40 57 -0.075 0.12 1000 -1000 -0.038 -1000
a4b1 and a4b7 Integrin signaling 0.0000 0 0 5 0.034 0.054 1000 -1000 0.02 -1000
Glypican 2 network 0.0000 0 0 4 0 0.032 1000 -1000 0 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0000 0 22 27 0 0.078 1000 -1000 -0.03 -1000
Arf1 pathway 0.0000 0 52 54 -0.001 0.062 1000 -1000 -0.008 -1000
Alternative NF-kappaB pathway 0.0000 0 2 13 0 0.096 1000 -1000 0 -1000
Total NA 4355 263452 7203 -30 -990 131000 -131000 -3.1 -131000
Signaling mediated by p38-alpha and p38-beta

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.61 0.54 0.4 4 -1 306 310
MKNK1 0.034 0.006 -10000 0 -10000 0 0
MAPK14 -0.2 0.2 -10000 0 -0.35 306 306
ATF2/c-Jun -0.26 0.32 -10000 0 -0.69 142 142
MAPK11 -0.19 0.2 -10000 0 -0.36 286 286
MITF -0.24 0.23 -10000 0 -0.42 307 307
MAPKAPK5 -0.23 0.22 -10000 0 -0.41 308 308
KRT8 -0.22 0.22 -10000 0 -0.41 274 274
MAPKAPK3 0.034 0.012 -10000 0 -10000 0 0
MAPKAPK2 0.028 0.015 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.31 0.32 -10000 0 -0.54 309 309
CEBPB -0.22 0.23 0.3 1 -0.41 284 285
SLC9A1 -0.23 0.23 -10000 0 -0.42 303 303
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.24 0.24 -10000 0 -0.42 306 306
p38alpha-beta/MNK1 -0.25 0.28 -10000 0 -0.45 306 306
JUN -0.26 0.31 -10000 0 -0.68 142 142
PPARGC1A -0.28 0.29 0.28 1 -0.48 314 315
USF1 -0.21 0.22 0.33 4 -0.39 293 297
RAB5/GDP/GDI1 -0.17 0.18 -10000 0 -0.31 301 301
NOS2 -0.24 0.22 -10000 0 -0.41 308 308
DDIT3 -0.23 0.22 -10000 0 -0.41 304 304
RAB5A 0.034 0.005 -10000 0 -10000 0 0
HSPB1 -0.19 0.18 -10000 0 -0.34 269 269
p38alpha-beta/HBP1 -0.25 0.28 -10000 0 -0.45 304 304
CREB1 -0.25 0.24 -10000 0 -0.43 305 305
RAB5/GDP 0.025 0.004 -10000 0 -10000 0 0
EIF4E -0.23 0.24 -10000 0 -0.41 292 292
RPS6KA4 -0.23 0.23 -10000 0 -0.41 304 304
PLA2G4A -0.36 0.27 -10000 0 -0.52 356 356
GDI1 -0.23 0.22 -10000 0 -0.4 308 308
TP53 -0.31 0.29 -10000 0 -0.54 297 297
RPS6KA5 -0.25 0.23 -10000 0 -0.42 315 315
ESR1 -0.29 0.27 0.32 1 -0.43 354 355
HBP1 0.034 0.005 -10000 0 -10000 0 0
MEF2C -0.26 0.26 -10000 0 -0.44 313 313
MEF2A -0.23 0.23 0.3 1 -0.41 303 304
EIF4EBP1 -0.25 0.25 -10000 0 -0.44 300 300
KRT19 -0.21 0.23 0.33 1 -0.39 298 299
ELK4 -0.21 0.22 0.33 2 -0.39 288 290
ATF6 -0.21 0.22 0.33 4 -0.39 294 298
ATF1 -0.25 0.24 -10000 0 -0.43 307 307
p38alpha-beta/MAPKAPK2 -0.22 0.24 -10000 0 -0.42 288 288
p38alpha-beta/MAPKAPK3 -0.25 0.28 -10000 0 -0.45 305 305
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.3 0.16 -10000 0 -0.38 384 384
CRKL -0.32 0.17 -10000 0 -0.4 395 395
HRAS -0.23 0.15 -10000 0 -0.35 215 215
mol:PIP3 -0.28 0.17 -10000 0 -0.39 297 297
SPRED1 0.031 0.037 -10000 0 -0.54 2 2
SPRED2 0.034 0.005 -10000 0 -10000 0 0
GAB1 -0.33 0.18 -10000 0 -0.42 402 402
FOXO3 -0.27 0.16 -10000 0 -0.38 283 283
AKT1 -0.3 0.18 -10000 0 -0.39 360 360
BAD -0.28 0.16 -10000 0 -0.37 325 325
megakaryocyte differentiation -0.32 0.17 -10000 0 -0.41 403 403
GSK3B -0.28 0.16 -10000 0 -0.37 330 330
RAF1 -0.19 0.13 -10000 0 -0.32 53 53
SHC1 0.028 0.014 -10000 0 -10000 0 0
STAT3 -0.33 0.18 -10000 0 -0.42 401 401
STAT1 -0.81 0.43 -10000 0 -0.99 421 421
HRAS/SPRED1 -0.19 0.14 -10000 0 -0.33 55 55
cell proliferation -0.33 0.17 -10000 0 -0.41 404 404
PIK3CA 0.032 0.008 -10000 0 -10000 0 0
TEC 0.034 0.005 -10000 0 -10000 0 0
RPS6KB1 -0.32 0.18 -10000 0 -0.4 401 401
HRAS/SPRED2 -0.19 0.14 -10000 0 -0.32 54 54
LYN/TEC/p62DOK -0.29 0.18 -10000 0 -0.4 333 333
MAPK3 -0.13 0.097 -10000 0 -0.28 13 13
STAP1 -0.32 0.18 -10000 0 -0.41 401 401
GRAP2 0.035 0.019 -10000 0 -10000 0 0
JAK2 -0.68 0.37 -10000 0 -0.85 408 408
STAT1 (dimer) -0.8 0.42 -10000 0 -0.97 422 422
mol:Gleevec 0.013 0.007 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.29 0.19 -10000 0 -0.4 320 320
actin filament polymerization -0.33 0.17 -10000 0 -0.41 406 406
LYN 0.03 0.015 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.47 0.26 -10000 0 -0.58 410 410
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CBL/CRKL/GRB2 -0.28 0.17 -10000 0 -0.38 348 348
PI3K -0.32 0.2 -10000 0 -0.42 373 373
PTEN 0.03 0.045 -10000 0 -0.54 3 3
SCF/KIT/EPO/EPOR -0.95 0.51 -10000 0 -1.2 403 403
MAPK8 -0.33 0.18 -10000 0 -0.42 404 404
STAT3 (dimer) -0.33 0.17 -10000 0 -0.41 401 401
positive regulation of transcription -0.11 0.083 -10000 0 -0.24 9 9
mol:GDP -0.24 0.16 -10000 0 -0.36 219 219
PIK3C2B -0.31 0.18 -10000 0 -0.42 329 329
CBL/CRKL -0.3 0.16 -10000 0 -0.38 388 388
FER -0.33 0.18 -10000 0 -0.42 402 402
SH2B3 -0.34 0.18 -10000 0 -0.42 403 403
PDPK1 -0.25 0.17 -10000 0 -0.37 258 258
SNAI2 -0.34 0.2 -10000 0 -0.45 363 363
positive regulation of cell proliferation -0.59 0.3 -10000 0 -0.72 417 417
KITLG -0.011 0.07 -10000 0 -0.56 2 2
cell motility -0.59 0.3 -10000 0 -0.72 417 417
PTPN6 0.05 0.021 0.2 4 -10000 0 4
EPOR -0.23 0.19 -10000 0 -1.1 12 12
STAT5A (dimer) -0.48 0.26 -10000 0 -0.6 410 410
SOCS1 0.032 0.012 -10000 0 -10000 0 0
cell migration 0.32 0.17 0.41 400 -10000 0 400
SOS1 0.034 0.004 -10000 0 -10000 0 0
EPO 0.01 0.065 -10000 0 -10000 0 0
VAV1 0.038 0.025 -10000 0 -10000 0 0
GRB10 -0.34 0.18 -10000 0 -0.42 402 402
PTPN11 0.047 0.009 -10000 0 -10000 0 0
SCF/KIT -0.35 0.19 -10000 0 -0.44 406 406
GO:0007205 0.018 0.009 -10000 0 -10000 0 0
MAP2K1 -0.15 0.11 -10000 0 -0.28 20 20
CBL 0.031 0.011 -10000 0 -10000 0 0
KIT -1 0.53 -10000 0 -1.3 403 403
MAP2K2 -0.15 0.11 -10000 0 -0.28 18 18
SHC/Grb2/SOS1 -0.28 0.18 -10000 0 -0.4 293 293
STAT5A -0.5 0.26 -10000 0 -0.61 410 410
GRB2 0.034 0.018 -10000 0 -10000 0 0
response to radiation -0.34 0.2 0.28 2 -0.44 364 366
SHC/GRAP2 0.04 0.026 -10000 0 -10000 0 0
PTPRO -0.33 0.18 -10000 0 -0.42 403 403
SH2B2 -0.33 0.18 -10000 0 -0.42 406 406
DOK1 0.036 0.016 -10000 0 -10000 0 0
MATK -0.33 0.18 -10000 0 -0.42 400 400
CREBBP -0.08 0.072 -10000 0 -0.18 61 61
BCL2 -0.43 0.51 -10000 0 -1.4 110 110
EGFR-dependent Endothelin signaling events

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.034 0.013 -9999 0 -10000 0 0
EGFR -0.27 0.29 -9999 0 -0.54 269 269
EGF/EGFR -0.3 0.26 -9999 0 -0.43 365 365
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.19 0.21 -9999 0 -0.36 268 268
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA 0.032 0.038 -9999 0 -0.54 2 2
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.15 0.27 -9999 0 -0.54 163 163
EGF/EGFR dimer/SHC -0.23 0.23 -9999 0 -0.41 289 289
mol:GDP -0.19 0.21 -9999 0 -0.36 268 268
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 -0.14 0.26 -9999 0 -0.54 153 153
GRB2/SOS1 0.048 0.019 -9999 0 -10000 0 0
HRAS/GTP -0.18 0.19 -9999 0 -0.34 264 264
SHC1 0.028 0.014 -9999 0 -10000 0 0
HRAS/GDP -0.18 0.2 -9999 0 -0.35 264 264
FRAP1 -0.2 0.17 -9999 0 -0.35 267 267
EGF/EGFR dimer -0.31 0.26 -9999 0 -0.46 356 356
SOS1 0.034 0.004 -9999 0 -10000 0 0
GRB2 0.034 0.018 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 -0.088 0.2 -9999 0 -0.4 154 154
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.047 0.03 -10000 0 -10000 0 0
NFATC2 -0.083 0.23 0.47 4 -0.56 52 56
NFATC3 -0.15 0.17 0.31 1 -0.32 229 230
CD40LG -0.67 0.53 0.78 4 -1 325 329
ITCH -0.064 0.14 -10000 0 -0.25 179 179
CBLB -0.067 0.14 -10000 0 -0.86 1 1
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.24 0.31 0.78 6 -0.72 63 69
JUNB 0.031 0.044 -10000 0 -0.54 3 3
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.077 0.17 -10000 0 -0.3 190 190
T cell anergy -0.13 0.21 0.33 1 -0.39 184 185
TLE4 -0.066 0.2 -10000 0 -0.61 35 35
Jun/NFAT1-c-4/p21SNFT -0.58 0.55 0.71 4 -0.97 308 312
AP-1/NFAT1-c-4 -0.8 0.68 0.92 5 -1.2 321 326
IKZF1 -0.045 0.17 0.46 10 -0.48 24 34
T-helper 2 cell differentiation -0.12 0.28 0.52 1 -0.78 46 47
AP-1/NFAT1 -0.3 0.3 0.53 6 -0.51 292 298
CALM1 -0.036 0.11 -10000 0 -0.31 1 1
EGR2 -0.8 0.77 0.69 4 -1.5 260 264
EGR3 -0.88 0.76 0.75 2 -1.4 318 320
NFAT1/FOXP3 -0.031 0.18 0.45 10 -0.42 42 52
EGR1 -0.43 0.23 -10000 0 -0.54 415 415
JUN -0.067 0.22 0.26 1 -0.54 89 90
EGR4 0.001 0.003 -10000 0 -10000 0 0
mol:Ca2+ -0.055 0.089 -10000 0 -0.17 186 186
GBP3 -0.079 0.24 0.44 1 -0.78 39 40
FOSL1 0.034 0.011 -10000 0 -10000 0 0
NFAT1-c-4/MAF/IRF4 -0.54 0.53 0.67 3 -0.94 288 291
DGKA -0.052 0.16 0.46 1 -0.46 27 28
CREM 0.033 0.008 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.75 0.55 -10000 0 -1.1 341 341
CTLA4 -0.023 0.16 0.42 15 -0.41 22 37
NFAT1-c-4 (dimer)/EGR1 -0.77 0.57 -10000 0 -1.1 350 350
NFAT1-c-4 (dimer)/EGR4 -0.56 0.52 0.67 1 -0.94 308 309
FOS -0.35 0.27 0.25 1 -0.54 344 345
IFNG -0.097 0.3 0.53 10 -0.76 50 60
T cell activation -0.38 0.34 0.68 3 -0.76 150 153
MAF -0.007 0.14 -10000 0 -0.54 33 33
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.45 0.41 0.8 241 -0.7 2 243
TNF -0.67 0.48 -10000 0 -0.98 340 340
FASLG -0.88 0.79 0.81 4 -1.4 329 333
TBX21 0.029 0.15 0.29 12 -0.54 30 42
BATF3 0 0.001 -10000 0 -10000 0 0
PRKCQ 0.043 0.036 0.25 2 -10000 0 2
PTPN1 -0.048 0.16 -10000 0 -0.48 22 22
NFAT1-c-4/ICER1 -0.55 0.53 0.61 1 -0.94 300 301
GATA3 0.036 0.16 -10000 0 -0.54 33 33
T-helper 1 cell differentiation -0.095 0.3 0.54 9 -0.73 53 62
IL2RA -0.25 0.31 0.74 6 -0.69 73 79
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.051 0.16 -10000 0 -0.46 27 27
E2F1 0.057 0.049 0.24 2 -10000 0 2
PPARG -0.38 0.26 -10000 0 -0.54 367 367
SLC3A2 -0.05 0.16 -10000 0 -0.46 28 28
IRF4 0.039 0.028 -10000 0 -10000 0 0
PTGS2 -0.77 0.57 0.73 4 -1.1 336 340
CSF2 -0.67 0.53 0.78 4 -1 320 324
JunB/Fra1/NFAT1-c-4 -0.53 0.52 0.6 2 -0.91 302 304
IL4 -0.12 0.3 0.52 1 -0.82 46 47
IL5 -0.68 0.52 0.73 4 -1 322 326
IL2 -0.39 0.35 0.68 3 -0.78 145 148
IL3 -0.088 0.16 -10000 0 -0.9 14 14
RNF128 -0.21 0.33 -10000 0 -0.63 191 191
NFATC1 -0.45 0.41 0.7 2 -0.8 239 241
CDK4 0.28 0.28 0.56 131 -0.63 2 133
PTPRK -0.085 0.24 -10000 0 -0.72 48 48
IL8 -0.66 0.53 0.73 5 -1 313 318
POU2F1 0.034 0.015 -10000 0 -10000 0 0
Endothelins

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.1 0.17 -10000 0 -0.35 138 138
PTK2B 0.027 0.014 -10000 0 -10000 0 0
mol:Ca2+ -0.17 0.29 -10000 0 -0.72 79 79
EDN1 -0.16 0.25 -10000 0 -0.54 153 153
EDN3 -0.39 0.25 -10000 0 -0.54 376 376
EDN2 0.098 0.078 -10000 0 -0.54 1 1
HRAS/GDP -0.25 0.24 -10000 0 -0.46 233 233
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.13 0.18 -10000 0 -0.39 118 118
ADCY4 -0.083 0.15 0.34 1 -0.32 96 97
ADCY5 -0.081 0.15 -10000 0 -0.3 137 137
ADCY6 -0.081 0.15 0.34 1 -0.3 131 132
ADCY7 -0.077 0.15 0.34 1 -0.3 130 131
ADCY1 -0.08 0.15 -10000 0 -0.3 129 129
ADCY2 -0.082 0.16 0.34 1 -0.31 119 120
ADCY3 -0.082 0.15 -10000 0 -0.3 142 142
ADCY8 -0.068 0.13 -10000 0 -0.3 103 103
ADCY9 -0.075 0.14 -10000 0 -0.3 116 116
arachidonic acid secretion -0.52 0.34 -10000 0 -0.7 372 372
ETB receptor/Endothelin-1/Gq/GTP -0.21 0.21 -10000 0 -0.38 252 252
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.032 0.013 -10000 0 -10000 0 0
ETA receptor/Endothelin-1/G12/GTP -0.092 0.16 -10000 0 -0.32 141 141
ETA receptor/Endothelin-1/Gs/GTP -0.088 0.15 -10000 0 -0.31 143 143
mol:GTP -0.007 0.008 -10000 0 -10000 0 0
COL3A1 -0.1 0.17 -10000 0 -0.35 109 109
EDNRB -0.21 0.28 -10000 0 -0.54 224 224
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.099 0.17 -10000 0 -0.37 40 40
CYSLTR1 -0.1 0.18 0.38 2 -0.36 120 122
SLC9A1 -0.068 0.12 -10000 0 -0.38 20 20
mol:GDP -0.27 0.25 -10000 0 -0.48 243 243
SLC9A3 -0.39 0.39 -10000 0 -0.73 240 240
RAF1 -0.35 0.27 -10000 0 -0.51 331 331
JUN -0.25 0.43 -10000 0 -1 111 111
JAK2 -0.099 0.17 -10000 0 -0.35 139 139
mol:IP3 -0.21 0.22 -10000 0 -0.44 187 187
ETA receptor/Endothelin-1 -0.12 0.2 -10000 0 -0.41 143 143
PLCB1 -0.048 0.2 -10000 0 -0.55 70 70
PLCB2 0.024 0.014 -10000 0 -10000 0 0
ETA receptor/Endothelin-3 -0.29 0.19 -10000 0 -0.4 375 375
FOS -0.68 0.43 -10000 0 -0.96 365 365
Gai/GDP -0.19 0.35 -10000 0 -0.95 81 81
CRK 0.031 0.01 -10000 0 -10000 0 0
mol:Ca ++ -0.26 0.26 -10000 0 -0.56 186 186
BCAR1 0.03 0.013 -10000 0 -10000 0 0
PRKCB1 -0.21 0.21 -10000 0 -0.42 198 198
GNAQ -0.008 0.009 -10000 0 -10000 0 0
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNAL 0.03 0.044 -10000 0 -0.54 3 3
Gs family/GDP -0.24 0.23 -10000 0 -0.45 226 226
ETA receptor/Endothelin-1/Gq/GTP -0.097 0.15 -10000 0 -0.37 71 71
MAPK14 -0.22 0.22 -10000 0 -0.42 234 234
TRPC6 -0.18 0.31 -10000 0 -0.77 79 79
GNAI2 0.033 0.01 -10000 0 -10000 0 0
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.23 0.23 -10000 0 -0.42 259 259
ETB receptor/Endothelin-2 -0.11 0.22 -10000 0 -0.34 221 221
ETB receptor/Endothelin-3 -0.42 0.27 -10000 0 -0.55 394 394
ETB receptor/Endothelin-1 -0.26 0.28 -10000 0 -0.48 296 296
MAPK3 -0.61 0.39 -10000 0 -0.84 369 369
MAPK1 -0.62 0.41 -10000 0 -0.86 369 369
Rac1/GDP -0.25 0.24 -10000 0 -0.46 228 228
cAMP biosynthetic process -0.031 0.15 0.41 3 -0.37 21 24
MAPK8 -0.18 0.3 -10000 0 -0.66 114 114
SRC 0.033 0.008 -10000 0 -10000 0 0
ETB receptor/Endothelin-1/Gi/GTP -0.28 0.29 -10000 0 -0.56 221 221
p130Cas/CRK/Src/PYK2 -0.27 0.29 -10000 0 -0.57 199 199
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.25 0.23 -10000 0 -0.47 217 217
COL1A2 -0.23 0.27 0.42 1 -0.55 144 145
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 0.072 0.077 0.27 1 -0.4 3 4
mol:DAG -0.21 0.22 -10000 0 -0.44 188 188
MAP2K2 -0.47 0.32 -10000 0 -0.64 371 371
MAP2K1 -0.47 0.32 0.36 1 -0.64 371 372
EDNRA 0.006 0.057 -10000 0 -0.55 2 2
positive regulation of muscle contraction -0.091 0.14 -10000 0 -0.31 129 129
Gq family/GDP -0.21 0.22 -10000 0 -0.45 177 177
HRAS/GTP -0.27 0.24 -10000 0 -0.45 259 259
PRKCH -0.21 0.21 -10000 0 -0.44 181 181
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA -0.2 0.21 -10000 0 -0.44 173 173
PRKCB -0.21 0.21 -10000 0 -0.42 200 200
PRKCE -0.21 0.21 -10000 0 -0.44 185 185
PRKCD -0.21 0.21 -10000 0 -0.44 184 184
PRKCG -0.21 0.21 0.3 1 -0.44 182 183
regulation of vascular smooth muscle contraction -0.81 0.51 -10000 0 -1.1 365 365
PRKCQ -0.2 0.21 -10000 0 -0.44 174 174
PLA2G4A -0.59 0.4 -10000 0 -0.79 374 374
GNA14 0.027 0.073 -10000 0 -0.55 4 4
GNA15 0.021 0.031 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA11 0.019 0.024 -10000 0 -10000 0 0
Rac1/GTP -0.092 0.16 -10000 0 -0.32 141 141
MMP1 0.17 0.15 0.41 81 -10000 0 81
Class IB PI3K non-lipid kinase events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process 0.11 0.25 0.54 126 -10000 0 126
PI3K Class IB/PDE3B -0.11 0.25 -10000 0 -0.54 126 126
PDE3B -0.11 0.25 -10000 0 -0.54 126 126
IGF1 pathway

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.035 0.008 -10000 0 -10000 0 0
PTK2 0.027 0.014 -10000 0 -10000 0 0
CRKL -0.16 0.2 -10000 0 -0.34 256 256
GRB2/SOS1/SHC 0.053 0.034 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
IRS1/Crk -0.16 0.21 -10000 0 -0.34 259 259
IGF-1R heterotetramer/IGF1/PTP1B -0.13 0.21 -10000 0 -0.36 223 223
AKT1 -0.16 0.19 0.23 1 -0.47 96 97
BAD -0.15 0.18 0.22 1 -0.45 91 92
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.17 0.2 -10000 0 -0.34 259 259
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.16 0.21 -10000 0 -0.34 258 258
RAF1 -0.12 0.18 0.32 1 -0.45 75 76
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos -0.12 0.22 -10000 0 -0.34 227 227
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.17 0.23 -10000 0 -0.36 261 261
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
RPS6KB1 -0.15 0.18 0.23 1 -0.45 93 94
GNB2L1 0.034 0.005 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade -0.099 0.15 0.29 1 -0.39 65 66
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
HRAS/GTP -0.11 0.18 -10000 0 -0.32 170 170
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc -0.07 0.18 -10000 0 -0.3 162 162
IGF-1R heterotetramer -0.048 0.14 -10000 0 -0.64 21 21
IGF-1R heterotetramer/IGF1/IRS/Nck -0.15 0.22 -10000 0 -0.34 257 257
Crk/p130 Cas/Paxillin -0.13 0.21 -10000 0 -0.33 237 237
IGF1R -0.048 0.14 -10000 0 -0.64 21 21
IGF1 -0.26 0.3 -10000 0 -0.57 253 253
IRS2/Crk -0.22 0.26 -10000 0 -0.42 275 275
PI3K -0.15 0.24 -10000 0 -0.37 244 244
apoptosis 0.11 0.15 0.4 58 -0.31 1 59
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
PRKCD -0.18 0.23 -10000 0 -0.39 241 241
RAF1/14-3-3 E -0.096 0.17 0.31 1 -0.39 73 74
BAD/14-3-3 -0.1 0.17 0.32 1 -0.41 68 69
PRKCZ -0.16 0.19 0.22 1 -0.34 225 226
Crk/p130 Cas/Paxillin/FAK1 -0.1 0.17 -10000 0 -0.4 78 78
PTPN1 0.037 0.03 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.19 0.23 -10000 0 -0.41 250 250
BCAR1 0.029 0.013 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 -0.095 0.19 -10000 0 -0.33 184 184
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.034 0.004 -10000 0 -10000 0 0
IRS1/NCK2 -0.15 0.21 -10000 0 -0.34 257 257
GRB10 0.03 0.051 -10000 0 -0.54 4 4
PTPN11 -0.16 0.2 -10000 0 -0.34 258 258
IRS1 -0.18 0.22 -10000 0 -0.36 259 259
IRS2 -0.23 0.26 -10000 0 -0.43 280 280
IGF-1R heterotetramer/IGF1 -0.2 0.26 -10000 0 -0.45 249 249
GRB2 0.034 0.018 -10000 0 -10000 0 0
PDPK1 -0.16 0.21 -10000 0 -0.36 225 225
YWHAE 0.031 0.01 -10000 0 -10000 0 0
PRKD1 -0.22 0.28 -10000 0 -0.47 247 247
SHC1 0.028 0.014 -10000 0 -10000 0 0
FOXM1 transcription factor network

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 0.55 0.46 1.1 117 -0.95 3 120
PLK1 0.22 0.19 0.64 34 -10000 0 34
BIRC5 0.36 0.25 0.69 101 -0.66 3 104
HSPA1B 0.55 0.46 1.1 140 -0.96 3 143
MAP2K1 0.16 0.12 0.33 126 -10000 0 126
BRCA2 0.58 0.49 1.1 138 -0.95 3 141
FOXM1 0.59 0.6 1.3 142 -1.3 3 145
XRCC1 0.55 0.46 1.1 117 -0.95 3 120
FOXM1B/p19 0.074 0.29 0.93 7 -1 4 11
Cyclin D1/CDK4 0.47 0.46 1 107 -0.89 10 117
CDC2 0.6 0.51 1.2 144 -1 3 147
TGFA 0.43 0.52 1 122 -0.92 22 144
SKP2 0.56 0.47 1.1 122 -0.95 3 125
CCNE1 0.086 0.063 0.24 27 -10000 0 27
CKS1B 0.55 0.46 1.1 140 -0.96 3 143
RB1 0.26 0.34 0.72 123 -0.74 9 132
FOXM1C/SP1 0.49 0.45 0.99 102 -1 7 109
AURKB 0.2 0.31 0.64 65 -0.8 23 88
CENPF 0.67 0.52 1.2 161 -1.3 1 162
CDK4 0.09 0.059 0.23 17 -10000 0 17
MYC 0.3 0.44 0.94 85 -0.88 10 95
CHEK2 0.16 0.13 0.33 127 -10000 0 127
ONECUT1 0.49 0.48 1 127 -0.88 7 134
CDKN2A -0.014 0.077 -10000 0 -0.21 21 21
LAMA4 0.54 0.48 1.1 118 -0.98 6 124
FOXM1B/HNF6 0.49 0.5 1.1 111 -1 7 118
FOS -0.14 0.65 1.1 48 -0.99 87 135
SP1 0.032 0.032 -10000 0 -0.27 2 2
CDC25B 0.56 0.47 1.1 117 -0.95 3 120
response to radiation 0.11 0.092 0.24 109 -10000 0 109
CENPB 0.55 0.46 1.1 119 -0.95 3 122
CENPA 0.62 0.5 1.2 150 -0.95 3 153
NEK2 0.68 0.52 1.2 161 -1.2 1 162
HIST1H2BA 0.55 0.46 1.1 108 -1.1 2 110
CCNA2 0.11 0.077 0.23 75 -10000 0 75
EP300 0.033 0.009 -10000 0 -10000 0 0
CCNB1/CDK1 0.58 0.52 1.2 125 -1.1 3 128
CCNB2 0.61 0.5 1.2 145 -1.1 2 147
CCNB1 0.62 0.53 1.2 140 -1 3 143
ETV5 0.52 0.52 1.1 110 -1.2 10 120
ESR1 0.37 0.61 1.1 108 -0.96 18 126
CCND1 0.48 0.51 1.1 135 -0.91 10 145
GSK3A 0.14 0.1 0.3 74 -10000 0 74
Cyclin A-E1/CDK1-2 0.2 0.13 0.38 125 -10000 0 125
CDK2 0.069 0.036 0.24 5 -10000 0 5
G2/M transition of mitotic cell cycle 0.14 0.11 0.28 150 -10000 0 150
FOXM1B/Cbp/p300 0.32 0.38 0.87 27 -1 3 30
GAS1 0.26 0.71 1.1 104 -1 63 167
MMP2 0.54 0.48 1.1 110 -1.2 6 116
RB1/FOXM1C 0.44 0.46 0.98 123 -0.92 9 132
CREBBP 0.032 0.01 -10000 0 -10000 0 0
Arf6 signaling events

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.018 0.018 -10000 0 -0.34 1 1
ARNO/beta Arrestin1-2 -0.11 0.14 -10000 0 -0.26 245 245
EGFR -0.27 0.29 -10000 0 -0.54 269 269
EPHA2 0.026 0.062 -10000 0 -0.54 6 6
USP6 0.033 0.018 -10000 0 -10000 0 0
IQSEC1 0.033 0.006 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF -0.31 0.26 -10000 0 -0.46 356 356
ARRB2 0.016 0.029 -10000 0 -0.33 3 3
mol:GTP 0.012 0.028 0.12 23 -10000 0 23
ARRB1 0.03 0.028 -10000 0 -0.54 1 1
FBXO8 0.033 0.007 -10000 0 -10000 0 0
TSHR 0.03 0.045 -10000 0 -0.54 3 3
EGF -0.15 0.27 -10000 0 -0.54 163 163
somatostatin receptor activity 0 0 -10000 0 -0.001 214 214
ARAP2 0 0 -10000 0 0 216 216
mol:GDP -0.14 0.14 -10000 0 -0.28 185 185
mol:PI-3-4-5-P3 0 0 -10000 0 -0.001 213 213
ITGA2B 0.034 0.012 -10000 0 -10000 0 0
ARF6 0.034 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.058 0.059 -10000 0 -0.32 6 6
ADAP1 0 0 -10000 0 0 133 133
KIF13B 0.027 0.029 -10000 0 -0.54 1 1
HGF/MET 0.006 0.13 -10000 0 -0.4 51 51
PXN 0.034 0.004 -10000 0 -10000 0 0
ARF6/GTP -0.14 0.12 -10000 0 -0.26 212 212
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.26 0.24 -10000 0 -0.41 347 347
ADRB2 -0.26 0.29 -10000 0 -0.54 264 264
receptor agonist activity 0 0 -10000 0 0 200 200
actin filament binding 0 0 -10000 0 0 234 234
SRC 0.033 0.008 -10000 0 -10000 0 0
ITGB3 0.035 0.019 -10000 0 -10000 0 0
GNAQ 0 0 -10000 0 -0.001 146 146
EFA6/PI-4-5-P2 0 0 -10000 0 -0.001 141 141
ARF6/GDP -0.03 0.084 -10000 0 -0.29 21 21
ARF6/GDP/GULP/ACAP1 -0.16 0.18 -10000 0 -0.36 182 182
alphaIIb/beta3 Integrin/paxillin/GIT1 0.082 0.031 -10000 0 -10000 0 0
ACAP1 0 0 -10000 0 -10000 0 0
ACAP2 0 0 -10000 0 0 235 235
LHCGR/beta Arrestin2 0.022 0.048 -10000 0 -0.46 3 3
EFNA1 0.028 0.015 -10000 0 -10000 0 0
HGF 0.035 0.01 -10000 0 -10000 0 0
CYTH3 0 0 -10000 0 -0.001 204 204
CYTH2 -0.002 0.002 -10000 0 -0.004 223 223
NCK1 0.034 0.005 -10000 0 -10000 0 0
fibronectin binding 0 0 -10000 0 0 131 131
endosomal lumen acidification 0 0 0 6 0 148 154
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 -0.071 0.22 -10000 0 -0.54 94 94
GNAQ/ARNO -0.003 0.003 -10000 0 -0.007 139 139
mol:Phosphatidic acid 0 0 -10000 0 0 235 235
PIP3-E 0 0 -10000 0 0 290 290
MET -0.022 0.17 -10000 0 -0.54 50 50
GNA14 0.043 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GIT1 0.032 0.011 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -0.001 172 172
GNA11 0.033 0.006 -10000 0 -10000 0 0
LHCGR 0.032 0.046 -10000 0 -0.54 3 3
AGTR1 -0.18 0.3 -10000 0 -0.54 208 208
desensitization of G-protein coupled receptor protein signaling pathway 0.022 0.048 -10000 0 -0.46 3 3
IPCEF1/ARNO -0.21 0.18 -10000 0 -0.32 355 355
alphaIIb/beta3 Integrin 0.05 0.018 -10000 0 -10000 0 0
Nongenotropic Androgen signaling

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.006 0.005 -10000 0 -10000 0 0
GNB1/GNG2 0.011 0.13 -10000 0 -0.32 66 66
regulation of S phase of mitotic cell cycle -0.045 0.13 -10000 0 -0.3 92 92
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.032 0.013 -10000 0 -10000 0 0
SHBG/T-DHT 0.021 0.008 -10000 0 -10000 0 0
PELP1 0.029 0.01 -10000 0 -10000 0 0
AKT1 0.011 0.014 0.14 6 -10000 0 6
MAP2K1 -0.11 0.11 -10000 0 -0.36 61 61
T-DHT/AR -0.032 0.14 -10000 0 -0.4 67 67
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.005 0.003 -10000 0 -0.007 363 363
GNAI2 0.033 0.01 -10000 0 -10000 0 0
GNAI3 0.033 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
mol:GDP -0.079 0.16 -10000 0 -0.4 90 90
cell proliferation -0.29 0.21 -10000 0 -0.43 323 323
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
FOS -0.57 0.37 -10000 0 -0.8 365 365
mol:Ca2+ -0.037 0.037 -10000 0 -0.075 231 231
MAPK3 -0.2 0.16 -10000 0 -0.36 167 167
MAPK1 -0.16 0.16 -10000 0 -0.4 80 80
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 -0.003 0.002 -10000 0 -0.004 342 342
cAMP biosynthetic process 0.017 0.027 -10000 0 -10000 0 0
GNG2 0.033 0.026 -10000 0 -0.54 1 1
potassium channel inhibitor activity -0.003 0.002 -10000 0 -0.004 342 342
HRAS/GTP -0.058 0.12 -10000 0 -0.33 64 64
actin cytoskeleton reorganization 0.016 0.094 -10000 0 -0.28 43 43
SRC 0.031 0.008 -10000 0 -10000 0 0
voltage-gated calcium channel activity -0.003 0.002 -10000 0 -0.004 342 342
PI3K 0.007 0.11 -10000 0 -0.34 44 44
apoptosis 0.3 0.22 0.43 351 -10000 0 351
T-DHT/AR/PELP1 -0.014 0.13 -10000 0 -0.35 66 66
HRAS/GDP -0.069 0.17 -10000 0 -0.46 66 66
CREB1 -0.32 0.23 -10000 0 -0.46 350 350
RAC1-CDC42/GTP 0.025 0.1 -10000 0 -0.29 43 43
AR -0.042 0.2 -10000 0 -0.55 66 66
GNB1 0.034 0.011 -10000 0 -10000 0 0
RAF1 -0.085 0.11 -10000 0 -0.34 61 61
RAC1-CDC42/GDP -0.032 0.17 -10000 0 -0.44 66 66
T-DHT/AR/PELP1/Src -0.005 0.13 -10000 0 -0.33 65 65
MAP2K2 -0.11 0.11 -10000 0 -0.36 61 61
T-DHT/AR/PELP1/Src/PI3K -0.046 0.13 -10000 0 -0.3 92 92
GNAZ 0.025 0.062 -10000 0 -0.54 6 6
SHBG 0.031 0.011 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.11 0.19 -10000 0 -0.48 74 74
mol:T-DHT -0.001 0.002 -10000 0 -0.004 88 88
RAC1 0.034 0.005 -10000 0 -10000 0 0
GNRH1 -0.001 0.056 0.14 1 -0.4 10 11
Gi family/GTP -0.1 0.14 -10000 0 -0.26 185 185
CDC42 0.033 0.008 -10000 0 -10000 0 0
Glucocorticoid receptor regulatory network

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.11 0.11 0.52 5 -10000 0 5
SMARCC2 0.034 0.004 -10000 0 -10000 0 0
SMARCC1 0.035 0.02 -10000 0 -10000 0 0
TBX21 -0.12 0.22 0.41 1 -0.84 31 32
SUMO2 0.002 0.025 -10000 0 -10000 0 0
STAT1 (dimer) 0.072 0.069 0.28 25 -10000 0 25
FKBP4 0.037 0.026 -10000 0 -10000 0 0
FKBP5 0.025 0.082 -10000 0 -0.54 10 10
GR alpha/HSP90/FKBP51/HSP90 0.13 0.14 0.33 40 -0.36 4 44
PRL -0.06 0.11 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/TIF2 0.21 0.26 0.53 172 -10000 0 172
RELA -0.092 0.11 0.27 3 -0.25 38 41
FGG 0.24 0.23 0.47 183 -10000 0 183
GR beta/TIF2 0.11 0.14 0.32 72 -0.35 3 75
IFNG -0.39 0.34 0.47 4 -0.68 244 248
apoptosis -0.25 0.18 -10000 0 -0.57 32 32
CREB1 0.058 0.041 -10000 0 -10000 0 0
histone acetylation 0.035 0.14 0.41 33 -0.33 8 41
BGLAP -0.095 0.14 -10000 0 -0.69 1 1
GR/PKAc 0.15 0.14 0.35 42 -0.31 3 45
NF kappa B1 p50/RelA -0.16 0.19 0.47 3 -0.34 135 138
SMARCD1 0.034 0.004 -10000 0 -10000 0 0
MDM2 0.12 0.1 0.23 153 -10000 0 153
GATA3 0.043 0.16 -10000 0 -0.54 33 33
AKT1 0.028 0.024 -10000 0 -10000 0 0
CSF2 -0.008 0.11 -10000 0 -10000 0 0
GSK3B 0.002 0.027 -10000 0 -10000 0 0
NR1I3 -0.19 0.16 -10000 0 -0.56 8 8
CSN2 0.19 0.19 0.38 197 -10000 0 197
BRG1/BAF155/BAF170/BAF60A 0.084 0.028 -10000 0 -10000 0 0
NFATC1 0.038 0.038 -10000 0 -0.54 2 2
POU2F1 0.034 0.015 -10000 0 -10000 0 0
CDKN1A 0.022 0.12 -10000 0 -1.4 2 2
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.011 0.006 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.14 0.14 0.35 27 -0.36 3 30
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.66 0.33 -10000 0 -0.8 426 426
JUN -0.21 0.24 0.38 2 -0.5 144 146
IL4 -0.12 0.15 -10000 0 -0.51 10 10
CDK5R1 0.028 0.014 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.35 0.24 -10000 0 -0.5 327 327
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.15 0.14 0.36 29 -0.4 2 31
cortisol/GR alpha (monomer) 0.29 0.31 0.59 214 -10000 0 214
NCOA2 0.029 0.015 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.42 0.26 -10000 0 -0.57 361 361
AP-1/NFAT1-c-4 -0.58 0.41 -10000 0 -0.83 341 341
AFP -0.18 0.2 -10000 0 -0.65 11 11
SUV420H1 0.032 0.01 -10000 0 -10000 0 0
IRF1 0.21 0.18 0.5 50 -10000 0 50
TP53 0.046 0.034 -10000 0 -0.51 1 1
PPP5C 0.036 0.017 -10000 0 -10000 0 0
KRT17 -0.9 0.65 -10000 0 -1.4 323 323
KRT14 -0.83 0.63 -10000 0 -1.3 325 325
TBP 0.039 0.012 -10000 0 -10000 0 0
CREBBP 0.18 0.14 0.3 278 -10000 0 278
HDAC1 0.029 0.012 -10000 0 -10000 0 0
HDAC2 0.029 0.022 -10000 0 -10000 0 0
AP-1 -0.58 0.41 -10000 0 -0.83 341 341
MAPK14 0.014 0.021 -10000 0 -10000 0 0
MAPK10 -0.009 0.082 -10000 0 -0.55 10 10
MAPK11 0 0.025 -10000 0 -10000 0 0
KRT5 -0.95 0.63 -10000 0 -1.4 354 354
interleukin-1 receptor activity -0.003 0.006 -10000 0 -10000 0 0
NCOA1 0.037 0.027 -10000 0 -0.54 1 1
STAT1 0.072 0.069 0.28 25 -10000 0 25
CGA -0.085 0.16 -10000 0 -0.51 7 7
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.15 0.19 0.38 78 -0.39 1 79
MAPK3 0.002 0.024 -10000 0 -10000 0 0
MAPK1 0.013 0.021 -10000 0 -10000 0 0
ICAM1 -0.25 0.25 0.59 2 -0.52 158 160
NFKB1 -0.095 0.11 0.32 1 -0.25 32 33
MAPK8 -0.15 0.19 0.57 1 -0.37 138 139
MAPK9 0.014 0.022 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) -0.26 0.19 -10000 0 -0.6 32 32
BAX 0.028 0.076 -10000 0 -10000 0 0
POMC -0.14 0.19 -10000 0 -0.72 13 13
EP300 0.18 0.14 0.29 282 -10000 0 282
cortisol/GR alpha (dimer)/p53 0.23 0.26 0.53 178 -10000 0 178
proteasomal ubiquitin-dependent protein catabolic process 0.091 0.11 0.29 66 -10000 0 66
SGK1 0.23 0.17 0.36 300 -0.43 1 301
IL13 -0.29 0.25 0.49 1 -0.66 77 78
IL6 -0.75 0.48 0.61 1 -1 376 377
PRKACG 0.033 0.026 -10000 0 -0.54 1 1
IL5 -0.24 0.21 -10000 0 -0.67 27 27
IL2 -0.42 0.32 -10000 0 -0.7 238 238
CDK5 0.032 0.024 -10000 0 -10000 0 0
PRKACB 0.035 0.083 -10000 0 -0.54 8 8
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
IL8 -0.24 0.26 0.59 2 -0.6 77 79
CDK5R1/CDK5 0.038 0.022 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.094 0.18 0.43 3 -0.43 24 27
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.25 0.25 0.51 208 -10000 0 208
SMARCA4 0.035 0.012 -10000 0 -10000 0 0
chromatin remodeling 0.17 0.16 0.34 170 -10000 0 170
NF kappa B1 p50/RelA/Cbp -0.003 0.19 0.49 23 -0.34 6 29
JUN (dimer) -0.21 0.24 0.38 2 -0.5 144 146
YWHAH 0.033 0.014 -10000 0 -10000 0 0
VIPR1 -0.11 0.17 -10000 0 -0.53 29 29
NR3C1 0.19 0.2 0.4 164 -0.44 5 169
NR4A1 0.014 0.12 -10000 0 -0.55 24 24
TIF2/SUV420H1 0.039 0.023 -10000 0 -10000 0 0
MAPKKK cascade -0.25 0.18 -10000 0 -0.57 32 32
cortisol/GR alpha (dimer)/Src-1 0.27 0.26 0.52 219 -10000 0 219
PBX1 0.043 0.042 -10000 0 -10000 0 0
POU1F1 0.039 0.026 -10000 0 -0.54 1 1
SELE -0.26 0.35 0.59 2 -0.83 84 86
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.17 0.16 0.34 170 -10000 0 170
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.25 0.25 0.51 208 -10000 0 208
mol:cortisol 0.18 0.17 0.34 224 -10000 0 224
MMP1 -0.025 0.35 -10000 0 -0.95 52 52
S1P1 pathway

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.051 0.038 -10000 0 -10000 0 0
PDGFRB 0.03 0.007 -10000 0 -10000 0 0
SPHK1 -0.042 0.14 -10000 0 -0.9 11 11
mol:S1P -0.044 0.14 0.3 1 -0.82 11 12
S1P1/S1P/Gi -0.28 0.29 0.33 5 -0.49 309 314
GNAO1 0.003 0.028 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 -0.25 0.26 0.36 5 -0.45 293 298
PLCG1 -0.27 0.27 0.33 6 -0.46 301 307
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.03 0.007 -10000 0 -10000 0 0
GNAI2 0.004 0.03 -10000 0 -10000 0 0
GNAI3 0.006 0.029 -10000 0 -10000 0 0
GNAI1 -0.19 0.27 -10000 0 -0.56 183 183
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.004 0.04 -10000 0 -10000 0 0
S1P1/S1P -0.064 0.13 0.29 7 -0.66 11 18
negative regulation of cAMP metabolic process -0.28 0.28 0.33 5 -0.47 309 314
MAPK3 -0.37 0.35 0.34 9 -0.63 313 322
calcium-dependent phospholipase C activity -0.005 0.005 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
KDR 0.029 0.011 -10000 0 -10000 0 0
PLCB2 -0.054 0.12 0.33 4 -0.57 11 15
RAC1 0.034 0.005 -10000 0 -10000 0 0
RhoA/GTP -0.064 0.1 -10000 0 -0.54 11 11
receptor internalization -0.063 0.12 0.24 6 -0.6 11 17
PTGS2 -0.62 0.53 0.44 3 -1 314 317
Rac1/GTP -0.063 0.1 -10000 0 -0.54 11 11
RHOA 0.033 0.008 -10000 0 -10000 0 0
VEGFA 0.046 0.048 -10000 0 -10000 0 0
negative regulation of T cell proliferation -0.28 0.28 0.33 5 -0.47 309 314
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ -0.001 0.066 -10000 0 -0.56 6 6
MAPK1 -0.4 0.38 0.37 5 -0.67 318 323
S1P1/S1P/PDGFB-D/PDGFRB -0.079 0.14 0.34 8 -0.62 11 19
ABCC1 0.032 0.023 -10000 0 -10000 0 0
Signaling events mediated by PTP1B

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.005 -10000 0 -10000 0 0
Jak2/Leptin Receptor -0.24 0.21 -10000 0 -0.41 245 245
PTP1B/AKT1 -0.16 0.15 0.25 1 -0.32 159 160
FYN 0.03 0.037 -10000 0 -0.54 2 2
p210 bcr-abl/PTP1B -0.19 0.16 0.25 1 -0.32 247 248
EGFR -0.29 0.28 -10000 0 -0.56 269 269
EGF/EGFR -0.36 0.26 -10000 0 -0.51 354 354
CSF1 0.034 0.008 -10000 0 -10000 0 0
AKT1 0.035 0.017 -10000 0 -10000 0 0
INSR 0.034 0.006 -10000 0 -10000 0 0
PTP1B/N-cadherin -0.16 0.17 0.34 1 -0.32 194 195
Insulin Receptor/Insulin -0.11 0.14 -10000 0 -0.4 34 34
HCK 0.037 0.022 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
TYK2 -0.18 0.16 0.44 1 -0.32 215 216
EGF -0.18 0.26 -10000 0 -0.56 163 163
YES1 0.032 0.027 -10000 0 -0.54 1 1
CAV1 -0.37 0.23 -10000 0 -0.49 365 365
TXN 0.028 0.012 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 -0.2 0.18 -10000 0 -0.37 187 187
cell migration 0.19 0.16 0.32 247 -0.25 1 248
STAT3 0.032 0.007 -10000 0 -10000 0 0
PRLR 0.075 0.064 -10000 0 -10000 0 0
ITGA2B 0.032 0.011 -10000 0 -10000 0 0
CSF1R 0.034 0.005 -10000 0 -10000 0 0
Prolactin Receptor/Prolactin 0.082 0.049 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
PTP1B/p130 Cas -0.18 0.16 0.24 1 -0.32 221 222
Crk/p130 Cas -0.17 0.16 -10000 0 -0.33 163 163
DOK1 -0.15 0.15 0.27 1 -0.42 56 57
JAK2 -0.081 0.15 -10000 0 -0.52 33 33
Jak2/Leptin Receptor/Leptin -0.25 0.2 -10000 0 -0.44 224 224
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
PTPN1 -0.19 0.16 0.25 1 -0.32 250 251
LYN 0.03 0.015 -10000 0 -10000 0 0
CDH2 0.058 0.056 -10000 0 -10000 0 0
SRC -0.05 0.12 -10000 0 -0.66 14 14
ITGB3 0.033 0.018 -10000 0 -10000 0 0
CAT1/PTP1B -0.15 0.18 0.36 1 -0.45 82 83
CAPN1 0.031 0.015 -10000 0 -10000 0 0
CSK 0.034 0.011 -10000 0 -10000 0 0
PI3K -0.12 0.17 -10000 0 -0.44 55 55
mol:H2O2 -0.005 0.006 -10000 0 -10000 0 0
STAT3 (dimer) -0.22 0.19 -10000 0 -0.4 214 214
negative regulation of transcription -0.08 0.14 -10000 0 -0.52 33 33
FCGR2A 0.031 0.025 -10000 0 -10000 0 0
FER 0.027 0.008 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin 0.046 0.017 -10000 0 -10000 0 0
BLK 0.039 0.044 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.053 0.03 -10000 0 -10000 0 0
RHOA 0.03 0.007 -10000 0 -10000 0 0
LEPR -0.33 0.28 -10000 0 -0.54 321 321
BCAR1 0.029 0.013 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.034 0.018 -10000 0 -10000 0 0
mol:NADPH -0.006 0.004 -10000 0 -10000 0 0
TRPV6 -0.006 0.15 0.42 2 -0.41 38 40
PRL 0.037 0.009 -10000 0 -10000 0 0
SOCS3 0 0.25 -10000 0 -1.3 17 17
SPRY2 -0.32 0.28 -10000 0 -0.55 304 304
Insulin Receptor/Insulin/IRS1 0.015 0.13 -10000 0 -0.35 59 59
CSF1/CSF1R -0.17 0.16 -10000 0 -0.38 94 94
Ras protein signal transduction 0.088 0.18 0.67 36 -10000 0 36
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
INS 0.033 0.007 -10000 0 -10000 0 0
LEP -0.23 0.29 -10000 0 -0.55 237 237
STAT5B -0.14 0.16 0.24 1 -0.38 88 89
STAT5A -0.14 0.16 0.26 1 -0.37 92 93
GRB2 0.034 0.018 -10000 0 -10000 0 0
PDGFB-D/PDGFRB -0.18 0.16 0.24 1 -0.32 220 221
CSN2 0.079 0.06 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
LAT -0.036 0.081 -10000 0 -0.63 4 4
YBX1 0.044 0.028 -10000 0 -10000 0 0
LCK 0.049 0.044 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
NOX4 0.052 0.055 -10000 0 -10000 0 0
Calcium signaling in the CD4+ TCR pathway

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 0.008 0.057 0.26 9 -0.34 2 11
NFATC2 0.009 0.054 0.26 9 -0.34 1 10
NFATC3 0.012 0.052 0.26 9 -10000 0 9
CD40LG -0.22 0.29 0.6 15 -0.51 188 203
PTGS2 -0.32 0.36 0.57 15 -0.62 266 281
JUNB 0.031 0.044 -10000 0 -0.54 3 3
CaM/Ca2+/Calcineurin A alpha-beta B1 0.013 0.031 -10000 0 -10000 0 0
CaM/Ca2+ 0.013 0.031 -10000 0 -10000 0 0
CALM1 0.034 0.018 -10000 0 -10000 0 0
JUN -0.066 0.22 -10000 0 -0.54 89 89
mol:Ca2+ -0.003 0.012 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.024 0.012 0.12 2 -10000 0 2
FOSL1 0.034 0.011 -10000 0 -10000 0 0
CREM 0.033 0.007 -10000 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.033 0.17 0.45 15 -0.35 58 73
FOS -0.35 0.27 -10000 0 -0.54 344 344
IFNG -0.19 0.31 0.64 18 -0.51 185 203
AP-1/NFAT1-c-4 -0.25 0.34 0.71 11 -0.59 192 203
FASLG -0.19 0.29 0.64 17 -0.48 179 196
NFAT1-c-4/ICER1 0.015 0.097 0.4 9 -0.31 2 11
IL2RA -0.21 0.3 0.62 16 -0.51 183 199
FKBP12/FK506 0.025 0.008 0.13 2 -10000 0 2
CSF2 -0.22 0.3 0.61 16 -0.51 188 204
JunB/Fra1/NFAT1-c-4 0.041 0.11 0.43 10 -0.3 5 15
IL4 -0.22 0.29 0.58 15 -0.51 191 206
IL2 -0.009 0.14 -10000 0 -0.97 11 11
IL3 -0.009 0.13 -10000 0 -0.76 12 12
FKBP1A 0.034 0.012 0.18 2 -10000 0 2
BATF3 0 0 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
POU2F1 0.034 0.015 -10000 0 -10000 0 0
PDGFR-alpha signaling pathway

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.09 0.18 -10000 0 -0.58 61 61
PDGF/PDGFRA/CRKL -0.052 0.14 -10000 0 -0.41 63 63
positive regulation of JUN kinase activity 0.016 0.12 -10000 0 -0.32 45 45
CRKL 0.032 0.009 -10000 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.053 0.14 -10000 0 -0.41 65 65
AP1 -0.7 0.45 -10000 0 -0.97 366 366
mol:IP3 -0.085 0.14 -10000 0 -0.45 57 57
PLCG1 -0.085 0.14 -10000 0 -0.45 57 57
PDGF/PDGFRA/alphaV Integrin -0.053 0.14 -10000 0 -0.42 62 62
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
mol:Ca2+ -0.085 0.14 -10000 0 -0.45 57 57
CAV3 0.032 0.037 -10000 0 -0.54 2 2
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
SHC/Grb2/SOS1 0.017 0.12 -10000 0 -0.32 45 45
PDGF/PDGFRA/Shf -0.051 0.14 -10000 0 -0.4 63 63
FOS -0.69 0.44 -10000 0 -0.95 366 366
JUN -0.13 0.16 -10000 0 -0.46 86 86
oligodendrocyte development -0.053 0.14 -10000 0 -0.42 62 62
GRB2 0.034 0.018 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:DAG -0.085 0.14 -10000 0 -0.45 57 57
PDGF/PDGFRA -0.09 0.18 -10000 0 -0.58 61 61
actin cytoskeleton reorganization -0.05 0.14 -10000 0 -0.41 60 60
SRF 0.031 0.014 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
PI3K -0.029 0.18 -10000 0 -0.42 83 83
PDGF/PDGFRA/Crk/C3G 0.002 0.14 -10000 0 -0.36 61 61
JAK1 -0.064 0.13 -10000 0 -0.4 63 63
ELK1/SRF -0.065 0.12 0.33 1 -0.36 56 57
SHB 0.036 0.018 -10000 0 -10000 0 0
SHF 0.034 0.013 -10000 0 -10000 0 0
CSNK2A1 0.063 0.025 -10000 0 -10000 0 0
GO:0007205 -0.092 0.14 -10000 0 -0.46 62 62
SOS1 0.034 0.004 -10000 0 -10000 0 0
Ras protein signal transduction 0.016 0.12 -10000 0 -0.32 45 45
PDGF/PDGFRA/SHB -0.05 0.14 -10000 0 -0.41 60 60
PDGF/PDGFRA/Caveolin-1 -0.33 0.24 -10000 0 -0.46 376 376
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
ELK1 -0.11 0.13 0.23 2 -0.44 60 62
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PDGF/PDGFRA/Crk -0.053 0.14 -10000 0 -0.41 64 64
JAK-STAT cascade -0.064 0.13 -10000 0 -0.4 63 63
cell proliferation -0.051 0.14 -10000 0 -0.4 63 63
HIF-1-alpha transcription factor network

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.058 0.4 0.72 4 -0.73 78 82
HDAC7 0.007 0.015 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.001 0.37 0.78 8 -0.72 47 55
SMAD4 0.034 0.008 -10000 0 -10000 0 0
ID2 -0.007 0.43 -10000 0 -0.74 75 75
AP1 -0.33 0.27 -10000 0 -0.48 354 354
ABCG2 -0.021 0.44 -10000 0 -0.75 83 83
HIF1A 0.021 0.13 0.33 2 -0.49 5 7
TFF3 -0.056 0.44 -10000 0 -0.75 88 88
GATA2 0.021 0.049 -10000 0 -10000 0 0
AKT1 0.019 0.13 0.33 4 -0.2 15 19
response to hypoxia -0.006 0.11 0.25 13 -0.16 60 73
MCL1 -0.035 0.4 -10000 0 -0.73 75 75
NDRG1 -0.024 0.4 0.88 1 -0.74 70 71
SERPINE1 0.004 0.44 0.83 9 -0.73 79 88
FECH -0.01 0.42 -10000 0 -0.73 78 78
FURIN -0.002 0.43 -10000 0 -0.73 77 77
NCOA2 0.035 0.023 -10000 0 -10000 0 0
EP300 0.031 0.17 0.44 15 -0.29 34 49
HMOX1 0.001 0.44 0.82 7 -0.73 78 85
BHLHE40 -0.058 0.4 0.72 4 -0.73 78 82
BHLHE41 -0.058 0.4 0.72 4 -0.73 78 82
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.041 0.16 -10000 0 -0.36 2 2
ENG 0.043 0.14 0.43 3 -0.39 1 4
JUN -0.074 0.22 -10000 0 -0.55 89 89
RORA -0.015 0.43 -10000 0 -0.74 81 81
ABCB1 -0.3 0.47 -10000 0 -0.94 164 164
TFRC -0.001 0.43 0.84 6 -0.74 76 82
CXCR4 0.002 0.43 0.82 2 -0.73 77 79
TF -0.014 0.44 -10000 0 -0.76 81 81
CITED2 -0.013 0.43 -10000 0 -0.74 79 79
HIF1A/ARNT -0.074 0.44 0.89 4 -0.88 62 66
LDHA -0.01 0.13 -10000 0 -0.76 12 12
ETS1 -0.01 0.43 0.77 1 -0.73 78 79
PGK1 -0.001 0.43 0.83 3 -0.73 78 81
NOS2 -0.058 0.4 0.72 4 -0.73 78 82
ITGB2 -0.001 0.43 0.81 8 -0.73 77 85
ALDOA -0.003 0.42 -10000 0 -0.73 75 75
Cbp/p300/CITED2 -0.019 0.43 0.81 2 -0.8 63 65
FOS -0.36 0.27 -10000 0 -0.55 344 344
HK2 -0.004 0.43 -10000 0 -0.73 78 78
SP1 -0.018 0.093 -10000 0 -0.24 31 31
GCK 0.06 0.22 0.67 3 -0.52 2 5
HK1 -0.003 0.43 -10000 0 -0.73 77 77
NPM1 -0.006 0.43 -10000 0 -0.73 78 78
EGLN1 -0.03 0.4 -10000 0 -0.73 76 76
CREB1 0.04 0.01 -10000 0 -10000 0 0
PGM1 -0.008 0.43 -10000 0 -0.73 77 77
SMAD3 0.034 0.01 -10000 0 -10000 0 0
EDN1 -0.4 0.6 0.62 1 -1.2 163 164
IGFBP1 -0.005 0.43 -10000 0 -0.74 78 78
VEGFA 0.062 0.36 0.8 18 -0.61 45 63
HIF1A/JAB1 0.039 0.1 0.32 3 -0.41 4 7
CP -0.069 0.51 0.84 6 -0.8 120 126
CXCL12 -0.095 0.48 -10000 0 -0.8 118 118
COPS5 0.033 0.019 -10000 0 -10000 0 0
SMAD3/SMAD4 0.048 0.022 -10000 0 -0.17 3 3
BNIP3 -0.008 0.43 0.84 1 -0.74 79 80
EGLN3 0.013 0.44 0.82 12 -0.74 76 88
CA9 0.007 0.44 0.83 7 -0.73 78 85
TERT -0.019 0.42 -10000 0 -0.73 77 77
ENO1 -0.005 0.43 -10000 0 -0.73 77 77
PFKL -0.006 0.43 -10000 0 -0.74 76 76
NCOA1 0.036 0.027 -10000 0 -0.54 1 1
ADM -0.11 0.5 -10000 0 -0.78 133 133
ARNT 0.019 0.098 0.29 2 -10000 0 2
HNF4A 0.036 0.009 -10000 0 -10000 0 0
ADFP -0.058 0.4 0.72 4 -0.73 78 82
SLC2A1 0.063 0.36 0.8 16 -0.61 46 62
LEP -0.15 0.48 -10000 0 -0.8 130 130
HIF1A/ARNT/Cbp/p300 -0.024 0.37 0.78 6 -0.72 50 56
EPO 0.065 0.32 0.79 12 -0.65 19 31
CREBBP 0.038 0.16 0.44 15 -0.29 14 29
HIF1A/ARNT/Cbp/p300/HDAC7 -0.015 0.35 0.78 6 -0.7 46 52
PFKFB3 -0.013 0.42 -10000 0 -0.75 72 72
NT5E -0.012 0.44 -10000 0 -0.75 79 79
BMP receptor signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS 0.11 0.08 -10000 0 -0.3 3 3
SMAD6-7/SMURF1 0.064 0.021 -10000 0 -10000 0 0
NOG 0.031 0.03 -10000 0 -0.54 1 1
SMAD9 -0.081 0.23 -10000 0 -0.67 60 60
SMAD4 0.033 0.008 -10000 0 -10000 0 0
SMAD5 -0.098 0.19 -10000 0 -0.44 72 72
BMP7/USAG1 -0.24 0.2 -10000 0 -0.37 350 350
SMAD5/SKI -0.087 0.19 -10000 0 -0.44 70 70
SMAD1 0.005 0.09 -10000 0 -0.44 10 10
BMP2 -0.23 0.29 -10000 0 -0.54 230 230
SMAD1/SMAD1/SMAD4 0.03 0.087 -10000 0 -0.43 6 6
BMPR1A 0.031 0.044 -10000 0 -0.54 3 3
BMPR1B 0.088 0.071 -10000 0 -10000 0 0
BMPR1A-1B/BAMBI 0.082 0.13 -10000 0 -0.3 38 38
AHSG 0.034 0.006 -10000 0 -10000 0 0
CER1 0.033 0.011 -10000 0 -10000 0 0
BMP2-4/CER1 -0.16 0.23 -10000 0 -0.38 261 261
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.097 0.18 -10000 0 -0.4 88 88
BMP2-4 (homodimer) -0.21 0.25 -10000 0 -0.43 277 277
RGMB 0.033 0.007 -10000 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B -0.019 0.19 -10000 0 -0.28 168 168
RGMA -0.052 0.2 -10000 0 -0.54 76 76
SMURF1 0.034 0.005 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.11 0.18 -10000 0 -0.39 106 106
BMP2-4/USAG1 -0.4 0.26 -10000 0 -0.51 411 411
SMAD6/SMURF1/SMAD5 -0.089 0.19 -10000 0 -0.44 69 69
SOSTDC1 -0.37 0.26 -10000 0 -0.54 359 359
BMP7/BMPR2/BMPR1A-1B 0.11 0.072 -10000 0 -0.31 3 3
SKI 0.033 0.007 -10000 0 -10000 0 0
BMP6 (homodimer) -0.16 0.27 -10000 0 -0.54 168 168
HFE2 0.027 0.039 -10000 0 -0.54 2 2
ZFYVE16 0.033 0.007 -10000 0 -10000 0 0
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
BMP2-4/CHRD -0.17 0.23 -10000 0 -0.38 262 262
SMAD5/SMAD5/SMAD4 -0.089 0.19 -10000 0 -0.45 68 68
MAPK1 0.033 0.009 -10000 0 -10000 0 0
TAK1/TAB family -0.082 0.17 -10000 0 -0.36 96 96
BMP7 (homodimer) 0.043 0.043 -10000 0 -10000 0 0
NUP214 0.034 0.005 -10000 0 -10000 0 0
BMP6/FETUA -0.098 0.21 -10000 0 -0.39 171 171
SMAD1/SKI 0.015 0.096 -10000 0 -0.41 10 10
SMAD6 0.033 0.007 -10000 0 -10000 0 0
CTDSP2 0.034 0.006 -10000 0 -10000 0 0
BMP2-4/FETUA -0.17 0.23 -10000 0 -0.38 262 262
MAP3K7IP1 0 0 -10000 0 -10000 0 0
GREM1 0.049 0.046 -10000 0 -10000 0 0
BMPR2 (homodimer) 0.034 0.005 -10000 0 -10000 0 0
GADD34/PP1CA 0.061 0.037 -10000 0 -0.34 2 2
BMPR1A-1B (homodimer) 0.084 0.064 -10000 0 -0.4 3 3
CHRDL1 -0.3 0.28 -10000 0 -0.54 300 300
ENDOFIN/SMAD1 0.016 0.097 -10000 0 -0.44 9 9
SMAD6-7/SMURF1/SMAD1 0.048 0.1 -10000 0 -0.48 6 6
SMAD6/SMURF1 0.034 0.005 -10000 0 -10000 0 0
BAMBI 0.018 0.16 -10000 0 -0.54 36 36
SMURF2 0.031 0.013 -10000 0 -10000 0 0
BMP2-4/CHRDL1 -0.36 0.31 -10000 0 -0.54 356 356
BMP2-4/GREM1 -0.16 0.24 0.26 2 -0.37 266 268
SMAD7 0.033 0.008 -10000 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.073 0.23 -10000 0 -0.63 64 64
SMAD1/SMAD6 0.015 0.098 -10000 0 -0.43 10 10
TAK1/SMAD6 0.047 0.015 -10000 0 -10000 0 0
BMP7 0.043 0.043 -10000 0 -10000 0 0
BMP6 -0.16 0.27 -10000 0 -0.54 168 168
MAP3K7IP2 0 0 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.098 0.18 -10000 0 -0.4 100 100
PPM1A 0.034 0.006 -10000 0 -10000 0 0
SMAD1/SMURF2 0.012 0.093 -10000 0 -0.46 8 8
SMAD7/SMURF1 0.048 0.013 -10000 0 -10000 0 0
CTDSPL 0.031 0.036 -10000 0 -0.54 2 2
PPP1CA 0.034 0.021 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
CTDSP1 0.034 0.005 -10000 0 -10000 0 0
PPP1R15A 0.032 0.036 -10000 0 -0.54 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.099 0.19 -10000 0 -0.39 100 100
CHRD 0.036 0.021 -10000 0 -10000 0 0
BMPR2 0.034 0.005 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.12 0.21 -10000 0 -0.45 109 109
BMP4 -0.039 0.2 -10000 0 -0.54 67 67
FST 0.032 0.039 -10000 0 -0.54 2 2
BMP2-4/NOG -0.16 0.22 -10000 0 -0.38 246 246
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.11 0.075 -10000 0 -0.3 3 3
Ephrin B reverse signaling

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.026 0.058 -10000 0 -0.54 5 5
EPHB2 0.043 0.038 -10000 0 -10000 0 0
EFNB1 0.016 0.028 -10000 0 -0.4 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.048 0.18 -10000 0 -0.28 180 180
Ephrin B2/EPHB1-2 -0.074 0.19 -10000 0 -0.31 189 189
neuron projection morphogenesis -0.06 0.16 -10000 0 -0.27 180 180
Ephrin B1/EPHB1-2/Tiam1 -0.059 0.18 -10000 0 -0.3 186 186
DNM1 0.035 0.008 -10000 0 -10000 0 0
cell-cell signaling -0.001 0.003 -10000 0 -10000 0 0
MAP2K4 -0.057 0.18 -10000 0 -0.57 56 56
YES1 -0.069 0.26 -10000 0 -0.8 56 56
Ephrin B1/EPHB1-2/NCK2 -0.06 0.18 -10000 0 -0.3 187 187
PI3K -0.045 0.22 -10000 0 -0.61 56 56
mol:GDP -0.06 0.18 -10000 0 -0.29 186 186
ITGA2B 0.034 0.012 -10000 0 -10000 0 0
endothelial cell proliferation 0.038 0.046 -10000 0 -0.31 7 7
FYN -0.072 0.26 -10000 0 -0.79 56 56
MAP3K7 -0.058 0.19 -10000 0 -0.6 56 56
FGR -0.065 0.26 -10000 0 -0.79 56 56
TIAM1 0.035 0.012 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RGS3 0.034 0.005 -10000 0 -10000 0 0
cell adhesion -0.046 0.2 -10000 0 -0.56 54 54
LYN -0.065 0.25 -10000 0 -0.78 56 56
Ephrin B1/EPHB1-2/Src Family Kinases -0.071 0.24 -10000 0 -0.74 57 57
Ephrin B1/EPHB1-2 -0.061 0.21 -10000 0 -0.64 56 56
SRC -0.064 0.26 -10000 0 -0.78 57 57
ITGB3 0.035 0.019 -10000 0 -10000 0 0
EPHB1 -0.18 0.28 -10000 0 -0.54 190 190
EPHB4 0.036 0.032 -10000 0 -0.54 1 1
RAC1 0.034 0.005 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.039 0.046 -10000 0 -0.31 7 7
alphaIIb/beta3 Integrin 0.05 0.018 -10000 0 -10000 0 0
BLK -0.077 0.26 -10000 0 -0.8 56 56
HCK -0.064 0.25 -10000 0 -0.78 56 56
regulation of stress fiber formation 0.06 0.18 0.29 187 -10000 0 187
MAPK8 -0.056 0.18 -10000 0 -0.55 56 56
Ephrin B1/EPHB1-2/RGS3 -0.06 0.18 -10000 0 -0.3 188 188
endothelial cell migration -0.051 0.17 0.26 1 -0.52 55 56
NCK2 0.035 0.008 -10000 0 -10000 0 0
PTPN13 -0.026 0.2 -10000 0 -0.65 46 46
regulation of focal adhesion formation 0.06 0.18 0.29 187 -10000 0 187
chemotaxis 0.06 0.18 0.29 188 -10000 0 188
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
Rac1/GTP -0.053 0.17 -10000 0 -0.28 180 180
angiogenesis -0.061 0.2 -10000 0 -0.64 56 56
LCK -0.061 0.26 -10000 0 -0.78 57 57
Ras signaling in the CD4+ TCR pathway

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.2 0.19 -10000 0 -0.35 219 219
MAP3K8 -0.047 0.19 -10000 0 -0.55 65 65
FOS -0.098 0.12 -10000 0 -0.36 30 30
PRKCA -0.006 0.028 -10000 0 -10000 0 0
PTPN7 -0.002 0.044 0.18 8 -10000 0 8
HRAS 0.032 0.013 -10000 0 -10000 0 0
PRKCB -0.013 0.009 -10000 0 -0.018 364 364
NRAS 0.033 0.016 -10000 0 -10000 0 0
RAS family/GTP 0.032 0.036 -10000 0 -10000 0 0
MAPK3 -0.029 0.075 -10000 0 -0.61 3 3
MAP2K1 -0.054 0.089 -10000 0 -0.28 41 41
ELK1 -0.015 0.037 -10000 0 -10000 0 0
BRAF -0.016 0.037 -10000 0 -0.25 6 6
mol:GTP -0.004 0.003 -10000 0 -0.006 365 365
MAPK1 -0.051 0.12 -10000 0 -0.46 28 28
RAF1 -0.017 0.035 -10000 0 -0.25 5 5
KRAS 0.033 0.019 -10000 0 -10000 0 0
Plasma membrane estrogen receptor signaling

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.008 0.16 -10000 0 -0.3 104 104
ER alpha/Gai/GDP/Gbeta gamma -0.15 0.24 -10000 0 -0.43 161 161
AKT1 -0.19 0.37 -10000 0 -0.78 138 138
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.19 0.38 -10000 0 -0.8 135 135
mol:Ca2+ -0.031 0.12 0.26 3 -0.31 46 49
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
E2/ER alpha (dimer)/Striatin -0.019 0.17 -10000 0 -0.33 111 111
SHC1 0.028 0.014 -10000 0 -10000 0 0
apoptosis 0.18 0.35 0.74 138 -10000 0 138
RhoA/GTP -0.024 0.11 -10000 0 -0.27 81 81
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.13 0.23 0.3 2 -0.45 138 140
regulation of stress fiber formation 0.014 0.12 -10000 0 -0.32 6 6
E2/ERA-ERB (dimer) -0.022 0.17 -10000 0 -0.33 110 110
KRAS 0.035 0.019 -10000 0 -10000 0 0
G13/GTP -0.019 0.15 -10000 0 -0.31 99 99
pseudopodium formation -0.014 0.12 0.32 6 -10000 0 6
E2/ER alpha (dimer)/PELP1 -0.025 0.17 -10000 0 -0.33 110 110
GRB2 0.034 0.018 -10000 0 -10000 0 0
GNG2 0.033 0.026 -10000 0 -0.54 1 1
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.14 0.25 -10000 0 -0.5 142 142
E2/ER beta (dimer) 0.025 0.005 -10000 0 -10000 0 0
mol:GDP -0.047 0.18 0.23 10 -0.38 105 115
mol:NADP -0.14 0.25 -10000 0 -0.5 142 142
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 -0.033 0.12 0.26 3 -0.32 45 48
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
PLCB1 -0.034 0.13 -10000 0 -0.32 51 51
PLCB2 0.003 0.088 -10000 0 -0.46 8 8
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
mol:L-citrulline -0.14 0.25 -10000 0 -0.5 142 142
RHOA 0.033 0.008 -10000 0 -10000 0 0
Gai/GDP -0.14 0.28 -10000 0 -0.73 79 79
JNK cascade 0.024 0.005 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
ESR2 0.033 0.007 -10000 0 -10000 0 0
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 -0.059 0.25 -10000 0 -0.54 106 106
Gq family/GDP/Gbeta gamma 0.009 0.16 -10000 0 -0.84 14 14
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.031 0.14 -10000 0 -0.54 13 13
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.12 0.21 0.31 1 -0.45 108 109
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
E2/ER alpha (dimer) -0.045 0.18 -10000 0 -0.39 110 110
STRN 0.034 0.028 -10000 0 -0.54 1 1
GNAL 0.03 0.044 -10000 0 -0.54 3 3
PELP1 0.031 0.011 -10000 0 -10000 0 0
MAPK11 0.017 0.006 -10000 0 -10000 0 0
GNAI2 0.033 0.01 -10000 0 -10000 0 0
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
HBEGF -0.11 0.23 0.37 7 -0.56 56 63
cAMP biosynthetic process -0.02 0.13 -10000 0 -0.28 102 102
SRC -0.14 0.23 0.31 4 -0.55 69 73
PI3K 0.005 0.13 -10000 0 -0.4 44 44
GNB1 0.034 0.011 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma -0.021 0.18 -10000 0 -0.37 88 88
SOS1 0.034 0.004 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.21 0.21 -10000 0 -0.42 210 210
Gs family/GTP -0.012 0.14 -10000 0 -0.28 102 102
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.062 0.025 -10000 0 -10000 0 0
vasodilation -0.14 0.24 -10000 0 -0.48 142 142
mol:DAG -0.033 0.12 0.26 3 -0.32 45 48
Gs family/GDP/Gbeta gamma -0.041 0.16 -10000 0 -0.36 84 84
MSN -0.016 0.12 0.38 4 -10000 0 4
Gq family/GTP 0.003 0.093 -10000 0 -0.43 10 10
mol:PI-3-4-5-P3 -0.18 0.36 -10000 0 -0.76 136 136
NRAS 0.036 0.016 -10000 0 -10000 0 0
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.14 0.24 0.48 142 -10000 0 142
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
RhoA/GDP -0.028 0.19 -10000 0 -0.37 105 105
NOS3 -0.15 0.26 -10000 0 -0.53 141 141
GNA11 0.034 0.006 -10000 0 -10000 0 0
MAPKKK cascade -0.13 0.27 -10000 0 -0.56 134 134
E2/ER alpha (dimer)/PELP1/Src -0.14 0.23 0.31 3 -0.46 139 142
ruffle organization -0.014 0.12 0.32 6 -10000 0 6
ROCK2 -0.013 0.13 0.35 6 -10000 0 6
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
MMP9 -0.097 0.22 0.39 8 -0.54 55 63
MMP2 -0.14 0.22 0.3 5 -0.55 60 65
FAS signaling pathway (CD95)

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.02 0.092 0.21 71 -10000 0 71
RFC1 0.019 0.087 0.21 66 -10000 0 66
PRKDC 0.039 0.11 0.23 105 -10000 0 105
RIPK1 0.041 0.009 -10000 0 -10000 0 0
CASP7 -0.042 0.12 -10000 0 -0.76 10 10
FASLG/FAS/FADD/FAF1 -0.024 0.091 0.26 9 -0.31 18 27
MAP2K4 -0.18 0.19 -10000 0 -0.46 84 84
mol:ceramide -0.074 0.13 0.27 1 -0.37 33 34
GSN -0.058 0.17 0.22 53 -0.34 107 160
FASLG/FAS/FADD/FAF1/Caspase 8 -0.032 0.097 0.32 3 -0.32 15 18
FAS -0.047 0.14 -10000 0 -0.56 33 33
BID -0.023 0.021 -10000 0 -10000 0 0
MAP3K1 -0.093 0.14 0.28 1 -0.49 23 24
MAP3K7 0.026 0.01 -10000 0 -10000 0 0
RB1 0.021 0.084 0.21 65 -10000 0 65
CFLAR 0.04 0.026 -10000 0 -0.52 1 1
HGF/MET -0.009 0.16 -10000 0 -0.36 89 89
ARHGDIB 0.022 0.091 0.22 66 -10000 0 66
FADD -0.008 0.028 -10000 0 -10000 0 0
actin filament polymerization 0.058 0.17 0.34 108 -0.22 53 161
NFKB1 -0.1 0.13 -10000 0 -0.65 9 9
MAPK8 -0.32 0.25 -10000 0 -0.46 353 353
DFFA 0.019 0.087 0.21 68 -10000 0 68
DNA fragmentation during apoptosis 0.019 0.088 0.21 66 -10000 0 66
FAS/FADD/MET -0.029 0.15 -10000 0 -0.39 65 65
CFLAR/RIP1 0.06 0.027 -10000 0 -0.37 1 1
FAIM3 0.035 0.03 -10000 0 -10000 0 0
FAF1 -0.016 0.033 -10000 0 -10000 0 0
PARP1 0.024 0.099 0.24 73 -10000 0 73
DFFB 0.018 0.088 0.21 66 -10000 0 66
CHUK -0.11 0.12 -10000 0 -0.61 9 9
FASLG 0.001 0.061 -10000 0 -0.55 1 1
FAS/FADD -0.033 0.1 -10000 0 -0.39 32 32
HGF 0.035 0.01 -10000 0 -10000 0 0
LMNA 0.022 0.099 0.42 14 -10000 0 14
CASP6 0.02 0.088 0.21 70 -10000 0 70
CASP10 -0.012 0.03 -10000 0 -10000 0 0
CASP3 0.02 0.1 0.26 66 -0.22 16 82
PTPN13 -0.018 0.16 -10000 0 -0.54 46 46
CASP8 -0.027 0.022 -10000 0 -10000 0 0
IL6 -0.88 0.56 -10000 0 -1.2 380 380
MET -0.022 0.17 -10000 0 -0.54 50 50
ICAD/CAD 0.01 0.074 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1/Caspase 10 -0.076 0.13 0.27 1 -0.37 33 34
activation of caspase activity by cytochrome c -0.022 0.021 -10000 0 -10000 0 0
PAK2 0.015 0.094 0.22 73 -10000 0 73
BCL2 -0.068 0.22 -10000 0 -0.54 91 91
IL6-mediated signaling events

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.025 0.3 0.68 2 -0.79 22 24
CRP -0.001 0.31 0.77 3 -0.76 25 28
cell cycle arrest -0.053 0.34 0.71 3 -0.84 37 40
TIMP1 -0.013 0.28 0.67 8 -0.64 27 35
IL6ST 0.038 0.084 -10000 0 -0.54 9 9
Rac1/GDP -0.089 0.22 0.42 7 -0.45 75 82
AP1 -0.16 0.24 0.49 4 -0.53 87 91
GAB2 0.033 0.016 -10000 0 -10000 0 0
TNFSF11 -0.007 0.32 0.7 6 -0.74 27 33
HSP90B1 0.043 0.14 -10000 0 -0.95 6 6
GAB1 0.036 0.027 -10000 0 -0.54 1 1
MAPK14 -0.13 0.2 0.32 1 -0.54 62 63
AKT1 0.032 0.099 0.34 1 -0.43 11 12
FOXO1 0.005 0.14 0.33 2 -0.42 24 26
MAP2K6 -0.12 0.2 0.35 3 -0.46 84 87
mol:GTP 0.001 0.003 -10000 0 -10000 0 0
MAP2K4 -0.057 0.24 0.47 9 -0.5 60 69
MITF -0.11 0.21 0.37 4 -0.46 81 85
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.034 0.006 -10000 0 -10000 0 0
A2M -0.16 0.49 -10000 0 -1.3 74 74
CEBPB 0.039 0.03 -10000 0 -0.54 1 1
GRB2/SOS1/GAB family/SHP2 -0.001 0.14 0.4 1 -0.47 22 23
STAT3 -0.072 0.36 0.71 3 -0.93 37 40
STAT1 0.032 0.14 -10000 0 -0.84 9 9
CEBPD -0.081 0.44 0.68 3 -1 69 72
PIK3CA 0.034 0.009 -10000 0 -10000 0 0
PI3K 0.008 0.13 -10000 0 -0.4 44 44
JUN -0.066 0.22 -10000 0 -0.54 89 89
PIAS3/MITF -0.1 0.2 0.37 1 -0.44 72 73
MAPK11 -0.13 0.2 0.32 1 -0.53 62 63
STAT3 (dimer)/FOXO1 -0.086 0.33 0.63 5 -0.7 60 65
GRB2/SOS1/GAB family -0.083 0.18 0.37 2 -0.44 46 48
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.14 0.19 0.32 4 -0.42 98 102
GRB2 0.036 0.019 -10000 0 -10000 0 0
JAK2 0.033 0.011 -10000 0 -10000 0 0
LBP 0.008 0.28 0.73 5 -0.67 17 22
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
JAK1 0.038 0.013 -10000 0 -10000 0 0
MYC -0.015 0.38 0.73 8 -0.98 40 48
FGG -0.026 0.3 0.69 3 -0.77 25 28
macrophage differentiation -0.053 0.34 0.71 3 -0.84 37 40
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.15 0.19 -10000 0 -0.3 271 271
JUNB -0.031 0.3 0.65 2 -0.75 30 32
FOS -0.35 0.27 -10000 0 -0.54 344 344
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.12 0.22 0.38 6 -0.44 98 104
STAT1/PIAS1 -0.073 0.23 0.43 7 -0.45 70 77
GRB2/SOS1/GAB family/SHP2/PI3K 0.028 0.1 0.26 1 -0.43 13 14
STAT3 (dimer) -0.069 0.35 0.71 3 -0.92 36 39
PRKCD -0.035 0.26 0.52 10 -0.6 36 46
IL6R 0.03 0.031 -10000 0 -0.55 1 1
SOCS3 -0.15 0.24 -10000 0 -0.75 43 43
gp130 (dimer)/JAK1/JAK1/LMO4 0.073 0.12 0.3 4 -0.32 31 35
Rac1/GTP -0.077 0.23 0.43 9 -0.46 71 80
HCK 0.037 0.022 -10000 0 -10000 0 0
MAPKKK cascade 0.021 0.16 0.4 1 -0.57 24 25
bone resorption -0.003 0.3 0.69 7 -0.69 27 34
IRF1 -0.024 0.3 0.77 2 -0.77 24 26
mol:GDP -0.1 0.21 0.39 9 -0.43 88 97
SOS1 0.038 0.009 -10000 0 -10000 0 0
VAV1 -0.1 0.22 0.4 9 -0.44 88 97
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.16 0.2 -10000 0 -0.56 65 65
PTPN11 0.021 0.093 -10000 0 -0.81 5 5
IL6/IL6RA -0.23 0.2 -10000 0 -0.39 292 292
gp130 (dimer)/TYK2/TYK2/LMO4 0.068 0.11 0.28 1 -0.33 27 28
gp130 (dimer)/JAK2/JAK2/LMO4 0.063 0.11 0.28 1 -0.32 30 31
IL6 -0.37 0.27 0.22 1 -0.53 366 367
PIAS3 0.028 0.014 -10000 0 -10000 0 0
PTPRE 0.004 0.043 -10000 0 -0.52 1 1
PIAS1 0.033 0.007 -10000 0 -10000 0 0
RAC1 0.036 0.006 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.14 0.17 0.29 3 -0.37 104 107
LMO4 0.03 0.12 0.22 12 -0.54 21 33
STAT3 (dimer)/PIAS3 -0.067 0.32 0.67 2 -0.84 35 37
MCL1 0.068 0.12 0.52 2 -0.54 3 5
Integrins in angiogenesis

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.06 0.035 -10000 0 -10000 0 0
alphaV beta3 Integrin -0.24 0.18 -10000 0 -0.34 370 370
PTK2 -0.046 0.12 0.38 3 -0.49 6 9
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
PI4KB 0.028 0.014 -10000 0 -10000 0 0
MFGE8 0.008 0.13 -10000 0 -0.54 25 25
SRC 0.033 0.008 -10000 0 -10000 0 0
CDKN1B -0.1 0.13 -10000 0 -0.57 28 28
VEGFA 0.05 0.047 -10000 0 -10000 0 0
ILK -0.087 0.095 -10000 0 -0.47 16 16
ROCK1 0.034 0.006 -10000 0 -10000 0 0
AKT1 -0.082 0.089 -10000 0 -0.45 15 15
PTK2B 0.027 0.05 0.32 4 -0.3 1 5
alphaV/beta3 Integrin/JAM-A -0.16 0.17 -10000 0 -0.3 276 276
CBL 0.031 0.011 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.065 0.03 -10000 0 -0.34 1 1
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.16 0.25 -10000 0 -0.38 258 258
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.038 0.062 -10000 0 -0.34 6 6
alphaV/beta3 Integrin/Syndecan-1 0.09 0.052 -10000 0 -0.34 1 1
PI4KA 0.032 0.009 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.3 0.25 -10000 0 -0.49 274 274
PI4 Kinase 0.039 0.023 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin 0.1 0.068 -10000 0 -0.34 4 4
RPS6KB1 -0.28 0.23 0.6 1 -0.51 204 205
TLN1 0.034 0.006 -10000 0 -10000 0 0
MAPK3 -0.36 0.29 -10000 0 -0.56 328 328
GPR124 0.008 0.1 -10000 0 -0.54 17 17
MAPK1 -0.38 0.29 -10000 0 -0.56 343 343
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
alphaV/beta3 Integrin/Tumstatin 0.066 0.029 -10000 0 -0.34 1 1
cell adhesion 0.034 0.093 -10000 0 -0.3 32 32
ANGPTL3 0.033 0.007 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Src 0.073 0.038 -10000 0 -10000 0 0
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
TGFBR2 -0.004 0.14 -10000 0 -0.54 34 34
ITGB3 0.035 0.019 -10000 0 -10000 0 0
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
RAC1 0.034 0.005 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.04 0.08 -10000 0 -0.34 18 18
apoptosis 0.034 0.027 -10000 0 -0.54 1 1
CD47 0.023 0.08 -10000 0 -0.54 10 10
alphaV/beta3 Integrin/CD47 0.057 0.064 -10000 0 -0.34 11 11
VCL 0.034 0.005 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Del1 0.057 0.096 -10000 0 -0.34 23 23
CSF1 0.034 0.008 -10000 0 -10000 0 0
PIK3C2A -0.084 0.09 -10000 0 -0.46 13 13
PI4 Kinase/Pyk2 -0.15 0.13 -10000 0 -0.51 1 1
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.09 0.045 -10000 0 -0.32 1 1
FAK1/Vinculin -0.033 0.11 0.39 3 -0.39 6 9
alphaV beta3/Integrin/ppsTEM5 0.04 0.081 -10000 0 -0.34 18 18
RHOA 0.033 0.008 -10000 0 -10000 0 0
VTN 0.033 0.011 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
F11R -0.23 0.2 -10000 0 -0.4 299 299
alphaV/beta3 Integrin/Lactadherin 0.047 0.091 -10000 0 -0.34 23 23
alphaV/beta3 Integrin/TGFBR2 0.04 0.1 -10000 0 -0.34 33 33
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.07 0.041 -10000 0 -0.32 1 1
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.062 0.028 -10000 0 -0.31 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.13 0.068 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Pyk2 0.057 0.048 0.29 1 -0.3 1 2
SDC1 0.073 0.065 -10000 0 -10000 0 0
VAV3 0.013 0.071 -10000 0 -0.3 19 19
PTPN11 0.034 0.004 -10000 0 -10000 0 0
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
FAK1/Paxillin -0.032 0.11 0.37 4 -0.39 6 10
cell migration -0.033 0.1 0.38 3 -0.36 6 9
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
PI3K -0.17 0.18 -10000 0 -0.31 270 270
SPP1 0.091 0.087 -10000 0 -0.54 3 3
KDR 0.034 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.034 0.027 -10000 0 -0.54 1 1
COL4A3 0.034 0.006 -10000 0 -10000 0 0
angiogenesis -0.37 0.28 -10000 0 -0.56 325 325
Rac1/GTP 0.031 0.068 -10000 0 -0.28 18 18
EDIL3 0.024 0.13 -10000 0 -0.54 22 22
cell proliferation 0.039 0.1 -10000 0 -0.34 33 33
EPHB forward signaling

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.048 0.034 0.23 2 -0.34 1 3
cell-cell adhesion 0.1 0.12 0.27 176 -10000 0 176
Ephrin B/EPHB2/RasGAP 0.081 0.068 -10000 0 -0.3 7 7
ITSN1 0.034 0.005 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
Ephrin B1/EPHB3 0.045 0.027 -10000 0 -0.34 2 2
Ephrin B1/EPHB1 -0.098 0.19 -10000 0 -0.34 192 192
HRAS/GDP -0.081 0.16 -10000 0 -0.37 47 47
Ephrin B/EPHB1/GRB7 -0.055 0.18 -10000 0 -0.31 158 158
Endophilin/SYNJ1 0.018 0.049 0.26 1 -0.28 7 8
KRAS 0.035 0.019 -10000 0 -10000 0 0
Ephrin B/EPHB1/Src -0.056 0.19 -10000 0 -0.31 174 174
endothelial cell migration 0.027 0.11 -10000 0 -0.3 47 47
GRB2 0.034 0.018 -10000 0 -10000 0 0
GRB7 0.029 0.013 -10000 0 -10000 0 0
PAK1 0.008 0.064 0.3 5 -0.28 5 10
HRAS 0.034 0.013 -10000 0 -10000 0 0
RRAS 0.017 0.049 0.26 1 -0.28 7 8
DNM1 0.035 0.008 -10000 0 -10000 0 0
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.092 0.16 0.36 2 -0.29 188 190
lamellipodium assembly -0.1 0.12 -10000 0 -0.27 176 176
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.063 0.15 -10000 0 -0.29 128 128
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
EPHB2 0.043 0.038 -10000 0 -10000 0 0
EPHB3 0.035 0.016 -10000 0 -10000 0 0
EPHB1 -0.18 0.28 -10000 0 -0.54 190 190
EPHB4 0.036 0.032 -10000 0 -0.54 1 1
mol:GDP -0.08 0.14 0.24 1 -0.4 43 44
Ephrin B/EPHB2 0.068 0.059 -10000 0 -0.3 7 7
Ephrin B/EPHB3 0.062 0.054 -10000 0 -0.3 7 7
JNK cascade -0.089 0.16 0.39 5 -0.3 181 186
Ephrin B/EPHB1 -0.069 0.18 -10000 0 -0.3 188 188
RAP1/GDP -0.058 0.14 -10000 0 -0.36 40 40
EFNB2 0.026 0.058 -10000 0 -0.54 5 5
EFNB3 0.031 0.011 -10000 0 -10000 0 0
EFNB1 0.032 0.036 -10000 0 -0.54 2 2
Ephrin B2/EPHB1-2 -0.075 0.19 -10000 0 -0.32 189 189
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CDC42/GTP -0.061 0.17 -10000 0 -0.35 42 42
Rap1/GTP -0.074 0.14 -10000 0 -0.47 7 7
axon guidance 0.047 0.033 0.23 2 -0.34 1 3
MAPK3 -0.047 0.14 0.26 1 -0.39 30 31
MAPK1 -0.054 0.14 -10000 0 -0.38 32 32
Rac1/GDP -0.073 0.14 -10000 0 -0.37 44 44
actin cytoskeleton reorganization -0.076 0.12 -10000 0 -0.32 28 28
CDC42/GDP -0.072 0.14 -10000 0 -0.37 43 43
PI3K 0.032 0.12 -10000 0 -0.3 47 47
EFNA5 0.033 0.029 -10000 0 -0.54 1 1
Ephrin B2/EPHB4 0.039 0.046 -10000 0 -0.31 7 7
Ephrin B/EPHB2/Intersectin/N-WASP 0.019 0.068 -10000 0 -0.38 3 3
CDC42 0.033 0.008 -10000 0 -10000 0 0
RAS family/GTP -0.076 0.14 -10000 0 -0.46 7 7
PTK2 0.14 0.27 0.67 101 -10000 0 101
MAP4K4 -0.09 0.16 0.39 5 -0.3 181 186
SRC 0.033 0.008 -10000 0 -10000 0 0
KALRN 0.034 0.006 -10000 0 -10000 0 0
Intersectin/N-WASP 0.049 0.022 -10000 0 -0.4 1 1
neuron projection morphogenesis -0.053 0.14 0.45 5 -0.39 8 13
MAP2K1 -0.059 0.14 -10000 0 -0.4 32 32
WASL 0.033 0.026 -10000 0 -0.54 1 1
Ephrin B1/EPHB1-2/NCK1 -0.06 0.2 -10000 0 -0.31 189 189
cell migration -0.064 0.17 0.31 4 -0.43 36 40
NRAS 0.036 0.016 -10000 0 -10000 0 0
SYNJ1 0.018 0.05 0.26 1 -0.28 7 8
PXN 0.034 0.004 -10000 0 -10000 0 0
TF -0.014 0.068 0.25 1 -0.28 22 23
HRAS/GTP -0.06 0.17 -10000 0 -0.28 177 177
Ephrin B1/EPHB1-2 -0.072 0.19 -10000 0 -0.31 189 189
cell adhesion mediated by integrin -0.008 0.048 0.27 7 -0.23 3 10
RAC1 0.034 0.005 -10000 0 -10000 0 0
mol:GTP -0.06 0.18 -10000 0 -0.29 179 179
RAC1-CDC42/GTP -0.087 0.14 -10000 0 -0.27 142 142
RASA1 0.034 0.012 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.061 0.14 -10000 0 -0.36 41 41
ruffle organization -0.094 0.14 0.41 3 -0.47 8 11
NCK1 0.034 0.005 -10000 0 -10000 0 0
receptor internalization -0.006 0.049 0.25 1 -0.27 7 8
Ephrin B/EPHB2/KALRN 0.082 0.067 -10000 0 -0.3 7 7
ROCK1 0.024 0.037 -10000 0 -0.31 2 2
RAS family/GDP -0.084 0.095 -10000 0 -0.32 26 26
Rac1/GTP -0.088 0.14 -10000 0 -0.28 176 176
Ephrin B/EPHB1/Src/Paxillin -0.087 0.16 -10000 0 -0.29 178 178
IL4-mediated signaling events

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.14 0.62 0.96 1 -1.2 85 86
STAT6 (cleaved dimer) -0.23 0.54 -10000 0 -1.1 104 104
IGHG1 0.027 0.3 0.63 15 -0.66 8 23
IGHG3 -0.15 0.58 -10000 0 -1.1 105 105
AKT1 -0.025 0.35 0.65 1 -0.84 22 23
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 0.029 0.28 0.66 1 -0.92 11 12
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.024 0.37 -10000 0 -0.81 32 32
THY1 -0.14 0.62 1.1 3 -1.2 89 92
MYB -0.006 0.16 -10000 0 -0.54 40 40
HMGA1 0.037 0.023 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.003 0.4 0.77 7 -0.71 37 44
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP 0.001 0.34 -10000 0 -0.85 16 16
SP1 0.057 0.044 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.007 0.057 -10000 0 -0.55 1 1
STAT6 (dimer)/ETS1 -0.16 0.59 0.84 1 -1.1 103 104
SOCS1 -0.06 0.41 0.76 1 -0.72 78 79
SOCS3 -0.016 0.39 0.69 1 -1.1 21 22
FCER2 -0.14 0.52 0.89 4 -0.88 77 81
PARP14 0.042 0.032 -10000 0 -10000 0 0
CCL17 -0.12 0.64 1 10 -1.1 94 104
GRB2 0.034 0.018 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP 0.03 0.29 0.6 4 -0.73 12 16
T cell proliferation -0.18 0.62 -10000 0 -1.2 96 96
IL4R/JAK1 -0.15 0.61 -10000 0 -1.2 86 86
EGR2 -0.51 0.86 1 2 -1.3 246 248
JAK2 0.03 0.089 0.27 1 -10000 0 1
JAK3 0.036 0.019 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
JAK1 0.036 0.047 -10000 0 -10000 0 0
COL1A2 0.037 0.31 0.66 8 -1.2 10 18
CCL26 -0.14 0.62 1.1 4 -1.2 89 93
IL4R -0.14 0.68 1.1 6 -1.3 88 94
PTPN6 0.016 0.044 0.19 3 -10000 0 3
IL13RA2 -0.15 0.63 1 2 -1.2 93 95
IL13RA1 0.032 0.091 -10000 0 -10000 0 0
IRF4 0.065 0.21 0.75 2 -0.7 6 8
ARG1 0.048 0.26 0.72 4 -1.2 4 8
CBL -0.014 0.36 0.67 4 -0.67 37 41
GTF3A 0.1 0.065 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL13RA1/JAK2 0.05 0.13 0.37 4 -10000 0 4
IRF4/BCL6 0.029 0.21 -10000 0 -0.68 8 8
CD40LG 0.049 0.033 0.31 2 -10000 0 2
MAPK14 -0.013 0.38 0.69 2 -0.78 29 31
mitosis -0.02 0.34 0.65 1 -0.78 22 23
STAT6 -0.15 0.75 1.2 13 -1.3 102 115
SPI1 0.044 0.033 -10000 0 -0.24 1 1
RPS6KB1 -0.003 0.33 0.66 4 -0.76 20 24
STAT6 (dimer) -0.15 0.76 1.2 13 -1.3 102 115
STAT6 (dimer)/PARP14 -0.17 0.64 -10000 0 -1.2 101 101
mast cell activation -0.006 0.026 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.016 0.36 0.64 2 -0.79 31 33
FRAP1 -0.026 0.35 0.65 1 -0.84 22 23
LTA -0.14 0.62 0.96 1 -1.2 91 92
FES 0.031 0.037 -10000 0 -0.54 2 2
T-helper 1 cell differentiation 0.14 0.73 1.3 102 -1.2 13 115
CCL11 -0.1 0.61 0.91 3 -1.1 85 88
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES 0.011 0.34 0.64 1 -0.92 15 16
IL2RG 0.045 0.042 0.22 1 -10000 0 1
IL10 -0.1 0.62 1.1 7 -1.1 84 91
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
IRS2 -0.1 0.24 -10000 0 -0.54 117 117
IL4 0.045 0.3 0.79 7 -1 14 21
IL5 -0.14 0.62 1 3 -1.2 89 92
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.06 0.55 0.99 12 -0.88 87 99
COL1A1 0.12 0.4 0.76 40 -0.93 25 65
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.16 0.62 -10000 0 -1.2 84 84
IL2R gamma/JAK3 0.063 0.039 -10000 0 -10000 0 0
TFF3 -0.27 0.73 0.96 1 -1.3 125 126
ALOX15 -0.14 0.62 0.96 1 -1.2 92 93
MYBL1 0.049 0.054 -10000 0 -10000 0 0
T-helper 2 cell differentiation -0.092 0.53 0.83 5 -0.93 92 97
SHC1 0.028 0.014 -10000 0 -10000 0 0
CEBPB 0.035 0.034 -10000 0 -0.39 2 2
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.042 0.36 0.64 1 -0.75 35 36
mol:PI-3-4-5-P3 -0.025 0.36 0.65 1 -0.84 22 23
PI3K -0.032 0.37 -10000 0 -0.92 22 22
DOK2 0.026 0.039 -10000 0 -0.54 2 2
ETS1 0.002 0.059 0.19 2 -0.51 1 3
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 0.039 0.28 0.58 5 -0.71 10 15
ITGB3 -0.14 0.62 1 2 -1.2 89 91
PIGR -0.4 0.84 1.1 5 -1.3 190 195
IGHE -0.043 0.1 0.18 13 -0.26 26 39
MAPKKK cascade 0.04 0.27 0.57 7 -0.69 10 17
BCL6 -0.025 0.17 -10000 0 -0.54 51 51
OPRM1 -0.14 0.62 0.96 1 -1.2 87 88
RETNLB -0.14 0.62 0.96 1 -1.2 87 88
SELP -0.29 0.82 1 7 -1.4 152 159
AICDA -0.14 0.59 0.94 1 -1.1 89 90
Visual signal transduction: Rods

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.034 0.007 -10000 0 -10000 0 0
GNAT1/GTP 0.025 0.005 -10000 0 -10000 0 0
Metarhodopsin II/Arrestin 0.058 0.041 -10000 0 -0.24 2 2
PDE6G/GNAT1/GTP 0.043 0.016 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.033 0.007 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
CNG Channel -0.09 0.17 -10000 0 -0.28 211 211
mol:Na + -0.088 0.17 -10000 0 -0.28 216 216
mol:ADP 0 0 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.05 0.1 -10000 0 -0.32 28 28
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel -0.082 0.19 -10000 0 -0.29 216 216
CNGB1 0.03 0.012 -10000 0 -10000 0 0
RDH5 -0.43 0.23 -10000 0 -0.54 412 412
SAG 0.056 0.06 -10000 0 -0.54 1 1
mol:Ca2+ -0.12 0.15 0.36 6 -0.51 7 13
Na + (4 Units) -0.089 0.16 -10000 0 -0.27 215 215
RGS9 0.002 0.13 -10000 0 -0.54 27 27
GNB1/GNGT1 0.071 0.046 0.26 1 -10000 0 1
GNAT1/GDP 0.058 0.092 -10000 0 -0.27 27 27
GUCY2D 0.031 0.011 -10000 0 -10000 0 0
GNGT1 0.067 0.061 -10000 0 -10000 0 0
GUCY2F 0.033 0.038 -10000 0 -0.54 2 2
GNB5 0.032 0.026 -10000 0 -0.54 1 1
mol:GMP (4 units) 0.026 0.052 -10000 0 -0.3 11 11
mol:11-cis-retinal -0.43 0.23 -10000 0 -0.54 412 412
mol:cGMP 0.056 0.073 -10000 0 -0.34 13 13
GNB1 0.034 0.011 -10000 0 -10000 0 0
Rhodopsin -0.31 0.18 -10000 0 -0.39 417 417
SLC24A1 0.034 0.007 -10000 0 -10000 0 0
CNGA1 -0.21 0.29 -10000 0 -0.54 219 219
Metarhodopsin II 0.022 0.003 -10000 0 -10000 0 0
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.067 0.072 -10000 0 -0.34 12 12
RGS9BP 0.055 0.065 -10000 0 -0.54 2 2
Metarhodopsin II/Transducin 0.037 0.038 -10000 0 -10000 0 0
GCAP Family/Ca ++ 0.055 0.064 -10000 0 -0.34 12 12
PDE6A/B 0.038 0.071 -10000 0 -0.37 14 14
mol:Pi 0.049 0.1 -10000 0 -0.32 28 28
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin 0.079 0.043 -10000 0 -10000 0 0
PDE6B 0.021 0.089 -10000 0 -0.54 12 12
PDE6A 0.034 0.009 -10000 0 -10000 0 0
PDE6G 0.034 0.014 0.18 3 -10000 0 3
RHO 0.034 0.005 -10000 0 -10000 0 0
PDE6 0.067 0.11 -10000 0 -0.3 25 25
GUCA1A 0.024 0.077 -10000 0 -0.54 9 9
GC2/GCAP Family 0.074 0.076 -10000 0 -0.36 13 13
GUCA1C 0.031 0.046 -10000 0 -0.54 3 3
GUCA1B 0.033 0.027 -10000 0 -0.54 1 1
Fc-epsilon receptor I signaling in mast cells

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A -0.034 0.18 -10000 0 -0.54 60 60
LAT2 -0.029 0.13 -10000 0 -0.34 51 51
AP1 -0.19 0.23 -10000 0 -0.46 155 155
mol:PIP3 0.004 0.2 0.34 30 -0.42 48 78
IKBKB 0.021 0.14 0.28 52 -0.27 34 86
AKT1 -0.007 0.21 0.34 74 -0.46 29 103
IKBKG 0.004 0.13 0.26 27 -0.27 37 64
MS4A2 -0.056 0.21 -10000 0 -0.53 83 83
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
MAP3K1 0.01 0.15 0.34 14 -0.41 24 38
mol:Ca2+ 0.012 0.16 0.3 34 -0.34 34 68
LYN 0.032 0.018 -10000 0 -10000 0 0
CBLB -0.029 0.13 -10000 0 -0.35 49 49
SHC1 0.028 0.014 -10000 0 -10000 0 0
RasGAP/p62DOK -0.09 0.18 -10000 0 -0.31 204 204
positive regulation of cell migration 0 0 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.013 0.2 0.35 63 -0.34 91 154
PTPN13 -0.038 0.19 -10000 0 -0.59 27 27
PTPN11 0.033 0.021 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation 0.003 0.16 0.35 24 -0.34 30 54
SYK 0.041 0.027 -10000 0 -10000 0 0
GRB2 0.034 0.018 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.04 0.15 -10000 0 -0.42 51 51
LAT -0.026 0.12 0.21 2 -0.34 49 51
PAK2 0.008 0.16 0.35 14 -0.43 26 40
NFATC2 -0.011 0.057 -10000 0 -0.69 1 1
HRAS 0.004 0.16 0.3 13 -0.45 28 41
GAB2 0.03 0.012 -10000 0 -10000 0 0
PLA2G1B 0.01 0.11 -10000 0 -0.83 7 7
Fc epsilon R1 -0.036 0.19 -10000 0 -0.41 95 95
Antigen/IgE/Fc epsilon R1 -0.031 0.18 0.23 1 -0.37 95 96
mol:GDP -0.023 0.15 0.28 2 -0.45 29 31
JUN -0.067 0.22 -10000 0 -0.54 89 89
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
FOS -0.35 0.27 -10000 0 -0.54 344 344
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.026 0.13 -10000 0 -0.35 53 53
CHUK 0.003 0.13 0.26 28 -0.26 39 67
KLRG1 -0.024 0.12 -10000 0 -0.31 48 48
VAV1 -0.029 0.13 0.21 2 -0.35 48 50
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.028 0.12 -10000 0 -0.35 48 48
negative regulation of mast cell degranulation -0.027 0.11 -10000 0 -0.29 46 46
BTK -0.023 0.15 -10000 0 -0.48 27 27
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.046 0.17 -10000 0 -0.42 67 67
GAB2/PI3K/SHP2 -0.062 0.15 -10000 0 -0.38 68 68
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.032 0.13 -10000 0 -0.46 29 29
RAF1 0.008 0.12 -10000 0 -0.9 7 7
Fc epsilon R1/FcgammaRIIB/SHIP -0.018 0.18 -10000 0 -0.36 95 95
FCER1G 0.032 0.021 -10000 0 -10000 0 0
FCER1A -0.045 0.19 -10000 0 -0.55 64 64
Antigen/IgE/Fc epsilon R1/Fyn -0.02 0.17 -10000 0 -0.35 93 93
MAPK3 0.011 0.11 -10000 0 -0.86 7 7
MAPK1 0.005 0.11 -10000 0 -0.82 7 7
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.018 0.2 -10000 0 -0.63 32 32
DUSP1 -0.2 0.28 -10000 0 -0.54 208 208
NF-kappa-B/RelA 0.013 0.083 0.18 13 -0.18 20 33
actin cytoskeleton reorganization -0.013 0.18 -10000 0 -0.57 23 23
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.013 0.17 -10000 0 -0.46 37 37
FER -0.028 0.13 -10000 0 -0.35 47 47
RELA 0.033 0.007 -10000 0 -10000 0 0
ITK -0.002 0.069 -10000 0 -0.34 14 14
SOS1 0.034 0.004 -10000 0 -10000 0 0
PLCG1 -0.001 0.17 0.3 8 -0.46 28 36
cytokine secretion -0.006 0.047 -10000 0 -10000 0 0
SPHK1 -0.027 0.12 -10000 0 -0.35 43 43
PTK2 -0.015 0.18 -10000 0 -0.61 23 23
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.039 0.17 -10000 0 -0.43 53 53
EDG1 0 0 -10000 0 -10000 0 0
mol:DAG -0.03 0.22 0.34 22 -0.5 55 77
MAP2K2 0.005 0.11 -10000 0 -0.84 7 7
MAP2K1 0.005 0.11 -10000 0 -0.84 7 7
MAP2K7 0.034 0.005 -10000 0 -10000 0 0
KLRG1/SHP2 -0.013 0.11 0.24 1 -0.37 23 24
MAP2K4 -0.08 0.32 -10000 0 -0.86 72 72
Fc epsilon R1/FcgammaRIIB -0.018 0.19 -10000 0 -0.38 95 95
mol:Choline -0.012 0.2 0.34 63 -0.34 91 154
SHC/Grb2/SOS1 0.01 0.14 -10000 0 -0.41 23 23
FYN 0.03 0.037 -10000 0 -0.54 2 2
DOK1 0.036 0.016 -10000 0 -10000 0 0
PXN -0.014 0.17 -10000 0 -0.56 22 22
HCLS1 -0.028 0.13 0.21 2 -0.35 46 48
PRKCB -0.004 0.16 0.29 27 -0.32 59 86
FCGR2B 0.026 0.039 -10000 0 -0.54 2 2
IGHE 0.001 0.008 -10000 0 -10000 0 0
KLRG1/SHIP -0.028 0.11 -10000 0 -0.3 46 46
LCP2 0.037 0.023 -10000 0 -10000 0 0
PLA2G4A -0.15 0.2 -10000 0 -0.34 220 220
RASA1 0.034 0.012 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.012 0.2 0.34 63 -0.34 91 154
IKK complex 0.023 0.12 0.27 39 -0.22 19 58
WIPF1 0.038 0.022 -10000 0 -10000 0 0
PLK1 signaling events

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.035 0.043 0.12 4 -0.11 45 49
BUB1B 0.093 0.063 0.16 157 -0.14 1 158
PLK1 0.046 0.035 0.11 62 -0.084 1 63
PLK1S1 0.023 0.019 0.059 48 -0.043 1 49
KIF2A 0.038 0.037 0.27 4 -10000 0 4
regulation of mitotic centrosome separation 0.046 0.035 0.11 62 -0.084 1 63
GOLGA2 0.035 0.008 -10000 0 -10000 0 0
Hec1/SPC24 0.1 0.062 0.16 226 -10000 0 226
WEE1 0.049 0.079 0.22 2 -0.31 18 20
cytokinesis 0.13 0.081 0.23 71 -0.39 1 72
PP2A-alpha B56 0.14 0.11 -10000 0 -0.44 9 9
AURKA 0.051 0.04 0.12 27 -0.15 3 30
PICH/PLK1 0.13 0.094 0.24 174 -10000 0 174
CENPE 0.083 0.066 0.16 170 -10000 0 170
RhoA/GTP 0.025 0.006 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.039 0.037 0.27 4 -10000 0 4
PPP2CA 0.034 0.006 -10000 0 -10000 0 0
FZR1 0.034 0.009 -10000 0 -10000 0 0
TPX2 0.081 0.038 0.13 60 -10000 0 60
PAK1 0.043 0.044 -10000 0 -10000 0 0
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.034 0.006 -10000 0 -10000 0 0
CLSPN 0.044 0.053 0.15 6 -0.2 12 18
GORASP1 0.034 0.006 -10000 0 -10000 0 0
metaphase 0.001 0.004 0.015 38 -10000 0 38
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.023 0.019 0.059 48 -0.043 1 49
G2 phase of mitotic cell cycle 0.001 0.003 0.016 7 -10000 0 7
STAG2 0.034 0.004 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP 0.021 0.093 -10000 0 -0.5 15 15
spindle elongation 0.046 0.035 0.11 62 -0.084 1 63
ODF2 0.037 0.015 -10000 0 -10000 0 0
BUB1 0.12 0.12 -10000 0 -0.48 9 9
TPT1 0.014 0.059 0.12 2 -0.16 47 49
CDC25C 0.084 0.065 -10000 0 -0.22 8 8
CDC25B 0.048 0.041 -10000 0 -10000 0 0
SGOL1 0.035 0.043 0.11 45 -0.12 4 49
RHOA 0.033 0.008 -10000 0 -10000 0 0
CCNB1/CDK1 0.091 0.067 0.24 26 -0.21 1 27
CDC14B -0.001 0.065 -10000 0 -0.4 13 13
CDC20 0.083 0.069 -10000 0 -10000 0 0
PLK1/PBIP1 0.073 0.054 0.14 179 -10000 0 179
mitosis -0.001 0.003 0.033 2 -10000 0 2
FBXO5 0.038 0.043 0.16 20 -0.12 1 21
CDC2 0.005 0.004 0.016 31 -10000 0 31
NDC80 0.11 0.074 -10000 0 -10000 0 0
metaphase plate congression 0.027 0.057 -10000 0 -0.21 25 25
ERCC6L 0.12 0.094 0.24 167 -0.2 1 168
NLP/gamma Tubulin 0.025 0.024 0.084 11 -0.08 4 15
microtubule cytoskeleton organization 0.014 0.059 0.12 2 -0.16 47 49
G2/M transition DNA damage checkpoint 0 0.003 0.013 13 -10000 0 13
PPP1R12A 0.035 0.006 -10000 0 -10000 0 0
interphase 0 0.003 0.013 13 -10000 0 13
PLK1/PRC1-2 0.17 0.099 0.27 216 -10000 0 216
GRASP65/GM130/RAB1/GTP/PLK1 0.084 0.033 -10000 0 -10000 0 0
RAB1A 0.034 0.005 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.04 0.032 0.094 77 -10000 0 77
mitotic prometaphase 0.001 0.005 0.021 26 -10000 0 26
proteasomal ubiquitin-dependent protein catabolic process 0.051 0.045 -10000 0 -10000 0 0
microtubule-based process 0.12 0.065 0.18 227 -10000 0 227
Golgi organization 0.046 0.035 0.11 62 -0.084 1 63
Cohesin/SA2 0.055 0.027 0.16 2 -10000 0 2
PPP1CB/MYPT1 0.051 0.01 -10000 0 -10000 0 0
KIF20A 0.13 0.071 -10000 0 -10000 0 0
APC/C/CDC20 0.094 0.066 0.19 146 -10000 0 146
PPP2R1A 0.034 0.005 -10000 0 -10000 0 0
chromosome segregation 0.072 0.054 0.13 179 -10000 0 179
PRC1 0.1 0.074 -10000 0 -10000 0 0
ECT2 0.072 0.073 0.19 115 -10000 0 115
C13orf34 0.039 0.031 0.093 62 -0.07 1 63
NUDC 0.027 0.058 -10000 0 -0.21 25 25
regulation of attachment of spindle microtubules to kinetochore 0.093 0.063 0.16 159 -0.14 1 160
spindle assembly 0.036 0.029 0.095 34 -10000 0 34
spindle stabilization 0.023 0.019 0.059 48 -0.043 1 49
APC/C/HCDH1 0.022 0.059 -10000 0 -0.34 13 13
MKLP2/PLK1 0.12 0.066 0.18 227 -10000 0 227
CCNB1 0.088 0.07 -10000 0 -10000 0 0
PPP1CB 0.035 0.004 -10000 0 -10000 0 0
BTRC 0.037 0.021 -10000 0 -10000 0 0
ROCK2 0.04 0.049 0.21 1 -0.33 4 5
TUBG1 0.027 0.039 0.12 4 -0.15 17 21
G2/M transition of mitotic cell cycle 0.061 0.063 0.21 25 -0.21 1 26
MLF1IP 0.071 0.065 0.14 247 -10000 0 247
INCENP 0.048 0.04 -10000 0 -10000 0 0
IL23-mediated signaling events

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.28 0.52 1 5 -1.3 58 63
IL23A -0.24 0.47 1.1 6 -1.1 42 48
NF kappa B1 p50/RelA/I kappa B alpha -0.24 0.46 -10000 0 -1 56 56
positive regulation of T cell mediated cytotoxicity -0.27 0.52 1.1 8 -1.1 57 65
ITGA3 -0.23 0.46 0.98 5 -1 47 52
IL17F -0.18 0.34 0.7 9 -0.67 64 73
IL12B 0.007 0.082 0.3 8 -10000 0 8
STAT1 (dimer) -0.25 0.49 0.91 5 -1.1 56 61
CD4 -0.24 0.46 1 3 -1 51 54
IL23 -0.24 0.45 0.98 4 -1 42 46
IL23R -0.019 0.21 0.81 3 -1.1 10 13
IL1B -0.25 0.48 1.1 6 -1.1 46 52
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.21 0.46 0.94 7 -0.99 51 58
TYK2 0.004 0.059 0.27 3 -10000 0 3
STAT4 0.028 0.069 -10000 0 -0.54 7 7
STAT3 0.034 0.007 -10000 0 -10000 0 0
IL18RAP -0.006 0.16 -10000 0 -0.54 42 42
IL12RB1 0.004 0.06 0.27 3 -10000 0 3
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 0.01 0.073 0.28 4 -10000 0 4
IL23R/JAK2 -0.023 0.22 0.69 3 -1 10 13
positive regulation of chronic inflammatory response -0.27 0.52 1.1 8 -1.1 57 65
natural killer cell activation 0.001 0.014 0.08 2 -0.061 6 8
JAK2 0.004 0.076 0.32 4 -10000 0 4
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
NFKB1 0.034 0.009 -10000 0 -10000 0 0
RELA 0.034 0.01 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.22 0.44 0.94 5 -0.99 42 47
ALOX12B -0.24 0.46 1 3 -1 52 55
CXCL1 -0.65 0.73 1.1 5 -1.2 292 297
T cell proliferation -0.27 0.52 1.1 8 -1.1 57 65
NFKBIA 0.033 0.01 -10000 0 -10000 0 0
IL17A -0.12 0.3 0.65 12 -0.54 46 58
PI3K -0.28 0.47 0.82 1 -1 70 71
IFNG 0.022 0.074 0.18 63 -0.12 7 70
STAT3 (dimer) -0.26 0.45 0.8 1 -0.99 68 69
IL18R1 0.04 0.03 -10000 0 -0.54 1 1
IL23/IL23R/JAK2/TYK2/SOCS3 -0.13 0.33 0.78 10 -0.75 27 37
IL18/IL18R 0.065 0.14 0.29 18 -0.34 42 60
macrophage activation -0.013 0.028 0.077 19 -0.045 8 27
TNF -0.24 0.48 1.1 5 -1.1 44 49
STAT3/STAT4 -0.26 0.47 0.81 2 -1.1 58 60
STAT4 (dimer) -0.27 0.49 0.9 4 -1.1 61 65
IL18 0.047 0.046 -10000 0 -10000 0 0
IL19 -0.2 0.46 0.94 7 -0.99 50 57
STAT5A (dimer) -0.27 0.48 0.92 3 -1.1 57 60
STAT1 0.059 0.055 -10000 0 -10000 0 0
SOCS3 0.019 0.087 -10000 0 -0.54 12 12
CXCL9 -0.22 0.5 1.1 6 -1.1 51 57
MPO -0.23 0.46 1 4 -1 50 54
positive regulation of humoral immune response -0.27 0.52 1.1 8 -1.1 57 65
IL23/IL23R/JAK2/TYK2 -0.28 0.53 1.1 8 -1.2 57 65
IL6 -0.79 0.67 1 3 -1.2 356 359
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
IL2 0.049 0.039 0.25 1 -0.52 1 2
positive regulation of tyrosine phosphorylation of STAT protein 0.001 0.014 0.08 2 -0.061 6 8
CD3E -0.24 0.46 0.98 5 -1 52 57
keratinocyte proliferation -0.27 0.52 1.1 8 -1.1 57 65
NOS2 -0.24 0.46 0.96 5 -0.98 58 63
E-cadherin signaling in keratinocytes

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation -0.023 0.12 -10000 0 -0.33 42 42
adherens junction organization -0.024 0.13 0.23 1 -0.32 54 55
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.14 0.18 0.32 2 -0.38 99 101
FMN1 -0.024 0.12 -10000 0 -0.31 54 54
mol:IP3 -0.023 0.099 -10000 0 -0.28 44 44
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.022 0.12 -10000 0 -0.32 54 54
CTNNB1 0.03 0.051 -10000 0 -0.54 4 4
AKT1 -0.019 0.11 -10000 0 -0.35 16 16
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.027 0.18 -10000 0 -0.51 41 41
CTNND1 0.034 0.008 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.02 0.11 0.26 1 -0.39 21 22
VASP -0.019 0.12 0.24 1 -0.32 44 45
ZYX -0.025 0.12 -10000 0 -0.32 48 48
JUB -0.024 0.12 -10000 0 -0.31 54 54
EGFR(dimer) -0.16 0.2 -10000 0 -0.32 253 253
E-cadherin/beta catenin-gamma catenin 0.036 0.09 -10000 0 -0.32 25 25
mol:PI-3-4-5-P3 -0.006 0.12 -10000 0 -0.3 49 49
PIK3CA 0.032 0.01 -10000 0 -10000 0 0
PI3K -0.005 0.13 -10000 0 -0.3 49 49
FYN -0.023 0.11 0.24 1 -0.38 22 23
mol:Ca2+ -0.022 0.098 -10000 0 -0.28 44 44
JUP 0.034 0.009 -10000 0 -10000 0 0
PIK3R1 -0.018 0.17 -10000 0 -0.54 47 47
mol:DAG -0.023 0.099 -10000 0 -0.28 44 44
CDH1 0.007 0.12 -10000 0 -0.54 22 22
RhoA/GDP -0.14 0.18 0.32 2 -0.38 98 100
establishment of polarity of embryonic epithelium -0.019 0.12 0.24 1 -0.31 44 45
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
CASR -0.021 0.098 0.23 3 -0.31 16 19
RhoA/GTP -0.005 0.1 -10000 0 -0.3 16 16
AKT2 -0.02 0.11 -10000 0 -0.34 20 20
actin cable formation -0.019 0.12 0.25 3 -0.31 44 47
apoptosis 0.017 0.12 0.31 49 -0.28 2 51
CTNNA1 0.034 0.007 -10000 0 -10000 0 0
mol:GDP -0.16 0.18 -10000 0 -0.4 101 101
PIP5K1A -0.021 0.11 -10000 0 -0.4 21 21
PLCG1 -0.023 0.1 -10000 0 -0.29 44 44
Rac1/GTP -0.14 0.19 -10000 0 -0.39 113 113
homophilic cell adhesion -0.001 0.004 -10000 0 -10000 0 0
Aurora B signaling

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex 0.05 0.077 0.25 33 -10000 0 33
STMN1 0.054 0.083 0.28 45 -10000 0 45
Aurora B/RasGAP/Survivin 0.11 0.077 0.27 1 -10000 0 1
Chromosomal passenger complex/Cul3 protein complex -0.072 0.13 0.21 25 -0.23 129 154
BIRC5 0.12 0.076 -10000 0 -10000 0 0
DES -0.011 0.13 -10000 0 -0.55 25 25
Aurora C/Aurora B/INCENP 0.076 0.052 0.23 14 -10000 0 14
Aurora B/TACC1 0.026 0.087 -10000 0 -0.3 26 26
Aurora B/PP2A 0.058 0.042 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CBX5 0.02 0.022 0.14 3 -10000 0 3
mitotic metaphase/anaphase transition -0.003 0.004 -10000 0 -10000 0 0
NDC80 0.1 0.1 0.28 85 -10000 0 85
Cul3 protein complex -0.23 0.18 -10000 0 -0.34 366 366
KIF2C 0.14 0.1 0.23 258 -10000 0 258
PEBP1 0.039 0.026 -10000 0 -0.54 1 1
KIF20A 0.12 0.07 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
Aurora B/RasGAP 0.057 0.041 -10000 0 -10000 0 0
SEPT1 0.035 0.023 -10000 0 -10000 0 0
SMC2 0.041 0.03 -10000 0 -10000 0 0
SMC4 0.047 0.042 -10000 0 -10000 0 0
NSUN2/NPM1/Nucleolin 0.063 0.16 0.31 11 -0.4 38 49
PSMA3 0.034 0.006 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.001 0.005 -10000 0 -10000 0 0
H3F3B 0.031 0.037 -10000 0 -10000 0 0
AURKB 0.051 0.054 -10000 0 -10000 0 0
AURKC 0.036 0.019 0.18 8 -10000 0 8
CDCA8 0.11 0.075 -10000 0 -10000 0 0
cytokinesis 0.18 0.15 0.35 198 -10000 0 198
Aurora B/Septin1 0.18 0.15 0.38 129 -10000 0 129
AURKA 0.078 0.069 -10000 0 -10000 0 0
INCENP 0.053 0.041 -10000 0 -10000 0 0
KLHL13 -0.38 0.26 -10000 0 -0.54 371 371
BUB1 0.15 0.054 0.2 17 -10000 0 17
hSgo1/Aurora B/Survivin 0.13 0.099 0.31 63 -10000 0 63
EVI5 0.036 0.026 -10000 0 -0.53 1 1
RhoA/GTP 0.22 0.14 0.36 211 -10000 0 211
SGOL1 0.074 0.065 -10000 0 -10000 0 0
CENPA 0.14 0.12 0.28 179 -10000 0 179
NCAPG 0 0 -10000 0 -10000 0 0
Aurora B/HC8 Proteasome 0.058 0.042 -10000 0 -10000 0 0
NCAPD2 0.035 0.021 -10000 0 -10000 0 0
Aurora B/PP1-gamma 0.059 0.042 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
NCAPH 0.08 0.068 -10000 0 -10000 0 0
NPM1 0.028 0.1 -10000 0 -0.35 17 17
RASA1 0.034 0.012 -10000 0 -10000 0 0
KLHL9 0.032 0.009 -10000 0 -10000 0 0
mitotic prometaphase 0.005 0.004 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.058 0.042 -10000 0 -10000 0 0
PPP1CC 0.034 0.004 -10000 0 -10000 0 0
Centraspindlin 0.24 0.15 0.37 244 -10000 0 244
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
NSUN2 0.028 0.093 0.26 1 -0.36 11 12
MYLK -0.071 0.17 -10000 0 -0.34 139 139
KIF23 0.12 0.075 0.19 17 -10000 0 17
VIM -0.006 0.13 -10000 0 -0.39 47 47
RACGAP1 0.082 0.067 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
NCL 0.025 0.11 -10000 0 -0.48 12 12
Chromosomal passenger complex 0.16 0.13 0.28 247 -10000 0 247
Chromosomal passenger complex/EVI5 0.15 0.11 0.36 30 -10000 0 30
TACC1 0.002 0.12 -10000 0 -0.54 23 23
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
CUL3 0.032 0.036 -10000 0 -0.54 2 2
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
IL12-mediated signaling events

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 0.012 0.094 0.35 8 -0.31 8 16
TBX21 -0.13 0.37 0.73 5 -1.2 37 42
B2M 0.039 0.013 -10000 0 -10000 0 0
TYK2 0.018 0.036 -10000 0 -10000 0 0
IL12RB1 0.018 0.036 -10000 0 -10000 0 0
GADD45B -0.069 0.28 0.62 6 -0.75 45 51
IL12RB2 0.037 0.072 0.25 8 -0.55 1 9
GADD45G -0.06 0.26 0.69 3 -0.74 33 36
natural killer cell activation -0.008 0.022 0.089 9 -0.041 54 63
RELB 0.037 0.02 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
IL18 0.045 0.046 0.22 9 -10000 0 9
IL2RA 0.041 0.035 -10000 0 -10000 0 0
IFNG 0.063 0.066 -10000 0 -0.54 1 1
STAT3 (dimer) -0.061 0.24 0.56 10 -0.59 47 57
HLA-DRB5 -0.016 0.012 -10000 0 -0.025 293 293
FASLG -0.06 0.26 0.72 7 -0.78 19 26
NF kappa B2 p52/RelB -0.08 0.25 0.53 6 -0.59 61 67
CD4 -0.006 0.031 -10000 0 -10000 0 0
SOCS1 0.032 0.012 -10000 0 -10000 0 0
EntrezGene:6955 -0.014 0.015 0.029 20 -0.026 255 275
CD3D 0.004 0.05 0.21 5 -10000 0 5
CD3E -0.001 0.033 0.21 1 -10000 0 1
CD3G 0.004 0.081 -10000 0 -0.55 5 5
IL12Rbeta2/JAK2 0.028 0.075 0.3 7 -0.41 1 8
CCL3 -0.084 0.25 0.7 2 -0.76 22 24
CCL4 -0.084 0.25 0.7 2 -0.76 22 24
HLA-A 0.005 0.009 0.027 70 -10000 0 70
IL18/IL18R 0.059 0.14 0.37 15 -0.36 42 57
NOS2 -0.085 0.25 0.59 9 -0.58 69 78
IL12/IL12R/TYK2/JAK2/SPHK2 0.01 0.098 0.36 7 -0.32 8 15
IL1R1 -0.17 0.43 0.7 2 -1.2 63 65
IL4 0.038 0.03 -10000 0 -10000 0 0
JAK2 0.017 0.037 0.25 1 -10000 0 1
EntrezGene:6957 -0.011 0.013 0.027 20 -0.023 249 269
TCR/CD3/MHC I/CD8 -0.007 0.14 0.33 21 -0.36 35 56
RAB7A -0.043 0.24 0.67 2 -0.71 24 26
lysosomal transport -0.04 0.23 0.63 4 -0.68 24 28
FOS -0.83 0.6 0.56 1 -1.2 367 368
STAT4 (dimer) -0.032 0.27 0.62 9 -0.68 40 49
STAT5A (dimer) -0.06 0.26 0.57 8 -0.6 57 65
GZMA -0.091 0.24 0.57 7 -0.58 64 71
GZMB -0.089 0.26 0.71 6 -0.78 25 31
HLX 0.026 0.038 -10000 0 -0.54 2 2
LCK -0.083 0.27 0.69 9 -0.63 61 70
TCR/CD3/MHC II/CD4 -0.12 0.16 0.24 9 -0.27 188 197
IL2/IL2R 0.088 0.057 0.38 4 -0.32 1 5
MAPK14 -0.058 0.28 0.63 8 -0.75 41 49
CCR5 -0.066 0.28 0.7 10 -0.73 42 52
IL1B 0.015 0.07 0.26 1 -0.55 5 6
STAT6 -0.038 0.18 0.39 7 -0.65 27 34
STAT4 0.028 0.069 -10000 0 -0.54 7 7
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT1 0.059 0.055 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
NFKB2 0.035 0.012 -10000 0 -10000 0 0
IL12B 0.017 0.046 0.24 3 -10000 0 3
CD8A 0.005 0.009 0.027 70 -10000 0 70
CD8B 0.043 0.027 -10000 0 -10000 0 0
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity -0.012 0.094 0.31 8 -0.35 8 16
IL2RB 0.035 0.022 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.026 0.26 0.61 10 -0.63 39 49
IL2RG 0.044 0.035 -10000 0 -10000 0 0
IL12 0.008 0.089 0.29 3 -0.41 11 14
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
CD247 -0.003 0.11 -10000 0 -0.55 15 15
IL2 0.033 0.027 -10000 0 -0.54 1 1
SPHK2 0.034 0.005 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A 0.007 0.093 -10000 0 -0.56 11 11
IL12/IL12R/TYK2/JAK2 -0.099 0.27 0.67 8 -0.66 62 70
MAP2K3 -0.069 0.29 0.62 8 -0.75 50 58
RIPK2 0.029 0.022 -10000 0 -10000 0 0
MAP2K6 -0.06 0.27 0.62 8 -0.72 44 52
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.018 0.014 -10000 0 -0.029 302 302
IL18RAP -0.009 0.16 -10000 0 -0.55 42 42
IL12Rbeta1/TYK2 0.03 0.047 0.25 1 -10000 0 1
EOMES 0.04 0.1 -10000 0 -0.57 5 5
STAT1 (dimer) -0.011 0.26 0.67 15 -0.6 37 52
T cell proliferation -0.03 0.22 0.53 9 -0.54 41 50
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.038 0.031 0.21 1 -0.55 1 2
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.02 0.23 0.52 2 -0.61 40 42
ATF2 -0.054 0.26 0.6 7 -0.7 41 48
Glypican 1 network

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer -0.22 0.18 -10000 0 -0.35 322 322
fibroblast growth factor receptor signaling pathway -0.22 0.18 -10000 0 -0.35 322 322
LAMA1 0.033 0.011 -10000 0 -10000 0 0
PRNP 0.017 0.094 -10000 0 -0.54 14 14
GPC1/SLIT2 -0.008 0.15 -10000 0 -0.39 66 66
SMAD2 -0.001 0.084 0.28 1 -0.31 32 33
GPC1/PrPc/Cu2+ 0.034 0.064 -10000 0 -0.34 14 14
GPC1/Laminin alpha1 0.048 0.017 -10000 0 -10000 0 0
TDGF1 0.033 0.008 -10000 0 -10000 0 0
CRIPTO/GPC1 0.049 0.016 -10000 0 -10000 0 0
APP/GPC1 0.045 0.048 -10000 0 -0.4 5 5
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.019 0.019 -10000 0 -0.34 1 1
FLT1 0.032 0.013 -10000 0 -10000 0 0
GPC1/TGFB/TGFBR1/TGFBR2 0.041 0.1 -10000 0 -0.34 34 34
SERPINC1 0.032 0.024 -10000 0 -10000 0 0
FYN 0.018 0.025 -10000 0 -0.34 2 2
FGR 0.02 0.01 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade 0.025 0.086 0.29 2 -0.37 10 12
SLIT2 -0.038 0.19 -10000 0 -0.54 63 63
GPC1/NRG -0.001 0.12 -10000 0 -0.32 60 60
NRG1 -0.017 0.15 -10000 0 -0.54 40 40
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.07 0.039 0.26 1 -10000 0 1
LYN 0.018 0.013 -10000 0 -10000 0 0
mol:Spermine 0.01 0.01 -10000 0 -10000 0 0
cell growth -0.22 0.18 -10000 0 -0.35 322 322
BMP signaling pathway -0.034 0.013 -10000 0 -10000 0 0
SRC 0.019 0.009 -10000 0 -10000 0 0
TGFBR1 0.036 0.016 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.031 0.2 -10000 0 -0.54 64 64
GPC1 0.034 0.013 -10000 0 -10000 0 0
TGFBR1 (dimer) 0.036 0.016 -10000 0 -10000 0 0
VEGFA 0.05 0.047 -10000 0 -10000 0 0
BLK 0.025 0.032 -10000 0 -10000 0 0
HCK 0.022 0.018 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
FGFR1 0.018 0.076 -10000 0 -0.54 9 9
VEGFR1 homodimer 0.032 0.013 -10000 0 -10000 0 0
TGFBR2 -0.004 0.14 -10000 0 -0.54 34 34
cell death 0.045 0.048 -10000 0 -0.4 5 5
ATIII/GPC1 0.044 0.027 -10000 0 -10000 0 0
PLA2G2A/GPC1 -0.004 0.16 -10000 0 -0.4 64 64
LCK 0.031 0.033 -10000 0 -10000 0 0
neuron differentiation -0.001 0.12 -10000 0 -0.32 60 60
PrPc/Cu2+ 0.013 0.069 -10000 0 -0.4 14 14
APP 0.029 0.06 -10000 0 -0.54 5 5
TGFBR2 (dimer) -0.004 0.14 -10000 0 -0.54 34 34
Signaling events mediated by the Hedgehog family

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.044 0.24 0.59 2 -0.56 74 76
IHH 0.021 0.075 -10000 0 -0.2 1 1
SHH Np/Cholesterol/GAS1 -0.068 0.15 -10000 0 -0.31 128 128
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.068 0.15 0.31 128 -10000 0 128
SMO/beta Arrestin2 -0.001 0.18 0.41 2 -0.49 27 29
SMO -0.016 0.18 0.44 2 -0.5 29 31
AKT1 -0.02 0.19 0.31 1 -0.59 37 38
ARRB2 0.031 0.011 -10000 0 -10000 0 0
BOC -0.091 0.24 -10000 0 -0.54 111 111
ADRBK1 0.032 0.01 -10000 0 -10000 0 0
heart looping -0.015 0.18 0.44 2 -0.49 29 31
STIL 0.041 0.15 0.35 24 -0.34 7 31
DHH N/PTCH2 0.05 0.01 -10000 0 -10000 0 0
DHH N/PTCH1 0.006 0.16 0.38 2 -0.42 25 27
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DHH 0.034 0.004 -10000 0 -10000 0 0
PTHLH -0.11 0.39 0.66 2 -0.9 94 96
determination of left/right symmetry -0.015 0.18 0.44 2 -0.49 29 31
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
skeletal system development -0.11 0.39 0.66 2 -0.89 94 96
IHH N/Hhip 0.038 0.053 -10000 0 -10000 0 0
DHH N/Hhip 0.05 0.011 -10000 0 -10000 0 0
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.015 0.18 0.44 2 -0.49 29 31
pancreas development 0.034 0.011 -10000 0 -10000 0 0
HHAT 0.024 0.059 -10000 0 -0.54 5 5
PI3K 0.005 0.13 -10000 0 -0.4 44 44
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.14 0.27 -10000 0 -0.54 158 158
somite specification -0.015 0.18 0.44 2 -0.49 29 31
SHH Np/Cholesterol/PTCH1 -0.009 0.12 -10000 0 -0.37 9 9
SHH Np/Cholesterol/PTCH2 0.024 0.037 -10000 0 -0.31 5 5
SHH Np/Cholesterol/Megalin -0.055 0.14 -10000 0 -0.32 110 110
SHH 0.011 0.043 -10000 0 -0.4 5 5
catabolic process -0.009 0.17 0.46 2 -0.36 82 84
SMO/Vitamin D3 0.01 0.17 0.41 15 -0.46 12 27
SHH Np/Cholesterol/Hhip 0.025 0.038 -10000 0 -0.31 5 5
LRP2 -0.12 0.26 -10000 0 -0.54 136 136
receptor-mediated endocytosis -0.061 0.2 0.35 8 -0.51 37 45
SHH Np/Cholesterol/BOC -0.038 0.13 -10000 0 -0.31 87 87
SHH Np/Cholesterol/CDO 0.02 0.049 -10000 0 -0.35 7 7
mesenchymal cell differentiation -0.025 0.038 0.31 5 -10000 0 5
mol:Vitamin D3 0.027 0.16 0.41 16 -0.37 9 25
IHH N/PTCH2 0.038 0.051 -10000 0 -10000 0 0
CDON 0.027 0.045 -10000 0 -0.54 3 3
IHH N/PTCH1 0 0.18 0.47 2 -0.36 83 85
Megalin/LRPAP1 -0.071 0.2 -10000 0 -0.4 136 136
PTCH2 0.034 0.006 -10000 0 -10000 0 0
SHH Np/Cholesterol 0.014 0.034 -10000 0 -0.31 5 5
PTCH1 -0.009 0.17 0.46 2 -0.36 82 84
HHIP 0.034 0.011 -10000 0 -10000 0 0
Nectin adhesion pathway

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.005 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.049 0.027 -10000 0 -0.4 1 1
PTK2 -0.054 0.18 -10000 0 -0.43 74 74
positive regulation of JNK cascade -0.026 0.15 -10000 0 -0.32 78 78
CDC42/GDP -0.02 0.21 0.46 1 -0.43 87 88
Rac1/GDP -0.02 0.2 -10000 0 -0.42 89 89
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
CDC42/GTP -0.025 0.19 -10000 0 -0.4 77 77
nectin-3/I-afadin -0.024 0.17 -10000 0 -0.39 85 85
RAPGEF1 -0.045 0.2 0.47 1 -0.46 82 83
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.057 0.22 -10000 0 -0.51 86 86
PDGFB-D/PDGFRB 0.034 0.005 -10000 0 -10000 0 0
TLN1 -0.039 0.12 0.2 4 -0.47 23 27
Rap1/GTP -0.031 0.15 -10000 0 -0.33 79 79
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.054 0.042 -10000 0 -0.31 3 3
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.024 0.17 -10000 0 -0.39 85 85
PVR 0.036 0.015 -10000 0 -10000 0 0
Necl-5(dimer) 0.036 0.015 -10000 0 -10000 0 0
mol:GDP -0.047 0.24 0.47 1 -0.52 90 91
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PI3K -0.004 0.18 -10000 0 -0.34 105 105
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
positive regulation of lamellipodium assembly -0.021 0.16 -10000 0 -0.33 86 86
PVRL1 0.031 0.015 -10000 0 -10000 0 0
PVRL3 -0.052 0.21 0.18 1 -0.54 77 78
PVRL2 0.039 0.027 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CDH1 0.007 0.12 0.18 6 -0.54 22 28
CLDN1 -0.003 0.16 -10000 0 -0.54 41 41
JAM-A/CLDN1 -0.007 0.17 -10000 0 -0.35 83 83
SRC -0.077 0.24 -10000 0 -0.56 89 89
ITGB3 0.035 0.019 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
FARP2 -0.048 0.24 0.48 1 -0.54 77 78
RAC1 0.034 0.005 -10000 0 -10000 0 0
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) -0.001 0.15 -10000 0 -0.35 79 79
nectin-1/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
nectin-2/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
RAC1/GTP/IQGAP1/filamentous actin 0.044 0.011 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin -0.005 0.15 -10000 0 -0.35 79 79
CDC42/GTP/IQGAP1/filamentous actin 0.043 0.014 -10000 0 -10000 0 0
F11R 0.028 0.017 -10000 0 -10000 0 0
positive regulation of filopodium formation -0.026 0.15 -10000 0 -0.32 78 78
alphaV/beta3 Integrin/Talin -0.005 0.13 0.3 1 -0.47 20 21
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
nectin-2(dimer)/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
PIP5K1C -0.037 0.13 -10000 0 -0.27 84 84
VAV2 -0.044 0.24 0.46 1 -0.52 85 86
RAP1/GDP -0.016 0.19 -10000 0 -0.39 83 83
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.001 0.15 -10000 0 -0.34 79 79
nectin-3(dimer)/I-afadin/I-afadin -0.024 0.17 -10000 0 -0.39 85 85
Rac1/GTP -0.023 0.19 -10000 0 -0.4 86 86
PTPRM -0.035 0.14 -10000 0 -0.3 84 84
E-cadherin/beta catenin/alpha catenin 0.052 0.1 -10000 0 -0.29 26 26
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
S1P5 pathway

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration 0.066 0.14 0.32 55 -10000 0 55
GNAI2 0.033 0.01 -10000 0 -10000 0 0
S1P/S1P5/G12 0.023 0.004 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 0.03 0.012 -10000 0 -10000 0 0
RhoA/GTP -0.066 0.14 -10000 0 -0.32 55 55
negative regulation of cAMP metabolic process -0.079 0.14 -10000 0 -0.25 184 184
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
S1PR5 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.079 0.14 -10000 0 -0.25 184 184
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
TCGA08_retinoblastoma

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.036 0.033 0.19 11 -10000 0 11
CDKN2C -0.022 0.15 -10000 0 -0.52 41 41
CDKN2A 0.058 0.055 0.2 7 -10000 0 7
CCND2 -0.008 0.06 0.16 33 -0.19 16 49
RB1 0.005 0.071 0.21 13 -0.2 31 44
CDK4 -0.004 0.073 0.21 37 -0.21 13 50
CDK6 -0.005 0.072 0.21 33 -0.22 16 49
G1/S progression 0.002 0.085 0.21 52 -0.22 15 67
Insulin Pathway

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP -0.15 0.2 -10000 0 -0.32 283 283
TC10/GTP -0.13 0.16 -10000 0 -0.28 271 271
Insulin Receptor/Insulin/IRS1/Shp2 0.04 0.14 -10000 0 -0.32 59 59
HRAS 0.034 0.013 -10000 0 -10000 0 0
APS homodimer 0 0 -10000 0 -10000 0 0
GRB14 0.001 0.19 -10000 0 -0.54 51 51
FOXO3 -0.032 0.16 -10000 0 -0.6 35 35
AKT1 -0.045 0.16 0.32 8 -0.45 22 30
INSR 0.039 0.013 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.091 0.072 0.36 23 -10000 0 23
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 0.03 0.051 -10000 0 -0.54 4 4
SORBS1 -0.28 0.29 -10000 0 -0.54 277 277
CRK 0.031 0.01 -10000 0 -10000 0 0
PTPN1 0.02 0.053 0.28 19 -10000 0 19
CAV1 -0.23 0.18 -10000 0 -0.33 366 366
CBL/APS/CAP/Crk-II/C3G -0.13 0.18 -10000 0 -0.3 275 275
Insulin Receptor/Insulin/IRS1/NCK2 0.042 0.13 -10000 0 -0.32 57 57
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.002 0.15 -10000 0 -0.3 93 93
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.02 0.096 0.36 1 -0.4 6 7
RPS6KB1 -0.039 0.14 0.31 8 -0.4 21 29
PARD6A 0.031 0.019 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.019 0.055 -10000 0 -0.56 4 4
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.012 0.15 0.26 1 -0.42 20 21
HRAS/GTP -0.009 0.078 -10000 0 -0.26 39 39
Insulin Receptor 0.039 0.013 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.04 0.12 -10000 0 -0.3 43 43
PRKCI 0.012 0.087 -10000 0 -0.51 8 8
Insulin Receptor/Insulin/GRB14/PDK1 -0.044 0.16 -10000 0 -0.32 106 106
SHC1 0.028 0.014 -10000 0 -10000 0 0
negative regulation of MAPKKK cascade 0.059 0.052 -10000 0 -0.47 4 4
PI3K 0.008 0.15 -10000 0 -0.3 93 93
NCK2 0.035 0.008 -10000 0 -10000 0 0
RHOQ 0.033 0.026 -10000 0 -0.54 1 1
mol:H2O2 0.001 0.003 -10000 0 -10000 0 0
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
AKT2 -0.047 0.16 0.32 7 -0.44 22 29
PRKCZ -0.006 0.083 -10000 0 -0.43 13 13
SH2B2 0 0 -10000 0 -10000 0 0
SHC/SHIP -0.01 0.091 -10000 0 -0.28 46 46
F2RL2 0.046 0.065 -10000 0 -0.54 3 3
TRIP10 0.033 0.026 -10000 0 -0.54 1 1
Insulin Receptor/Insulin/Shc 0.056 0.036 -10000 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0.044 0.026 -10000 0 -0.34 2 2
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.078 0.055 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
CBL/APS/CAP/Crk-II -0.14 0.18 -10000 0 -0.31 277 277
TC10/GDP 0.024 0.019 -10000 0 -0.4 1 1
Insulin Receptor/Insulin/SHC/GRB10 0.07 0.057 -10000 0 -0.32 4 4
INPP5D -0.037 0.095 -10000 0 -0.3 59 59
SOS1 0.034 0.004 -10000 0 -10000 0 0
SGK1 -0.009 0.012 -10000 0 -10000 0 0
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
p62DOK/RasGAP 0.059 0.053 -10000 0 -0.48 4 4
INS 0.039 0.014 -10000 0 -10000 0 0
mol:PI-3-4-P2 -0.036 0.095 -10000 0 -0.29 59 59
GRB2 0.034 0.018 -10000 0 -10000 0 0
EIF4EBP1 -0.043 0.14 0.31 5 -0.4 21 26
PTPRA 0.038 0.013 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
TC10/GTP/CIP4 0.044 0.026 -10000 0 -0.34 2 2
PDPK1 0.032 0.01 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0 0.088 -10000 0 -0.25 42 42
Insulin Receptor/Insulin/IRS1 0.023 0.13 -10000 0 -0.32 59 59
Insulin Receptor/Insulin/IRS3 0.057 0.024 -10000 0 -10000 0 0
Par3/Par6 0.073 0.058 -10000 0 -0.29 5 5
p75(NTR)-mediated signaling

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.049 0.012 -10000 0 -10000 0 0
Necdin/E2F1 -0.044 0.18 -10000 0 -0.36 118 118
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.002 0.15 -10000 0 -0.31 89 89
NGF (dimer)/p75(NTR)/BEX1 -0.006 0.14 -10000 0 -0.33 76 76
NT-4/5 (dimer)/p75(NTR) -0.041 0.15 -10000 0 -0.38 80 80
IKBKB 0.029 0.013 -10000 0 -10000 0 0
AKT1 -0.033 0.16 0.34 3 -0.32 97 100
IKBKG 0.034 0.004 -10000 0 -10000 0 0
BDNF 0.038 0.048 -10000 0 -0.54 2 2
MGDIs/NGR/p75(NTR)/LINGO1 0.013 0.15 0.26 4 -0.33 72 76
FURIN 0.037 0.023 -10000 0 -10000 0 0
proBDNF (dimer)/p75(NTR)/Sortilin 0.001 0.15 -10000 0 -0.34 75 75
LINGO1 0.056 0.053 -10000 0 -10000 0 0
Sortilin/TRAF6/NRIF 0.033 0.029 -10000 0 -0.28 1 1
proBDNF (dimer) 0.038 0.047 -10000 0 -0.54 2 2
NTRK1 0.031 0.022 -10000 0 -10000 0 0
RTN4R 0.041 0.035 -10000 0 -10000 0 0
neuron apoptosis -0.012 0.16 0.51 2 -0.47 15 17
IRAK1 0.036 0.015 -10000 0 -10000 0 0
SHC1 -0.026 0.11 -10000 0 -0.34 54 54
ARHGDIA 0.033 0.011 -10000 0 -10000 0 0
RhoA/GTP 0.025 0.006 -10000 0 -10000 0 0
Gamma Secretase 0.076 0.054 -10000 0 -0.3 1 1
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 -0.007 0.14 -10000 0 -0.32 83 83
MAGEH1 0.019 0.094 -10000 0 -0.54 14 14
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.078 0.2 -10000 0 -0.37 151 151
Mammalian IAPs/DIABLO 0.046 0.078 -10000 0 -0.31 17 17
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 0.044 0.036 -10000 0 -10000 0 0
APP 0.029 0.06 -10000 0 -0.54 5 5
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.033 0.007 -10000 0 -10000 0 0
RhoA/GDP/RHOGDI -0.01 0.12 -10000 0 -0.29 74 74
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest -0.036 0.11 0.21 30 -0.27 74 104
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK -0.016 0.095 -10000 0 -0.25 58 58
NT-4/5 (dimer)/p75(NTR)/TRAF6 -0.018 0.14 -10000 0 -0.34 76 76
NCSTN 0.028 0.014 -10000 0 -10000 0 0
mol:GTP -0.018 0.15 -10000 0 -0.35 79 79
PSENEN 0.035 0.015 -10000 0 -10000 0 0
mol:ceramide -0.021 0.13 -10000 0 -0.31 74 74
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.012 0.078 -10000 0 -0.21 57 57
p75(NTR)/beta APP -0.025 0.16 -10000 0 -0.39 83 83
BEX1 0.055 0.05 -10000 0 -10000 0 0
mol:GDP -0.053 0.12 -10000 0 -0.34 76 76
NGF (dimer) 0.004 0.13 -10000 0 -0.31 65 65
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.028 0.15 -10000 0 -0.31 70 70
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RAC1/GTP -0.013 0.12 -10000 0 -0.29 75 75
MYD88 0.034 0.011 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA -0.017 0.15 -10000 0 -0.35 79 79
RHOB 0.033 0.037 -10000 0 -0.54 2 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.058 0.036 -10000 0 -10000 0 0
NT3 (dimer) -0.12 0.25 -10000 0 -0.54 134 134
TP53 -0.027 0.13 0.41 6 -10000 0 6
PRDM4 -0.018 0.13 -10000 0 -0.31 74 74
BDNF (dimer) 0.056 0.17 -10000 0 -0.31 70 70
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
SORT1 0.034 0.006 -10000 0 -10000 0 0
activation of caspase activity -0.007 0.14 -10000 0 -0.31 89 89
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0 0.13 -10000 0 -0.31 74 74
RHOC 0.034 0.005 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 -0.028 0.14 0.31 5 -0.34 65 70
DIABLO 0.035 0.003 -10000 0 -10000 0 0
SMPD2 -0.021 0.13 -10000 0 -0.31 74 74
APH1B 0.033 0.027 -10000 0 -0.54 1 1
APH1A 0.032 0.028 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin -0.017 0.14 -10000 0 -0.34 74 74
PSEN1 0.033 0.007 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.049 0.012 -10000 0 -10000 0 0
NT3 (dimer)/p75(NTR) -0.13 0.24 -10000 0 -0.41 196 196
MAPK8 -0.024 0.14 0.3 6 -0.33 64 70
MAPK9 -0.024 0.13 0.28 6 -0.32 63 69
APAF1 0.035 0.003 -10000 0 -10000 0 0
NTF3 -0.12 0.26 -10000 0 -0.54 134 134
NTF4 0 0 -10000 0 -10000 0 0
NDN -0.099 0.24 -10000 0 -0.54 117 117
RAC1/GDP 0.025 0.004 -10000 0 -10000 0 0
RhoA-B-C/GDP 0.009 0.14 -10000 0 -0.29 79 79
p75 CTF/Sortilin/TRAF6/NRIF 0.08 0.027 -10000 0 -10000 0 0
RhoA-B-C/GTP -0.018 0.15 -10000 0 -0.35 79 79
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.027 0.14 -10000 0 -0.3 71 71
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.017 0.14 -10000 0 -0.31 75 75
PRKACB 0.035 0.083 -10000 0 -0.54 8 8
proBDNF (dimer)/p75 ECD 0.052 0.037 -10000 0 -0.4 2 2
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BIRC2 0.031 0.011 -10000 0 -10000 0 0
neuron projection morphogenesis -0.1 0.16 -10000 0 -0.39 99 99
BAD -0.024 0.15 0.46 6 -0.34 64 70
RIPK2 0.029 0.022 -10000 0 -10000 0 0
NGFR -0.055 0.2 -10000 0 -0.54 76 76
CYCS -0.009 0.13 0.27 5 -0.29 67 72
ADAM17 0.034 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 -0.003 0.12 -10000 0 -0.31 62 62
BCL2L11 -0.024 0.15 0.44 7 -0.33 64 71
BDNF (dimer)/p75(NTR) -0.02 0.16 -10000 0 -0.39 77 77
PI3K -0.03 0.16 -10000 0 -0.34 100 100
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0 0.13 -10000 0 -0.31 74 74
NDNL2 0.033 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
PRKCI 0.035 0.017 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR) -0.041 0.15 -10000 0 -0.38 80 80
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.006 0.13 -10000 0 -0.3 74 74
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
PLG 0.031 0.027 -10000 0 -0.54 1 1
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 -0.027 0.13 -10000 0 -0.33 74 74
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
NGFRAP1 0.01 0.12 -10000 0 -0.54 22 22
CASP3 -0.022 0.14 0.41 8 -0.31 65 73
E2F1 0.051 0.048 -10000 0 -10000 0 0
CASP9 0.033 0.008 -10000 0 -10000 0 0
IKK complex 0.03 0.086 -10000 0 -0.3 1 1
NGF (dimer)/TRKA 0.023 0.016 -10000 0 -10000 0 0
MMP7 -0.041 0.19 -10000 0 -0.54 64 64
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.012 0.13 -10000 0 -0.3 73 73
MMP3 0.094 0.099 -10000 0 -0.54 5 5
APAF-1/Caspase 9 -0.033 0.1 -10000 0 -0.27 62 62
Presenilin action in Notch and Wnt signaling

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.037 0.085 -10000 0 -0.41 14 14
HDAC1 0.023 0.028 -10000 0 -10000 0 0
AES 0.033 0.008 -10000 0 -10000 0 0
FBXW11 0.034 0.006 -10000 0 -10000 0 0
DTX1 0.031 0.044 -10000 0 -0.54 3 3
LRP6/FZD1 0.047 0.024 -10000 0 -0.4 1 1
TLE1 0.016 0.098 -10000 0 -0.55 15 15
AP1 -0.22 0.19 -10000 0 -0.34 327 327
NCSTN 0.028 0.014 -10000 0 -10000 0 0
ADAM10 0.034 0.013 -10000 0 -10000 0 0
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.019 0.14 -10000 0 -0.68 11 11
NICD/RBPSUH 0.055 0.092 -10000 0 -0.41 14 14
WIF1 -0.38 0.26 -10000 0 -0.54 370 370
NOTCH1 0.02 0.072 -10000 0 -0.42 12 12
PSENEN 0.035 0.015 -10000 0 -10000 0 0
KREMEN2 0.11 0.076 -10000 0 -10000 0 0
DKK1 0.007 0.18 -10000 0 -0.54 44 44
beta catenin/beta TrCP1 0.009 0.092 -10000 0 -0.43 8 8
APH1B 0.033 0.027 -10000 0 -0.54 1 1
APH1A 0.032 0.028 -10000 0 -10000 0 0
AXIN1 0.015 0.07 -10000 0 -0.6 4 4
CtBP/CBP/TCF1/TLE1/AES 0.001 0.079 0.28 3 -0.37 7 10
PSEN1 0.033 0.007 -10000 0 -10000 0 0
FOS -0.35 0.27 -10000 0 -0.54 344 344
JUN -0.067 0.22 -10000 0 -0.54 89 89
MAP3K7 0.031 0.011 -10000 0 -10000 0 0
CTNNB1 -0.002 0.09 -10000 0 -0.42 10 10
MAPK3 0.032 0.01 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.1 0.07 -10000 0 -0.31 3 3
HNF1A 0.035 0.013 -10000 0 -10000 0 0
CTBP1 0.032 0.009 -10000 0 -10000 0 0
MYC -0.052 0.32 -10000 0 -1.3 31 31
NKD1 0.032 0.021 -10000 0 -10000 0 0
FZD1 0.033 0.026 -10000 0 -0.54 1 1
NOTCH1 precursor/Deltex homolog 1 0.056 0.095 -10000 0 -0.41 14 14
apoptosis -0.22 0.19 -10000 0 -0.34 327 327
Delta 1/NOTCHprecursor 0.053 0.092 -10000 0 -0.41 14 14
DLL1 0.032 0.009 -10000 0 -10000 0 0
PPARD 0.024 0.1 -10000 0 -0.79 7 7
Gamma Secretase 0.076 0.055 -10000 0 -0.3 1 1
APC 0.005 0.1 -10000 0 -0.53 13 13
DVL1 -0.039 0.095 -10000 0 -0.36 29 29
CSNK2A1 0.034 0.008 -10000 0 -10000 0 0
MAP3K7IP1 -0.002 0.006 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 0.082 0.13 0.26 50 -0.29 42 92
LRP6 0.033 0.008 -10000 0 -10000 0 0
CSNK1A1 0.034 0.006 -10000 0 -10000 0 0
NLK 0.015 0.025 -10000 0 -10000 0 0
CCND1 0.036 0.23 -10000 0 -1.3 12 12
WNT1 0.034 0.005 -10000 0 -10000 0 0
Axin1/APC/beta catenin 0.018 0.12 0.34 2 -0.47 14 16
DKK2 0.032 0.054 -10000 0 -0.54 4 4
NOTCH1 precursor/DVL1 -0.014 0.12 -10000 0 -0.66 11 11
GSK3B 0.034 0.009 -10000 0 -10000 0 0
FRAT1 0.034 0.008 -10000 0 -10000 0 0
NOTCH/Deltex homolog 1 0.037 0.087 -10000 0 -0.41 14 14
PPP2R5D -0.002 0.063 -10000 0 -0.37 10 10
MAPK1 0.033 0.009 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 -0.2 0.18 -10000 0 -0.31 355 355
RBPJ 0.033 0.008 -10000 0 -10000 0 0
CREBBP 0.034 0.016 -10000 0 -10000 0 0
Stabilization and expansion of the E-cadherin adherens junction

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.01 0.091 -10000 0 -0.26 46 46
epithelial cell differentiation 0.04 0.086 -10000 0 -0.29 26 26
CYFIP2 0.05 0.047 -10000 0 -10000 0 0
ENAH -0.008 0.071 0.28 5 -0.32 1 6
EGFR -0.27 0.29 -10000 0 -0.54 269 269
EPHA2 0.026 0.062 -10000 0 -0.54 6 6
MYO6 0.001 0.074 -10000 0 -0.28 25 25
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
ABI1/Sra1/Nap1 0.074 0.035 -10000 0 -10000 0 0
AQP5 -0.14 0.24 -10000 0 -0.49 151 151
CTNND1 0.033 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.001 0.072 -10000 0 -0.28 25 25
regulation of calcium-dependent cell-cell adhesion -0.023 0.1 -10000 0 -0.29 63 63
EGF -0.15 0.27 -10000 0 -0.54 163 163
NCKAP1 0.034 0.005 -10000 0 -10000 0 0
AQP3 -0.052 0.18 -10000 0 -0.49 62 62
cortical microtubule organization 0.04 0.086 -10000 0 -0.29 26 26
GO:0000145 -0.021 0.064 -10000 0 -0.27 25 25
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.046 0.089 -10000 0 -0.29 26 26
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
ARF6/GDP -0.029 0.059 -10000 0 -0.3 6 6
ARF6 0.034 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.058 0.059 -10000 0 -0.32 6 6
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.001 0.07 -10000 0 -0.26 26 26
PVRL2 0.039 0.027 -10000 0 -10000 0 0
ZYX -0.002 0.073 -10000 0 -0.28 26 26
ARF6/GTP 0.064 0.062 -10000 0 -0.3 6 6
CDH1 0.007 0.12 -10000 0 -0.54 22 22
EGFR/EGFR/EGF/EGF -0.23 0.2 -10000 0 -0.35 354 354
RhoA/GDP 0.041 0.084 -10000 0 -0.28 26 26
actin cytoskeleton organization -0.021 0.068 -10000 0 -0.28 25 25
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
GIT1 0.032 0.011 -10000 0 -10000 0 0
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
DIAPH1 0.059 0.12 -10000 0 -0.56 7 7
Wnt receptor signaling pathway -0.04 0.086 0.29 26 -10000 0 26
RHOA 0.033 0.008 -10000 0 -10000 0 0
RhoA/GTP -0.029 0.059 -10000 0 -0.28 20 20
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
VCL -0.021 0.069 -10000 0 -0.28 25 25
EFNA1 0.028 0.015 -10000 0 -10000 0 0
LPP -0.023 0.066 -10000 0 -0.27 25 25
Ephrin A1/EPHA2 0.023 0.084 -10000 0 -0.29 26 26
SEC6/SEC8 -0.007 0.068 -10000 0 -0.27 26 26
MGAT3 -0.023 0.11 -10000 0 -0.29 63 63
HGF/MET 0.005 0.13 -10000 0 -0.29 73 73
HGF 0.035 0.01 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.01 0.092 -10000 0 -0.26 46 46
actin cable formation 0.054 0.11 0.35 14 -0.29 1 15
KIAA1543 -0.021 0.065 -10000 0 -0.27 25 25
KIFC3 0.001 0.07 -10000 0 -0.28 25 25
NCK1 0.034 0.005 -10000 0 -10000 0 0
EXOC3 0.033 0.008 -10000 0 -10000 0 0
ACTN1 -0.001 0.073 -10000 0 -0.28 25 25
NCK1/GIT1 0.047 0.016 -10000 0 -10000 0 0
mol:GDP 0.04 0.086 -10000 0 -0.29 26 26
EXOC4 0.034 0.006 -10000 0 -10000 0 0
STX4 -0.001 0.072 -10000 0 -0.28 25 25
PIP5K1C -0.001 0.073 -10000 0 -0.28 25 25
LIMA1 0.013 0.11 -10000 0 -0.54 19 19
ABI1 0.034 0.007 -10000 0 -10000 0 0
ROCK1 0.012 0.1 0.3 11 -0.34 2 13
adherens junction assembly -0.03 0.13 0.3 1 -0.62 14 15
IGF-1R heterotetramer/IGF1 -0.13 0.18 -10000 0 -0.3 248 248
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
MET -0.022 0.17 -10000 0 -0.54 50 50
PLEKHA7 -0.001 0.073 -10000 0 -0.28 25 25
mol:GTP 0.056 0.058 -10000 0 -0.31 6 6
establishment of epithelial cell apical/basal polarity -0.012 0.087 0.36 5 -0.35 1 6
cortical actin cytoskeleton stabilization -0.01 0.091 -10000 0 -0.26 46 46
regulation of cell-cell adhesion -0.021 0.068 -10000 0 -0.28 25 25
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.01 0.092 -10000 0 -0.26 46 46
Syndecan-3-mediated signaling events

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.028 0.014 -9999 0 -10000 0 0
Syndecan-3/Src/Cortactin -0.13 0.17 -9999 0 -0.29 198 198
Syndecan-3/Neurocan 0.043 0.1 -9999 0 -0.46 17 17
POMC 0.035 0.031 -9999 0 -0.54 1 1
EGFR -0.27 0.29 -9999 0 -0.54 269 269
Syndecan-3/EGFR -0.12 0.18 -9999 0 -0.3 207 207
AGRP 0.031 0.015 -9999 0 -10000 0 0
NCSTN 0.028 0.014 -9999 0 -10000 0 0
PSENEN 0.035 0.015 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.033 0.027 -9999 0 -0.54 1 1
APH1A 0.032 0.028 -9999 0 -10000 0 0
NCAN 0.039 0.028 -9999 0 -10000 0 0
long-term memory 0.041 0.096 -9999 0 -0.44 14 14
Syndecan-3/IL8 0.049 0.11 -9999 0 -0.44 18 18
PSEN1 0.033 0.007 -9999 0 -10000 0 0
Src/Cortactin 0.04 0.022 -9999 0 -10000 0 0
FYN 0.03 0.037 -9999 0 -0.54 2 2
limb bud formation -0.001 0.089 -9999 0 -0.48 16 16
MC4R 0.034 0.013 -9999 0 -10000 0 0
SRC 0.033 0.008 -9999 0 -10000 0 0
PTN -0.36 0.27 -9999 0 -0.54 354 354
FGFR/FGF/Syndecan-3 -0.001 0.09 -9999 0 -0.49 16 16
neuron projection morphogenesis -0.12 0.16 -9999 0 -0.55 19 19
Syndecan-3/AgRP 0.034 0.1 -9999 0 -0.46 17 17
Syndecan-3/AgRP/MC4R 0.05 0.1 -9999 0 -0.46 15 15
Fyn/Cortactin 0.038 0.031 -9999 0 -0.4 1 1
SDC3 -0.001 0.091 -9999 0 -0.49 16 16
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration 0.048 0.11 -9999 0 -0.43 18 18
IL8 0.048 0.053 -9999 0 -0.54 1 1
Syndecan-3/Fyn/Cortactin 0.042 0.098 -9999 0 -0.45 14 14
Syndecan-3/CASK -0.003 0.087 -9999 0 -0.46 17 17
alpha-MSH/MC4R 0.05 0.027 -9999 0 -0.4 1 1
Gamma Secretase 0.076 0.054 -9999 0 -0.3 1 1
ErbB4 signaling events

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.035 0.11 0.31 6 -0.35 6 12
epithelial cell differentiation 0.088 0.092 -10000 0 -10000 0 0
ITCH 0.047 0.025 -10000 0 -10000 0 0
WWP1 0.049 0.15 0.52 29 -10000 0 29
FYN 0.03 0.037 -10000 0 -0.54 2 2
EGFR -0.27 0.29 -10000 0 -0.54 269 269
PRL 0.034 0.006 -10000 0 -10000 0 0
neuron projection morphogenesis 0.029 0.12 0.38 10 -0.35 6 16
PTPRZ1 -0.36 0.27 -10000 0 -0.54 353 353
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.017 0.1 -10000 0 -0.38 6 6
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.012 0.11 0.27 7 -0.32 34 41
ADAM17 0.048 0.025 -10000 0 -10000 0 0
ErbB4/ErbB4 0.031 0.13 0.4 31 -0.34 6 37
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.035 0.11 0.32 7 -0.34 4 11
NCOR1 0.031 0.011 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.005 0.11 -10000 0 -0.39 7 7
GRIN2B -0.014 0.11 0.41 1 -0.37 7 8
ErbB4/ErbB2/betacellulin 0.03 0.1 -10000 0 -0.31 10 10
STAT1 0.059 0.055 -10000 0 -10000 0 0
HBEGF 0.029 0.051 -10000 0 -0.54 4 4
PRLR 0.071 0.064 -10000 0 -10000 0 0
E4ICDs/ETO2 -0.006 0.15 0.31 2 -0.39 42 44
axon guidance 0.12 0.14 0.39 56 -0.31 1 57
NEDD4 0.04 0.06 -10000 0 -0.52 5 5
Prolactin receptor/Prolactin receptor/Prolactin 0.074 0.047 -10000 0 -10000 0 0
CBFA2T3 -0.022 0.17 -10000 0 -0.54 47 47
ErbB4/ErbB2/HBEGF 0.038 0.088 -10000 0 -0.33 3 3
MAPK3 0.029 0.12 0.4 6 -0.36 6 12
STAT1 (dimer) 0.055 0.11 0.35 10 -0.36 3 13
MAPK1 0.035 0.12 0.42 9 -0.36 6 15
JAK2 0.033 0.011 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta 0.003 0.11 -10000 0 -0.38 7 7
NRG1 -0.013 0.11 -10000 0 -0.4 38 38
NRG3 0.035 0.043 -10000 0 -0.54 2 2
NRG2 -0.35 0.27 -10000 0 -0.54 339 339
NRG4 0.035 0.012 -10000 0 -10000 0 0
heart development 0.12 0.14 0.39 56 -0.31 1 57
neural crest cell migration 0.004 0.11 -10000 0 -0.38 7 7
ERBB2 0.021 0.029 0.3 1 -0.37 1 2
WWOX/E4ICDs 0.026 0.1 0.35 5 -0.36 3 8
SHC1 0.028 0.014 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 -0.13 0.16 -10000 0 -0.29 189 189
apoptosis -0.037 0.1 0.32 6 -0.31 26 32
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.18 0.17 -10000 0 -0.32 255 255
ErbB4/ErbB2/epiregulin 0.049 0.096 0.36 4 -0.34 1 5
ErbB4/ErbB4/betacellulin/betacellulin 0.022 0.13 0.29 28 -0.35 18 46
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.088 0.12 0.38 9 -0.32 3 12
MDM2 0.028 0.11 0.34 27 -0.36 3 30
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.001 0.1 -10000 0 -0.3 35 35
STAT5A 0.11 0.13 0.4 33 -10000 0 33
ErbB4/EGFR/neuregulin 1 beta -0.15 0.18 -10000 0 -0.45 59 59
DLG4 0.031 0.011 -10000 0 -10000 0 0
GRB2/SHC 0.039 0.026 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.024 0.091 0.27 2 -0.33 3 5
STAT5A (dimer) 0.14 0.12 0.4 24 -10000 0 24
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.13 0.12 0.4 30 -0.36 1 31
LRIG1 0.014 0.1 -10000 0 -0.54 17 17
EREG 0.045 0.049 -10000 0 -0.54 1 1
BTC 0.011 0.12 -10000 0 -0.54 21 21
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.11 0.14 0.39 54 -0.32 1 55
ERBB4 0.031 0.13 0.4 31 -0.34 6 37
STAT5B 0.033 0.01 -10000 0 -10000 0 0
YAP1 -0.001 0.12 0.26 6 -0.43 27 33
GRB2 0.034 0.018 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.04 0.084 -10000 0 -10000 0 0
glial cell differentiation -0.023 0.091 0.33 3 -0.27 2 5
WWOX 0.034 0.031 -10000 0 -10000 0 0
cell proliferation 0.055 0.14 0.43 14 -0.41 6 20
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 0.006 0.13 -10000 0 -0.4 48 48
CRKL 0 0.12 0.32 2 -0.39 17 19
mol:PIP3 0.005 0.062 0.49 3 -0.8 1 4
AKT1 0.018 0.08 0.36 8 -0.7 1 9
PTK2B 0.028 0.014 -10000 0 -10000 0 0
RAPGEF1 -0.001 0.11 0.31 2 -0.42 11 13
RANBP10 0.03 0.012 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
HGF/MET/SHIP2 0.023 0.12 -10000 0 -0.34 50 50
MAP3K5 -0.011 0.13 0.37 1 -0.41 24 25
HGF/MET/CIN85/CBL/ENDOPHILINS 0.037 0.12 -10000 0 -0.31 51 51
AP1 -0.29 0.24 -10000 0 -0.43 346 346
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
apoptosis -0.54 0.38 -10000 0 -0.77 367 367
STAT3 (dimer) -0.007 0.11 -10000 0 -0.42 16 16
GAB1/CRKL/SHP2/PI3K 0.012 0.15 -10000 0 -0.44 16 16
INPP5D 0 0 -10000 0 -10000 0 0
CBL/CRK 0.015 0.11 0.36 1 -0.4 12 13
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.033 0.008 -10000 0 -10000 0 0
PTEN 0.029 0.045 -10000 0 -0.54 3 3
ELK1 -0.019 0.085 0.29 9 -10000 0 9
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 0.007 0.065 -10000 0 -0.26 5 5
PAK1 0.043 0.098 0.38 13 -0.67 1 14
HGF/MET/RANBP10 0.022 0.12 -10000 0 -0.34 50 50
HRAS -0.031 0.2 -10000 0 -0.59 56 56
DOCK1 -0.003 0.11 0.43 2 -0.42 11 13
GAB1 -0.003 0.12 -10000 0 -0.38 22 22
CRK -0.002 0.11 0.37 1 -0.39 17 18
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.022 0.18 -10000 0 -0.54 55 55
JUN -0.067 0.22 -10000 0 -0.54 89 89
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.012 0.087 -10000 0 -0.27 51 51
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
cell morphogenesis -0.016 0.15 0.4 7 -0.44 18 25
GRB2/SHC 0.02 0.083 -10000 0 -0.25 32 32
FOS -0.35 0.27 -10000 0 -0.54 344 344
GLMN 0.005 0.004 -10000 0 -10000 0 0
cell motility -0.019 0.085 0.28 9 -10000 0 9
HGF/MET/MUC20 0.008 0.12 -10000 0 -0.34 51 51
cell migration 0.019 0.081 -10000 0 -0.25 32 32
GRB2 0.034 0.018 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
MET/RANBP10 0.001 0.13 -10000 0 -0.4 50 50
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.011 0.098 -10000 0 -0.29 41 41
MET/MUC20 -0.016 0.12 -10000 0 -0.39 52 52
RAP1B 0.005 0.11 0.36 3 -0.41 9 12
RAP1A -0.001 0.11 0.51 1 -0.4 10 11
HGF/MET/RANBP9 0.027 0.12 -10000 0 -0.34 48 48
RAF1 -0.024 0.19 -10000 0 -0.56 56 56
STAT3 -0.007 0.11 -10000 0 -0.43 16 16
cell proliferation 0.023 0.15 0.32 10 -0.38 38 48
RPS6KB1 0.002 0.061 -10000 0 -0.35 8 8
MAPK3 -0.037 0.081 0.62 3 -10000 0 3
MAPK1 -0.004 0.17 0.66 28 -10000 0 28
RANBP9 0.034 0.009 -10000 0 -10000 0 0
MAPK8 -0.002 0.13 0.45 1 -0.38 23 24
SRC -0.006 0.097 -10000 0 -0.37 14 14
PI3K -0.009 0.13 -10000 0 -0.28 85 85
MET/Glomulin -0.012 0.11 -10000 0 -0.35 50 50
SOS1 0.034 0.004 -10000 0 -10000 0 0
MAP2K1 -0.02 0.18 0.48 1 -0.52 55 56
MET -0.022 0.17 -10000 0 -0.54 50 50
MAP4K1 0.004 0.12 0.39 1 -0.43 16 17
PTK2 0.027 0.014 -10000 0 -10000 0 0
MAP2K2 -0.021 0.18 0.48 1 -0.52 55 56
BAD 0.015 0.075 0.35 5 -0.67 1 6
MAP2K4 -0.011 0.12 0.35 1 -0.38 23 24
SHP2/GRB2/SOS1/GAB1 0.02 0.14 -10000 0 -0.36 52 52
INPPL1 0.032 0.01 -10000 0 -10000 0 0
PXN 0.034 0.004 -10000 0 -10000 0 0
SH3KBP1 0.033 0.027 -10000 0 -0.54 1 1
HGS -0.015 0.078 -10000 0 -0.25 46 46
PLCgamma1/PKC 0.024 0.006 -10000 0 -10000 0 0
HGF 0.035 0.01 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
PTPRJ 0.035 0.017 -10000 0 -10000 0 0
NCK/PLCgamma1 0.026 0.094 -10000 0 -0.24 48 48
PDPK1 0.02 0.084 0.41 5 -0.74 1 6
HGF/MET/SHIP 0.008 0.12 -10000 0 -0.34 51 51
TCGA08_p53

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A 0.028 0.046 0.14 78 -10000 0 78
TP53 -0.002 0.055 -10000 0 -0.19 36 36
Senescence -0.005 0.06 -10000 0 -0.19 46 46
Apoptosis -0.005 0.06 -10000 0 -0.19 46 46
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 -0.009 0.067 0.3 18 -10000 0 18
MDM4 0.029 0.017 -10000 0 -10000 0 0
LPA receptor mediated events

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.047 0.035 -10000 0 -0.3 3 3
NF kappa B1 p50/RelA/I kappa B alpha 0.058 0.06 0.28 3 -0.24 2 5
AP1 -0.21 0.19 -10000 0 -0.33 344 344
mol:PIP3 -0.15 0.16 -10000 0 -0.28 277 277
AKT1 0.005 0.091 -10000 0 -0.33 7 7
PTK2B -0.015 0.08 -10000 0 -0.18 87 87
RHOA 0.01 0.066 -10000 0 -0.27 18 18
PIK3CB 0.034 0.006 -10000 0 -10000 0 0
mol:Ca2+ 0.026 0.057 0.19 43 -0.27 1 44
MAGI3 0.041 0.042 -10000 0 -0.54 1 1
RELA 0.034 0.007 -10000 0 -10000 0 0
apoptosis 0.017 0.022 -10000 0 -0.19 5 5
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization -0.014 0.078 0.22 6 -0.24 11 17
NF kappa B1 p50/RelA 0.02 0.04 0.17 1 -0.31 1 2
endothelial cell migration 0.017 0.053 0.27 2 -0.47 5 7
ADCY4 -0.047 0.095 -10000 0 -0.3 16 16
ADCY5 -0.045 0.093 -10000 0 -0.29 12 12
ADCY6 -0.045 0.093 -10000 0 -0.29 12 12
ADCY7 -0.037 0.09 -10000 0 -0.3 13 13
ADCY1 -0.045 0.093 -10000 0 -0.29 13 13
ADCY2 -0.047 0.097 -10000 0 -0.31 17 17
ADCY3 -0.045 0.093 -10000 0 -0.23 35 35
ADCY8 -0.04 0.087 -10000 0 -0.31 10 10
ADCY9 -0.042 0.09 -10000 0 -0.3 12 12
GSK3B -0.014 0.079 0.24 5 -0.21 20 25
arachidonic acid secretion -0.052 0.1 -10000 0 -0.25 51 51
GNG2 0.033 0.026 -10000 0 -0.54 1 1
TRIP6 0.024 0.02 -10000 0 -0.39 1 1
GNAO1 0.019 0.021 -10000 0 -0.26 2 2
HRAS 0.034 0.013 -10000 0 -10000 0 0
NFKBIA 0.026 0.06 0.26 3 -0.25 3 6
GAB1 0.033 0.027 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly 0.047 0.12 -10000 0 -0.84 9 9
JUN -0.066 0.22 -10000 0 -0.54 89 89
LPA/LPA2/NHERF2 0.024 0.016 -10000 0 -0.13 1 1
TIAM1 0.028 0.14 -10000 0 -0.98 9 9
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.026 0.055 0.19 43 -10000 0 43
PLCB3 0.036 0.049 0.19 40 -10000 0 40
FOS -0.35 0.27 -10000 0 -0.54 344 344
positive regulation of mitosis -0.052 0.1 -10000 0 -0.25 51 51
LPA/LPA1-2-3 0.007 0.02 -10000 0 -0.18 5 5
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
stress fiber formation 0.015 0.061 -10000 0 -0.28 8 8
GNAZ 0.016 0.044 -10000 0 -0.28 10 10
EGFR/PI3K-beta/Gab1 -0.15 0.17 -10000 0 -0.3 277 277
positive regulation of dendritic cell cytokine production 0.007 0.019 -10000 0 -0.18 5 5
LPA/LPA2/MAGI-3 0.029 0.03 -10000 0 -0.2 3 3
ARHGEF1 0.038 0.056 -10000 0 -0.22 2 2
GNAI2 0.02 0.025 -10000 0 -0.21 5 5
GNAI3 0.021 0.023 -10000 0 -0.22 4 4
GNAI1 -0.1 0.17 -10000 0 -0.34 184 184
LPA/LPA3 0.002 0.01 -10000 0 -0.093 5 5
LPA/LPA2 0.002 0.01 -10000 0 -0.092 5 5
LPA/LPA1 0.007 0.025 -10000 0 -0.24 5 5
HB-EGF/EGFR -0.12 0.2 -10000 0 -0.31 250 250
HBEGF 0.066 0.076 -10000 0 -0.4 4 4
mol:DAG 0.026 0.055 0.19 43 -10000 0 43
cAMP biosynthetic process -0.054 0.1 0.24 1 -0.3 21 22
NFKB1 0.034 0.005 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
GNB1 0.034 0.012 -10000 0 -10000 0 0
LYN 0.04 0.068 0.26 19 -0.28 1 20
GNAQ 0.003 0.009 0.056 2 -0.074 5 7
LPAR2 0 0.001 -10000 0 -10000 0 0
LPAR3 0 0 -10000 0 -10000 0 0
LPAR1 0.003 0.016 0.074 2 -0.14 5 7
IL8 -0.19 0.22 0.37 8 -0.39 246 254
PTK2 0.02 0.021 -10000 0 -0.16 4 4
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
CASP3 0.017 0.022 -10000 0 -0.19 5 5
EGFR -0.27 0.29 -10000 0 -0.54 269 269
PLCG1 0.017 0.018 -10000 0 -0.11 2 2
PLD2 0.023 0.025 -10000 0 -0.2 5 5
G12/G13 0.045 0.03 -10000 0 -0.23 2 2
PI3K-beta -0.009 0.089 -10000 0 -0.37 8 8
cell migration 0.027 0.047 -10000 0 -0.25 9 9
SLC9A3R2 0.033 0.015 -10000 0 -10000 0 0
PXN 0.015 0.061 -10000 0 -0.29 8 8
HRAS/GTP -0.053 0.1 -10000 0 -0.25 52 52
RAC1 0.034 0.005 -10000 0 -10000 0 0
MMP9 0.095 0.074 -10000 0 -10000 0 0
PRKCE 0.034 0.004 -10000 0 -10000 0 0
PRKCD 0.024 0.058 0.21 10 -0.26 1 11
Gi(beta/gamma) -0.049 0.11 -10000 0 -0.32 26 26
mol:LPA 0.003 0.016 0.074 2 -0.14 5 7
TRIP6/p130 Cas/FAK1/Paxillin 0.03 0.052 -10000 0 -0.24 4 4
MAPKKK cascade -0.052 0.1 -10000 0 -0.25 51 51
contractile ring contraction involved in cytokinesis 0.009 0.068 -10000 0 -0.27 18 18
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 0.021 0.039 -10000 0 -0.31 4 4
GNA15 0.017 0.014 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
MAPT -0.014 0.08 0.22 6 -0.25 11 17
GNA11 0.015 0.009 -10000 0 -10000 0 0
Rac1/GTP 0.049 0.13 -10000 0 -0.89 9 9
MMP2 0.017 0.053 0.27 2 -0.47 5 7
Neurotrophic factor-mediated Trk receptor signaling

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.032 0.009 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.027 0.096 -10000 0 -0.27 18 18
NT3 (dimer)/TRKC -0.082 0.21 -10000 0 -0.4 150 150
NT3 (dimer)/TRKB -0.25 0.29 -10000 0 -0.47 290 290
SHC/Grb2/SOS1/GAB1/PI3K 0.003 0.074 -10000 0 -0.24 27 27
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
BDNF 0.038 0.048 -10000 0 -0.54 2 2
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DYNLT1 0.032 0.009 -10000 0 -10000 0 0
NTRK1 0.031 0.022 -10000 0 -10000 0 0
NTRK2 -0.23 0.29 -10000 0 -0.54 236 236
NTRK3 0.015 0.1 -10000 0 -0.54 16 16
NT-4/5 (dimer)/TRKB -0.17 0.24 -10000 0 -0.37 263 263
neuron apoptosis 0.12 0.21 0.45 112 -10000 0 112
SHC 2-3/Grb2 -0.13 0.23 -10000 0 -0.49 112 112
SHC1 0.028 0.014 -10000 0 -10000 0 0
SHC2 -0.14 0.24 -10000 0 -0.53 117 117
SHC3 -0.12 0.21 -10000 0 -0.52 81 81
STAT3 (dimer) 0.055 0.077 -10000 0 -0.36 10 10
NT3 (dimer)/TRKA -0.086 0.2 -10000 0 -0.38 141 141
RIN/GDP 0.005 0.11 0.27 5 -0.28 18 23
GIPC1 0.035 0.01 -10000 0 -10000 0 0
KRAS 0.035 0.019 -10000 0 -10000 0 0
DNAJA3 -0.055 0.13 -10000 0 -0.35 73 73
RIN/GTP 0.024 0.019 -10000 0 -0.4 1 1
CCND1 0.015 0.12 -10000 0 -0.78 10 10
MAGED1 0.044 0.036 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.053 0.034 -10000 0 -10000 0 0
GRB2 0.034 0.018 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.041 0.027 -10000 0 -10000 0 0
TRKA/NEDD4-2 0.033 0.068 -10000 0 -0.33 14 14
ELMO1 0.034 0.005 -10000 0 -10000 0 0
RhoG/GTP/ELMO1/DOCK1 0.042 0.032 -10000 0 -0.29 4 4
NGF 0 0 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
DOCK1 0.03 0.044 -10000 0 -0.54 3 3
GAB2 0.03 0.012 -10000 0 -10000 0 0
RIT2 0.032 0.026 -10000 0 -0.54 1 1
RIT1 0.029 0.013 -10000 0 -10000 0 0
FRS2 0.033 0.029 -10000 0 -0.54 1 1
DNM1 0.035 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP -0.034 0.15 -10000 0 -0.34 81 81
mol:GDP -0.01 0.15 0.34 6 -0.42 21 27
NGF (dimer) 0 0 -10000 0 -10000 0 0
RhoG/GDP 0.025 0.004 -10000 0 -10000 0 0
RIT1/GDP -0.006 0.098 0.27 1 -0.28 17 18
TIAM1 0.035 0.012 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
BDNF (dimer)/TRKB -0.12 0.2 -10000 0 -0.34 233 233
KIDINS220/CRKL/C3G 0.047 0.015 -10000 0 -10000 0 0
SHC/RasGAP 0.04 0.023 -10000 0 -10000 0 0
FRS2 family/SHP2 0.064 0.028 -10000 0 -0.34 1 1
SHC/GRB2/SOS1/GAB1 0.065 0.043 -10000 0 -10000 0 0
RIT1/GTP 0.021 0.01 -10000 0 -10000 0 0
NT3 (dimer) -0.12 0.25 -10000 0 -0.54 134 134
RAP1/GDP 0.001 0.09 -10000 0 -0.25 15 15
KIDINS220/CRKL 0.032 0.009 -10000 0 -10000 0 0
BDNF (dimer) 0.038 0.047 -10000 0 -0.54 2 2
ubiquitin-dependent protein catabolic process 0.03 0.059 -10000 0 -0.28 14 14
Schwann cell development -0.037 0.032 -10000 0 -10000 0 0
EHD4 0.033 0.007 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.076 0.038 -10000 0 -0.32 1 1
FRS2 family/SHP2/CRK family/C3G/GAB2 0.026 0.068 -10000 0 -0.3 7 7
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CDC42/GTP -0.16 0.22 -10000 0 -0.35 270 270
ABL1 0.034 0.005 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
Rap1/GTP -0.042 0.12 -10000 0 -0.44 24 24
STAT3 0.055 0.077 -10000 0 -0.36 10 10
axon guidance -0.17 0.2 -10000 0 -0.34 270 270
MAPK3 0.047 0.064 0.28 3 -10000 0 3
MAPK1 0.05 0.067 0.28 4 -10000 0 4
CDC42/GDP 0.006 0.11 0.29 6 -0.28 17 23
NTF3 -0.12 0.26 -10000 0 -0.54 134 134
NTF4 0 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/FAIM 0.039 0.022 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
FRS3 0.034 0.006 -10000 0 -10000 0 0
FAIM 0.034 0.006 -10000 0 -10000 0 0
GAB1 0.033 0.027 -10000 0 -0.54 1 1
RASGRF1 -0.053 0.14 -10000 0 -0.35 77 77
SOS1 0.034 0.004 -10000 0 -10000 0 0
MCF2L -0.083 0.17 -10000 0 -0.35 140 140
RGS19 0.034 0.022 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
RAS family/GTP 0.049 0.1 0.36 1 -0.43 5 6
Rac1/GDP 0.006 0.11 0.27 6 -0.28 18 24
NGF (dimer)/TRKA/GRIT 0.021 0.014 -10000 0 -10000 0 0
neuron projection morphogenesis -0.026 0.22 0.42 1 -0.73 28 29
NGF (dimer)/TRKA/NEDD4-2 0.03 0.059 -10000 0 -0.28 14 14
MAP2K1 0.061 0.084 0.36 11 -10000 0 11
NGFR -0.055 0.2 -10000 0 -0.54 76 76
NGF (dimer)/TRKA/GIPC/GAIP 0.025 0.025 -10000 0 -10000 0 0
RAS family/GTP/PI3K 0 0.086 -10000 0 -0.26 40 40
FRS2 family/SHP2/GRB2/SOS1 0.087 0.044 -10000 0 -0.3 1 1
NRAS 0.036 0.016 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
PRKCI 0.035 0.017 -10000 0 -10000 0 0
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAPKKK cascade -0.017 0.071 -10000 0 -0.56 4 4
RASA1 0.034 0.012 -10000 0 -10000 0 0
TRKA/c-Abl 0.043 0.024 -10000 0 -10000 0 0
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
BDNF (dimer)/TRKB/GIPC -0.098 0.2 -10000 0 -0.31 231 231
NGF (dimer)/TRKA/p62/Atypical PKCs 0.05 0.029 -10000 0 -10000 0 0
MATK 0.039 0.028 -10000 0 -10000 0 0
NEDD4L 0.019 0.091 0.18 2 -0.54 13 15
RAS family/GDP -0.034 0.058 -10000 0 -0.22 17 17
NGF (dimer)/TRKA -0.06 0.14 -10000 0 -0.36 82 82
Rac1/GTP -0.05 0.098 -10000 0 -0.28 41 41
FRS2 family/SHP2/CRK family 0.081 0.047 -10000 0 -0.3 1 1
S1P4 pathway

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -9999 0 -10000 0 0
GNAO1 0.03 0.012 -9999 0 -10000 0 0
CDC42/GTP -0.066 0.14 -9999 0 -0.32 56 56
PLCG1 -0.072 0.13 -9999 0 -0.33 52 52
mol:GTP 0 0 -9999 0 -10000 0 0
GNAI2 0.033 0.01 -9999 0 -10000 0 0
GNAI3 0.034 0.006 -9999 0 -10000 0 0
G12/G13 0.045 0.017 -9999 0 -10000 0 0
cell migration -0.066 0.14 -9999 0 -0.32 56 56
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
MAPK3 -0.068 0.13 -9999 0 -0.34 46 46
MAPK1 -0.076 0.13 -9999 0 -0.33 54 54
S1P/S1P5/Gi -0.079 0.14 -9999 0 -0.25 184 184
GNAI1 -0.17 0.28 -9999 0 -0.54 183 183
CDC42/GDP 0.024 0.006 -9999 0 -10000 0 0
S1P/S1P5/G12 0.023 0.004 -9999 0 -10000 0 0
RHOA 0.034 0.051 -9999 0 -10000 0 0
S1P/S1P4/Gi -0.079 0.14 -9999 0 -0.25 184 184
mol:GDP 0 0 -9999 0 -10000 0 0
GNAZ 0.026 0.062 -9999 0 -0.54 6 6
S1P/S1P4/G12/G13 0.039 0.015 -9999 0 -10000 0 0
GNA12 0.034 0.005 -9999 0 -10000 0 0
GNA13 0.031 0.01 -9999 0 -10000 0 0
CDC42 0.033 0.008 -9999 0 -10000 0 0
Signaling events regulated by Ret tyrosine kinase

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.029 0.079 -10000 0 -0.49 7 7
Crk/p130 Cas/Paxillin -0.082 0.14 -10000 0 -0.38 73 73
JUN -0.002 0.15 0.29 2 -0.43 20 22
HRAS 0.034 0.013 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/GRB10 0.11 0.17 -10000 0 -0.29 60 60
RAP1A 0.034 0.005 -10000 0 -10000 0 0
FRS2 0.033 0.029 -10000 0 -0.54 1 1
RAP1A/GDP 0.025 0.004 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 0.12 0.17 0.35 3 -0.3 56 59
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma 0.057 0.14 0.24 1 -0.31 60 61
RHOA 0.033 0.008 -10000 0 -10000 0 0
RAP1A/GTP 0.078 0.15 -10000 0 -0.27 57 57
GRB7 0.029 0.013 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF 0.12 0.17 -10000 0 -0.3 56 56
MAPKKK cascade 0.059 0.14 0.25 8 -0.29 41 49
BCAR1 0.029 0.013 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 0.017 0.2 -10000 0 -0.38 92 92
lamellipodium assembly -0.042 0.16 -10000 0 -0.35 76 76
RET51/GFRalpha1/GDNF/SHC 0.094 0.16 -10000 0 -0.3 44 44
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC 0.046 0.13 -10000 0 -0.31 45 45
RET9/GFRalpha1/GDNF/Shank3 0.051 0.14 -10000 0 -0.31 60 60
MAPK3 0.042 0.13 0.28 9 -0.28 44 53
DOK1 0.036 0.016 -10000 0 -10000 0 0
DOK6 0.032 0.049 -10000 0 -0.54 3 3
PXN 0.034 0.004 -10000 0 -10000 0 0
neurite development 0.043 0.12 0.33 1 -0.33 2 3
DOK5 0.012 0.11 -10000 0 -0.54 18 18
GFRA1 0.031 0.22 -10000 0 -0.54 63 63
MAPK8 0.054 0.12 0.27 4 -0.37 8 12
HRAS/GTP 0.094 0.16 0.31 4 -0.32 42 46
tube development 0.056 0.14 0.31 12 -0.3 57 69
MAPK1 0.045 0.13 0.28 9 -0.28 44 53
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.021 0.11 -10000 0 -0.26 57 57
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
PDLIM7 0.034 0.009 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 0.11 0.17 0.35 2 -0.3 42 44
SHC1 0.028 0.014 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 0.092 0.17 -10000 0 -0.3 58 58
RET51/GFRalpha1/GDNF/Dok5 0.088 0.18 -10000 0 -0.3 63 63
PRKCA 0.031 0.013 -10000 0 -10000 0 0
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
CREB1 0.044 0.12 0.24 1 -0.28 32 33
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.019 0.097 -10000 0 -0.25 40 40
RET51/GFRalpha1/GDNF/Grb7 0.1 0.16 -10000 0 -0.3 43 43
mol:GDP 0 0 -10000 0 -10000 0 0
RET 0.1 0.073 -10000 0 -10000 0 0
DOK4 0.03 0.012 -10000 0 -10000 0 0
JNK cascade -0.001 0.15 0.29 2 -0.42 20 22
RET9/GFRalpha1/GDNF/FRS2 0.051 0.14 0.24 1 -0.31 60 61
SHANK3 0.032 0.009 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.02 0.099 -10000 0 -0.25 41 41
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.055 0.13 0.26 7 -0.26 44 51
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK 0.062 0.13 0.24 4 -0.39 8 12
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.048 0.12 0.24 6 -0.26 32 38
PI3K -0.04 0.25 0.31 6 -0.54 77 83
SOS1 0.034 0.004 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 0.059 0.14 -10000 0 -0.3 57 57
GRB10 0.03 0.051 -10000 0 -0.54 4 4
activation of MAPKK activity 0.055 0.12 0.24 10 -0.34 3 13
RET51/GFRalpha1/GDNF/FRS2 0.1 0.17 0.35 1 -0.3 58 59
GAB1 0.033 0.027 -10000 0 -0.54 1 1
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
IRS2 -0.1 0.24 -10000 0 -0.54 117 117
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.048 0.12 0.24 6 -0.25 32 38
RET51/GFRalpha1/GDNF/PKC alpha 0.099 0.17 -10000 0 -0.3 55 55
GRB2 0.034 0.018 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GDNF 0.034 0.009 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 0.073 0.23 -10000 0 -0.38 85 85
Rac1/GTP -0.032 0.2 -10000 0 -0.42 73 73
RET9/GFRalpha1/GDNF 0.039 0.15 -10000 0 -0.33 63 63
GFRalpha1/GDNF 0.041 0.17 -10000 0 -0.39 63 63
TCR signaling in naïve CD8+ T cells

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.083 0.16 0.33 67 -0.36 16 83
FYN 0.054 0.16 0.38 27 -0.38 22 49
LAT/GRAP2/SLP76 0.066 0.16 0.45 21 -0.41 11 32
IKBKB 0.029 0.013 -10000 0 -10000 0 0
AKT1 0.053 0.16 0.34 51 -0.31 30 81
B2M 0.037 0.011 -10000 0 -10000 0 0
IKBKG 0.032 0.069 0.18 51 -10000 0 51
MAP3K8 -0.039 0.19 -10000 0 -0.54 65 65
mol:Ca2+ -0.011 0.017 0.032 9 -0.09 12 21
integrin-mediated signaling pathway 0.038 0.023 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1/PI3K Class IA 0.046 0.18 0.48 21 -0.4 31 52
TRPV6 0.012 0.22 1.3 10 -0.54 17 27
CD28 0.028 0.084 -10000 0 -0.54 10 10
SHC1 0.066 0.18 0.33 76 -0.35 42 118
receptor internalization 0.019 0.18 0.34 26 -0.4 64 90
PRF1 0.033 0.16 0.53 9 -0.79 6 15
KRAS 0.035 0.019 -10000 0 -10000 0 0
GRB2 0.034 0.018 -10000 0 -10000 0 0
COT/AKT1 0.032 0.16 0.34 41 -0.32 32 73
LAT 0.048 0.17 0.38 31 -0.35 41 72
EntrezGene:6955 0.001 0.004 -10000 0 -10000 0 0
CD3D 0.04 0.036 0.2 19 -10000 0 19
CD3E 0.034 0.016 0.22 1 -10000 0 1
CD3G 0.039 0.073 -10000 0 -0.54 5 5
RASGRP2 0.008 0.048 0.16 10 -0.16 27 37
RASGRP1 0.059 0.16 0.43 28 -0.34 14 42
HLA-A 0.003 0.006 0.042 4 -10000 0 4
RASSF5 0.03 0.023 -10000 0 -10000 0 0
RAP1A/GTP/RAPL 0.038 0.023 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.063 0.094 0.22 80 -0.13 2 82
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.009 0.048 -10000 0 -0.18 15 15
PRKCA 0.039 0.099 0.32 24 -0.22 6 30
GRAP2 0.035 0.019 -10000 0 -10000 0 0
mol:IP3 0.002 0.091 0.28 10 -0.32 10 20
EntrezGene:6957 0.003 0.005 0.043 1 -10000 0 1
TCR/CD3/MHC I/CD8 0.008 0.12 0.27 27 -0.31 47 74
ORAI1 -0.019 0.17 -10000 0 -1.1 10 10
CSK 0.039 0.15 0.37 21 -0.33 44 65
B7 family/CD28 0.081 0.17 0.48 22 -0.45 13 35
CHUK 0.034 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 0.035 0.17 0.36 26 -0.37 47 73
PTPN6 0.036 0.15 0.35 26 -0.33 43 69
VAV1 0.038 0.16 0.41 21 -0.34 43 64
Monovalent TCR/CD3 0.023 0.1 0.28 21 -0.37 21 42
CBL 0.031 0.011 -10000 0 -10000 0 0
LCK 0.056 0.15 0.37 31 -0.35 22 53
PAG1 0.056 0.16 0.37 32 -0.34 41 73
RAP1A 0.034 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK 0.033 0.16 0.34 28 -0.35 50 78
CD80 0.045 0.038 -10000 0 -10000 0 0
CD86 0.036 0.013 -10000 0 -10000 0 0
PDK1/CARD11/BCL10/MALT1 0.009 0.067 -10000 0 -0.21 15 15
HRAS 0.034 0.013 -10000 0 -10000 0 0
GO:0035030 0.04 0.14 0.38 25 -0.39 13 38
CD8A 0.003 0.006 0.042 4 -10000 0 4
CD8B 0.041 0.026 0.21 3 -10000 0 3
PTPRC 0.035 0.035 0.18 24 -10000 0 24
PDK1/PKC theta 0.064 0.18 0.41 53 -0.36 24 77
CSK/PAG1 0.056 0.16 0.35 33 -0.36 25 58
SOS1 0.034 0.004 -10000 0 -10000 0 0
peptide-MHC class I 0.03 0.012 -10000 0 -10000 0 0
GRAP2/SLP76 0.06 0.16 0.46 17 -0.4 20 37
STIM1 0.004 0.1 1.2 3 -10000 0 3
RAS family/GTP 0.072 0.1 0.27 50 -0.18 10 60
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin 0.017 0.19 0.34 25 -0.42 64 89
mol:DAG -0.016 0.068 0.13 2 -0.28 12 14
RAP1A/GDP 0.034 0.046 0.13 45 -10000 0 45
PLCG1 0.033 0.008 -10000 0 -10000 0 0
CD247 0.023 0.11 -10000 0 -0.55 15 15
cytotoxic T cell degranulation 0.033 0.16 0.52 9 -0.71 7 16
RAP1A/GTP 0.002 0.015 -10000 0 -0.06 26 26
mol:PI-3-4-5-P3 0.048 0.16 0.44 24 -0.35 31 55
LAT/GRAP2/SLP76/VAV1/PLCgamma1 0.022 0.12 0.33 9 -0.41 9 18
NRAS 0.036 0.016 -10000 0 -10000 0 0
ZAP70 0.039 0.024 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 0.043 0.13 0.34 8 -0.4 11 19
MALT1 0.034 0.01 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
CD8 heterodimer 0.033 0.022 0.19 5 -10000 0 5
CARD11 0.039 0.027 -10000 0 -10000 0 0
PRKCB -0.013 0.051 0.16 4 -0.2 13 17
PRKCE 0.042 0.1 0.31 28 -0.22 8 36
PRKCQ 0.053 0.18 0.47 25 -0.38 28 53
LCP2 0.037 0.023 -10000 0 -10000 0 0
BCL10 0.034 0.007 -10000 0 -10000 0 0
regulation of survival gene product expression 0.054 0.14 0.33 51 -0.27 29 80
IKK complex 0.052 0.089 0.22 69 -10000 0 69
RAS family/GDP 0 0.009 -10000 0 -10000 0 0
MAP3K14 0.025 0.13 0.28 47 -0.26 25 72
PDPK1 0.057 0.16 0.37 52 -0.3 26 78
TCR/CD3/MHC I/CD8/Fyn 0.006 0.16 0.37 15 -0.4 50 65
IL27-mediated signaling events

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.042 0.009 -10000 0 -10000 0 0
CD4-positive alpha-beta T cell lineage commitment 0 0.001 -10000 0 -10000 0 0
cytokine production during immune response -0.01 0.22 0.7 24 -0.52 8 32
IL27/IL27R/JAK1 0.029 0.28 0.71 12 -1.1 19 31
TBX21 0.023 0.26 0.62 25 -0.6 38 63
IL12B 0.042 0.027 0.2 11 -10000 0 11
IL12A 0.005 0.061 -10000 0 -0.4 11 11
IL6ST 0.034 0.079 0.24 1 -0.54 8 9
IL27RA/JAK1 0.002 0.24 0.53 3 -1.2 18 21
IL27 -0.02 0.18 0.33 1 -0.54 52 53
TYK2 0.043 0.026 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.19 0.14 -10000 0 -0.78 2 2
T-helper 2 cell differentiation -0.01 0.22 0.7 24 -0.52 8 32
T cell proliferation during immune response -0.01 0.22 0.7 24 -0.52 8 32
MAPKKK cascade 0.01 0.22 0.52 8 -0.7 24 32
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT2 0.034 0.004 -10000 0 -10000 0 0
STAT1 0.061 0.057 0.22 2 -10000 0 2
IL12RB1 0.037 0.007 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 0.049 0.25 0.56 45 -0.64 22 67
IL27/IL27R/JAK2/TYK2 0.009 0.22 0.53 8 -0.72 24 32
positive regulation of T cell mediated cytotoxicity 0.01 0.22 0.52 8 -0.7 24 32
STAT1 (dimer) 0.034 0.32 0.8 22 -1 21 43
JAK2 0.039 0.023 0.24 1 -10000 0 1
JAK1 0.036 0.013 -10000 0 -10000 0 0
STAT2 (dimer) 0.025 0.21 0.5 6 -0.67 24 30
T cell proliferation -0.18 0.25 0.5 5 -0.59 76 81
IL12/IL12R/TYK2/JAK2 0.068 0.19 0.52 2 -0.76 14 16
IL17A -0.19 0.14 -10000 0 -0.78 2 2
mast cell activation -0.01 0.22 0.7 24 -0.52 8 32
IFNG 0.033 0.065 0.14 102 -0.1 12 114
T cell differentiation 0 0.009 0.019 27 -0.024 20 47
STAT3 (dimer) 0.024 0.21 0.5 6 -0.68 23 29
STAT5A (dimer) 0.024 0.21 0.5 6 -0.66 25 31
STAT4 (dimer) 0.022 0.21 0.5 6 -0.67 25 31
STAT4 0.028 0.069 -10000 0 -0.54 7 7
T cell activation -0.005 0.028 0.12 17 -0.12 9 26
IL27R/JAK2/TYK2 0.052 0.25 0.59 2 -1.1 18 20
GATA3 -0.013 0.37 0.66 17 -1.3 33 50
IL18 0.019 0.036 0.14 41 -10000 0 41
positive regulation of mast cell cytokine production 0.025 0.2 0.49 6 -0.66 23 29
IL27/EBI3 0.015 0.14 0.3 5 -0.39 51 56
IL27RA -0.016 0.25 0.54 4 -1.3 18 22
IL6 -0.37 0.26 -10000 0 -0.54 366 366
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
monocyte differentiation 0.002 0.003 -10000 0 -10000 0 0
IL2 -0.009 0.11 0.47 18 -1.2 1 19
IL1B 0.009 0.044 0.14 10 -0.4 5 15
EBI3 0.041 0.026 0.25 1 -10000 0 1
TNF 0.014 0.02 -10000 0 -10000 0 0
ErbB2/ErbB3 signaling events

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 -0.005 0.015 -10000 0 -10000 0 0
RAS family/GTP -0.005 0.1 -10000 0 -0.3 8 8
NFATC4 -0.026 0.083 0.26 7 -10000 0 7
ERBB2IP 0.034 0.008 -10000 0 -10000 0 0
HSP90 (dimer) 0.034 0.007 -10000 0 -10000 0 0
mammary gland morphogenesis -0.035 0.086 -10000 0 -0.3 26 26
JUN -0.055 0.072 -10000 0 -10000 0 0
HRAS 0.033 0.013 -10000 0 -10000 0 0
DOCK7 -0.035 0.088 0.26 2 -0.29 26 28
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.019 0.097 -10000 0 -0.31 24 24
AKT1 0.007 0.016 0.14 3 -10000 0 3
BAD -0.004 0.014 -10000 0 -10000 0 0
MAPK10 -0.019 0.073 0.23 6 -0.25 7 13
mol:GTP -0.002 0.002 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta -0.036 0.092 -10000 0 -0.32 26 26
RAF1 -0.037 0.096 -10000 0 -0.33 7 7
ErbB2/ErbB3/neuregulin 2 -0.18 0.17 -10000 0 -0.33 274 274
STAT3 0.01 0.16 -10000 0 -0.84 18 18
cell migration -0.011 0.074 0.29 5 -0.26 3 8
mol:PI-3-4-5-P3 -0.001 0.002 -10000 0 -10000 0 0
cell proliferation -0.26 0.28 -10000 0 -0.67 113 113
FOS -0.33 0.26 -10000 0 -0.5 365 365
NRAS 0.035 0.016 -10000 0 -10000 0 0
mol:Ca2+ -0.035 0.086 -10000 0 -0.3 26 26
MAPK3 -0.16 0.21 -10000 0 -0.51 88 88
MAPK1 -0.18 0.24 -10000 0 -0.56 102 102
JAK2 -0.032 0.088 0.26 2 -0.29 26 28
NF2 0.004 0.062 -10000 0 -0.69 4 4
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0 0.079 -10000 0 -0.28 23 23
NRG1 -0.018 0.15 -10000 0 -0.55 40 40
GRB2/SOS1 0.047 0.018 -10000 0 -10000 0 0
MAPK8 -0.038 0.1 -10000 0 -0.29 29 29
MAPK9 -0.017 0.067 0.23 5 -10000 0 5
ERBB2 -0.022 0.013 -10000 0 -10000 0 0
ERBB3 0.037 0.025 -10000 0 -10000 0 0
SHC1 0.027 0.013 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
apoptosis 0.019 0.027 -10000 0 -0.18 2 2
STAT3 (dimer) 0.011 0.16 -10000 0 -0.82 18 18
RNF41 -0.008 0.014 -10000 0 -10000 0 0
FRAP1 -0.002 0.013 0.11 5 -10000 0 5
RAC1-CDC42/GTP -0.036 0.059 -10000 0 -0.22 26 26
ErbB2/ErbB2/HSP90 (dimer) -0.007 0.023 -10000 0 -10000 0 0
CHRNA1 -0.12 0.17 -10000 0 -0.43 37 37
myelination -0.018 0.093 0.31 9 -10000 0 9
PPP3CB -0.033 0.084 0.25 2 -0.27 25 27
KRAS 0.034 0.019 -10000 0 -10000 0 0
RAC1-CDC42/GDP 0.035 0.1 -10000 0 -0.32 2 2
NRG2 -0.35 0.27 -10000 0 -0.54 339 339
mol:GDP 0 0.079 -10000 0 -0.28 23 23
SOS1 0.033 0.004 -10000 0 -10000 0 0
MAP2K2 -0.053 0.1 -10000 0 -0.35 11 11
SRC 0.033 0.008 -10000 0 -10000 0 0
mol:cAMP -0.001 0.001 -10000 0 -10000 0 0
PTPN11 -0.033 0.09 0.27 2 -0.29 26 28
MAP2K1 -0.17 0.22 -10000 0 -0.59 55 55
heart morphogenesis -0.035 0.086 -10000 0 -0.3 26 26
RAS family/GDP 0.029 0.11 -10000 0 -0.29 6 6
GRB2 0.033 0.018 -10000 0 -10000 0 0
PRKACA 0.006 0.075 -10000 0 -0.68 6 6
CHRNE -0.005 0.018 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
activation of caspase activity -0.007 0.016 -10000 0 -0.14 4 4
nervous system development -0.035 0.086 -10000 0 -0.3 26 26
CDC42 0.033 0.008 -10000 0 -10000 0 0
TCGA08_rtk_signaling

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.035 0.19 -10000 0 -0.54 61 61
HRAS 0.034 0.013 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
AKT -0.017 0.12 0.36 5 -0.26 37 42
FOXO3 0.032 0.01 -10000 0 -10000 0 0
AKT1 0.035 0.017 -10000 0 -10000 0 0
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
AKT3 0.029 0.019 -10000 0 -10000 0 0
FOXO4 0.035 0.002 -10000 0 -10000 0 0
MET -0.022 0.17 -10000 0 -0.54 50 50
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PIK3CB 0.034 0.006 -10000 0 -10000 0 0
NRAS 0.036 0.016 -10000 0 -10000 0 0
PIK3CG 0.037 0.022 -10000 0 -10000 0 0
PIK3R3 0.042 0.035 -10000 0 -10000 0 0
PIK3R2 0.036 0.017 -10000 0 -10000 0 0
NF1 0.032 0.009 -10000 0 -10000 0 0
RAS -0.076 0.14 0.24 1 -0.33 85 86
ERBB2 0.028 0.029 -10000 0 -0.54 1 1
proliferation/survival/translation -0.017 0.1 0.3 28 -0.3 1 29
PI3K -0.067 0.16 0.29 11 -0.31 104 115
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
KRAS 0.035 0.019 -10000 0 -10000 0 0
FOXO 0.036 0.081 0.33 6 -0.17 9 15
AKT2 0.034 0.005 -10000 0 -10000 0 0
PTEN 0.029 0.045 -10000 0 -0.54 3 3
Syndecan-2-mediated signaling events

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin 0.071 0.094 0.23 3 -0.32 16 19
EPHB2 0.043 0.038 -10000 0 -10000 0 0
Syndecan-2/TACI 0.016 0.066 -10000 0 -0.33 16 16
LAMA1 0.033 0.011 -10000 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 -0.058 0.17 -10000 0 -0.32 137 137
HRAS 0.034 0.013 -10000 0 -10000 0 0
Syndecan-2/CASK -0.001 0.06 -10000 0 -0.33 16 16
ITGA5 0.035 0.008 -10000 0 -10000 0 0
BAX -0.001 0.064 0.49 2 -10000 0 2
EPB41 0.033 0.007 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.016 0.059 -10000 0 -0.3 16 16
LAMA3 -0.15 0.27 -10000 0 -0.54 161 161
EZR 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 -0.32 0.28 -10000 0 -0.54 318 318
Syndecan-2/MMP2 0.014 0.073 -10000 0 -0.35 17 17
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.033 0.08 -10000 0 -0.4 16 16
dendrite morphogenesis 0.022 0.071 -10000 0 -0.33 16 16
Syndecan-2/GM-CSF 0.021 0.068 -10000 0 -0.33 16 16
determination of left/right symmetry 0 0.071 -10000 0 -0.39 16 16
Syndecan-2/PKC delta 0.018 0.066 -10000 0 -0.33 16 16
GNB2L1 0.034 0.005 -10000 0 -10000 0 0
MAPK3 0.041 0.093 0.2 85 -0.3 16 101
MAPK1 0.047 0.097 0.2 101 -0.3 16 117
Syndecan-2/RACK1 0.031 0.062 -10000 0 -0.28 16 16
NF1 0.032 0.009 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 0 0.071 -10000 0 -0.39 16 16
ITGA2 0.015 0.1 -10000 0 -0.54 17 17
MAPK8 0.002 0.067 0.34 3 -0.33 17 20
Syndecan-2/alpha2/beta1 Integrin 0.035 0.091 -10000 0 -0.33 23 23
Syndecan-2/Kininogen 0.017 0.065 -10000 0 -0.33 16 16
ITGB1 0.034 0.006 -10000 0 -10000 0 0
SRC 0.043 0.089 0.3 6 -0.28 15 21
Syndecan-2/CASK/Protein 4.1 0.015 0.059 -10000 0 -0.3 16 16
extracellular matrix organization 0.018 0.065 -10000 0 -0.33 16 16
actin cytoskeleton reorganization 0.071 0.094 0.23 3 -0.32 16 19
Syndecan-2/Caveolin-2/Ras -0.15 0.18 -10000 0 -0.32 237 237
Syndecan-2/Laminin alpha3 -0.082 0.17 -10000 0 -0.35 134 134
Syndecan-2/RasGAP 0.042 0.066 -10000 0 -0.27 16 16
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
PRKCD 0.035 0.017 -10000 0 -10000 0 0
Syndecan-2 dimer 0.022 0.071 -10000 0 -0.33 16 16
GO:0007205 0.003 0.005 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.028 0.058 -10000 0 -0.27 15 15
RHOA 0.033 0.008 -10000 0 -10000 0 0
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
TNFRSF13B 0.032 0.014 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
alpha2/beta1 Integrin 0.033 0.08 -10000 0 -0.4 16 16
Syndecan-2/Synbindin 0.015 0.065 -10000 0 -0.33 16 16
TGFB1 0.034 0.008 -10000 0 -10000 0 0
CASP3 0.042 0.095 0.2 93 -0.3 16 109
FN1 0.13 0.068 -10000 0 -10000 0 0
Syndecan-2/IL8 0.025 0.074 0.23 1 -0.33 16 17
SDC2 0 0.071 -10000 0 -0.39 16 16
KNG1 0.034 0.006 -10000 0 -10000 0 0
Syndecan-2/Neurofibromin 0.016 0.065 -10000 0 -0.33 16 16
TRAPPC4 0.031 0.011 -10000 0 -10000 0 0
CSF2 0.039 0.028 -10000 0 -10000 0 0
Syndecan-2/TGFB1 0.018 0.066 -10000 0 -0.33 16 16
Syndecan-2/Syntenin/PI-4-5-P2 0.016 0.06 -10000 0 -0.3 16 16
Syndecan-2/Ezrin 0.016 0.059 -10000 0 -0.3 16 16
PRKACA 0.044 0.096 0.2 101 -0.3 16 117
angiogenesis 0.025 0.074 0.23 1 -0.33 16 17
MMP2 0.028 0.039 -10000 0 -0.54 2 2
IL8 0.048 0.053 -10000 0 -0.54 1 1
calcineurin-NFAT signaling pathway 0.016 0.065 -10000 0 -0.33 16 16
Canonical Wnt signaling pathway

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.027 0.042 0.26 5 -10000 0 5
AES 0.026 0.036 0.22 4 -10000 0 4
FBXW11 0.034 0.006 -10000 0 -10000 0 0
mol:GTP 0 0.002 -10000 0 -10000 0 0
LRP6/FZD1 0.048 0.024 -10000 0 -0.4 1 1
SMAD4 0.033 0.008 -10000 0 -10000 0 0
DKK2 0.031 0.054 -10000 0 -0.54 4 4
TLE1 0.01 0.1 0.24 4 -0.55 15 19
MACF1 0.035 0.006 -10000 0 -10000 0 0
CTNNB1 0.15 0.11 0.34 32 -0.41 3 35
WIF1 -0.38 0.26 -10000 0 -0.54 370 370
beta catenin/RanBP3 0.042 0.15 0.5 40 -0.4 3 43
KREMEN2 0.11 0.076 -10000 0 -10000 0 0
DKK1 0.007 0.18 -10000 0 -0.54 44 44
beta catenin/beta TrCP1 0.16 0.1 0.34 31 -0.38 3 34
FZD1 0.034 0.026 -10000 0 -0.54 1 1
AXIN2 0.026 0.28 0.65 44 -1.2 13 57
AXIN1 0.033 0.01 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.071 0.086 -10000 0 -0.53 8 8
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.092 0.15 0.41 4 -0.58 13 17
Axin1/APC/GSK3 0.065 0.058 0.32 1 -10000 0 1
Axin1/APC/GSK3/beta catenin/Macf1 0.062 0.076 0.37 1 -0.55 1 2
HNF1A 0.028 0.042 0.26 6 -10000 0 6
CTBP1 0.025 0.038 0.25 4 -10000 0 4
MYC 0.096 0.44 0.64 109 -1.3 29 138
RANBP3 0.034 0.006 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.1 0.07 -10000 0 -0.31 3 3
NKD1 0.032 0.021 -10000 0 -10000 0 0
TCF4 0.019 0.076 0.24 5 -0.53 7 12
TCF3 0.028 0.043 0.27 5 -10000 0 5
WNT1/LRP6/FZD1/Axin1 0.077 0.039 -10000 0 -0.32 1 1
Ran/GTP 0.025 0.005 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.001 0.21 0.55 32 -0.55 13 45
LEF1 0.054 0.068 0.25 10 -10000 0 10
DVL1 0.08 0.058 0.25 3 -10000 0 3
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.097 0.17 0.34 3 -0.59 15 18
DKK1/LRP6/Kremen 2 0.082 0.13 0.26 50 -0.29 42 92
LRP6 0.034 0.009 -10000 0 -10000 0 0
CSNK1A1 0.028 0.042 0.26 5 -10000 0 5
NLK 0.036 0.032 -10000 0 -10000 0 0
CCND1 0.12 0.38 0.74 97 -1.2 14 111
WNT1 0.035 0.005 -10000 0 -10000 0 0
GSK3A 0.035 0.005 -10000 0 -10000 0 0
GSK3B 0.034 0.009 -10000 0 -10000 0 0
FRAT1 0.035 0.008 -10000 0 -10000 0 0
PPP2R5D 0.056 0.058 -10000 0 -0.39 3 3
APC 0.038 0.062 0.38 4 -0.3 1 5
WNT1/LRP6/FZD1 0.16 0.1 0.23 303 -0.3 1 304
CREBBP 0.024 0.037 0.26 3 -10000 0 3
Regulation of nuclear SMAD2/3 signaling

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.036 0.016 -10000 0 -10000 0 0
HSPA8 0.03 0.012 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha -0.071 0.19 0.33 1 -0.39 107 108
AKT1 0.038 0.02 -10000 0 -10000 0 0
GSC -0.096 0.4 -10000 0 -1.3 47 47
NKX2-5 -0.002 0.016 -10000 0 -10000 0 0
muscle cell differentiation 0.005 0.13 0.49 17 -10000 0 17
SMAD2-3/SMAD4/SP1 0.054 0.12 -10000 0 -0.32 11 11
SMAD4 -0.026 0.08 -10000 0 -0.24 26 26
CBFB 0.03 0.014 -10000 0 -10000 0 0
SAP18 0.032 0.009 -10000 0 -10000 0 0
Cbp/p300/MSG1 -0.16 0.2 -10000 0 -0.34 275 275
SMAD3/SMAD4/VDR 0.054 0.093 -10000 0 -0.38 4 4
MYC -0.006 0.12 -10000 0 -0.55 25 25
CDKN2B -0.05 0.2 -10000 0 -0.75 20 20
AP1 -0.26 0.29 -10000 0 -0.63 136 136
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.015 0.11 -10000 0 -0.39 20 20
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.01 0.11 -10000 0 -0.35 25 25
SP3 0.035 0.008 -10000 0 -10000 0 0
CREB1 0.034 0.006 -10000 0 -10000 0 0
FOXH1 0.018 0.041 -10000 0 -0.18 1 1
SMAD3/SMAD4/GR -0.042 0.14 -10000 0 -0.39 51 51
GATA3 0.039 0.16 -10000 0 -0.53 33 33
SKI/SIN3/HDAC complex/NCoR1 0.017 0.084 -10000 0 -0.39 14 14
MEF2C/TIF2 0.003 0.15 0.33 3 -0.51 30 33
endothelial cell migration -0.059 0.11 0.56 7 -10000 0 7
MAX 0.025 0.024 -10000 0 -10000 0 0
RBBP7 0.037 0.022 -10000 0 -10000 0 0
RBBP4 0.033 0.006 -10000 0 -10000 0 0
RUNX2 0.036 0.019 -10000 0 -10000 0 0
RUNX3 -0.006 0.15 -10000 0 -0.54 36 36
RUNX1 0.017 0.098 -10000 0 -0.54 15 15
CTBP1 0.033 0.008 -10000 0 -10000 0 0
NR3C1 -0.019 0.16 -10000 0 -0.55 40 40
VDR 0.032 0.037 -10000 0 -0.54 2 2
CDKN1A 0.005 0.11 -10000 0 -1.1 3 3
KAT2B 0.001 0.004 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.027 0.11 -10000 0 -0.32 32 32
DCP1A 0.033 0.008 -10000 0 -10000 0 0
SKI 0.033 0.007 -10000 0 -10000 0 0
SERPINE1 0.059 0.11 -10000 0 -0.56 7 7
SMAD3/SMAD4/ATF2 0.011 0.09 -10000 0 -0.26 14 14
SMAD3/SMAD4/ATF3 -0.086 0.2 -10000 0 -0.41 132 132
SAP30 0.034 0.009 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.056 0.043 -10000 0 -10000 0 0
JUN -0.26 0.28 -10000 0 -0.67 122 122
SMAD3/SMAD4/IRF7 0.022 0.092 -10000 0 -0.26 13 13
TFE3 0.03 0.045 -10000 0 -10000 0 0
COL1A2 0.073 0.13 0.39 10 -0.71 5 15
mesenchymal cell differentiation -0.011 0.091 0.26 14 -10000 0 14
DLX1 0.043 0.036 -10000 0 -10000 0 0
TCF3 0.035 0.017 -10000 0 -10000 0 0
FOS -0.37 0.28 -10000 0 -0.56 344 344
SMAD3/SMAD4/Max -0.015 0.088 -10000 0 -0.26 13 13
Cbp/p300/SNIP1 0.062 0.028 -10000 0 -10000 0 0
ZBTB17 0.028 0.021 -10000 0 -10000 0 0
LAMC1 -0.037 0.15 -10000 0 -0.6 28 28
TGIF2/HDAC complex/SMAD3/SMAD4 0.011 0.089 -10000 0 -0.27 10 10
IRF7 0.04 0.024 0.22 1 -10000 0 1
ESR1 -0.069 0.25 0.23 3 -0.55 106 109
HNF4A 0.033 0.008 -10000 0 -10000 0 0
MEF2C 0.007 0.17 0.41 8 -0.52 34 42
SMAD2-3/SMAD4 0.01 0.11 -10000 0 -0.28 26 26
Cbp/p300/Src-1 0.063 0.035 -10000 0 -0.32 1 1
IGHV3OR16-13 -0.005 0.066 -10000 0 -0.44 9 9
TGIF2/HDAC complex 0.033 0.01 -10000 0 -10000 0 0
CREBBP 0.034 0.013 -10000 0 -10000 0 0
SKIL 0.046 0.042 -10000 0 -10000 0 0
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC2 0.033 0.017 -10000 0 -10000 0 0
SNIP1 0.033 0.006 -10000 0 -10000 0 0
GCN5L2 0.003 0.009 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.019 0.12 -10000 0 -0.37 31 31
MSG1/HSC70 -0.21 0.22 -10000 0 -0.4 296 296
SMAD2 0.02 0.053 -10000 0 -0.19 3 3
SMAD3 -0.014 0.063 -10000 0 -0.21 7 7
SMAD3/E2F4-5/DP1/p107/SMAD4 0.006 0.069 -10000 0 -0.3 8 8
SMAD2/SMAD2/SMAD4 0.017 0.058 0.22 8 -0.21 4 12
NCOR1 0.031 0.011 -10000 0 -10000 0 0
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
MYOD/E2A 0.049 0.035 -10000 0 -0.4 2 2
SMAD2-3/SMAD4/SP1/MIZ-1 0.075 0.12 -10000 0 -0.33 6 6
IFNB1 -0.011 0.072 0.32 3 -0.27 3 6
SMAD3/SMAD4/MEF2C 0.015 0.18 -10000 0 -0.53 35 35
CITED1 -0.3 0.29 -10000 0 -0.54 296 296
SMAD2-3/SMAD4/ARC105 0.025 0.11 -10000 0 -0.29 14 14
RBL1 0.04 0.032 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.002 0.11 -10000 0 -0.39 19 19
RUNX1-3/PEBPB2 0.02 0.13 -10000 0 -0.35 49 49
SMAD7 -0.18 0.22 -10000 0 -0.52 84 84
MYC/MIZ-1 0.008 0.098 -10000 0 -0.41 25 25
SMAD3/SMAD4 0.039 0.097 0.33 12 -0.39 2 14
IL10 -0.005 0.11 0.36 2 -0.36 29 31
PIASy/HDAC complex 0.027 0.028 -10000 0 -10000 0 0
PIAS3 0.029 0.014 -10000 0 -10000 0 0
CDK2 0.04 0.024 -10000 0 -10000 0 0
IL5 -0.002 0.12 0.4 1 -0.36 31 32
CDK4 0.037 0.011 -10000 0 -10000 0 0
PIAS4 0.027 0.028 -10000 0 -10000 0 0
ATF3 -0.12 0.25 -10000 0 -0.54 128 128
SMAD3/SMAD4/SP1 0.039 0.1 -10000 0 -0.3 9 9
FOXG1 0.042 0.037 -10000 0 -10000 0 0
FOXO3 0.021 0.02 -10000 0 -10000 0 0
FOXO1 -0.018 0.12 -10000 0 -0.39 48 48
FOXO4 0.023 0.019 -10000 0 -10000 0 0
heart looping 0.007 0.17 0.41 8 -0.52 34 42
CEBPB 0.032 0.028 -10000 0 -0.54 1 1
SMAD3/SMAD4/DLX1 0.018 0.092 -10000 0 -0.26 12 12
MYOD1 0.034 0.041 -10000 0 -0.54 2 2
SMAD3/SMAD4/HNF4 0.012 0.089 -10000 0 -0.26 14 14
SMAD3/SMAD4/GATA3 0.027 0.15 -10000 0 -0.4 34 34
SnoN/SIN3/HDAC complex/NCoR1 0.046 0.042 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.007 0.15 -10000 0 -0.36 46 46
SMAD3/SMAD4/SP1-3 0.062 0.1 -10000 0 -0.35 3 3
MED15 0.032 0.009 -10000 0 -10000 0 0
SP1 0.047 0.023 -10000 0 -10000 0 0
SIN3B 0.035 0.014 -10000 0 -10000 0 0
SIN3A 0.033 0.006 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.024 0.12 -10000 0 -0.32 42 42
ITGB5 -0.001 0.083 0.33 1 -0.53 2 3
TGIF/SIN3/HDAC complex/CtBP 0.025 0.069 -10000 0 -0.35 10 10
SMAD3/SMAD4/AR -0.037 0.16 -10000 0 -0.38 75 75
AR -0.039 0.19 -10000 0 -0.54 66 66
negative regulation of cell growth -0.022 0.12 -10000 0 -0.36 29 29
SMAD3/SMAD4/MYOD 0.01 0.094 -10000 0 -0.29 11 11
E2F5 0.036 0.036 -10000 0 -10000 0 0
E2F4 0.03 0.012 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.051 0.1 -10000 0 -0.33 12 12
SMAD2-3/SMAD4/FOXO1-3a-4 -0.007 0.11 -10000 0 -0.36 24 24
TFDP1 0.033 0.021 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 -0.25 0.3 -10000 0 -0.66 128 128
SMAD3/SMAD4/RUNX2 0.012 0.091 -10000 0 -0.26 14 14
TGIF2 0.033 0.01 -10000 0 -10000 0 0
TGIF1 0.032 0.027 -10000 0 -0.54 1 1
ATF2 0.034 0.005 -10000 0 -10000 0 0
FOXA2 and FOXA3 transcription factor networks

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL 0.013 0.18 -10000 0 -0.76 3 3
PCK1 -0.75 0.54 -10000 0 -1 387 387
HNF4A 0.028 0.2 0.72 1 -0.88 1 2
KCNJ11 0.033 0.24 0.79 2 -0.76 3 5
AKT1 0.008 0.15 -10000 0 -0.5 4 4
response to starvation 0.005 0.002 -10000 0 -10000 0 0
DLK1 0.022 0.22 0.88 1 -0.82 3 4
NKX2-1 0.015 0.11 0.45 1 -0.36 3 4
ACADM 0.01 0.21 -10000 0 -0.86 8 8
TAT -0.062 0.2 -10000 0 -0.74 15 15
CEBPB 0.034 0.028 -10000 0 -0.54 1 1
CEBPA 0.036 0.045 -10000 0 -0.54 3 3
TTR -0.034 0.26 0.59 1 -0.66 39 40
PKLR 0.03 0.19 -10000 0 -0.79 2 2
APOA1 0.014 0.22 -10000 0 -0.89 3 3
CPT1C 0.023 0.2 0.71 1 -0.76 3 4
ALAS1 0.028 0.14 -10000 0 -10000 0 0
TFRC -0.021 0.2 0.67 3 -0.55 1 4
FOXF1 0.031 0.021 -10000 0 -10000 0 0
NF1 0.038 0.01 -10000 0 -10000 0 0
HNF1A (dimer) 0.051 0.022 -10000 0 -0.21 1 1
CPT1A 0.022 0.2 0.66 5 -0.7 3 8
HMGCS1 0.018 0.2 0.74 2 -0.76 3 5
NR3C1 0 0.16 -10000 0 -0.51 43 43
CPT1B 0.013 0.19 -10000 0 -0.76 3 3
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.041 0.015 -10000 0 -10000 0 0
GCK 0.018 0.19 -10000 0 -0.76 3 3
CREB1 -0.18 0.14 -10000 0 -0.27 318 318
IGFBP1 0.012 0.14 -10000 0 -0.83 2 2
PDX1 0.039 0.16 -10000 0 -1.1 2 2
UCP2 0.02 0.2 0.62 2 -0.7 3 5
ALDOB 0.017 0.22 -10000 0 -0.82 3 3
AFP -0.049 0.14 0.39 1 -0.42 1 2
BDH1 0.019 0.19 0.67 2 -0.76 3 5
HADH 0.013 0.23 -10000 0 -0.94 5 5
F2 0.031 0.22 -10000 0 -0.82 3 3
HNF1A 0.051 0.022 -10000 0 -0.21 1 1
G6PC -0.097 0.12 -10000 0 -10000 0 0
SLC2A2 0.044 0.16 -10000 0 -0.84 2 2
INS 0.023 0.014 0.25 1 -10000 0 1
FOXA1 0.003 0.23 0.32 7 -0.52 74 81
FOXA3 -0.11 0.14 -10000 0 -0.29 65 65
FOXA2 0.023 0.27 -10000 0 -0.92 3 3
ABCC8 -0.07 0.42 0.9 1 -0.94 85 86
ALB -0.052 0.15 0.39 1 -0.39 45 46
amb2 Integrin signaling

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.02 0.078 -10000 0 -0.28 5 5
alphaM/beta2 Integrin/GPIbA -0.015 0.079 0.29 1 -10000 0 1
alphaM/beta2 Integrin/proMMP-9 0.043 0.099 0.26 15 -10000 0 15
PLAUR 0.068 0.062 -10000 0 -10000 0 0
HMGB1 -0.029 0.045 -10000 0 -0.23 2 2
alphaM/beta2 Integrin/Talin -0.019 0.073 -10000 0 -10000 0 0
AGER -0.034 0.051 -10000 0 -0.38 2 2
RAP1A 0.034 0.005 -10000 0 -10000 0 0
SELPLG 0.034 0.028 -10000 0 -0.54 1 1
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.1 0.14 -10000 0 -0.38 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 0.095 0.074 -10000 0 -10000 0 0
CYR61 -0.13 0.26 -10000 0 -0.54 143 143
TLN1 0.034 0.006 -10000 0 -10000 0 0
Rap1/GTP 0.062 0.084 -10000 0 -0.33 7 7
RHOA 0.033 0.008 -10000 0 -10000 0 0
P-selectin oligomer -0.1 0.24 -10000 0 -0.54 117 117
MYH2 0.065 0.092 0.32 3 -0.5 4 7
MST1R 0.043 0.038 -10000 0 -10000 0 0
leukocyte activation during inflammatory response -0.012 0.068 -10000 0 -10000 0 0
APOB 0.034 0.004 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.028 0.039 -10000 0 -0.54 2 2
JAM3 -0.008 0.14 -10000 0 -0.54 34 34
GP1BA 0.036 0.029 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CTGF -0.032 0.1 -10000 0 -0.36 21 21
alphaM/beta2 Integrin 0.049 0.082 0.25 2 -0.36 8 10
JAM3 homodimer -0.008 0.14 -10000 0 -0.54 34 34
ICAM2 0.021 0.076 -10000 0 -0.54 9 9
ICAM1 0.04 0.029 -10000 0 -10000 0 0
phagocytosis triggered by activation of immune response cell surface activating receptor 0.047 0.086 0.25 2 -0.35 10 12
cell adhesion -0.016 0.079 0.29 1 -10000 0 1
NFKB1 -0.22 0.19 0.4 1 -0.36 297 298
THY1 0.034 0.025 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
Lipoprotein(a) 0.043 0.013 -10000 0 -10000 0 0
alphaM/beta2 Integrin/LRP/tPA -0.063 0.13 -10000 0 -0.34 70 70
IL6 -0.52 0.36 0.38 1 -0.74 374 375
ITGB2 -0.022 0.063 0.18 16 -10000 0 16
elevation of cytosolic calcium ion concentration 0.033 0.11 0.31 9 -10000 0 9
alphaM/beta2 Integrin/JAM2/JAM3 -0.11 0.2 -10000 0 -0.42 124 124
JAM2 -0.12 0.25 -10000 0 -0.54 133 133
alphaM/beta2 Integrin/ICAM1 0.009 0.093 0.3 1 -10000 0 1
alphaM/beta2 Integrin/uPA/Plg 0.011 0.091 -10000 0 -0.36 1 1
RhoA/GTP 0.045 0.1 -10000 0 -0.41 12 12
positive regulation of phagocytosis 0.038 0.081 0.3 2 -0.3 3 5
Ron/MSP 0.056 0.029 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPAR/uPA 0.035 0.11 0.32 9 -10000 0 9
alphaM/beta2 Integrin/uPAR 0.011 0.096 0.29 1 -10000 0 1
PLAU 0.057 0.053 -10000 0 -10000 0 0
PLAT -0.066 0.21 -10000 0 -0.54 85 85
actin filament polymerization 0.065 0.096 0.32 8 -0.44 5 13
MST1 0.033 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/lipoprotein(a) -0.01 0.072 -10000 0 -10000 0 0
TNF -0.21 0.18 0.41 3 -0.6 6 9
RAP1B 0.033 0.007 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA 0.004 0.086 0.26 1 -10000 0 1
fibrinolysis 0.01 0.089 -10000 0 -0.36 1 1
HCK 0.037 0.022 -10000 0 -10000 0 0
dendritic cell antigen processing and presentation 0.047 0.086 0.25 2 -0.35 10 12
VTN 0.033 0.011 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CYR61 -0.11 0.18 -10000 0 -0.37 139 139
LPA 0.032 0.009 -10000 0 -10000 0 0
LRP1 0.034 0.005 -10000 0 -10000 0 0
cell migration 0.031 0.091 0.27 2 -0.36 2 4
FN1 0.13 0.068 -10000 0 -10000 0 0
alphaM/beta2 Integrin/Thy1 -0.016 0.075 -10000 0 -10000 0 0
MPO 0.032 0.016 -10000 0 -10000 0 0
KNG1 0.034 0.006 -10000 0 -10000 0 0
RAP1/GDP 0.044 0.012 -10000 0 -10000 0 0
ROCK1 0.064 0.11 0.27 9 -0.41 10 19
ELA2 0 0 -10000 0 -10000 0 0
PLG 0.031 0.027 -10000 0 -0.54 1 1
CTGF 0.012 0.11 -10000 0 -0.54 19 19
alphaM/beta2 Integrin/Hck -0.017 0.077 0.27 5 -10000 0 5
ITGAM -0.028 0.044 -10000 0 -10000 0 0
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.073 0.16 -10000 0 -0.36 100 100
HP 0.03 0.012 -10000 0 -10000 0 0
leukocyte adhesion -0.17 0.2 -10000 0 -0.47 120 120
SELP -0.1 0.24 -10000 0 -0.54 117 117
mTOR signaling pathway

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0 0 -10000 0 -10000 0 0
MKNK1 0.034 0.006 -10000 0 -10000 0 0
mol:PIP3 -0.049 0.13 0.26 1 -0.3 93 94
FRAP1 -0.013 0.11 0.33 1 -0.5 18 19
AKT1 -0.039 0.12 0.2 1 -0.29 67 68
INSR 0.034 0.005 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.044 0.011 -10000 0 -10000 0 0
mol:GTP -0.001 0.12 0.26 2 -0.36 11 13
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.007 0.056 -10000 0 -0.23 8 8
TSC2 0.032 0.01 -10000 0 -10000 0 0
RHEB/GDP -0.013 0.092 -10000 0 -0.26 31 31
TSC1 0.034 0.006 -10000 0 -10000 0 0
Insulin Receptor/IRS1 -0.018 0.13 -10000 0 -0.33 72 72
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.006 0.072 -10000 0 -0.26 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.034 0.006 -10000 0 -10000 0 0
RPS6KB1 -0.008 0.11 0.31 3 -0.33 22 25
MAP3K5 -0.018 0.097 0.2 6 -0.29 51 57
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
apoptosis -0.018 0.097 0.2 6 -0.29 51 57
mol:LY294002 0 0.001 0.001 3 -0.002 62 65
EIF4B -0.006 0.097 0.32 2 -0.32 15 17
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.018 0.099 -10000 0 -0.3 14 14
eIF4E/eIF4G1/eIF4A1 -0.001 0.069 -10000 0 -0.3 18 18
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K -0.025 0.15 -10000 0 -0.31 104 104
mTOR/RHEB/GTP/Raptor/GBL 0.009 0.076 0.26 9 -0.21 11 20
FKBP1A 0.034 0.012 0.18 2 -10000 0 2
RHEB/GTP 0.007 0.1 0.25 1 -0.34 9 10
mol:Amino Acids 0 0.001 0.001 3 -0.002 62 65
FKBP12/Rapamycin 0.025 0.009 0.12 2 -10000 0 2
PDPK1 -0.051 0.12 0.19 6 -0.29 85 91
EIF4E 0.034 0.005 -10000 0 -10000 0 0
ASK1/PP5C -0.038 0.21 -10000 0 -0.57 61 61
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.009 0.05 -10000 0 -10000 0 0
TSC1/TSC2 0 0.12 0.28 2 -0.39 11 13
tumor necrosis factor receptor activity 0 0.001 0.002 62 -0.001 3 65
RPS6 0.032 0.026 -10000 0 -0.54 1 1
PPP5C 0.036 0.017 -10000 0 -10000 0 0
EIF4G1 0.034 0.006 -10000 0 -10000 0 0
IRS1 -0.04 0.13 -10000 0 -0.35 73 73
INS 0.033 0.007 -10000 0 -10000 0 0
PTEN 0.029 0.044 -10000 0 -0.54 3 3
PDK2 -0.046 0.12 0.19 9 -0.29 73 82
EIF4EBP1 -0.031 0.25 -10000 0 -1 28 28
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PPP2R5D -0.011 0.1 0.32 4 -0.44 18 22
peptide biosynthetic process 0.02 0.017 -10000 0 -10000 0 0
RHEB 0.034 0.009 -10000 0 -10000 0 0
EIF4A1 0.031 0.011 -10000 0 -10000 0 0
mol:Rapamycin 0 0.001 0.004 15 -0.003 6 21
EEF2 0.02 0.018 -10000 0 -10000 0 0
eIF4E/4E-BP1 -0.014 0.23 -10000 0 -0.97 28 28
Reelin signaling pathway

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.05 0.023 -10000 0 -10000 0 0
VLDLR -0.04 0.19 -10000 0 -0.54 65 65
CRKL 0.032 0.009 -10000 0 -10000 0 0
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
ITGA3 0.03 0.028 -10000 0 -0.54 1 1
RELN/VLDLR/Fyn -0.01 0.16 -10000 0 -0.36 82 82
MAPK8IP1/MKK7/MAP3K11/JNK1 0.078 0.05 -10000 0 -0.3 1 1
AKT1 -0.055 0.14 -10000 0 -0.3 108 108
MAP2K7 0.034 0.005 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
DAB1 0.033 0.007 -10000 0 -10000 0 0
RELN/LRP8/DAB1 0.069 0.084 0.24 1 -0.29 20 21
LRPAP1/LRP8 0.073 0.048 -10000 0 -10000 0 0
RELN/LRP8/DAB1/Fyn 0.074 0.089 -10000 0 -0.28 22 22
DAB1/alpha3/beta1 Integrin 0.018 0.13 -10000 0 -0.3 58 58
long-term memory 0.08 0.11 -10000 0 -0.32 20 20
DAB1/LIS1 0.034 0.15 -10000 0 -0.3 64 64
DAB1/CRLK/C3G 0.017 0.14 -10000 0 -0.3 64 64
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DAB1/NCK2 0.039 0.15 -10000 0 -0.31 64 64
ARHGEF2 0.031 0.022 -10000 0 -10000 0 0
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.032 0.012 -10000 0 -10000 0 0
CDK5R1 0.033 0.014 -10000 0 -10000 0 0
RELN 0.012 0.11 -10000 0 -0.54 20 20
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RELN/LRP8/Fyn 0.066 0.095 -10000 0 -0.32 22 22
GRIN2A/RELN/LRP8/DAB1/Fyn 0.083 0.095 -10000 0 -0.28 20 20
MAPK8 0.033 0.026 -10000 0 -0.54 1 1
RELN/VLDLR/DAB1 -0.005 0.15 -10000 0 -0.33 80 80
ITGB1 0.034 0.006 -10000 0 -10000 0 0
MAP1B -0.037 0.16 0.28 9 -0.34 93 102
RELN/LRP8 0.07 0.091 0.26 1 -0.32 20 21
GRIN2B/RELN/LRP8/DAB1/Fyn 0.078 0.11 -10000 0 -0.31 29 29
PI3K 0.005 0.13 -10000 0 -0.4 44 44
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.043 0.027 -10000 0 -0.4 1 1
RAP1A -0.026 0.13 0.36 5 -0.48 5 10
PAFAH1B1 0.032 0.01 -10000 0 -10000 0 0
MAPK8IP1 0.034 0.005 -10000 0 -10000 0 0
CRLK/C3G 0.047 0.015 -10000 0 -10000 0 0
GRIN2B 0.021 0.085 -10000 0 -0.54 11 11
NCK2 0.035 0.008 -10000 0 -10000 0 0
neuron differentiation 0.048 0.069 0.24 3 -0.54 1 4
neuron adhesion -0.01 0.14 0.38 7 -0.46 4 11
LRP8 0.072 0.065 -10000 0 -10000 0 0
GSK3B -0.05 0.14 -10000 0 -0.5 24 24
RELN/VLDLR/DAB1/Fyn 0.005 0.15 -10000 0 -0.31 82 82
MAP3K11 0.033 0.007 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.055 0.16 -10000 0 -0.31 114 114
CDK5 0.038 0.024 -10000 0 -10000 0 0
MAPT 0.016 0.13 0.82 11 -0.49 3 14
neuron migration -0.028 0.15 0.34 7 -0.38 37 44
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.046 0.068 -10000 0 -0.55 1 1
RELN/VLDLR 0.029 0.16 -10000 0 -0.31 80 80
IL1-mediated signaling events

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.025 0.004 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
ERC1 0.033 0.013 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.005 0.1 -10000 0 -0.38 20 20
IRAK/TOLLIP 0.039 0.014 -10000 0 -10000 0 0
IKBKB 0.029 0.013 -10000 0 -10000 0 0
IKBKG 0.034 0.004 -10000 0 -10000 0 0
IL1 alpha/IL1R2 0.055 0.044 0.26 1 -0.4 3 4
IL1A 0.036 0.016 -10000 0 -10000 0 0
IL1B -0.017 0.12 -10000 0 -0.42 41 41
IRAK/TRAF6/p62/Atypical PKCs 0.065 0.027 -10000 0 -10000 0 0
IL1R2 0.038 0.055 -10000 0 -0.54 3 3
IL1R1 -0.031 0.18 -10000 0 -0.54 58 58
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.031 0.14 -10000 0 -0.42 34 34
TOLLIP 0.033 0.007 -10000 0 -10000 0 0
TICAM2 0 0 -10000 0 -10000 0 0
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.022 0.006 -10000 0 -10000 0 0
IKK complex/ELKS 0.038 0.068 -10000 0 -0.35 1 1
JUN -0.049 0.1 0.33 1 -0.27 82 83
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.025 0.2 -10000 0 -0.37 112 112
IL1 alpha/IL1R1/IL1RAP/MYD88 0.04 0.13 -10000 0 -0.31 58 58
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.053 0.13 -10000 0 -0.3 57 57
IL1 beta fragment/IL1R1/IL1RAP -0.023 0.16 -10000 0 -0.35 91 91
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.009 0.053 0.34 1 -0.27 11 12
IRAK1 0.019 0.011 -10000 0 -10000 0 0
IL1RN/IL1R1 0.014 0.15 -10000 0 -0.39 58 58
IRAK4 0.034 0.005 -10000 0 -10000 0 0
PRKCI 0.035 0.017 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.022 0.14 -10000 0 -0.41 35 35
CHUK 0.034 0.005 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.023 0.16 -10000 0 -0.35 91 91
IL1 beta/IL1R2 0.007 0.12 -10000 0 -0.36 44 44
IRAK/TRAF6/TAK1/TAB1/TAB2 0.046 0.02 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.033 0.18 -10000 0 -0.35 110 110
IRAK3 0.035 0.033 -10000 0 -0.54 1 1
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.008 0.16 -10000 0 -0.32 90 90
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP 0.001 0.1 -10000 0 -0.27 56 56
IL1 alpha/IL1R1/IL1RAP 0.022 0.13 -10000 0 -0.34 58 58
RELA 0.033 0.007 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
MYD88 0.034 0.011 -10000 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.054 0.028 -10000 0 -10000 0 0
IL1RAP 0.034 0.006 -10000 0 -10000 0 0
UBE2N 0.034 0.005 -10000 0 -10000 0 0
IRAK/TRAF6 -0.023 0.12 -10000 0 -0.29 83 83
CASP1 -0.012 0.15 -10000 0 -0.54 38 38
IL1RN/IL1R2 0.068 0.056 0.26 6 -0.4 3 9
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.005 0.16 -10000 0 -0.34 89 89
TMEM189-UBE2V1 0 0 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.005 0.13 -10000 0 -0.34 61 61
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL1RN 0.055 0.05 -10000 0 -10000 0 0
TRAF6/TAK1/TAB1/TAB2 0.046 0.016 -10000 0 -10000 0 0
MAP2K6 0.016 0.055 0.36 2 -0.28 10 12
Angiopoietin receptor Tie2-mediated signaling

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.008 0.23 -10000 0 -0.9 24 24
NCK1/PAK1/Dok-R -0.034 0.094 -10000 0 -0.41 24 24
NCK1/Dok-R 0.018 0.24 -10000 0 -1 23 23
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
mol:beta2-estradiol -0.001 0.04 0.23 14 -10000 0 14
RELA 0.033 0.007 -10000 0 -10000 0 0
SHC1 0.029 0.014 -10000 0 -10000 0 0
Rac/GDP 0.025 0.004 -10000 0 -10000 0 0
F2 0.018 0.048 0.28 13 -10000 0 13
TNIP2 0.034 0.014 -10000 0 -10000 0 0
NF kappa B/RelA 0.043 0.23 -10000 0 -0.94 23 23
FN1 0.13 0.068 -10000 0 -10000 0 0
PLD2 -0.002 0.23 -10000 0 -1 23 23
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GRB14 0.001 0.19 -10000 0 -0.54 51 51
ELK1 0.007 0.21 -10000 0 -0.93 23 23
GRB7 0.029 0.013 -10000 0 -10000 0 0
PAK1 0.044 0.046 -10000 0 -10000 0 0
Tie2/Ang1/alpha5/beta1 Integrin 0.098 0.25 -10000 0 -0.96 23 23
CDKN1A -0.002 0.19 -10000 0 -0.67 19 19
ITGA5 0.035 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R 0.018 0.24 -10000 0 -1 23 23
CRK 0.031 0.01 -10000 0 -10000 0 0
mol:NO 0.017 0.18 -10000 0 -0.65 24 24
PLG -0.002 0.23 -10000 0 -1 23 23
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis 0 0.21 -10000 0 -0.84 24 24
GRB2 0.034 0.018 -10000 0 -10000 0 0
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
ANGPT2 -0.073 0.23 -10000 0 -0.68 31 31
BMX -0.16 0.28 -10000 0 -1.3 23 23
ANGPT1 -0.012 0.21 -10000 0 -1.2 14 14
tube development -0.011 0.2 -10000 0 -0.72 21 21
ANGPT4 0.033 0.008 -10000 0 -10000 0 0
response to hypoxia -0.001 0.015 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 0 0.27 -10000 0 -1.1 23 23
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
STAT5A (dimer) -0.001 0.23 -10000 0 -0.84 21 21
mol:L-citrulline 0.017 0.18 -10000 0 -0.65 24 24
AGTR1 -0.18 0.3 -10000 0 -0.54 208 208
MAPK14 -0.002 0.26 -10000 0 -1 26 26
Tie2/SHP2 0.002 0.21 -10000 0 -1 15 15
TEK -0.002 0.22 -10000 0 -1.1 15 15
RPS6KB1 0.021 0.23 -10000 0 -0.86 24 24
Angiotensin II/AT1 -0.13 0.22 -10000 0 -0.39 210 210
Tie2/Ang1/GRB2 0.013 0.24 -10000 0 -1.1 23 23
MAPK3 0.007 0.22 -10000 0 -0.93 23 23
MAPK1 -0.002 0.21 -10000 0 -0.95 23 23
Tie2/Ang1/GRB7 0.005 0.24 -10000 0 -1 23 23
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.003 0.23 -10000 0 -1 23 23
PI3K -0.004 0.26 -10000 0 -1 24 24
FES -0.008 0.26 -10000 0 -1.1 26 26
Crk/Dok-R 0.018 0.24 -10000 0 -1 23 23
Tie2/Ang1/ABIN2 0.014 0.24 -10000 0 -1.1 23 23
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity 0.014 0.21 -10000 0 -0.79 24 24
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 0.034 0.23 -10000 0 -0.82 24 24
Tie2/Ang2 -0.026 0.25 -10000 0 -1 21 21
Tie2/Ang1 0.002 0.25 -10000 0 -1.1 23 23
FOXO1 0.007 0.22 -10000 0 -0.82 24 24
ELF1 0.036 0.027 -10000 0 -10000 0 0
ELF2 0.003 0.23 -10000 0 -1 23 23
mol:Choline 0 0.22 -10000 0 -0.98 23 23
cell migration -0.015 0.054 -10000 0 -0.23 24 24
FYN -0.016 0.22 -10000 0 -0.84 21 21
DOK2 0.026 0.039 -10000 0 -0.54 2 2
negative regulation of cell cycle 0.003 0.17 -10000 0 -0.6 19 19
ETS1 0.031 0.056 -10000 0 -0.29 11 11
PXN 0.038 0.2 -10000 0 -0.68 24 24
ITGB1 0.034 0.006 -10000 0 -10000 0 0
NOS3 0.013 0.2 -10000 0 -0.74 24 24
RAC1 0.034 0.005 -10000 0 -10000 0 0
TNF 0.038 0.054 0.26 1 -0.25 13 14
MAPKKK cascade 0 0.22 -10000 0 -0.98 23 23
RASA1 0.034 0.012 -10000 0 -10000 0 0
Tie2/Ang1/Shc 0.005 0.24 -10000 0 -1 22 22
NCK1 0.034 0.005 -10000 0 -10000 0 0
vasculogenesis 0.02 0.16 -10000 0 -0.58 24 24
mol:Phosphatidic acid 0 0.22 -10000 0 -0.98 23 23
mol:Angiotensin II 0.001 0.001 -10000 0 -10000 0 0
mol:NADP 0.017 0.18 -10000 0 -0.65 24 24
Rac1/GTP 0.015 0.21 -10000 0 -0.8 24 24
MMP2 -0.001 0.24 -10000 0 -1 23 23
Thromboxane A2 receptor signaling

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.046 0.042 -10000 0 -10000 0 0
GNB1/GNG2 -0.019 0.054 -10000 0 -0.18 47 47
AKT1 0.06 0.13 0.41 18 -0.28 11 29
EGF -0.15 0.27 -10000 0 -0.54 163 163
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.03 0.053 0.26 2 -10000 0 2
mol:Ca2+ 0.06 0.16 0.49 16 -0.3 45 61
LYN 0.027 0.052 0.26 3 -10000 0 3
RhoA/GTP 0.026 0.067 0.19 15 -0.14 6 21
mol:PGI2 0 0.001 -10000 0 -10000 0 0
SYK 0.058 0.17 0.49 18 -0.34 44 62
GNG2 0.033 0.026 -10000 0 -0.54 1 1
ARRB2 0.031 0.011 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 0.014 0.12 -10000 0 -0.63 14 14
G beta5/gamma2 -0.014 0.075 -10000 0 -0.24 45 45
PRKCH 0.053 0.17 0.55 12 -0.36 45 57
DNM1 0.035 0.008 -10000 0 -10000 0 0
TXA2/TP beta/beta Arrestin3 0.015 0.029 -10000 0 -0.53 1 1
mol:GTP 0.001 0.003 -10000 0 -10000 0 0
PTGDR 0.031 0.06 -10000 0 -0.54 5 5
G12 family/GTP 0.005 0.11 -10000 0 -0.3 42 42
ADRBK1 0.032 0.01 -10000 0 -10000 0 0
ADRBK2 0.03 0.037 -10000 0 -0.54 2 2
RhoA/GTP/ROCK1 0.045 0.012 -10000 0 -10000 0 0
mol:GDP -0.042 0.12 0.38 13 -0.46 9 22
mol:NADP 0.034 0.006 -10000 0 -10000 0 0
RAB11A 0.034 0.007 -10000 0 -10000 0 0
PRKG1 0.034 0.006 -10000 0 -10000 0 0
mol:IP3 0.059 0.18 0.64 9 -0.37 45 54
cell morphogenesis 0.044 0.012 -10000 0 -10000 0 0
PLCB2 0.052 0.22 0.7 8 -0.5 45 53
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK 0.031 0.054 0.25 2 -10000 0 2
mol:PDG2 0 0.001 -10000 0 -10000 0 0
HCK 0.03 0.055 0.26 2 -10000 0 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
PTGIR 0.034 0.005 -10000 0 -10000 0 0
PRKCB1 0.055 0.18 0.63 9 -0.37 45 54
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.034 0.006 -10000 0 -10000 0 0
TXA2/TXA2-R family 0.054 0.22 0.72 8 -0.51 46 54
LCK 0.039 0.061 0.25 6 -10000 0 6
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.045 0.041 -10000 0 -10000 0 0
TXA2-R family/G12 family/GDP/G beta/gamma 0.024 0.1 -10000 0 -0.42 21 21
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.041 0.042 -10000 0 -0.23 1 1
MAPK14 0.052 0.13 0.41 19 -0.24 15 34
TGM2/GTP 0.056 0.2 0.67 9 -0.41 37 46
MAPK11 0.051 0.13 0.41 19 -0.24 15 34
ARHGEF1 0.047 0.11 0.34 18 -0.19 13 31
GNAI2 0.033 0.01 -10000 0 -10000 0 0
JNK cascade 0.06 0.18 0.52 16 -0.38 46 62
RAB11/GDP 0.032 0.01 -10000 0 -10000 0 0
ICAM1 0.058 0.15 0.45 20 -0.28 44 64
cAMP biosynthetic process 0.055 0.17 0.57 10 -0.34 41 51
Gq family/GTP/EBP50 0.034 0.048 -10000 0 -0.22 6 6
actin cytoskeleton reorganization 0.044 0.012 -10000 0 -10000 0 0
SRC 0.028 0.053 0.26 2 -10000 0 2
GNB5 0.033 0.026 -10000 0 -0.54 1 1
GNB1 0.034 0.011 -10000 0 -10000 0 0
EGF/EGFR -0.063 0.11 0.27 2 -0.29 40 42
VCAM1 0.054 0.16 0.46 18 -0.31 46 64
TP beta/Gq family/GDP/G beta5/gamma2 0.014 0.12 -10000 0 -0.63 14 14
platelet activation 0.063 0.16 0.48 19 -0.3 35 54
PGI2/IP 0.026 0.004 -10000 0 -10000 0 0
PRKACA 0.023 0.031 -10000 0 -0.26 5 5
Gq family/GDP/G beta5/gamma2 0.016 0.11 -10000 0 -0.55 14 14
TXA2/TP beta/beta Arrestin2 -0.003 0.061 -10000 0 -0.39 7 7
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.013 0.031 -10000 0 -0.25 5 5
mol:DAG 0.058 0.2 0.65 9 -0.42 45 54
EGFR -0.27 0.29 -10000 0 -0.54 269 269
TXA2/TP alpha 0.058 0.21 0.7 8 -0.46 41 49
Gq family/GTP 0.01 0.052 0.22 1 -0.22 18 19
YES1 0.03 0.057 0.26 2 -0.42 1 3
GNAI2/GTP 0.031 0.04 -10000 0 -0.24 4 4
PGD2/DP 0.023 0.044 -10000 0 -0.4 5 5
SLC9A3R1 0.06 0.059 -10000 0 -10000 0 0
FYN 0.027 0.055 0.27 1 -0.29 2 3
mol:NO 0.034 0.006 -10000 0 -10000 0 0
GNA15 0.036 0.019 -10000 0 -10000 0 0
PGK/cGMP 0.045 0.011 -10000 0 -10000 0 0
RhoA/GDP 0.031 0.011 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma 0.067 0.056 -10000 0 -0.34 1 1
NOS3 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.064 0.18 0.54 13 -0.35 40 53
PRKCB 0.054 0.17 0.54 12 -0.35 47 59
PRKCE 0.055 0.17 0.58 11 -0.35 45 56
PRKCD 0.054 0.18 0.56 12 -0.38 46 58
PRKCG 0.056 0.18 0.6 10 -0.38 45 55
muscle contraction 0.055 0.21 0.68 9 -0.47 46 55
PRKCZ 0.057 0.17 0.5 16 -0.34 46 62
ARR3 0.035 0.002 -10000 0 -10000 0 0
TXA2/TP beta 0.045 0.048 -10000 0 -0.25 5 5
PRKCQ 0.06 0.18 0.48 21 -0.35 45 66
MAPKKK cascade 0.055 0.2 0.65 9 -0.44 44 53
SELE 0.049 0.18 0.46 19 -0.38 49 68
TP beta/GNAI2/GDP/G beta/gamma 0.063 0.049 -10000 0 -0.34 1 1
ROCK1 0.034 0.006 -10000 0 -10000 0 0
GNA14 0.044 0.068 -10000 0 -0.54 4 4
chemotaxis 0.05 0.25 0.75 8 -0.59 49 57
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
Rac1/GTP 0.026 0.004 -10000 0 -10000 0 0
Ceramide signaling pathway

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 -0.021 0.12 -10000 0 -0.4 46 46
MAP4K4 0.005 0.082 -10000 0 -0.39 6 6
BAG4 0.028 0.016 -10000 0 -10000 0 0
PKC zeta/ceramide -0.013 0.067 0.15 3 -0.28 8 11
NFKBIA 0.033 0.007 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BAX 0.008 0.049 -10000 0 -0.35 5 5
RIPK1 0.034 0.006 -10000 0 -10000 0 0
AKT1 0.009 0.075 0.72 5 -10000 0 5
BAD -0.013 0.07 0.18 2 -0.34 5 7
SMPD1 0.019 0.063 0.24 6 -0.25 10 16
RB1 -0.012 0.067 -10000 0 -0.34 5 5
FADD/Caspase 8 0.032 0.12 0.29 11 -0.4 9 20
MAP2K4 -0.013 0.07 -10000 0 -0.35 6 6
NSMAF 0.029 0.028 -10000 0 -0.54 1 1
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.007 0.075 0.29 4 -0.35 4 8
EGF -0.15 0.27 -10000 0 -0.54 163 163
mol:ceramide -0.012 0.074 0.16 32 -0.28 9 41
MADD 0.034 0.005 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.023 0.12 -10000 0 -0.41 47 47
ASAH1 0.027 0.042 -10000 0 -0.54 2 2
negative regulation of cell cycle -0.014 0.068 -10000 0 -0.34 5 5
cell proliferation -0.1 0.14 -10000 0 -0.27 155 155
BID -0.014 0.19 -10000 0 -0.68 33 33
MAP3K1 -0.011 0.073 0.2 1 -0.34 6 7
EIF2A -0.005 0.072 0.27 7 -0.25 5 12
TRADD 0.03 0.012 -10000 0 -10000 0 0
CRADD 0.034 0.005 -10000 0 -10000 0 0
MAPK3 -0.002 0.073 0.26 6 -0.31 5 11
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.007 0.079 0.26 6 -0.35 4 10
Cathepsin D/ceramide 0.011 0.08 -10000 0 -0.31 5 5
FADD 0.029 0.1 0.28 2 -0.31 12 14
KSR1 -0.007 0.073 0.21 7 -0.36 4 11
MAPK8 -0.008 0.07 -10000 0 -0.29 8 8
PRKRA -0.012 0.071 0.2 1 -0.32 6 7
PDGFA -0.018 0.16 -10000 0 -0.54 46 46
TRAF2 0.035 0.012 -10000 0 -10000 0 0
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.012 0.074 0.16 32 -0.28 9 41
CTSD 0.047 0.043 -10000 0 -10000 0 0
regulation of nitric oxide biosynthetic process 0.048 0.012 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta -0.11 0.15 -10000 0 -0.29 140 140
PRKCD 0.035 0.017 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.023 0.12 -10000 0 -0.41 47 47
RelA/NF kappa B1 0.049 0.012 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.034 0.03 -10000 0 -0.54 1 1
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD 0.009 0.09 -10000 0 -0.32 19 19
TNFR1A/BAG4/TNF-alpha 0.053 0.035 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate -0.021 0.12 -10000 0 -0.4 46 46
MAP2K1 -0.007 0.074 0.28 5 -0.34 4 9
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
CYCS 0.027 0.082 0.19 56 -0.25 6 62
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
TNFR1A/BAG4 0.038 0.023 -10000 0 -10000 0 0
EIF2AK2 -0.008 0.069 0.21 4 -0.3 5 9
TNF-alpha/TNFR1A/FAN 0.057 0.037 -10000 0 -0.33 1 1
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.02 0.1 -10000 0 -0.41 20 20
MAP2K2 -0.007 0.074 0.28 5 -0.33 4 9
SMPD3 -0.001 0.12 0.24 3 -0.3 55 58
TNF 0.038 0.023 -10000 0 -10000 0 0
PKC zeta/PAR4 0.025 0.022 -10000 0 -0.4 1 1
mol:PHOSPHOCHOLINE 0.083 0.12 0.24 173 -0.22 3 176
NF kappa B1/RelA/I kappa B alpha 0.073 0.033 -10000 0 -0.3 1 1
AIFM1 0.026 0.082 0.19 60 -0.24 7 67
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
HIF-2-alpha transcription factor network

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 0.037 0.1 0.46 3 -0.67 4 7
oxygen homeostasis 0.025 0.029 0.19 4 -10000 0 4
TCEB2 0.032 0.01 -10000 0 -10000 0 0
TCEB1 0.028 0.014 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A 0.13 0.14 0.45 20 -0.32 5 25
EPO 0.22 0.24 0.68 57 -0.46 3 60
FIH (dimer) 0.056 0.03 0.22 3 -10000 0 3
APEX1 0.058 0.038 0.23 2 -10000 0 2
SERPINE1 0.26 0.24 0.7 44 -0.5 4 48
FLT1 -0.014 0.17 -10000 0 -0.64 26 26
ADORA2A 0.26 0.25 0.66 73 -0.48 4 77
germ cell development 0.24 0.23 0.7 33 -0.49 3 36
SLC11A2 0.25 0.24 0.71 36 -0.5 4 40
BHLHE40 0.18 0.23 0.66 36 -0.49 4 40
HIF1AN 0.056 0.03 0.21 3 -10000 0 3
HIF2A/ARNT/SIRT1 0.17 0.19 0.54 46 -0.36 5 51
ETS1 0.041 0.034 -10000 0 -0.54 1 1
CITED2 0.005 0.15 -10000 0 -0.79 14 14
KDR -0.006 0.15 -10000 0 -0.67 16 16
PGK1 0.26 0.24 0.71 38 -0.49 4 42
SIRT1 0.036 0.008 -10000 0 -10000 0 0
response to hypoxia 0.002 0.006 -10000 0 -10000 0 0
HIF2A/ARNT 0.23 0.26 0.76 28 -0.56 4 32
EPAS1 0.16 0.17 0.46 63 -0.32 10 73
SP1 0.047 0.028 -10000 0 -10000 0 0
ABCG2 0.24 0.26 0.7 33 -0.62 10 43
EFNA1 0.18 0.22 0.67 18 -0.5 4 22
FXN 0.24 0.23 0.66 46 -0.48 3 49
POU5F1 0.25 0.23 0.71 32 -0.5 3 35
neuron apoptosis -0.23 0.26 0.54 4 -0.75 28 32
EP300 0.033 0.009 -10000 0 -10000 0 0
EGLN3 0.08 0.074 0.25 28 -0.54 1 29
EGLN2 0.06 0.035 0.26 2 -10000 0 2
EGLN1 0.045 0.034 0.24 1 -10000 0 1
VHL/Elongin B/Elongin C 0.054 0.033 -10000 0 -10000 0 0
VHL 0.036 0.018 -10000 0 -10000 0 0
ARNT 0.046 0.038 0.21 1 -10000 0 1
SLC2A1 0.25 0.24 0.66 55 -0.48 4 59
TWIST1 0.21 0.28 0.68 38 -0.54 30 68
ELK1 0.04 0.019 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 0.15 0.18 0.54 24 -0.36 5 29
VEGFA 0.26 0.24 0.73 41 -0.5 4 45
CREBBP 0.032 0.01 -10000 0 -10000 0 0
S1P3 pathway

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.005 -10000 0 -10000 0 0
mol:S1P 0.001 0.003 0.03 6 -10000 0 6
S1P1/S1P/Gi -0.089 0.16 -10000 0 -0.28 184 184
GNAO1 0.032 0.013 -10000 0 -10000 0 0
S1P/S1P3/G12/G13 0.042 0.016 -10000 0 -10000 0 0
AKT1 -0.011 0.11 -10000 0 -0.49 18 18
AKT3 -0.013 0.12 0.44 1 -0.56 5 6
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.034 0.005 -10000 0 -10000 0 0
GNAI2 0.035 0.011 -10000 0 -10000 0 0
GNAI3 0.035 0.007 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
mol:GDP 0 0 -10000 0 -10000 0 0
S1PR3 0.002 0.004 0.035 6 -10000 0 6
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
mol:Ca2+ -0.069 0.14 0.24 2 -0.34 56 58
MAPK3 -0.06 0.13 0.23 1 -0.34 45 46
MAPK1 -0.067 0.13 0.23 1 -0.33 53 54
JAK2 -0.061 0.14 0.28 2 -0.34 60 62
CXCR4 -0.062 0.14 0.24 2 -0.33 51 53
FLT1 0.035 0.015 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
SRC -0.064 0.13 0.31 2 -0.33 52 54
S1P/S1P3/Gi -0.069 0.14 0.24 2 -0.34 56 58
RAC1 0.034 0.005 -10000 0 -10000 0 0
RhoA/GTP -0.057 0.14 -10000 0 -0.32 55 55
VEGFA 0.053 0.047 0.22 1 -10000 0 1
S1P/S1P2/Gi -0.073 0.14 -10000 0 -0.34 57 57
VEGFR1 homodimer/VEGFA homodimer 0.063 0.04 0.27 1 -10000 0 1
RHOA 0.033 0.008 -10000 0 -10000 0 0
S1P/S1P3/Gq 0.026 0.038 -10000 0 -0.29 4 4
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.027 0.063 -10000 0 -0.54 6 6
G12/G13 0.045 0.017 -10000 0 -10000 0 0
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
Rac1/GTP -0.058 0.14 -10000 0 -0.32 55 55
Coregulation of Androgen receptor activity

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.029 0.064 -10000 0 -0.54 6 6
SVIL 0.022 0.084 -10000 0 -0.54 11 11
ZNF318 0.031 0.009 -10000 0 -10000 0 0
JMJD2C 0.007 0.01 0.12 4 -10000 0 4
T-DHT/AR/Ubc9 -0.036 0.14 -10000 0 -0.35 65 65
CARM1 0.035 0.014 -10000 0 -10000 0 0
PRDX1 0.035 0.015 -10000 0 -10000 0 0
PELP1 0.031 0.01 -10000 0 -10000 0 0
CTNNB1 0.03 0.052 -10000 0 -0.54 4 4
AKT1 0.034 0.017 -10000 0 -10000 0 0
PTK2B 0.028 0.015 -10000 0 -10000 0 0
MED1 0.028 0.013 -10000 0 -10000 0 0
MAK 0.037 0.032 -10000 0 -10000 0 0
response to oxidative stress 0 0.001 -10000 0 -10000 0 0
HIP1 0.036 0.008 -10000 0 -10000 0 0
GSN -0.11 0.25 -10000 0 -0.54 132 132
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA6 0.035 0.008 -10000 0 -10000 0 0
DNA-PK 0.054 0.031 -10000 0 -10000 0 0
NCOA4 0.033 0.026 -10000 0 -0.54 1 1
PIAS3 0.029 0.014 -10000 0 -10000 0 0
cell proliferation -0.001 0.07 -10000 0 -0.47 6 6
XRCC5 0.033 0.006 -10000 0 -10000 0 0
UBE3A 0.035 0.009 -10000 0 -10000 0 0
T-DHT/AR/SNURF -0.052 0.13 -10000 0 -0.31 87 87
FHL2 -0.11 0.32 -10000 0 -0.99 58 58
RANBP9 0.035 0.01 -10000 0 -10000 0 0
JMJD1A -0.027 0.061 -10000 0 -0.14 122 122
CDK6 0.028 0.063 -10000 0 -0.54 6 6
TGFB1I1 0.03 0.045 -10000 0 -0.54 3 3
T-DHT/AR/CyclinD1 -0.036 0.15 -10000 0 -0.38 67 67
XRCC6 0.032 0.009 -10000 0 -10000 0 0
T-DHT/AR -0.057 0.17 -10000 0 -0.36 83 83
CTDSP1 0.034 0.005 -10000 0 -10000 0 0
CTDSP2 0.032 0.008 -10000 0 -10000 0 0
BRCA1 0.037 0.022 -10000 0 -10000 0 0
TCF4 0.024 0.067 -10000 0 -0.54 7 7
CDKN2A 0.052 0.055 -10000 0 -10000 0 0
SRF 0.021 0.059 -10000 0 -10000 0 0
NKX3-1 -0.072 0.11 -10000 0 -0.22 173 173
KLK3 0.015 0.056 -10000 0 -10000 0 0
TMF1 0.034 0.007 -10000 0 -10000 0 0
HNRNPA1 0.033 0.006 -10000 0 -10000 0 0
AOF2 0.001 0.002 0.02 3 -10000 0 3
APPL1 0.016 0.014 -10000 0 -10000 0 0
T-DHT/AR/Caspase 8 -0.04 0.14 -10000 0 -0.32 81 81
AR -0.069 0.2 -10000 0 -0.56 66 66
UBA3 0 0.001 -10000 0 -10000 0 0
PATZ1 0.031 0.01 -10000 0 -10000 0 0
PAWR 0.034 0.03 -10000 0 -0.54 1 1
PRKDC 0.031 0.019 -10000 0 -10000 0 0
PA2G4 0.033 0.006 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.032 0.13 -10000 0 -0.29 78 78
RPS6KA3 0.034 0.037 -10000 0 -0.54 2 2
T-DHT/AR/ARA70 -0.039 0.14 -10000 0 -0.32 82 82
LATS2 0.021 0.076 -10000 0 -0.54 9 9
T-DHT/AR/PRX1 -0.034 0.13 -10000 0 -0.33 66 66
Cyclin D3/CDK11 p58 0.025 0.005 -10000 0 -10000 0 0
VAV3 0.03 0.12 -10000 0 -0.54 19 19
KLK2 -0.018 0.069 -10000 0 -0.42 1 1
CASP8 0.034 0.005 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.019 0.13 -10000 0 -0.32 56 56
TMPRSS2 -0.23 0.42 -10000 0 -0.97 122 122
CCND1 0.024 0.088 -10000 0 -0.54 10 10
PIAS1 0.035 0.007 -10000 0 -10000 0 0
mol:T-DHT -0.017 0.035 0.049 1 -0.071 141 142
CDC2L1 0 0 -10000 0 -10000 0 0
PIAS4 0.038 0.016 -10000 0 -10000 0 0
T-DHT/AR/CDK6 -0.043 0.14 -10000 0 -0.35 71 71
CMTM2 0.03 0.012 -10000 0 -10000 0 0
SNURF 0 0 -10000 0 -10000 0 0
ZMIZ1 0.004 0.053 -10000 0 -10000 0 0
CCND3 0.034 0.006 -10000 0 -10000 0 0
TGIF1 0.031 0.027 -10000 0 -0.54 1 1
FKBP4 0.038 0.026 -10000 0 -10000 0 0
Osteopontin-mediated events

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.099 0.076 0.32 5 -0.28 4 9
NF kappa B1 p50/RelA/I kappa B alpha 0.11 0.1 0.36 17 -10000 0 17
alphaV/beta3 Integrin/Osteopontin/Src 0.1 0.072 0.26 2 -0.39 4 6
AP1 -0.14 0.22 0.49 1 -0.48 75 76
ILK 0.076 0.072 0.36 2 -0.3 4 6
bone resorption 0.06 0.07 -10000 0 -10000 0 0
PTK2B 0.028 0.014 -10000 0 -10000 0 0
PYK2/p130Cas 0.1 0.09 -10000 0 -10000 0 0
ITGAV 0.04 0.029 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.048 0.031 -10000 0 -0.4 2 2
alphaV/beta3 Integrin/Osteopontin 0.12 0.078 0.32 3 -0.33 4 7
MAP3K1 0.078 0.077 0.31 8 -0.3 5 13
JUN -0.066 0.22 -10000 0 -0.54 89 89
MAPK3 0.078 0.094 0.34 16 -0.28 3 19
MAPK1 0.077 0.091 0.33 13 -0.28 4 17
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 0.063 0.076 0.3 8 -0.29 6 14
ITGB3 0.041 0.021 -10000 0 -10000 0 0
NFKBIA 0.076 0.098 0.35 20 -10000 0 20
FOS -0.35 0.27 -10000 0 -0.54 344 344
CD44 0.033 0.028 -10000 0 -0.54 1 1
CHUK 0.034 0.005 -10000 0 -10000 0 0
PLAU 0.084 0.15 0.47 16 -0.54 1 17
NF kappa B1 p50/RelA 0.13 0.1 0.41 14 -10000 0 14
BCAR1 0.029 0.013 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.062 0.033 -10000 0 -0.39 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
SYK 0.078 0.073 0.31 8 -0.3 4 12
VAV3 0.062 0.094 0.3 13 -0.29 11 24
MAP3K14 0.086 0.082 0.32 7 -0.3 4 11
ROCK2 0.033 0.026 -10000 0 -0.54 1 1
SPP1 0.096 0.088 -10000 0 -0.54 3 3
RAC1 0.034 0.005 -10000 0 -10000 0 0
Rac1/GTP 0.072 0.086 0.3 5 -10000 0 5
MMP2 -0.14 0.17 0.47 1 -0.42 69 70
Syndecan-4-mediated signaling events

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.12 0.11 0.28 7 -0.63 4 11
Syndecan-4/Syndesmos 0.13 0.12 0.41 3 -0.72 4 7
positive regulation of JNK cascade 0.062 0.18 0.41 1 -0.66 6 7
Syndecan-4/ADAM12 0.15 0.13 0.41 5 -0.76 4 9
CCL5 0.029 0.06 0.18 7 -0.54 5 12
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
DNM2 0.034 0.005 -10000 0 -10000 0 0
ITGA5 0.035 0.008 -10000 0 -10000 0 0
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
PLG 0.013 0.04 -10000 0 -0.54 1 1
ADAM12 0.057 0.061 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.032 0.012 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha 0.008 0.023 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 0.13 0.12 0.42 1 -0.76 4 5
Syndecan-4/CXCL12/CXCR4 0.066 0.19 0.42 1 -0.72 6 7
Syndecan-4/Laminin alpha3 0.054 0.16 0.42 2 -0.75 5 7
MDK 0.044 0.038 -10000 0 -10000 0 0
Syndecan-4/FZD7 0.061 0.18 0.41 1 -0.66 6 7
Syndecan-4/Midkine 0.14 0.12 0.39 6 -0.71 4 10
FZD7 -0.13 0.26 -10000 0 -0.54 145 145
Syndecan-4/FGFR1/FGF -0.065 0.16 0.4 1 -0.56 11 12
THBS1 0.038 0.025 -10000 0 -10000 0 0
integrin-mediated signaling pathway 0.14 0.12 0.39 3 -0.72 4 7
positive regulation of MAPKKK cascade 0.062 0.18 0.41 1 -0.66 6 7
Syndecan-4/TACI 0.13 0.12 0.42 2 -0.76 4 6
CXCR4 0.044 0.038 -10000 0 -10000 0 0
cell adhesion 0.092 0.072 0.27 51 -10000 0 51
Syndecan-4/Dynamin 0.14 0.12 0.42 1 -0.76 4 5
Syndecan-4/TSP1 0.14 0.12 0.43 3 -0.76 4 7
Syndecan-4/GIPC 0.14 0.12 0.42 3 -0.76 4 7
Syndecan-4/RANTES 0.13 0.12 0.41 1 -0.76 4 5
ITGB1 0.034 0.006 -10000 0 -10000 0 0
LAMA1 0.033 0.011 -10000 0 -10000 0 0
LAMA3 -0.15 0.27 -10000 0 -0.54 161 161
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.031 0.22 0.7 50 -10000 0 50
Syndecan-4/alpha-Actinin 0.14 0.12 0.42 1 -0.76 4 5
TFPI -0.19 0.28 -10000 0 -0.54 199 199
F2 0.039 0.02 -10000 0 -10000 0 0
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
positive regulation of cell adhesion 0.044 0.15 0.38 2 -0.72 5 7
ACTN1 0.033 0.007 -10000 0 -10000 0 0
TNC 0.037 0.036 -10000 0 -0.54 1 1
Syndecan-4/CXCL12 0.055 0.19 0.42 1 -0.66 8 9
FGF6 0.03 0.037 -10000 0 -0.54 2 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
CXCL12 -0.14 0.26 -10000 0 -0.54 152 152
TNFRSF13B 0.032 0.014 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
FGFR1 0.018 0.076 -10000 0 -0.54 9 9
Syndecan-4/PI-4-5-P2 0.097 0.12 -10000 0 -0.76 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.13 0.075 0.2 15 -10000 0 15
cell migration -0.013 0.009 -10000 0 -10000 0 0
PRKCD 0.017 0.035 -10000 0 -10000 0 0
vasculogenesis 0.14 0.12 0.43 3 -0.72 4 7
SDC4 0.11 0.12 -10000 0 -0.81 4 4
Syndecan-4/Tenascin C 0.14 0.12 0.4 3 -0.76 4 7
Syndecan-4/PI-4-5-P2/PKC alpha -0.005 0.014 -10000 0 -10000 0 0
Syndecan-4/Syntenin 0.12 0.12 0.41 1 -0.76 4 5
MMP9 0.095 0.079 0.19 10 -10000 0 10
Rac1/GTP 0.093 0.072 0.27 51 -10000 0 51
cytoskeleton organization 0.13 0.12 0.39 4 -0.69 4 8
GIPC1 0.035 0.01 -10000 0 -10000 0 0
Syndecan-4/TFPI 0.035 0.19 0.39 3 -0.6 10 13
RXR and RAR heterodimerization with other nuclear receptor

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.037 0.11 1 1 -10000 0 1
VDR 0.032 0.037 -10000 0 -0.54 2 2
FAM120B 0.032 0.009 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA 0.063 0.076 -10000 0 -10000 0 0
RXRs/LXRs/DNA/Oxysterols 0.09 0.089 -10000 0 -0.37 2 2
MED1 0.029 0.013 -10000 0 -10000 0 0
mol:9cRA 0.01 0.014 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.031 0.13 -10000 0 -0.63 8 8
RXRs/NUR77 0.071 0.093 -10000 0 -0.3 18 18
RXRs/PPAR -0.15 0.14 -10000 0 -0.41 41 41
NCOR2 0.034 0.005 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.024 0.027 -10000 0 -0.4 2 2
RARs/VDR/DNA/Vit D3 0.017 0.13 -10000 0 -0.3 71 71
RARA 0.031 0.013 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
VDR/VDR/DNA 0.032 0.037 -10000 0 -0.54 2 2
RARs/RARs/DNA/9cRA 0.008 0.12 -10000 0 -0.29 71 71
RARG 0.034 0.004 -10000 0 -10000 0 0
RPS6KB1 0.062 0.17 0.56 51 -10000 0 51
RARs/THRs/DNA/SMRT -0.03 0.13 -10000 0 -0.59 8 8
THRA -0.001 0.13 -10000 0 -0.54 28 28
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.024 0.027 -10000 0 -0.4 2 2
RXRs/PPAR/9cRA/PGJ2/DNA 0.076 0.07 -10000 0 -0.3 4 4
NR1H4 0.035 0.01 -10000 0 -10000 0 0
RXRs/LXRs/DNA 0.11 0.088 -10000 0 -0.28 5 5
NR1H2 0.043 0.015 -10000 0 -10000 0 0
NR1H3 0.043 0.031 -10000 0 -0.54 1 1
RXRs/VDR/DNA/Vit D3 0.078 0.062 -10000 0 -0.29 4 4
NR4A1 0.007 0.12 -10000 0 -0.54 24 24
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 0.056 0.059 -10000 0 -0.28 1 1
RXRG 0.032 0.055 -10000 0 -0.54 4 4
RXR alpha/CCPG 0.052 0.02 -10000 0 -10000 0 0
RXRA 0.042 0.015 -10000 0 -10000 0 0
RXRB 0.044 0.016 -10000 0 -10000 0 0
THRB 0.028 0.057 -10000 0 -0.54 5 5
PPARG -0.38 0.26 -10000 0 -0.54 367 367
PPARD 0.035 0.01 -10000 0 -10000 0 0
TNF 0.083 0.088 -10000 0 -10000 0 0
mol:Oxysterols 0.009 0.013 -10000 0 -10000 0 0
cholesterol transport 0.089 0.088 -10000 0 -0.37 2 2
PPARA 0.031 0.027 -10000 0 -0.54 1 1
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB -0.053 0.21 -10000 0 -0.54 77 77
RXRs/NUR77/BCL2 -0.027 0.12 -10000 0 -0.26 78 78
SREBF1 0.083 0.1 -10000 0 -10000 0 0
RXRs/RXRs/DNA/9cRA 0.076 0.07 -10000 0 -0.3 4 4
ABCA1 0.077 0.1 -10000 0 -1 2 2
RARs/THRs 0.006 0.16 -10000 0 -0.32 96 96
RXRs/FXR 0.085 0.065 -10000 0 -0.31 4 4
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
Regulation of p38-alpha and p38-beta

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.041 0.016 -10000 0 -10000 0 0
response to insulin stimulus 0 0 -10000 0 -10000 0 0
RIPK1 0.034 0.006 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.021 0.081 -10000 0 -0.54 10 10
mol:GTP 0 0 -10000 0 -10000 0 0
MAP2K4 0.03 0.012 -10000 0 -10000 0 0
RAC1-CDC42/GTP/PAK family -0.11 0.12 -10000 0 -0.23 239 239
response to UV 0 0 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
interleukin-1 receptor activity 0 0 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
MAP3K12 0.034 0.005 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
p38 alpha/TAB1 -0.041 0.095 -10000 0 -0.31 40 40
PRKG1 0.034 0.006 -10000 0 -10000 0 0
DUSP8 0.033 0.007 -10000 0 -10000 0 0
PGK/cGMP/p38 alpha 0.012 0.12 -10000 0 -0.35 28 28
apoptosis -0.039 0.09 -10000 0 -0.3 40 40
RAL/GTP 0.045 0.01 -10000 0 -10000 0 0
LYN 0.03 0.015 -10000 0 -10000 0 0
DUSP1 -0.2 0.28 -10000 0 -0.54 208 208
PAK1 0.044 0.046 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.072 0.036 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
mol:cGMP 0 0 -10000 0 -10000 0 0
CCM2 0.034 0.005 -10000 0 -10000 0 0
RAC1-CDC42/GTP 0.044 0.012 -10000 0 -10000 0 0
MAPK11 0.001 0.13 0.38 2 -0.38 29 31
BLK 0.039 0.044 -10000 0 -10000 0 0
HCK 0.037 0.022 -10000 0 -10000 0 0
MAP2K3 0.031 0.01 -10000 0 -10000 0 0
DUSP16 0.033 0.012 -10000 0 -10000 0 0
DUSP10 0.028 0.032 -10000 0 -0.54 1 1
TRAF6/MEKK3 0.038 0.016 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.006 0.13 0.5 1 -0.36 34 35
positive regulation of innate immune response 0 0.16 0.59 1 -0.43 32 33
LCK 0.049 0.044 -10000 0 -10000 0 0
p38alpha-beta/MKP7 0.014 0.16 0.58 1 -0.42 31 32
p38alpha-beta/MKP5 0.009 0.15 0.58 1 -0.42 28 29
PGK/cGMP 0.025 0.004 -10000 0 -10000 0 0
PAK2 0.034 0.007 -10000 0 -10000 0 0
p38alpha-beta/MKP1 -0.086 0.2 -10000 0 -0.42 72 72
CDC42 0.033 0.008 -10000 0 -10000 0 0
RALB 0.034 0.005 -10000 0 -10000 0 0
RALA 0.034 0.005 -10000 0 -10000 0 0
PAK3 -0.31 0.28 -10000 0 -0.54 308 308
Regulation of Telomerase

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex 0.003 0.18 0.44 1 -0.75 11 12
RAD9A 0.032 0.01 -10000 0 -10000 0 0
AP1 -0.31 0.27 -10000 0 -0.47 346 346
IFNAR2 0.039 0.012 -10000 0 -10000 0 0
AKT1 -0.005 0.12 -10000 0 -0.38 13 13
ER alpha/Oestrogen -0.042 0.19 -10000 0 -0.39 110 110
NFX1/SIN3/HDAC complex 0.036 0.074 -10000 0 -0.35 12 12
EGF -0.15 0.27 -10000 0 -0.54 163 163
SMG5 0.03 0.017 -10000 0 -10000 0 0
SMG6 0.032 0.01 -10000 0 -10000 0 0
SP3/HDAC2 0.056 0.025 -10000 0 -10000 0 0
TERT/c-Abl 0.011 0.17 -10000 0 -0.69 11 11
SAP18 0.033 0.01 -10000 0 -10000 0 0
MRN complex 0.049 0.033 -10000 0 -10000 0 0
WT1 0.087 0.07 0.21 1 -10000 0 1
WRN 0.028 0.015 0.18 1 -10000 0 1
SP1 0.041 0.016 -10000 0 -10000 0 0
SP3 0.036 0.007 -10000 0 -10000 0 0
TERF2IP 0.03 0.013 -10000 0 -10000 0 0
Telomerase/Nucleolin 0.031 0.16 -10000 0 -0.62 11 11
Mad/Max 0.055 0.018 -10000 0 -10000 0 0
TERT -0.004 0.18 -10000 0 -0.78 11 11
CCND1 0.036 0.26 0.55 13 -1 14 27
MAX 0.036 0.01 -10000 0 -10000 0 0
RBBP7 0.039 0.022 -10000 0 -10000 0 0
RBBP4 0.035 0.006 -10000 0 -10000 0 0
TERF2 0.027 0.028 -10000 0 -0.49 1 1
PTGES3 0.033 0.026 -10000 0 -0.54 1 1
SIN3A 0.035 0.006 -10000 0 -10000 0 0
Telomerase/911 0.04 0.06 -10000 0 -0.45 2 2
CDKN1B 0.043 0.11 0.31 1 -0.61 10 11
RAD1 0.034 0.009 -10000 0 -10000 0 0
XRCC5 0.034 0.005 -10000 0 -10000 0 0
XRCC6 0.032 0.009 -10000 0 -10000 0 0
SAP30 0.035 0.009 -10000 0 -10000 0 0
TRF2/PARP2 0.043 0.029 -10000 0 -0.39 1 1
UBE3A 0.035 0.009 -10000 0 -10000 0 0
JUN -0.065 0.22 -10000 0 -0.54 89 89
E6 0.002 0.004 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.029 0.012 -10000 0 -10000 0 0
FOS -0.35 0.27 -10000 0 -0.54 344 344
IFN-gamma/IRF1 0.082 0.083 0.27 28 -0.32 10 38
PARP2 0.034 0.006 -10000 0 -10000 0 0
BLM 0.074 0.067 -10000 0 -10000 0 0
Telomerase 0.004 0.095 -10000 0 -0.72 4 4
IRF1 0.046 0.048 -10000 0 -0.18 8 8
ESR1 -0.057 0.25 -10000 0 -0.54 106 106
KU/TER 0.048 0.014 -10000 0 -10000 0 0
ATM/TRF2 0.037 0.034 -10000 0 -0.29 1 1
ubiquitin-dependent protein catabolic process 0.043 0.069 -10000 0 -0.35 7 7
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.044 0.07 -10000 0 -0.36 7 7
HDAC1 0.035 0.006 -10000 0 -10000 0 0
HDAC2 0.039 0.021 -10000 0 -10000 0 0
ATM 0.017 0.021 0.21 1 -10000 0 1
SMAD3 0.01 0.017 -10000 0 -10000 0 0
ABL1 0.034 0.005 -10000 0 -10000 0 0
MXD1 0.037 0.009 -10000 0 -10000 0 0
MRE11A 0.031 0.011 -10000 0 -10000 0 0
HUS1 0.035 0.01 -10000 0 -10000 0 0
RPS6KB1 0.03 0.012 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 0.026 0.18 -10000 0 -0.71 12 12
NR2F2 0.008 0.094 -10000 0 -0.55 13 13
MAPK3 0.019 0.022 -10000 0 -0.4 1 1
MAPK1 0.019 0.022 -10000 0 -0.4 1 1
TGFB1/TGF beta receptor Type II 0.033 0.008 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
HNRNPC 0.034 0.006 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.017 0.021 0.21 1 -10000 0 1
NBN 0.028 0.016 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
mol:Oestrogen 0.001 0.002 -10000 0 -10000 0 0
EGF/EGFR -0.31 0.26 -10000 0 -0.46 355 355
MYC -0.001 0.12 -10000 0 -0.54 25 25
IL2 0.04 0.031 -10000 0 -0.54 1 1
KU 0.048 0.014 -10000 0 -10000 0 0
RAD50 0.034 0.006 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
TGFB1 0.033 0.008 -10000 0 -10000 0 0
TRF2/BLM 0.066 0.056 -10000 0 -0.39 1 1
FRAP1 0 0 -10000 0 -10000 0 0
KU/TERT 0.024 0.18 -10000 0 -0.7 11 11
SP1/HDAC2 0.061 0.032 -10000 0 -10000 0 0
PINX1 0.027 0.014 -10000 0 -10000 0 0
Telomerase/EST1A 0.024 0.16 -10000 0 -0.64 10 10
Smad3/Myc 0.006 0.081 -10000 0 -0.34 25 25
911 complex 0.062 0.026 -10000 0 -10000 0 0
IFNG 0.065 0.073 -10000 0 -0.22 9 9
Telomerase/PinX1 0.013 0.16 -10000 0 -0.64 10 10
Telomerase/AKT1/mTOR/p70S6K 0.022 0.12 -10000 0 -0.52 13 13
SIN3B 0.036 0.014 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
Telomerase/EST1B 0.03 0.15 -10000 0 -0.66 9 9
response to DNA damage stimulus -0.002 0.031 -10000 0 -10000 0 0
MRN complex/TRF2/Rap1 0.062 0.052 -10000 0 -0.31 1 1
TRF2/WRN 0.036 0.03 -10000 0 -0.39 1 1
Telomerase/hnRNP C1/C2 0.03 0.16 -10000 0 -0.64 10 10
E2F1 0.055 0.049 0.21 2 -10000 0 2
ZNFX1 0.034 0.017 -10000 0 -10000 0 0
PIF1 0.039 0.028 -10000 0 -10000 0 0
NCL 0.034 0.006 -10000 0 -10000 0 0
DKC1 0.035 0.012 -10000 0 -10000 0 0
telomeric DNA binding 0 0 -10000 0 -10000 0 0
Regulation of Androgen receptor activity

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.017 0.004 -10000 0 -10000 0 0
SMARCC1 0.016 0.052 -10000 0 -0.52 2 2
REL 0.037 0.024 -10000 0 -10000 0 0
HDAC7 -0.051 0.12 0.33 1 -0.33 42 43
JUN -0.066 0.22 -10000 0 -0.54 89 89
EP300 0.033 0.009 -10000 0 -10000 0 0
KAT2B 0 0 0.003 3 -10000 0 3
KAT5 0 0 -10000 0 -0.003 2 2
MAPK14 -0.003 0.063 -10000 0 -0.41 10 10
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
T-DHT/AR -0.025 0.14 0.36 1 -0.34 42 43
MAP2K6 0.009 0.084 -10000 0 -0.55 10 10
BRM/BAF57 0.046 0.018 -10000 0 -10000 0 0
MAP2K4 0.018 0.027 -10000 0 -10000 0 0
SMARCA2 0.033 0.009 -10000 0 -10000 0 0
PDE9A -0.059 0.26 -10000 0 -1 31 31
NCOA2 0.029 0.015 -10000 0 -10000 0 0
CEBPA 0.03 0.044 -10000 0 -0.54 3 3
EHMT2 0.035 0.005 -10000 0 -10000 0 0
cell proliferation 0.036 0.15 0.43 12 -0.46 3 15
NR0B1 -0.094 0.25 -10000 0 -0.54 120 120
EGR1 -0.43 0.22 -10000 0 -0.54 415 415
RXRs/9cRA 0.052 0.043 -10000 0 -0.31 4 4
AR/RACK1/Src 0.003 0.099 0.36 4 -0.34 7 11
AR/GR -0.04 0.14 -10000 0 -0.29 90 90
GNB2L1 0.034 0.006 -10000 0 -10000 0 0
PKN1 0.035 0.011 -10000 0 -10000 0 0
RCHY1 0.029 0.051 -10000 0 -0.54 4 4
epidermal growth factor receptor activity 0 0.001 0.009 4 -10000 0 4
MAPK8 0.003 0.032 -10000 0 -0.43 1 1
T-DHT/AR/TIF2/CARM1 0.007 0.094 0.35 1 -0.35 7 8
SRC -0.009 0.075 0.47 1 -0.33 7 8
NR3C1 -0.011 0.16 -10000 0 -0.54 40 40
KLK3 -0.042 0.099 0.45 1 -0.43 2 3
APPBP2 0.018 0.027 -10000 0 -10000 0 0
TRIM24 0.036 0.013 -10000 0 -10000 0 0
T-DHT/AR/TIP60 -0.036 0.072 -10000 0 -0.35 11 11
TMPRSS2 -0.22 0.45 -10000 0 -1 124 124
RXRG 0.025 0.053 -10000 0 -0.54 4 4
mol:9cRA 0 0 0.003 4 -10000 0 4
RXRA 0.034 0.006 -10000 0 -10000 0 0
RXRB 0.034 0.005 -10000 0 -10000 0 0
CARM1 0.036 0.014 -10000 0 -10000 0 0
NR2C2 0.035 0.015 -10000 0 -10000 0 0
KLK2 0.013 0.077 0.35 2 -10000 0 2
AR -0.025 0.1 -10000 0 -0.27 61 61
SENP1 0.034 0.004 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
MDM2 0.032 0.011 -10000 0 -10000 0 0
SRY -0.001 0.002 -10000 0 -0.025 4 4
GATA2 0.042 0.033 -10000 0 -10000 0 0
MYST2 0 0.001 -10000 0 -0.006 4 4
HOXB13 0.079 0.07 -10000 0 -10000 0 0
T-DHT/AR/RACK1/Src 0 0.1 0.37 4 -0.35 7 11
positive regulation of transcription 0.042 0.033 -10000 0 -10000 0 0
DNAJA1 0.019 0.03 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.02 0.032 -10000 0 -0.32 4 4
NCOA1 0.042 0.033 -10000 0 -0.57 1 1
SPDEF -0.019 0.17 -10000 0 -0.54 50 50
T-DHT/AR/TIF2 0.017 0.08 0.3 5 -0.3 5 10
T-DHT/AR/Hsp90 -0.011 0.098 0.39 2 -0.36 11 13
GSK3B 0.033 0.01 -10000 0 -10000 0 0
NR2C1 0.033 0.026 -10000 0 -0.54 1 1
mol:T-DHT -0.019 0.071 0.22 14 -0.35 10 24
SIRT1 0.034 0.005 -10000 0 -10000 0 0
ZMIZ2 0.032 0.008 -10000 0 -10000 0 0
POU2F1 0.003 0.065 -10000 0 -0.18 6 6
T-DHT/AR/DAX-1 -0.073 0.17 0.39 2 -0.34 114 116
CREBBP 0.032 0.01 -10000 0 -10000 0 0
SMARCE1 0.033 0.009 -10000 0 -10000 0 0
E-cadherin signaling in the nascent adherens junction

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.036 0.15 -10000 0 -0.43 44 44
KLHL20 0.042 0.11 0.3 41 -0.26 14 55
CYFIP2 0.05 0.047 -10000 0 -10000 0 0
Rac1/GDP 0.003 0.12 0.34 4 -0.3 26 30
ENAH -0.03 0.14 -10000 0 -0.43 38 38
AP1M1 0.034 0.005 -10000 0 -10000 0 0
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CTNNB1 0.03 0.052 -10000 0 -0.54 4 4
CDC42/GTP 0.009 0.075 -10000 0 -0.29 2 2
ABI1/Sra1/Nap1 -0.015 0.04 -10000 0 -0.17 13 13
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.05 0.095 -10000 0 -0.31 26 26
RAPGEF1 -0.028 0.14 0.31 2 -0.4 40 42
CTNND1 0.034 0.007 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.03 0.16 -10000 0 -0.44 51 51
CRK -0.026 0.14 0.35 1 -0.41 46 47
E-cadherin/gamma catenin/alpha catenin 0.037 0.089 -10000 0 -0.34 21 21
alphaE/beta7 Integrin 0.046 0.016 -10000 0 -10000 0 0
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
NCKAP1 0.034 0.005 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.055 0.042 -10000 0 -0.31 3 3
DLG1 -0.038 0.16 -10000 0 -0.43 51 51
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.021 0.061 -10000 0 -0.2 14 14
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
ARF6/GTP/NME1/Tiam1 0.058 0.025 -10000 0 -10000 0 0
PI3K -0.022 0.08 -10000 0 -0.26 13 13
ARF6 0.034 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.021 0.095 -10000 0 -0.32 32 32
TIAM1 0.035 0.012 -10000 0 -10000 0 0
E-cadherin(dimer)/Ca2+ 0.047 0.089 -10000 0 -0.29 26 26
AKT1 -0.007 0.056 -10000 0 -0.18 2 2
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CDH1 0.007 0.12 0.18 6 -0.54 22 28
RhoA/GDP 0.002 0.12 0.33 4 -0.3 25 29
actin cytoskeleton organization 0.037 0.093 0.25 44 -0.19 12 56
CDC42/GDP 0.001 0.12 0.33 4 -0.3 25 29
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.005 0.066 -10000 0 -0.23 30 30
ITGB7 0.034 0.004 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.051 0.096 -10000 0 -0.31 26 26
E-cadherin/Ca2+/beta catenin/alpha catenin 0.033 0.082 -10000 0 -0.29 26 26
mol:GDP -0.017 0.12 0.33 4 -0.34 35 39
CDC42/GTP/IQGAP1 0.043 0.014 -10000 0 -10000 0 0
JUP 0.033 0.009 -10000 0 -10000 0 0
p120 catenin/RhoA/GDP 0.009 0.12 0.34 3 -0.31 24 27
RAC1/GTP/IQGAP1 0.044 0.011 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.049 0.012 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle 0.016 0.068 0.22 20 -0.22 11 31
NME1 0.031 0.011 -10000 0 -10000 0 0
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 -0.036 0.16 -10000 0 -0.43 49 49
regulation of cell-cell adhesion 0 0.061 -10000 0 -0.24 3 3
WASF2 0.02 0.043 0.12 34 -0.11 4 38
Rap1/GTP 0.013 0.087 0.28 1 -0.29 5 6
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.06 0.092 -10000 0 -0.3 21 21
CCND1 0.017 0.08 0.25 20 -0.28 11 31
VAV2 -0.018 0.19 0.39 3 -0.62 19 22
RAP1/GDP 0.011 0.1 0.31 3 -0.33 5 8
adherens junction assembly -0.033 0.15 -10000 0 -0.42 49 49
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.034 0.007 -10000 0 -10000 0 0
PIP5K1C 0.034 0.009 -10000 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.045 0.088 -10000 0 -0.29 24 24
E-cadherin/beta catenin -0.006 0.089 -10000 0 -0.34 33 33
mol:GTP 0 0 -10000 0 -10000 0 0
SRC -0.037 0.16 -10000 0 -0.43 50 50
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
Rac1/GTP 0.013 0.14 0.28 59 -0.42 17 76
E-cadherin/beta catenin/alpha catenin 0.037 0.095 -10000 0 -0.34 26 26
ITGAE 0.031 0.01 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.031 0.17 -10000 0 -0.45 51 51
E-cadherin signaling events

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.035 0.094 -10000 0 -0.34 25 25
E-cadherin/beta catenin 0.019 0.1 -10000 0 -0.33 36 36
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
JUP 0.033 0.009 -10000 0 -10000 0 0
CDH1 0.007 0.12 0.18 6 -0.54 22 28
IL2 signaling events mediated by PI3K

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.02 0.093 -10000 0 -10000 0 0
UGCG 0.029 0.12 -10000 0 -0.65 11 11
AKT1/mTOR/p70S6K/Hsp90/TERT 0 0.18 0.33 1 -0.41 41 42
mol:GTP 0 0.001 -10000 0 -10000 0 0
mol:glucosylceramide 0.03 0.11 -10000 0 -0.64 11 11
mol:DAG 0.003 0.11 -10000 0 -0.82 8 8
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.02 0.22 0.35 1 -0.46 56 57
FRAP1 -0.036 0.24 0.38 1 -0.49 73 74
FOXO3 0.005 0.18 0.37 4 -0.59 20 24
AKT1 0.002 0.2 0.39 1 -0.55 31 32
GAB2 0.028 0.014 -10000 0 -10000 0 0
SMPD1 0.009 0.12 -10000 0 -0.65 15 15
SGMS1 0.018 0.082 -10000 0 -0.57 8 8
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.028 0.097 -10000 0 -0.34 44 44
CALM1 0.034 0.006 -10000 0 -10000 0 0
cell proliferation 0.049 0.12 0.42 1 -0.5 8 9
EIF3A 0.034 0.006 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
RPS6KB1 0.001 0.13 -10000 0 -0.83 8 8
mol:sphingomyelin 0.003 0.11 -10000 0 -0.82 8 8
natural killer cell activation -0.002 0.005 -10000 0 -0.02 3 3
JAK3 0.034 0.009 -10000 0 -10000 0 0
PIK3R1 -0.021 0.17 -10000 0 -0.54 47 47
JAK1 0.033 0.01 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MYC 0.023 0.27 0.54 1 -0.92 31 32
MYB -0.047 0.34 0.45 1 -1.2 42 43
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.027 0.13 0.31 2 -0.39 13 15
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.035 0.13 -10000 0 -0.71 9 9
mol:PI-3-4-5-P3 0.029 0.13 0.31 2 -0.38 13 15
Rac1/GDP -0.011 0.095 -10000 0 -0.31 44 44
T cell proliferation 0.028 0.12 0.31 1 -0.36 13 14
SHC1 0.026 0.016 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity 0.003 0.029 0.094 25 -0.068 41 66
PRKCZ 0.027 0.12 0.31 1 -0.37 13 14
NF kappa B1 p50/RelA -0.01 0.22 0.37 1 -0.5 44 45
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K 0.022 0.097 -10000 0 -0.39 8 8
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
IL2RA 0.039 0.035 -10000 0 -10000 0 0
IL2RB 0.035 0.023 -10000 0 -10000 0 0
TERT 0.032 0.028 -10000 0 -0.54 1 1
E2F1 0.014 0.14 0.31 2 -0.4 46 48
SOS1 0.032 0.01 -10000 0 -10000 0 0
RPS6 0.032 0.026 -10000 0 -0.54 1 1
mol:cAMP -0.002 0.014 0.032 41 -0.05 24 65
PTPN11 0.032 0.011 -10000 0 -10000 0 0
IL2RG 0.043 0.037 -10000 0 -10000 0 0
actin cytoskeleton organization 0.028 0.12 0.31 1 -0.36 13 14
GRB2 0.032 0.02 -10000 0 -10000 0 0
IL2 0.032 0.029 -10000 0 -0.54 1 1
PIK3CA 0.032 0.012 -10000 0 -10000 0 0
Rac1/GTP 0.015 0.1 -10000 0 -0.29 44 44
LCK 0.048 0.046 -10000 0 -10000 0 0
BCL2 -0.12 0.38 0.52 1 -0.84 104 105
Noncanonical Wnt signaling pathway

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.03 0.027 -10000 0 -0.54 1 1
GNB1/GNG2 0.025 0.15 -10000 0 -0.44 27 27
mol:DAG 0.006 0.13 -10000 0 -0.41 26 26
PLCG1 0.005 0.13 -10000 0 -0.42 26 26
YES1 -0.002 0.14 0.25 1 -0.48 24 25
FZD3 0.014 0.091 -10000 0 -0.54 13 13
FZD6 0.007 0.11 -10000 0 -0.54 18 18
G protein 0.036 0.15 0.34 5 -0.43 24 29
MAP3K7 -0.005 0.11 0.25 1 -0.38 20 21
mol:Ca2+ 0.006 0.13 -10000 0 -0.4 26 26
mol:IP3 0.006 0.13 -10000 0 -0.41 26 26
NLK 0.003 0.13 -10000 0 -0.8 13 13
GNB1 0.034 0.011 -10000 0 -10000 0 0
CAMK2A 0 0.12 0.26 1 -0.4 22 23
MAP3K7IP1 0 0 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.015 0.13 -10000 0 -0.48 25 25
CSNK1A1 0.034 0.005 -10000 0 -10000 0 0
GNAS -0.005 0.13 0.25 1 -0.45 24 25
GO:0007205 0 0.13 0.26 1 -0.41 25 26
WNT6 0.033 0.04 -10000 0 -0.54 2 2
WNT4 0.041 0.034 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.016 0.14 -10000 0 -0.46 20 20
GNG2 0.033 0.026 -10000 0 -0.54 1 1
WNT5A 0.01 0.13 -10000 0 -0.54 25 25
WNT11 0.024 0.079 -10000 0 -0.54 9 9
CDC42 -0.003 0.13 -10000 0 -0.46 22 22
Signaling events mediated by PRL

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.059 0.056 -10000 0 -10000 0 0
mol:Halofuginone 0.003 0.004 -10000 0 -10000 0 0
ITGA1 0.031 0.037 -10000 0 -0.54 2 2
CDKN1A -0.081 0.1 -10000 0 -0.52 18 18
PRL-3/alpha Tubulin 0.042 0.027 -10000 0 -10000 0 0
mol:Ca2+ -0.005 0.042 -10000 0 -10000 0 0
AGT 0.043 0.049 -10000 0 -10000 0 0
CCNA2 -0.18 0.12 -10000 0 -10000 0 0
TUBA1B 0.035 0.012 -10000 0 -10000 0 0
EGR1 -0.31 0.16 -10000 0 -0.39 413 413
CDK2/Cyclin E1 -0.042 0.11 -10000 0 -0.44 20 20
MAPK3 0.015 0.019 -10000 0 -10000 0 0
PRL-2 /Rab GGTase beta 0.052 0.018 -10000 0 -10000 0 0
MAPK1 0.015 0.018 -10000 0 -10000 0 0
PTP4A1 -0.22 0.13 -10000 0 -10000 0 0
PTP4A3 0.03 0.025 -10000 0 -10000 0 0
PTP4A2 0.037 0.021 -10000 0 -10000 0 0
ITGB1 0.015 0.018 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1 -0.057 0.075 -10000 0 -0.48 7 7
Rab GGTase beta/Rab GGTase alpha 0.049 0.011 -10000 0 -10000 0 0
PRL-1/ATF-5 -0.21 0.12 -10000 0 -10000 0 0
RABGGTA 0.034 0.006 -10000 0 -10000 0 0
BCAR1 -0.019 0.017 -10000 0 -10000 0 0
RHOC -0.059 0.084 -10000 0 -0.52 9 9
RHOA -0.064 0.1 -10000 0 -0.54 15 15
cell motility -0.085 0.096 0.27 1 -0.37 31 32
PRL-1/alpha Tubulin -0.21 0.12 -10000 0 -10000 0 0
PRL-3/alpha1 Integrin 0.04 0.034 -10000 0 -0.4 1 1
ROCK1 -0.082 0.095 0.27 1 -0.36 29 30
RABGGTB 0.034 0.006 -10000 0 -10000 0 0
CDK2 0.038 0.021 -10000 0 -10000 0 0
mitosis -0.22 0.13 -10000 0 -10000 0 0
ATF5 0.034 0.011 -10000 0 -10000 0 0
Caspase cascade in apoptosis

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 0.034 0.085 0.27 3 -0.4 9 12
ACTA1 0.007 0.083 0.24 3 -0.32 5 8
NUMA1 0.027 0.083 0.29 2 -0.37 9 11
SPTAN1 0.021 0.069 0.3 6 -0.48 1 7
LIMK1 0.033 0.074 0.28 12 -0.48 1 13
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BIRC2 0.031 0.011 -10000 0 -10000 0 0
BAX 0.035 0.012 0.18 3 -10000 0 3
CASP10 -0.003 0.04 0.24 8 -0.34 1 9
CRMA 0 0 -10000 0 -0.001 1 1
XIAP 0 0 0.001 1 -0.001 37 38
PTK2 0.029 0.095 0.28 3 -0.45 10 13
DIABLO 0.034 0.003 -10000 0 -10000 0 0
apoptotic nuclear changes 0.021 0.068 0.3 6 -0.48 1 7
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.034 0.005 -10000 0 -10000 0 0
GSN -0.054 0.14 0.29 2 -0.29 92 94
MADD 0.034 0.005 -10000 0 -10000 0 0
TFAP2A 0.039 0.1 -10000 0 -0.65 9 9
BID 0.013 0.025 0.16 9 -0.2 1 10
MAP3K1 0.011 0.095 -10000 0 -0.37 25 25
TRADD 0.03 0.012 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.049 0.012 -10000 0 -10000 0 0
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB 0.024 0.069 0.3 5 -0.48 1 6
CASP9 0.033 0.008 -10000 0 -10000 0 0
DNA repair -0.034 0.059 0.32 3 -0.2 17 20
neuron apoptosis 0.007 0.15 -10000 0 -0.68 20 20
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis 0.024 0.075 0.29 2 -0.37 4 6
APAF1 0.035 0.003 -10000 0 -10000 0 0
CASP6 0.021 0.14 -10000 0 -0.85 12 12
TRAF2 0.035 0.012 -10000 0 -10000 0 0
ICAD/CAD 0.017 0.062 0.27 3 -0.47 1 4
CASP7 0.015 0.083 0.26 22 -0.31 5 27
KRT18 0.036 0.096 -10000 0 -0.73 6 6
apoptosis 0.012 0.11 0.29 2 -0.45 9 11
DFFA 0.02 0.065 0.28 3 -0.48 1 4
DFFB 0.02 0.064 0.28 3 -0.48 1 4
PARP1 0.034 0.059 0.2 17 -0.33 3 20
actin filament polymerization 0.016 0.13 0.27 56 -0.29 10 66
TNF 0.038 0.023 -10000 0 -10000 0 0
CYCS 0.023 0.044 0.22 6 -0.23 3 9
SATB1 -0.011 0.16 -10000 0 -0.78 14 14
SLK 0.02 0.067 0.28 3 -0.38 2 5
p15 BID/BAX 0.026 0.051 0.2 1 -0.28 4 5
CASP2 0.005 0.085 0.24 6 -0.32 13 19
JNK cascade -0.011 0.095 0.37 25 -10000 0 25
CASP3 0.024 0.07 0.26 8 -0.38 2 10
LMNB2 0.018 0.13 0.35 2 -0.52 20 22
RIPK1 0.034 0.006 -10000 0 -10000 0 0
CASP4 0.025 0.057 -10000 0 -0.54 5 5
Mammalian IAPs/DIABLO 0.045 0.078 -10000 0 -0.31 17 17
negative regulation of DNA binding 0.04 0.1 -10000 0 -0.64 9 9
stress fiber formation 0.019 0.066 0.28 3 -0.37 2 5
GZMB 0.022 0.046 0.29 7 -0.4 2 9
CASP1 -0.017 0.12 -10000 0 -0.4 41 41
LMNB1 0.042 0.13 0.35 3 -0.57 13 16
APP 0.007 0.15 -10000 0 -0.69 20 20
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
response to stress 0 0 0.001 21 -0.001 27 48
CASP8 0.009 0.001 -10000 0 -10000 0 0
VIM 0.014 0.11 0.28 4 -0.45 10 14
LMNA 0.023 0.083 0.34 2 -0.38 8 10
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.006 0.087 -10000 0 -0.32 17 17
LRDD 0 0 -10000 0 -10000 0 0
SREBF1 0.027 0.069 0.27 5 -0.41 1 6
APAF-1/Caspase 9 0.017 0.12 -10000 0 -0.6 16 16
nuclear fragmentation during apoptosis 0.027 0.082 0.28 2 -0.36 9 11
CFL2 -0.017 0.13 0.3 10 -0.28 57 67
GAS2 -0.15 0.15 0.3 5 -0.28 248 253
positive regulation of apoptosis 0.036 0.12 0.38 2 -0.48 17 19
PRF1 0.038 0.022 -10000 0 -10000 0 0
Syndecan-1-mediated signaling events

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.034 0.008 -10000 0 -10000 0 0
CCL5 0.029 0.06 -10000 0 -0.54 5 5
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
FGFR/FGF2/Syndecan-1 0.087 0.14 0.32 29 -0.35 6 35
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 0.069 0.14 0.31 4 -0.36 6 10
Syndecan-1/Syntenin 0.071 0.14 0.34 6 -0.37 6 12
MAPK3 0.071 0.13 0.32 9 -0.34 6 15
HGF/MET 0.006 0.13 -10000 0 -0.4 51 51
TGFB1/TGF beta receptor Type II 0.034 0.008 -10000 0 -10000 0 0
BSG 0.034 0.015 -10000 0 -10000 0 0
keratinocyte migration 0.069 0.14 0.31 4 -0.36 6 10
Syndecan-1/RANTES 0.074 0.15 0.34 10 -0.42 7 17
Syndecan-1/CD147 0.091 0.15 0.38 7 -0.35 6 13
Syndecan-1/Syntenin/PIP2 0.066 0.13 0.34 4 -0.36 6 10
LAMA5 0.032 0.012 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.064 0.13 0.33 4 -0.35 6 10
MMP7 -0.041 0.19 -10000 0 -0.54 64 64
HGF 0.035 0.01 -10000 0 -10000 0 0
Syndecan-1/CASK 0.058 0.13 0.25 23 -0.35 7 30
Syndecan-1/HGF/MET 0.062 0.18 0.35 5 -0.39 26 31
regulation of cell adhesion 0.061 0.12 0.32 5 -0.33 5 10
HPSE 0.046 0.04 -10000 0 -10000 0 0
positive regulation of cell migration 0.087 0.14 0.32 29 -0.35 6 35
SDC1 0.086 0.13 0.31 26 -0.35 3 29
Syndecan-1/Collagen 0.087 0.14 0.32 29 -0.35 6 35
PPIB 0.034 0.009 -10000 0 -10000 0 0
MET -0.022 0.17 -10000 0 -0.54 50 50
PRKACA 0.034 0.005 -10000 0 -10000 0 0
MMP9 0.095 0.074 -10000 0 -10000 0 0
MAPK1 0.071 0.13 0.32 9 -0.34 5 14
homophilic cell adhesion 0.084 0.14 0.32 29 -0.35 6 35
MMP1 0.11 0.077 -10000 0 -10000 0 0
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.028 0.016 -10000 0 -10000 0 0
Caspase 8 (4 units) 0.047 0.14 -10000 0 -0.45 16 16
NEF 0.011 0.022 -10000 0 -10000 0 0
NFKBIA 0.029 0.036 -10000 0 -0.35 1 1
BIRC3 0.009 0.14 0.38 1 -0.5 25 26
CYCS 0.033 0.13 0.28 16 -0.44 14 30
RIPK1 0.034 0.006 -10000 0 -10000 0 0
CD247 0.03 0.11 -10000 0 -0.55 15 15
MAP2K7 0.039 0.18 0.35 1 -0.71 17 18
protein ubiquitination 0.016 0.12 0.37 2 -0.38 16 18
CRADD 0.034 0.005 -10000 0 -10000 0 0
DAXX 0.035 0.008 -10000 0 -10000 0 0
FAS -0.003 0.14 -10000 0 -0.54 33 33
BID 0.03 0.13 0.25 8 -0.45 16 24
NF-kappa-B/RelA/I kappa B alpha 0.059 0.086 -10000 0 -0.3 16 16
TRADD 0.03 0.012 -10000 0 -10000 0 0
MAP3K5 0.003 0.13 -10000 0 -0.54 26 26
CFLAR 0.033 0.026 -10000 0 -0.54 1 1
FADD 0.028 0.015 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.06 0.087 -10000 0 -0.3 16 16
MAPK8 0.038 0.17 0.43 3 -0.64 17 20
APAF1 0.035 0.003 -10000 0 -10000 0 0
TRAF1 0.036 0.015 -10000 0 -10000 0 0
TRAF2 0.035 0.012 -10000 0 -10000 0 0
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG 0.035 0.14 0.26 7 -0.33 38 45
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.014 0.14 -10000 0 -0.49 17 17
CHUK 0.014 0.12 0.38 2 -0.42 16 18
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.038 0.12 -10000 0 -0.33 42 42
TCRz/NEF 0.032 0.093 0.24 17 -0.41 15 32
TNF 0.038 0.023 -10000 0 -10000 0 0
FASLG 0.036 0.11 0.31 42 -0.37 15 57
NFKB1 0.03 0.034 -10000 0 -0.17 1 1
TNFR1A/BAG4/TNF-alpha 0.053 0.035 -10000 0 -10000 0 0
CASP6 0.053 0.15 -10000 0 -0.55 15 15
CASP7 0.02 0.19 0.39 17 -0.47 42 59
RELA 0.03 0.033 -10000 0 -0.17 1 1
CASP2 0.034 0.006 -10000 0 -10000 0 0
CASP3 0.016 0.19 0.4 17 -0.47 42 59
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
TNFR1A/BAG4 0.038 0.023 -10000 0 -10000 0 0
CASP8 0.034 0.005 -10000 0 -10000 0 0
CASP9 0.033 0.008 -10000 0 -10000 0 0
MAP3K14 0.016 0.13 0.36 1 -0.44 18 19
APAF-1/Caspase 9 0.019 0.13 0.26 2 -0.38 26 28
BCL2 -0.005 0.18 0.52 4 -0.55 22 26
Hedgehog signaling events mediated by Gli proteins

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC2 0.034 0.017 -10000 0 -10000 0 0
GNB1/GNG2 0.048 0.088 -10000 0 -0.34 23 23
forebrain development -0.041 0.2 -10000 0 -0.59 41 41
GNAO1 0.031 0.012 -10000 0 -10000 0 0
SMO/beta Arrestin2 0.029 0.092 -10000 0 -0.4 22 22
SMO 0.012 0.12 -10000 0 -0.54 22 22
ARRB2 0.032 0.011 -10000 0 -10000 0 0
GLI3/SPOP 0.03 0.11 -10000 0 -0.52 8 8
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
GSK3B 0.034 0.009 -10000 0 -10000 0 0
GNAI2 0.034 0.01 -10000 0 -10000 0 0
SIN3/HDAC complex 0.078 0.032 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
XPO1 0.037 0.006 -10000 0 -10000 0 0
GLI1/Su(fu) -0.031 0.19 -10000 0 -0.68 24 24
SAP30 0.034 0.009 -10000 0 -10000 0 0
mol:GDP 0.012 0.12 -10000 0 -0.54 22 22
MIM/GLI2A 0.033 0.029 0.31 1 -10000 0 1
IFT88 0.031 0.027 -10000 0 -0.54 1 1
GNAI3 0.035 0.006 -10000 0 -10000 0 0
GLI2 0.017 0.084 -10000 0 -0.37 14 14
GLI3 0.017 0.11 0.3 1 -0.51 10 11
CSNK1D 0.033 0.008 -10000 0 -10000 0 0
CSNK1E 0.033 0.009 -10000 0 -10000 0 0
SAP18 0.032 0.009 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.031 0.027 -10000 0 -0.54 1 1
GNG2 0.033 0.026 -10000 0 -0.54 1 1
Gi family/GTP -0.082 0.16 -10000 0 -0.37 71 71
SIN3B 0.035 0.014 -10000 0 -10000 0 0
SIN3A 0.034 0.006 -10000 0 -10000 0 0
GLI3/Su(fu) 0.026 0.11 -10000 0 -0.45 14 14
GLI2/Su(fu) 0.02 0.1 -10000 0 -0.46 12 12
FOXA2 0.017 0.12 -10000 0 -0.7 11 11
neural tube patterning -0.041 0.2 -10000 0 -0.59 41 41
SPOP 0.031 0.011 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.028 0.064 -10000 0 -0.35 1 1
GNB1 0.034 0.011 -10000 0 -10000 0 0
CSNK1G2 0.033 0.007 -10000 0 -10000 0 0
CSNK1G3 0.034 0.007 -10000 0 -10000 0 0
MTSS1 0.033 0.029 0.31 1 -10000 0 1
embryonic limb morphogenesis -0.041 0.2 -10000 0 -0.59 41 41
SUFU 0.019 0.049 -10000 0 -0.38 1 1
LGALS3 -0.029 0.18 -10000 0 -0.54 56 56
catabolic process 0.038 0.14 -10000 0 -0.58 13 13
GLI3A/CBP 0.004 0.11 -10000 0 -0.35 47 47
KIF3A 0.034 0.006 -10000 0 -10000 0 0
GLI1 -0.043 0.2 -10000 0 -0.61 41 41
RAB23 0.035 0.014 -10000 0 -10000 0 0
CSNK1A1 0.034 0.005 -10000 0 -10000 0 0
IFT172 0.033 0.026 -10000 0 -0.54 1 1
RBBP7 0.038 0.022 -10000 0 -10000 0 0
Su(fu)/Galectin3 -0.009 0.13 -10000 0 -0.32 60 60
GNAZ 0.026 0.063 -10000 0 -0.54 6 6
RBBP4 0.034 0.006 -10000 0 -10000 0 0
CSNK1G1 0.033 0.007 -10000 0 -10000 0 0
PIAS1 0.033 0.007 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GLI2/SPOP 0.029 0.089 -10000 0 -0.46 9 9
STK36 0.035 0.026 -10000 0 -0.54 1 1
Gi family/GNB1/GNG2/GDP -0.08 0.16 -10000 0 -0.39 68 68
PTCH1 -0.036 0.18 -10000 0 -0.74 14 14
MIM/GLI1 -0.022 0.18 -10000 0 -0.66 22 22
CREBBP 0.004 0.11 -10000 0 -0.35 47 47
Su(fu)/SIN3/HDAC complex 0.017 0.1 -10000 0 -0.49 14 14
ceramide signaling pathway

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.003 0.13 0.28 1 -0.46 21 22
BAG4 0.028 0.016 -10000 0 -10000 0 0
BAD 0.007 0.047 0.2 2 -0.18 7 9
NFKBIA 0.033 0.007 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BAX 0.008 0.051 0.3 2 -0.18 8 10
EnzymeConsortium:3.1.4.12 0.003 0.032 0.09 4 -0.098 19 23
IKBKB 0.013 0.13 0.29 5 -0.45 14 19
MAP2K2 0.012 0.06 0.23 9 -0.22 2 11
MAP2K1 0.013 0.061 0.23 10 -0.22 2 12
SMPD1 0.004 0.04 0.2 1 -0.17 10 11
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 0.031 0.15 0.31 12 -0.44 20 32
MAP2K4 0.008 0.052 0.2 3 -0.25 5 8
protein ubiquitination 0.003 0.13 0.36 3 -0.43 20 23
EnzymeConsortium:2.7.1.37 0.011 0.063 0.24 9 -0.24 2 11
response to UV 0 0.001 0.003 12 -0.002 1 13
RAF1 0.012 0.061 0.21 20 -0.21 3 23
CRADD 0.034 0.005 -10000 0 -10000 0 0
mol:ceramide 0.008 0.05 0.16 3 -0.15 19 22
I-kappa-B-alpha/RELA/p50/ubiquitin 0.043 0.015 -10000 0 -0.14 1 1
MADD 0.034 0.006 -10000 0 -10000 0 0
MAP3K1 0.008 0.054 0.2 2 -0.21 10 12
TRADD 0.03 0.012 -10000 0 -10000 0 0
RELA/p50 0.033 0.007 -10000 0 -10000 0 0
MAPK3 0.015 0.061 0.23 9 -0.22 2 11
MAPK1 0.011 0.069 0.23 10 -0.22 8 18
p50/RELA/I-kappa-B-alpha 0.047 0.017 -10000 0 -0.17 1 1
FADD 0.028 0.14 0.3 9 -0.45 18 27
KSR1 0.012 0.057 0.2 14 -0.18 7 21
MAPK8 0.005 0.057 0.26 4 -0.24 5 9
TRAF2 0.035 0.012 -10000 0 -10000 0 0
response to radiation 0 0 0.003 2 -10000 0 2
CHUK -0.006 0.12 -10000 0 -0.46 18 18
TNF R/SODD 0.038 0.023 -10000 0 -10000 0 0
TNF 0.038 0.023 -10000 0 -10000 0 0
CYCS 0.025 0.07 0.18 22 -0.17 9 31
IKBKG -0.006 0.13 0.45 1 -0.45 18 19
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.002 0.14 -10000 0 -0.45 24 24
RELA 0.033 0.007 -10000 0 -10000 0 0
RIPK1 0.034 0.006 -10000 0 -10000 0 0
AIFM1 0.024 0.069 0.18 21 -0.18 9 30
TNF/TNF R/SODD 0.053 0.035 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
response to heat 0 0 0.003 2 -10000 0 2
CASP8 0.009 0.15 -10000 0 -0.66 23 23
NSMAF 0.017 0.14 0.28 4 -0.44 19 23
response to hydrogen peroxide 0 0.001 0.003 12 -0.002 1 13
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
Wnt signaling

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.015 0.13 -9999 0 -0.48 25 25
FZD6 0.007 0.11 -9999 0 -0.54 18 18
WNT6 0.033 0.04 -9999 0 -0.54 2 2
WNT4 0.041 0.034 -9999 0 -10000 0 0
FZD3 0.014 0.091 -9999 0 -0.54 13 13
WNT5A 0.01 0.13 -9999 0 -0.54 25 25
WNT11 0.024 0.079 -9999 0 -0.54 9 9
BCR signaling pathway

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN 0.015 0.15 0.35 6 -0.36 22 28
IKBKB 0.049 0.092 0.35 7 -0.34 3 10
AKT1 0.061 0.11 0.3 47 -0.25 2 49
IKBKG 0.055 0.076 0.35 5 -0.29 3 8
CALM1 0.031 0.085 0.28 8 -0.39 6 14
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
MAP3K1 0.066 0.14 0.4 6 -0.49 12 18
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0.032 0.09 0.28 8 -0.41 6 14
DOK1 0.036 0.016 -10000 0 -10000 0 0
AP-1 -0.073 0.11 0.27 2 -0.24 61 63
LYN 0.03 0.015 -10000 0 -10000 0 0
BLNK 0.039 0.026 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
BCR complex 0.042 0.07 0.26 3 -0.4 10 13
CD22 0.015 0.088 0.29 4 -0.45 11 15
CAMK2G 0.03 0.083 0.26 9 -0.37 6 15
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.024 0.044 -10000 0 -10000 0 0
GO:0007205 0.032 0.091 0.29 7 -0.4 7 14
SYK 0.039 0.027 -10000 0 -10000 0 0
ELK1 0.033 0.089 0.28 8 -0.4 6 14
NFATC1 0.062 0.11 0.29 18 -0.41 8 26
B-cell antigen/BCR complex 0.042 0.07 0.26 3 -0.4 10 13
PAG1/CSK 0.043 0.028 0.26 1 -10000 0 1
NFKBIB 0.041 0.055 0.19 10 -0.12 21 31
HRAS 0.043 0.093 0.26 15 -0.35 8 23
NFKBIA 0.041 0.055 0.2 9 -0.12 13 22
NF-kappa-B/RelA/I kappa B beta 0.045 0.05 0.2 9 -10000 0 9
RasGAP/Csk 0.066 0.079 0.35 2 -0.39 6 8
mol:GDP 0.032 0.088 0.28 7 -0.38 7 14
PTEN 0.03 0.045 -10000 0 -0.54 3 3
CD79B 0.02 0.081 -10000 0 -0.54 10 10
NF-kappa-B/RelA/I kappa B alpha 0.045 0.05 0.2 9 -10000 0 9
GRB2 0.034 0.018 -10000 0 -10000 0 0
PI3K/BCAP/CD19 0.048 0.15 0.41 6 -0.5 12 18
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.031 0.089 0.29 7 -0.42 6 13
CSK 0.034 0.011 -10000 0 -10000 0 0
FOS -0.15 0.14 0.27 1 -0.36 56 57
CHUK 0.053 0.083 0.34 6 -0.33 6 12
IBTK 0.033 0.008 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 0.054 0.09 0.3 4 -0.37 5 9
PTPN6 0.031 0.1 0.29 13 -0.44 10 23
RELA 0.034 0.007 -10000 0 -10000 0 0
BCL2A1 0.041 0.044 0.18 11 -10000 0 11
VAV2 0.043 0.11 0.31 5 -0.57 6 11
ubiquitin-dependent protein catabolic process 0.044 0.055 0.2 9 -0.12 22 31
BTK 0.017 0.091 -10000 0 -0.97 4 4
CD19 0.022 0.093 0.3 5 -0.43 11 16
MAP4K1 0.037 0.021 -10000 0 -10000 0 0
CD72 0.063 0.059 -10000 0 -10000 0 0
PAG1 0.031 0.025 -10000 0 -10000 0 0
MAPK14 0.063 0.13 0.39 8 -0.42 12 20
SH3BP5 0.018 0.094 -10000 0 -0.54 14 14
PIK3AP1 0.03 0.095 0.33 6 -0.46 6 12
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 0.048 0.095 0.28 10 -0.44 7 17
RAF1 0.042 0.089 0.26 13 -0.4 4 17
RasGAP/p62DOK/SHIP 0.055 0.071 0.3 1 -0.37 6 7
CD79A 0.042 0.034 -10000 0 -10000 0 0
re-entry into mitotic cell cycle -0.071 0.11 0.27 2 -0.24 57 59
RASA1 0.034 0.012 -10000 0 -10000 0 0
MAPK3 0.049 0.091 0.27 20 -0.34 4 24
MAPK1 0.039 0.083 0.29 6 -0.34 4 10
CD72/SHP1 0.092 0.12 0.34 29 -0.52 6 35
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 0.063 0.13 0.37 10 -0.42 12 22
actin cytoskeleton organization 0.07 0.11 0.32 18 -0.49 6 24
NF-kappa-B/RelA 0.089 0.092 0.36 8 -0.21 1 9
Calcineurin 0.043 0.09 -10000 0 -0.38 5 5
PI3K -0.003 0.074 -10000 0 -0.4 7 7
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 0.033 0.093 0.32 6 -0.46 7 13
SOS1 0.034 0.004 -10000 0 -10000 0 0
Bam32/HPK1 0.062 0.16 -10000 0 -0.63 17 17
DAPP1 0.028 0.16 -10000 0 -0.7 18 18
cytokine secretion 0.061 0.11 0.28 22 -0.38 8 30
mol:DAG 0.031 0.089 0.29 7 -0.42 6 13
PLCG2 0.022 0.073 -10000 0 -0.54 8 8
MAP2K1 0.04 0.086 0.26 8 -0.37 4 12
B-cell antigen/BCR complex/FcgammaRIIB 0.047 0.074 0.35 1 -0.43 7 8
mol:PI-3-4-5-P3 0.027 0.091 0.26 17 -0.3 5 22
ETS1 0.027 0.079 0.3 3 -0.37 4 7
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.076 0.078 0.44 1 -0.3 8 9
B-cell antigen/BCR complex/LYN 0.016 0.084 -10000 0 -0.47 11 11
MALT1 0.033 0.01 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.061 0.11 0.32 16 -0.52 6 22
B-cell antigen/BCR complex/LYN/SYK 0.044 0.1 0.34 5 -0.53 6 11
CARD11 0.034 0.093 0.28 12 -0.4 6 18
FCGR2B 0.026 0.039 -10000 0 -0.54 2 2
PPP3CA 0.03 0.051 -10000 0 -0.54 4 4
BCL10 0.033 0.007 -10000 0 -10000 0 0
IKK complex 0.044 0.057 0.18 32 -0.14 1 33
PTPRC 0.035 0.035 0.18 24 -10000 0 24
PDPK1 0.035 0.085 0.25 30 -0.22 4 34
PPP3CB 0.034 0.004 -10000 0 -10000 0 0
PPP3CC 0.024 0.046 -10000 0 -0.54 3 3
POU2F2 0.035 0.04 0.24 5 -10000 0 5
JNK signaling in the CD4+ TCR pathway

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.08 0.055 0.4 6 -10000 0 6
MAP4K1 0.037 0.021 -10000 0 -10000 0 0
MAP3K8 -0.039 0.19 -10000 0 -0.54 65 65
PRKCB 0 0 -10000 0 -10000 0 0
DBNL 0.035 0.012 0.18 3 -10000 0 3
CRKL 0.032 0.009 -10000 0 -10000 0 0
MAP3K1 0.031 0.056 0.3 3 -0.28 4 7
JUN -0.04 0.13 -10000 0 -0.3 83 83
MAP3K7 0.029 0.051 0.27 3 -0.27 3 6
GRAP2 0.035 0.019 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
MAP2K4 0.001 0.1 0.28 3 -0.34 21 24
LAT 0.036 0.025 -10000 0 -10000 0 0
LCP2 0.037 0.023 -10000 0 -10000 0 0
MAPK8 0.011 0.081 -10000 0 -0.58 8 8
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0.037 0.06 0.3 3 -0.29 4 7
LAT/GRAP2/SLP76/HPK1/HIP-55 0.09 0.06 0.4 6 -10000 0 6
Cellular roles of Anthrax toxin

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.035 0.031 -10000 0 -0.54 1 1
ANTXR2 0.023 0.08 -10000 0 -0.54 10 10
negative regulation of myeloid dendritic cell antigen processing and presentation -0.002 0.01 -10000 0 -0.073 11 11
monocyte activation 0.012 0.088 -10000 0 -0.35 27 27
MAP2K2 0.005 0.094 -10000 0 -0.57 13 13
MAP2K1 -0.005 0.01 -10000 0 -10000 0 0
MAP2K7 -0.005 0.01 -10000 0 -10000 0 0
MAP2K6 -0.01 0.042 -10000 0 -0.3 10 10
CYAA -0.01 0.042 -10000 0 -0.29 11 11
MAP2K4 -0.005 0.012 -10000 0 -0.18 1 1
IL1B -0.012 0.05 0.24 1 -0.3 8 9
Channel 0.036 0.053 -10000 0 -0.31 11 11
NLRP1 -0.007 0.028 -10000 0 -0.27 5 5
CALM1 0.034 0.006 -10000 0 -10000 0 0
negative regulation of phagocytosis 0.002 0.075 -10000 0 -0.41 16 16
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.002 0.01 0.073 11 -10000 0 11
MAPK3 -0.005 0.01 -10000 0 -10000 0 0
MAPK1 -0.005 0.01 -10000 0 -10000 0 0
PGR -0.063 0.14 0.11 3 -0.29 143 146
PA/Cellular Receptors 0.038 0.058 -10000 0 -0.34 11 11
apoptosis -0.002 0.01 -10000 0 -0.073 11 11
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.036 0.05 -10000 0 -0.29 11 11
macrophage activation 0.008 0.051 0.18 39 -10000 0 39
TNF 0.038 0.023 -10000 0 -10000 0 0
VCAM1 0.011 0.088 -10000 0 -0.35 27 27
platelet activation 0.002 0.075 -10000 0 -0.41 16 16
MAPKKK cascade -0.003 0.029 0.12 3 -0.15 3 6
IL18 0 0.039 -10000 0 -0.25 3 3
negative regulation of macrophage activation -0.002 0.01 -10000 0 -0.073 11 11
LEF -0.002 0.01 -10000 0 -0.073 11 11
CASP1 -0.006 0.032 -10000 0 -0.11 34 34
mol:cAMP 0.002 0.075 -10000 0 -0.41 16 16
necrosis -0.002 0.01 -10000 0 -0.073 11 11
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.036 0.05 -10000 0 -0.29 11 11
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
IFN-gamma pathway

Figure S88.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S88.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.086 0.075 0.31 1 -0.28 5 6
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.032 0.009 -10000 0 -10000 0 0
STAT1 (dimer)/Cbp/p300 0.1 0.11 0.4 35 -10000 0 35
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.063 0.055 -10000 0 -0.34 5 5
antigen processing and presentation of peptide antigen via MHC class I -0.003 0.096 0.16 4 -0.28 36 40
CaM/Ca2+ 0.084 0.072 -10000 0 -0.27 5 5
RAP1A 0.034 0.005 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 0.077 0.089 0.31 25 -0.27 4 29
AKT1 0.02 0.11 0.32 9 -0.32 17 26
MAP2K1 0.028 0.074 0.31 5 -0.26 5 10
MAP3K11 0.045 0.071 0.32 5 -0.27 5 10
IFNGR1 0.031 0.058 -10000 0 -0.54 5 5
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII 0.047 0.087 -10000 0 -0.41 8 8
Rap1/GTP 0.018 0.035 -10000 0 -10000 0 0
CRKL/C3G 0.047 0.015 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.094 0.076 -10000 0 -0.3 5 5
CEBPB 0.058 0.14 0.4 8 -0.51 8 16
STAT3 0.033 0.007 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.092 0.11 -10000 0 -0.75 4 4
STAT1 0.061 0.092 0.3 31 -0.27 4 35
CALM1 0.034 0.006 -10000 0 -10000 0 0
IFN-gamma (dimer) 0.061 0.064 0.19 2 -0.55 1 3
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
STAT1 (dimer)/PIAS1 0.076 0.09 0.3 28 -0.26 4 32
CEBPB/PTGES2/Cbp/p300 0.04 0.086 0.29 3 -0.37 5 8
mol:Ca2+ 0.082 0.072 0.3 1 -0.28 5 6
MAPK3 0.044 0.12 -10000 0 -0.63 9 9
STAT1 (dimer) 0.021 0.15 0.32 3 -0.39 35 38
MAPK1 0.012 0.2 -10000 0 -0.7 33 33
JAK2 0.036 0.016 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
JAK1 0.036 0.014 -10000 0 -10000 0 0
CAMK2D 0.03 0.052 -10000 0 -0.54 4 4
DAPK1 0.059 0.11 0.41 12 -0.35 4 16
SMAD7 0.023 0.071 0.23 7 -0.19 3 10
CBL/CRKL/C3G 0.068 0.069 0.33 4 -0.26 4 8
PI3K 0.049 0.12 -10000 0 -0.3 33 33
IFNG 0.062 0.064 0.19 2 -0.55 1 3
apoptosis 0.05 0.11 0.38 11 -0.46 7 18
CAMK2G 0.034 0.004 -10000 0 -10000 0 0
STAT3 (dimer) 0.033 0.007 -10000 0 -10000 0 0
CAMK2A 0.034 0.005 -10000 0 -10000 0 0
CAMK2B 0.039 0.069 -10000 0 -0.54 5 5
FRAP1 0.004 0.1 0.3 11 -0.3 17 28
PRKCD 0.02 0.11 0.32 12 -0.31 18 30
RAP1B 0.033 0.007 -10000 0 -10000 0 0
negative regulation of cell growth -0.003 0.096 0.16 4 -0.28 36 40
PTPN2 0.033 0.007 -10000 0 -10000 0 0
EP300 0.034 0.009 -10000 0 -10000 0 0
IRF1 0.067 0.11 0.4 35 -10000 0 35
STAT1 (dimer)/PIASy 0.074 0.09 0.34 11 -0.27 3 14
SOCS1 0.019 0.1 -10000 0 -1 5 5
mol:GDP 0.063 0.065 0.31 4 -0.25 5 9
CASP1 0.006 0.11 0.24 11 -0.27 57 68
PTGES2 0.034 0.005 -10000 0 -10000 0 0
IRF9 0.052 0.068 0.27 16 -10000 0 16
mol:PI-3-4-5-P3 0.031 0.1 -10000 0 -0.3 33 33
RAP1/GDP 0.051 0.052 -10000 0 -10000 0 0
CBL 0.042 0.069 0.31 5 -0.27 5 10
MAP3K1 0.047 0.072 0.31 5 -0.27 6 11
PIAS1 0.033 0.007 -10000 0 -10000 0 0
PIAS4 0.035 0.016 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II -0.003 0.096 0.16 4 -0.28 36 40
PTPN11 0.045 0.072 0.3 6 -0.28 5 11
CREBBP 0.033 0.011 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
PLK2 and PLK4 events

Figure S89.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S89.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 0.016 0.1 -9999 0 -0.54 17 17
PLK4 0.055 0.052 -9999 0 -10000 0 0
regulation of centriole replication 0.023 0.086 -9999 0 -0.38 16 16
FoxO family signaling

Figure S90.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S90.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.003 0.097 -10000 0 -10000 0 0
PLK1 0.13 0.22 0.62 13 -0.86 4 17
CDKN1B 0.1 0.18 0.52 4 -0.46 14 18
FOXO3 0.11 0.23 0.55 21 -0.63 16 37
KAT2B 0.019 0.031 0.085 37 -0.054 16 53
FOXO1/SIRT1 0.007 0.1 -10000 0 -0.32 8 8
CAT 0.054 0.36 0.76 4 -1.1 39 43
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
AKT1 0.053 0.045 0.23 1 -10000 0 1
FOXO1 0.002 0.11 -10000 0 -0.34 9 9
MAPK10 0.024 0.058 0.24 2 -0.29 10 12
mol:GTP 0 0.004 -10000 0 -10000 0 0
FOXO4 0.044 0.12 0.4 3 -0.4 6 9
response to oxidative stress 0.023 0.032 0.09 37 -0.063 8 45
FOXO3A/SIRT1 0.086 0.2 0.47 14 -0.6 15 29
XPO1 0.034 0.005 -10000 0 -10000 0 0
EP300 0.035 0.01 -10000 0 -10000 0 0
BCL2L11 0.057 0.081 -10000 0 -0.82 3 3
FOXO1/SKP2 0.017 0.1 -10000 0 -0.31 9 9
mol:GDP 0.022 0.032 0.09 37 -0.063 8 45
RAN 0.035 0.005 -10000 0 -10000 0 0
GADD45A 0.082 0.21 -10000 0 -0.81 15 15
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
FOXO1/14-3-3 family 0.036 0.15 -10000 0 -0.52 21 21
MST1 0.047 0.042 -10000 0 -10000 0 0
CSNK1D 0.033 0.008 -10000 0 -10000 0 0
CSNK1E 0.033 0.009 -10000 0 -10000 0 0
FOXO4/14-3-3 family 0.024 0.14 -10000 0 -0.46 28 28
YWHAB 0.033 0.008 -10000 0 -10000 0 0
MAPK8 0.029 0.04 0.23 3 -0.27 1 4
MAPK9 0.029 0.038 0.24 2 -10000 0 2
YWHAG 0.035 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
SIRT1 0.022 0.023 -10000 0 -10000 0 0
SOD2 0.096 0.2 0.57 8 -0.56 11 19
RBL2 0.035 0.32 -10000 0 -0.8 44 44
RAL/GDP 0.058 0.035 -10000 0 -10000 0 0
CHUK 0.048 0.043 -10000 0 -10000 0 0
Ran/GTP 0.024 0.014 -10000 0 -10000 0 0
CSNK1G2 0.033 0.007 -10000 0 -10000 0 0
RAL/GTP 0.058 0.042 -10000 0 -10000 0 0
CSNK1G1 0.033 0.007 -10000 0 -10000 0 0
FASLG 0.075 0.12 -10000 0 -1.4 1 1
SKP2 0.036 0.019 -10000 0 -10000 0 0
USP7 0.032 0.01 -10000 0 -10000 0 0
IKBKB 0.041 0.041 -10000 0 -10000 0 0
CCNB1 0.15 0.24 0.6 21 -0.84 4 25
FOXO1-3a-4/beta catenin 0.096 0.22 0.54 9 -0.4 43 52
proteasomal ubiquitin-dependent protein catabolic process 0.017 0.1 -10000 0 -0.3 9 9
CSNK1A1 0.034 0.005 -10000 0 -10000 0 0
SGK1 0.019 0.031 0.085 37 -0.054 16 53
CSNK1G3 0.034 0.007 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.046 0.019 -10000 0 -10000 0 0
ZFAND5 0.044 0.11 0.44 2 -10000 0 2
SFN 0.033 0.04 -10000 0 -0.54 2 2
CDK2 0.04 0.022 -10000 0 -10000 0 0
FOXO3A/14-3-3 0.053 0.13 -10000 0 -0.48 15 15
CREBBP 0.034 0.011 -10000 0 -10000 0 0
FBXO32 0.12 0.35 0.64 27 -1.1 26 53
BCL6 0.017 0.4 0.54 1 -1.1 55 56
RALB 0.035 0.005 -10000 0 -10000 0 0
RALA 0.034 0.006 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
Signaling events mediated by VEGFR1 and VEGFR2

Figure S91.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S91.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.049 0.027 -10000 0 -0.4 1 1
AKT1 0.026 0.14 0.4 2 -0.49 11 13
PTK2B 0.015 0.085 0.36 2 -0.43 1 3
VEGFR2 homodimer/Frs2 0.022 0.086 -10000 0 -0.33 27 27
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
CALM1 0.034 0.006 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.049 0.091 -10000 0 -0.3 22 22
endothelial cell proliferation 0.052 0.13 0.4 9 -0.44 8 17
mol:Ca2+ 0.021 0.091 0.37 1 -0.5 4 5
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.07 0.093 -10000 0 -0.29 22 22
RP11-342D11.1 0.003 0.087 0.27 1 -0.54 4 5
CDH5 0.03 0.012 -10000 0 -10000 0 0
VEGFA homodimer 0.071 0.059 -10000 0 -0.28 3 3
SHC1 0.028 0.014 -10000 0 -10000 0 0
SHC2 0.006 0.12 -10000 0 -0.54 24 24
HRAS/GDP 0.031 0.083 -10000 0 -0.45 4 4
SH2D2A 0.044 0.049 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.057 0.12 -10000 0 -0.48 11 11
VEGFR2 homodimer/VEGFA homodimer/TsAd 0.05 0.095 -10000 0 -0.31 19 19
VEGFR1 homodimer 0.032 0.013 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.057 0.1 -10000 0 -0.48 4 4
GRB10 0.018 0.11 -10000 0 -0.61 7 7
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GRB2 0.034 0.018 -10000 0 -10000 0 0
PAK1 0.044 0.046 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.068 0.1 -10000 0 -0.43 1 1
HRAS 0.034 0.013 -10000 0 -10000 0 0
VEGF/Rho/ROCK1/Integrin Complex 0.028 0.081 -10000 0 -0.37 7 7
HIF1A 0.031 0.054 -10000 0 -0.54 4 4
FRS2 0.033 0.029 -10000 0 -0.54 1 1
oxygen and reactive oxygen species metabolic process 0.067 0.092 -10000 0 -0.29 22 22
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 0.034 0.006 -10000 0 -10000 0 0
Nck/Pak 0.053 0.037 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.045 0.095 -10000 0 -0.31 26 26
mol:GDP 0.043 0.093 -10000 0 -0.47 4 4
mol:NADP 0.033 0.11 0.59 1 -0.46 9 10
eNOS/Hsp90 0.047 0.11 0.58 1 -0.44 9 10
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.021 0.092 0.37 1 -0.5 4 5
HIF1A/ARNT 0.038 0.042 -10000 0 -0.4 3 3
SHB 0.036 0.018 -10000 0 -10000 0 0
VEGFA 0.051 0.048 -10000 0 -10000 0 0
VEGFC 0.021 0.084 -10000 0 -0.54 11 11
FAK1/Vinculin 0.041 0.11 0.37 1 -0.42 3 4
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.068 0.097 -10000 0 -0.44 1 1
PTPN6 0.034 0.016 -10000 0 -10000 0 0
EPAS1 0.011 0.13 -10000 0 -0.54 28 28
mol:L-citrulline 0.033 0.11 0.59 1 -0.46 9 10
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.063 0.094 -10000 0 -0.29 20 20
VEGFR2 homodimer/VEGFA homodimer 0.05 0.11 -10000 0 -0.34 25 25
VEGFR2/3 heterodimer 0.023 0.087 -10000 0 -0.34 28 28
VEGFB 0.034 0.006 -10000 0 -10000 0 0
MAPK11 0.003 0.1 -10000 0 -0.48 7 7
VEGFR2 homodimer 0.004 0.096 -10000 0 -0.39 28 28
FLT1 0.032 0.013 -10000 0 -10000 0 0
NEDD4 0.028 0.058 -10000 0 -0.54 5 5
MAPK3 0.017 0.093 0.37 1 -0.45 4 5
MAPK1 0.013 0.093 0.34 2 -0.45 4 6
VEGFA145/NRP2 0.061 0.038 0.26 1 -10000 0 1
VEGFR1/2 heterodimer 0.021 0.087 -10000 0 -0.33 28 28
KDR 0.004 0.096 -10000 0 -0.39 28 28
VEGFA165/NRP1/VEGFR2 homodimer 0.054 0.1 -10000 0 -0.54 4 4
SRC 0.033 0.008 -10000 0 -10000 0 0
platelet activating factor biosynthetic process 0.019 0.097 0.37 2 -0.46 4 6
PI3K 0.019 0.12 -10000 0 -0.5 8 8
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.051 0.092 -10000 0 -0.31 24 24
FES 0.019 0.096 -10000 0 -0.55 4 4
GAB1 0.042 0.1 0.36 1 -0.41 7 8
VEGFR2 homodimer/VEGFA homodimer/Src 0.05 0.089 -10000 0 -0.31 21 21
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
SOS1 0.034 0.004 -10000 0 -10000 0 0
ARNT 0.028 0.014 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.13 0.16 -10000 0 -0.46 38 38
VEGFR2 homodimer/VEGFA homodimer/Yes 0.049 0.093 -10000 0 -0.31 24 24
PI3K/GAB1 0.029 0.15 0.39 2 -0.46 13 15
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.075 0.096 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.032 0.1 -10000 0 -0.32 38 38
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
CDC42 0.02 0.097 0.37 1 -0.55 4 5
actin cytoskeleton reorganization 0.049 0.095 -10000 0 -0.31 19 19
PTK2 0.023 0.09 -10000 0 -0.44 3 3
EDG1 0.003 0.087 0.27 1 -0.54 4 5
mol:DAG 0.021 0.092 0.37 1 -0.5 4 5
CaM/Ca2+ 0.034 0.088 -10000 0 -0.47 4 4
MAP2K3 0.004 0.087 -10000 0 -0.53 4 4
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.047 0.12 -10000 0 -0.63 7 7
PLCG1 0.021 0.093 0.37 1 -0.51 4 5
VEGFR2 homodimer/VEGFA homodimer/Src/Shb 0.069 0.094 0.37 1 -0.44 1 2
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
VEGFR2 homodimer/VEGFA homodimer/SHP2 0.052 0.092 -10000 0 -0.31 24 24
VEGFR2 homodimer/VEGFA homodimer/SHP1 0.05 0.092 -10000 0 -0.31 23 23
cell migration 0.044 0.11 0.35 1 -0.47 2 3
mol:PI-3-4-5-P3 0.019 0.11 -10000 0 -0.46 8 8
FYN 0.03 0.037 -10000 0 -0.54 2 2
VEGFB/NRP1 0.023 0.089 -10000 0 -0.51 4 4
mol:NO 0.033 0.11 0.59 1 -0.46 9 10
PXN 0.034 0.004 -10000 0 -10000 0 0
HRAS/GTP 0.013 0.073 -10000 0 -0.45 4 4
VEGFR2 homodimer/VEGFA homodimer/GRB10 0.039 0.11 -10000 0 -0.62 7 7
VHL 0.036 0.018 -10000 0 -10000 0 0
ITGB3 0.035 0.019 -10000 0 -10000 0 0
NOS3 0.032 0.12 0.6 1 -0.53 9 10
VEGFR2 homodimer/VEGFA homodimer/Sck 0.033 0.12 -10000 0 -0.32 38 38
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.007 0.08 0.37 1 -0.43 4 5
PRKCB 0.006 0.084 0.36 1 -0.47 4 5
VCL 0.034 0.005 -10000 0 -10000 0 0
VEGFA165/NRP1 0.027 0.094 -10000 0 -0.43 7 7
VEGFR1/2 heterodimer/VEGFA homodimer 0.047 0.093 -10000 0 -0.31 24 24
VEGFA165/NRP2 0.061 0.038 0.26 1 -10000 0 1
MAPKKK cascade 0.062 0.12 0.38 6 -0.55 6 12
NRP2 0.035 0.015 -10000 0 -10000 0 0
VEGFC homodimer 0.021 0.084 -10000 0 -0.54 11 11
NCK1 0.034 0.005 -10000 0 -10000 0 0
ROCK1 0.034 0.006 -10000 0 -10000 0 0
FAK1/Paxillin 0.042 0.11 0.44 2 -0.42 3 5
MAP3K13 0.018 0.095 -10000 0 -0.55 4 4
PDPK1 0.006 0.098 -10000 0 -0.42 8 8
VEGFR1 specific signals

Figure S92.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S92.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.038 0.039 -10000 0 -0.33 4 4
VEGFR1 homodimer/NRP1 0.016 0.034 -10000 0 -0.33 4 4
mol:DAG 0.02 0.042 -10000 0 -0.3 4 4
VEGFR1 homodimer/NRP1/VEGFR 121 0.043 0.045 -10000 0 -0.3 3 3
CaM/Ca2+ 0.038 0.041 -10000 0 -10000 0 0
HIF1A 0.039 0.055 -10000 0 -0.54 4 4
GAB1 0.033 0.027 -10000 0 -0.54 1 1
AKT1 -0.007 0.1 -10000 0 -0.36 4 4
PLCG1 0.02 0.042 -10000 0 -0.31 4 4
NOS3 0.021 0.084 -10000 0 -0.49 5 5
CBL 0.031 0.011 -10000 0 -10000 0 0
mol:NO 0.021 0.09 -10000 0 -0.48 6 6
FLT1 0.022 0.043 -10000 0 -0.39 4 4
PGF 0.034 0.012 -10000 0 -10000 0 0
VEGFR1 homodimer/NRP2/VEGFR121 0.062 0.051 -10000 0 -0.31 3 3
CALM1 0.034 0.006 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
eNOS/Hsp90 0.037 0.092 -10000 0 -0.47 6 6
endothelial cell proliferation 0.028 0.07 0.36 3 -10000 0 3
mol:Ca2+ 0.02 0.042 -10000 0 -0.3 4 4
MAPK3 -0.005 0.035 0.25 1 -10000 0 1
MAPK1 -0.006 0.037 0.25 1 -10000 0 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
PLGF homodimer 0.034 0.012 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
VEGFA homodimer 0.05 0.047 -10000 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer 0.047 0.049 -10000 0 -0.33 3 3
platelet activating factor biosynthetic process 0.021 0.074 0.34 2 -10000 0 2
PI3K 0.038 0.11 -10000 0 -0.3 42 42
PRKCA -0.003 0.041 0.26 1 -10000 0 1
PRKCB -0.002 0.04 -10000 0 -0.28 4 4
VEGFR1 homodimer/PLGF homodimer 0.038 0.039 -10000 0 -0.33 4 4
VEGFA 0.05 0.047 -10000 0 -10000 0 0
VEGFB 0.034 0.006 -10000 0 -10000 0 0
mol:IP3 0.02 0.042 -10000 0 -0.3 4 4
RASA1 0.021 0.043 -10000 0 -0.31 4 4
NRP2 0.035 0.015 -10000 0 -10000 0 0
VEGFR1 homodimer 0.022 0.042 -10000 0 -0.39 4 4
VEGFB homodimer 0.034 0.006 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.16 0.16 -10000 0 -0.51 20 20
PTPN11 0.034 0.004 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.036 0.11 -10000 0 -0.3 42 42
mol:L-citrulline 0.021 0.09 -10000 0 -0.48 6 6
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.076 0.059 -10000 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.062 0.05 -10000 0 -0.31 3 3
CD2AP 0.034 0.009 -10000 0 -10000 0 0
PI3K/GAB1 0.048 0.12 -10000 0 -0.54 1 1
PDPK1 0 0.095 -10000 0 -0.36 1 1
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.062 0.05 -10000 0 -0.31 3 3
mol:NADP 0.021 0.09 -10000 0 -0.48 6 6
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.073 0.058 -10000 0 -10000 0 0
VEGFR1 homodimer/NRP2 0.039 0.04 -10000 0 -0.33 4 4
Sphingosine 1-phosphate (S1P) pathway

Figure S93.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S93.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.034 0.005 -10000 0 -10000 0 0
SPHK1 0.034 0.059 -10000 0 -0.54 4 4
GNAI2 0.033 0.01 -10000 0 -10000 0 0
mol:S1P 0.02 0.033 0.2 2 -0.26 4 6
GNAO1 0.03 0.012 -10000 0 -10000 0 0
mol:Sphinganine-1-P 0.018 0.045 -10000 0 -0.4 4 4
growth factor activity 0 0 -10000 0 -10000 0 0
S1P/S1P2/G12/G13 0.054 0.041 -10000 0 -0.21 2 2
GNAI3 0.034 0.006 -10000 0 -10000 0 0
G12/G13 0.045 0.017 -10000 0 -10000 0 0
S1PR3 0 0 -10000 0 -10000 0 0
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
S1P1/S1P 0.011 0.031 -10000 0 -0.24 4 4
S1PR5 0 0 -10000 0 -10000 0 0
S1PR4 0 0 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
S1P/S1P5/G12 0.042 0.04 -10000 0 -0.22 4 4
S1P/S1P3/Gq 0.037 0.054 -10000 0 -0.29 6 6
S1P/S1P4/Gi -0.066 0.15 0.27 1 -0.34 58 59
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
ABCC1 0.035 0.024 -10000 0 -10000 0 0
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S94.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S94.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.034 0.006 -10000 0 -10000 0 0
VLDLR -0.04 0.19 -10000 0 -0.54 65 65
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
NUDC 0.033 0.008 -10000 0 -10000 0 0
RELN/LRP8 0.07 0.091 0.26 1 -0.32 20 21
CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
KATNA1 0.033 0.009 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 0.029 0.079 0.28 3 -0.29 20 23
IQGAP1/CaM 0.048 0.014 -10000 0 -10000 0 0
DAB1 0.033 0.007 -10000 0 -10000 0 0
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
PLA2G7 0.044 0.098 -10000 0 -0.54 10 10
CALM1 0.034 0.006 -10000 0 -10000 0 0
DYNLT1 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.073 0.048 -10000 0 -10000 0 0
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.035 0.007 -10000 0 -10000 0 0
CDK5R1 0.033 0.014 -10000 0 -10000 0 0
LIS1/Poliovirus Protein 3A 0.011 0.004 -10000 0 -10000 0 0
CDK5R2 0.034 0.005 -10000 0 -10000 0 0
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.008 0.16 -10000 0 -0.36 80 80
YWHAE 0.031 0.01 -10000 0 -10000 0 0
NDEL1/14-3-3 E 0.042 0.078 0.38 2 -0.32 2 4
MAP1B -0.021 0.089 -10000 0 -0.29 49 49
RAC1 0.016 0.007 -10000 0 -10000 0 0
p35/CDK5 0.035 0.073 0.27 3 -0.28 13 16
RELN 0.012 0.11 -10000 0 -0.54 20 20
PAFAH/LIS1 0.04 0.067 -10000 0 -0.34 10 10
LIS1/CLIP170 0.034 0.014 -10000 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain 0.033 0.069 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.008 0.13 -10000 0 -0.3 61 61
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 0.025 0.073 0.32 4 -0.33 2 6
LIS1/IQGAP1 0.033 0.014 -10000 0 -10000 0 0
RHOA 0.016 0.007 -10000 0 -10000 0 0
PAFAH1B1 0.015 0.006 -10000 0 -10000 0 0
PAFAH1B3 0.083 0.069 -10000 0 -10000 0 0
PAFAH1B2 0.03 0.012 -10000 0 -10000 0 0
MAP1B/LIS1/Dynein heavy chain 0.006 0.075 -10000 0 -0.36 2 2
NDEL1/Katanin 60/Dynein heavy chain 0.048 0.087 0.36 3 -0.31 2 5
LRP8 0.072 0.065 -10000 0 -10000 0 0
NDEL1/Katanin 60 0.035 0.082 0.38 2 -0.32 2 4
P39/CDK5 0.036 0.072 0.27 2 -0.28 13 15
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.033 0.014 -10000 0 -10000 0 0
CDK5 0.006 0.075 0.28 2 -0.3 13 15
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.03 0.012 -10000 0 -10000 0 0
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 0.002 0.14 -10000 0 -0.32 80 80
RELN/VLDLR 0.029 0.16 -10000 0 -0.31 80 80
CDC42 0.016 0.007 -10000 0 -10000 0 0
EPO signaling pathway

Figure S95.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S95.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.024 0.14 -10000 0 -10000 0 0
CRKL 0.016 0.068 0.32 4 -10000 0 4
mol:DAG 0.035 0.08 -10000 0 -10000 0 0
HRAS 0.049 0.087 0.33 11 -10000 0 11
MAPK8 0.048 0.075 0.27 13 -0.32 1 14
RAP1A 0.017 0.069 0.32 4 -10000 0 4
GAB1 0.018 0.067 0.32 3 -10000 0 3
MAPK14 0.049 0.074 0.27 14 -10000 0 14
EPO 0.047 0.052 -10000 0 -10000 0 0
PLCG1 0.026 0.076 -10000 0 -10000 0 0
EPOR/TRPC2/IP3 Receptors 0.029 0.024 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.055 0.079 -10000 0 -0.33 12 12
GAB1/SHC/GRB2/SOS1 0.045 0.066 0.33 1 -10000 0 1
EPO/EPOR (dimer) 0.054 0.047 -10000 0 -10000 0 0
IRS2 -0.051 0.14 0.35 1 -0.32 90 91
STAT1 0.044 0.12 -10000 0 -0.36 1 1
STAT5B 0.03 0.1 -10000 0 -10000 0 0
cell proliferation 0.026 0.081 0.26 16 -0.3 1 17
GAB1/SHIP/PIK3R1/SHP2/SHC 0.003 0.088 -10000 0 -0.26 20 20
TEC 0.017 0.066 0.3 2 -10000 0 2
SOCS3 0.019 0.087 -10000 0 -0.54 12 12
STAT1 (dimer) 0.044 0.11 -10000 0 -0.35 1 1
JAK2 0.032 0.018 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
EPO/EPOR (dimer)/JAK2 0.069 0.091 0.32 1 -0.22 1 2
EPO/EPOR 0.054 0.047 -10000 0 -10000 0 0
LYN 0.022 0.026 -10000 0 -10000 0 0
TEC/VAV2 0.033 0.072 0.29 3 -10000 0 3
elevation of cytosolic calcium ion concentration 0.029 0.024 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
EPO/EPOR (dimer)/LYN 0.055 0.059 -10000 0 -10000 0 0
mol:IP3 0.035 0.08 -10000 0 -10000 0 0
PI3K regualtory subunit polypeptide 1/IRS2/SHIP -0.068 0.16 -10000 0 -0.31 121 121
SH2B3 0.034 0.016 -10000 0 -10000 0 0
NFKB1 0.048 0.074 0.27 13 -10000 0 13
EPO/EPOR (dimer)/JAK2/SOCS3 0.024 0.055 -10000 0 -0.27 10 10
PTPN6 0.011 0.061 -10000 0 -10000 0 0
TEC/VAV2/GRB2 0.046 0.076 0.3 3 -10000 0 3
EPOR 0.029 0.024 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.042 0.067 0.33 1 -10000 0 1
SOS1 0.034 0.004 -10000 0 -10000 0 0
PLCG2 0.022 0.073 -10000 0 -0.54 8 8
CRKL/CBL/C3G 0.038 0.077 0.3 3 -10000 0 3
VAV2 0.019 0.07 0.3 6 -10000 0 6
CBL 0.015 0.068 0.32 4 -10000 0 4
SHC/Grb2/SOS1 0.03 0.06 -10000 0 -10000 0 0
STAT5A 0.03 0.1 -10000 0 -0.32 1 1
GRB2 0.034 0.018 -10000 0 -10000 0 0
STAT5 (dimer) 0.027 0.15 -10000 0 -0.33 50 50
LYN/PLCgamma2 0.029 0.061 0.25 1 -0.4 8 9
PTPN11 0.034 0.004 -10000 0 -10000 0 0
BTK 0.022 0.072 0.32 4 -10000 0 4
BCL2 -0.089 0.36 -10000 0 -0.82 99 99
Class I PI3K signaling events mediated by Akt

Figure S96.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S96.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.017 0.004 -10000 0 -10000 0 0
BAD/BCL-XL/YWHAZ 0.042 0.028 -10000 0 -10000 0 0
CDKN1B 0.018 0.071 0.3 4 -0.47 2 6
CDKN1A 0.02 0.067 0.28 2 -0.4 4 6
FRAP1 0 0 -10000 0 -10000 0 0
PRKDC 0.031 0.019 -10000 0 -10000 0 0
FOXO3 0.023 0.061 0.28 1 -0.4 4 5
AKT1 0.022 0.064 -10000 0 -0.36 9 9
BAD 0.034 0.007 -10000 0 -10000 0 0
AKT3 0.015 0.012 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
FOXO4 0.019 0.062 -10000 0 -0.4 4 4
AKT1/ASK1 0.033 0.095 -10000 0 -0.36 8 8
BAD/YWHAZ 0.051 0.033 -10000 0 -10000 0 0
RICTOR 0.034 0.006 -10000 0 -10000 0 0
RAF1 0.034 0.006 -10000 0 -10000 0 0
JNK cascade -0.032 0.092 0.35 8 -10000 0 8
TSC1 0.021 0.056 -10000 0 -0.63 1 1
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
AKT1/RAF1 0.055 0.077 0.32 1 -0.34 9 10
EP300 0.033 0.009 -10000 0 -10000 0 0
mol:GDP 0.022 0.063 -10000 0 -0.35 9 9
mol:PI-3-4-5-P3 0 0 -10000 0 -10000 0 0
TSC2 0.026 0.079 0.28 20 -0.4 4 24
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
TBC1D4 0.003 0.048 0.25 2 -0.32 10 12
MAP3K5 0.003 0.13 -10000 0 -0.54 26 26
MAPKAP1 0.034 0.006 -10000 0 -10000 0 0
negative regulation of cell cycle -0.041 0.079 0.27 11 -0.26 3 14
YWHAH 0.033 0.014 -10000 0 -10000 0 0
AKT1S1 0.023 0.068 -10000 0 -0.4 4 4
CASP9 0.022 0.046 -10000 0 -0.3 4 4
YWHAB 0.033 0.008 -10000 0 -10000 0 0
p27Kip1/KPNA1 0.049 0.083 0.35 2 -0.6 1 3
GBL 0 0 -10000 0 -10000 0 0
PDK1/Src/Hsp90 0.059 0.026 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
AKT2/p21CIP1 0.023 0.062 -10000 0 -0.42 3 3
KIAA1303 0 0 -10000 0 -10000 0 0
mTOR/RHEB/GTP/Raptor/GBL 0.017 0.054 -10000 0 -0.33 9 9
CHUK 0.02 0.061 -10000 0 -0.42 3 3
BAD/BCL-XL 0.058 0.073 0.31 1 -0.6 1 2
mTORC2 0.042 0.01 -10000 0 -10000 0 0
AKT2 0.017 0.006 -10000 0 -10000 0 0
FOXO1-3a-4/14-3-3 family 0.043 0.11 0.37 4 -0.4 12 16
PDPK1 0.032 0.01 -10000 0 -10000 0 0
MDM2 0.024 0.071 0.28 4 -0.4 4 8
MAPKKK cascade -0.055 0.075 0.34 9 -0.3 2 11
MDM2/Cbp/p300 0.062 0.081 0.36 2 -0.58 1 3
TSC1/TSC2 0.025 0.079 0.35 3 -0.62 1 4
proteasomal ubiquitin-dependent protein catabolic process 0.059 0.077 0.35 2 -0.55 1 3
glucose import -0.15 0.15 0.21 1 -0.31 239 240
mTOR/RHEB/GDP/Raptor/GBL/PRAS40 0.022 0.055 -10000 0 -0.64 1 1
response to stress 0 0 -10000 0 -10000 0 0
SLC2A4 -0.15 0.16 0.21 1 -0.31 239 240
GSK3A 0.021 0.065 -10000 0 -0.4 4 4
FOXO1 -0.004 0.095 -10000 0 -0.43 9 9
GSK3B 0.021 0.063 0.28 1 -0.42 3 4
SFN 0.033 0.04 -10000 0 -0.54 2 2
G1/S transition of mitotic cell cycle 0.032 0.076 0.39 1 -0.62 1 2
p27Kip1/14-3-3 family 0.031 0.044 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
KPNA1 0.034 0.005 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
RHEB 0.034 0.009 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
Signaling events mediated by HDAC Class III

Figure S97.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S97.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.033 0.009 -10000 0 -10000 0 0
HDAC4 0.034 0.007 -10000 0 -10000 0 0
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle 0.005 0.008 -10000 0 -0.13 1 1
CDKN1A -0.01 0.043 -10000 0 -0.66 2 2
KAT2B 0 0 -10000 0 -10000 0 0
BAX 0.035 0.012 0.18 3 -10000 0 3
FOXO3 -0.006 0.004 -10000 0 -10000 0 0
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
FOXO4 0.018 0.007 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0.032 0.009 -10000 0 -10000 0 0
TAT 0.029 0.05 -10000 0 -0.54 3 3
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 0.009 0.03 -10000 0 -0.4 2 2
PPARGC1A -0.022 0.17 -10000 0 -0.54 51 51
FHL2 -0.026 0.18 -10000 0 -0.54 55 55
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0.045 0.016 -10000 0 -10000 0 0
HIST2H4A -0.005 0.008 0.13 1 -10000 0 1
SIRT1/FOXO3a 0.022 0.031 0.19 1 -0.2 1 2
SIRT1 0.031 0.012 0.22 1 -10000 0 1
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0.054 0.029 -10000 0 -10000 0 0
SIRT1/Histone H1b 0.052 0.052 -10000 0 -0.23 2 2
apoptosis -0.062 0.022 -10000 0 -10000 0 0
SIRT1/PGC1A 0.004 0.12 -10000 0 -0.33 53 53
p53/SIRT1 0.037 0.025 0.42 1 -10000 0 1
SIRT1/FOXO4 0.033 0.044 -10000 0 -0.23 2 2
FOXO1/FHL2/SIRT1 -0.019 0.16 -10000 0 -0.34 91 91
HIST1H1E 0.04 0.041 -10000 0 -10000 0 0
SIRT1/p300 0.045 0.016 -10000 0 -10000 0 0
muscle cell differentiation -0.019 0.026 0.34 2 -10000 0 2
TP53 0.028 0.017 0.22 1 -10000 0 1
KU70/SIRT1/BAX 0.062 0.022 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
MEF2D 0.029 0.013 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 0.04 0.042 -10000 0 -0.4 3 3
ACSS2 0.014 0.007 -10000 0 -10000 0 0
SIRT1/PCAF/MYOD 0.019 0.026 -10000 0 -0.34 2 2
TRAIL signaling pathway

Figure S98.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S98.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 0.012 0.11 -10000 0 -0.54 19 19
positive regulation of NF-kappaB transcription factor activity 0.023 0.085 -10000 0 -0.39 19 19
MAP2K4 0.016 0.085 -10000 0 -0.4 12 12
IKBKB 0.029 0.013 -10000 0 -10000 0 0
TNFRSF10B 0.028 0.016 -10000 0 -10000 0 0
TNFRSF10A 0.028 0.018 -10000 0 -10000 0 0
SMPD1 0.005 0.057 -10000 0 -0.27 18 18
IKBKG 0.034 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
TNFRSF10D 0.027 0.014 -10000 0 -10000 0 0
TRAIL/TRAILR2 0.023 0.086 -10000 0 -0.37 21 21
TRAIL/TRAILR3 0.024 0.086 -10000 0 -0.38 20 20
TRAIL/TRAILR1 0.023 0.085 -10000 0 -0.37 21 21
TRAIL/TRAILR4 0.023 0.085 -10000 0 -0.4 19 19
TRAIL/TRAILR1/DAP3/GTP 0.032 0.067 -10000 0 -0.3 14 14
IKK complex 0.024 0.074 -10000 0 -0.42 5 5
RIPK1 0.034 0.006 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
DAP3/GTP 0.021 0.01 -10000 0 -10000 0 0
MAPK3 0.001 0.076 -10000 0 -0.4 18 18
MAP3K1 0.016 0.1 -10000 0 -0.46 14 14
TRAILR4 (trimer) 0.027 0.014 -10000 0 -10000 0 0
TRADD 0.03 0.012 -10000 0 -10000 0 0
TRAILR1 (trimer) 0.028 0.018 -10000 0 -10000 0 0
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 -0.001 0.081 -10000 0 -0.37 15 15
CFLAR 0.033 0.026 -10000 0 -0.54 1 1
MAPK1 0.001 0.076 -10000 0 -0.4 18 18
TRAIL/TRAILR1/FADD/TRADD/RIP 0.047 0.079 -10000 0 -0.29 14 14
mol:ceramide 0.005 0.057 -10000 0 -0.26 18 18
FADD 0.028 0.015 -10000 0 -10000 0 0
MAPK8 0.001 0.1 -10000 0 -0.39 18 18
TRAF2 0.035 0.012 -10000 0 -10000 0 0
TRAILR3 (trimer) 0.028 0.017 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
TRAIL/TRAILR1/FADD 0.034 0.073 -10000 0 -0.33 14 14
DAP3 0.029 0.013 -10000 0 -10000 0 0
CASP10 0.024 0.077 0.34 3 -0.34 5 8
JNK cascade 0.023 0.085 -10000 0 -0.39 19 19
TRAIL (trimer) 0.012 0.11 -10000 0 -0.54 19 19
TNFRSF10C 0.028 0.017 -10000 0 -10000 0 0
TRAIL/TRAILR1/DAP3/GTP/FADD 0.036 0.065 -10000 0 -0.28 10 10
TRAIL/TRAILR2/FADD 0.033 0.074 -10000 0 -0.34 14 14
cell death 0.005 0.056 -10000 0 -0.26 18 18
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 -0.001 0.081 -10000 0 -0.36 16 16
TRAILR2 (trimer) 0.028 0.016 -10000 0 -10000 0 0
CASP8 0.019 0.057 -10000 0 -0.58 3 3
negative regulation of caspase activity 0 0 -10000 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.047 0.08 -10000 0 -0.3 14 14
Signaling mediated by p38-gamma and p38-delta

Figure S99.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S99.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K -0.006 0.029 0.35 1 -0.34 1 2
SNTA1 0.032 0.026 -10000 0 -0.54 1 1
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 0.012 0.058 0.33 6 -0.34 1 7
MAPK12 -0.005 0.044 0.19 2 -0.29 10 12
CCND1 0.01 0.076 0.2 2 -0.43 11 13
p38 gamma/SNTA1 0.034 0.071 0.38 1 -0.28 10 11
MAP2K3 0.031 0.01 -10000 0 -10000 0 0
PKN1 0.035 0.011 -10000 0 -10000 0 0
G2/M transition checkpoint 0.011 0.072 0.21 40 -0.29 10 50
MAP2K6 -0.002 0.046 -10000 0 -0.33 10 10
MAPT 0.013 0.073 0.27 9 -0.3 11 20
MAPK13 0.018 0.027 -10000 0 -0.4 1 1
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.01 0.006 -10000 0 -10000 0 0
Signaling events mediated by HDAC Class II

Figure S100.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S100.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G beta1gamma2/HDAC5 0.074 0.039 -9999 0 -0.32 1 1
HDAC3 0.034 0.006 -9999 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.009 0.003 -9999 0 -10000 0 0
GATA1/HDAC4 0.049 0.011 -9999 0 -10000 0 0
GATA1/HDAC5 0.049 0.012 -9999 0 -10000 0 0
GATA2/HDAC5 0.054 0.026 -9999 0 -10000 0 0
HDAC5/BCL6/BCoR 0.024 0.12 -9999 0 -0.34 50 50
HDAC9 0.035 0.016 -9999 0 -10000 0 0
Glucocorticoid receptor/Hsp90/HDAC6 0.033 0.11 -9999 0 -0.34 40 40
HDAC4/ANKRA2 0.046 0.032 -9999 0 -0.32 3 3
HDAC5/YWHAB 0.047 0.015 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.018 0.02 -9999 0 -10000 0 0
GATA2 0.042 0.033 -9999 0 -10000 0 0
HDAC4/RFXANK 0.049 0.012 -9999 0 -10000 0 0
BCOR 0.035 0.003 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
HDAC10 0.031 0.028 -9999 0 -0.54 1 1
HDAC5 0.033 0.007 -9999 0 -10000 0 0
GNB1/GNG2 0.048 0.024 -9999 0 -0.4 1 1
Histones 0.024 0.051 -9999 0 -0.28 4 4
ADRBK1 0.032 0.01 -9999 0 -10000 0 0
HDAC4 0.034 0.007 -9999 0 -10000 0 0
XPO1 0.034 0.005 -9999 0 -10000 0 0
HDAC5/ANKRA2 0.045 0.033 -9999 0 -0.32 3 3
HDAC4/Ubc9 0.045 0.017 -9999 0 -10000 0 0
HDAC7 0 0 -9999 0 -10000 0 0
HDAC5/14-3-3 E 0.046 0.019 -9999 0 -10000 0 0
TUBA1B 0.035 0.012 -9999 0 -10000 0 0
HDAC6 0.035 0.003 -9999 0 -10000 0 0
HDAC5/RFXANK 0.048 0.013 -9999 0 -10000 0 0
CAMK4 0.035 0.017 -9999 0 -10000 0 0
Tubulin/HDAC6 0.06 0.057 -9999 0 -0.34 9 9
SUMO1 0.034 0.005 -9999 0 -10000 0 0
EntrezGene:9972 0 0 -9999 0 -10000 0 0
YWHAB 0.033 0.008 -9999 0 -10000 0 0
GATA1 0.035 0.003 -9999 0 -10000 0 0
EntrezGene:8021 0 0 -9999 0 -10000 0 0
YWHAE 0.031 0.01 -9999 0 -10000 0 0
NR3C1 -0.011 0.16 -9999 0 -0.54 40 40
SUMO1/HDAC4 0.051 0.051 -9999 0 -0.25 3 3
SRF 0.034 0.006 -9999 0 -10000 0 0
HDAC4/YWHAB 0.047 0.015 -9999 0 -10000 0 0
Tubulin 0.042 0.06 -9999 0 -0.4 9 9
HDAC4/14-3-3 E 0.045 0.019 -9999 0 -10000 0 0
GNB1 0.034 0.011 -9999 0 -10000 0 0
RANGAP1 0.038 0.03 -9999 0 -10000 0 0
BCL6/BCoR 0.005 0.13 -9999 0 -0.39 52 52
HDAC4/HDAC3/SMRT (N-CoR2) 0.066 0.018 -9999 0 -10000 0 0
HDAC4/SRF 0.066 0.022 -9999 0 -10000 0 0
HDAC4/ER alpha -0.028 0.2 -9999 0 -0.4 108 108
EntrezGene:23225 0 0 -9999 0 -10000 0 0
positive regulation of chromatin silencing 0.024 0.051 -9999 0 -0.28 4 4
cell motility 0.059 0.056 -9999 0 -0.34 9 9
EntrezGene:23636 0 0 -9999 0 -10000 0 0
UBE2I 0.032 0.01 -9999 0 -10000 0 0
HDAC7/HDAC3 0.025 0.004 -9999 0 -10000 0 0
BCL6 -0.024 0.17 -9999 0 -0.54 51 51
HDAC4/CaMK II delta B 0.034 0.007 -9999 0 -10000 0 0
Hsp90/HDAC6 0.049 0.011 -9999 0 -10000 0 0
ESR1 -0.059 0.25 -9999 0 -0.54 106 106
HDAC6/HDAC11 0.053 0.019 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.052 0.05 -9999 0 -0.26 3 3
NPC 0.02 0.002 -9999 0 -10000 0 0
MEF2C 0.005 0.12 -9999 0 -0.54 25 25
RAN 0.034 0.005 -9999 0 -10000 0 0
HDAC4/MEF2C 0.067 0.092 -9999 0 -0.3 24 24
GNG2 0.033 0.026 -9999 0 -0.54 1 1
NCOR2 0.034 0.005 -9999 0 -10000 0 0
TUBB2A 0.024 0.076 -9999 0 -0.54 9 9
HDAC11 0.038 0.025 -9999 0 -10000 0 0
HSP90AA1 0.034 0.007 -9999 0 -10000 0 0
RANBP2 0.034 0.004 -9999 0 -10000 0 0
ANKRA2 0.031 0.037 -9999 0 -0.54 2 2
RFXANK 0.034 0.005 -9999 0 -10000 0 0
nuclear import -0.038 0.021 -9999 0 -10000 0 0
Circadian rhythm pathway

Figure S101.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S101.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification 0.1 0.086 -10000 0 -10000 0 0
CLOCK 0.039 0.009 -10000 0 -10000 0 0
TIMELESS/CRY2 0.069 0.069 -10000 0 -10000 0 0
DEC1/BMAL1 0.052 0.025 -10000 0 -0.4 1 1
ATR 0.034 0.006 -10000 0 -10000 0 0
NR1D1 0.04 0.052 -10000 0 -10000 0 0
ARNTL 0.038 0.028 -10000 0 -0.54 1 1
TIMELESS 0.059 0.089 -10000 0 -10000 0 0
NPAS2 0.042 0.02 -10000 0 -10000 0 0
CRY2 0.034 0.005 -10000 0 -10000 0 0
mol:CO -0.021 0.03 -10000 0 -0.11 54 54
CHEK1 0.087 0.075 -10000 0 -10000 0 0
mol:HEME 0.021 0.03 0.11 54 -10000 0 54
PER1 0.024 0.063 -10000 0 -0.54 6 6
BMAL/CLOCK/NPAS2 0.089 0.044 -10000 0 -0.34 1 1
BMAL1/CLOCK 0.058 0.073 -10000 0 -10000 0 0
S phase of mitotic cell cycle 0.1 0.086 -10000 0 -10000 0 0
TIMELESS/CHEK1/ATR 0.11 0.087 -10000 0 -10000 0 0
mol:NADPH 0.021 0.03 0.11 54 -10000 0 54
PER1/TIMELESS 0.059 0.073 -10000 0 -10000 0 0
PER1-2 / CRY1-2 0 0 -10000 0 -10000 0 0
DEC1 0.035 0.01 -10000 0 -10000 0 0
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S102.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S102.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.034 0.006 -10000 0 -10000 0 0
NFATC1 0.042 0.087 0.38 2 -0.39 6 8
NFATC2 0.004 0.073 0.29 1 -0.24 16 17
NFATC3 0.013 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/CABIN1 0.031 0.062 0.26 1 -0.27 6 7
Exportin 1/Ran/NUP214 0.066 0.017 -10000 0 -10000 0 0
mol:DAG 0 0.002 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV 0.055 0.065 -10000 0 -10000 0 0
BCL2/BAX -0.033 0.17 -10000 0 -0.38 98 98
CaM/Ca2+/Calcineurin A alpha-beta B1 0.023 0.012 -10000 0 -10000 0 0
CaM/Ca2+ 0.023 0.012 -10000 0 -10000 0 0
BAX 0.035 0.012 0.18 3 -10000 0 3
MAPK14 0.034 0.005 -10000 0 -10000 0 0
BAD 0.034 0.007 -10000 0 -10000 0 0
CABIN1/MEF2D 0.038 0.06 -10000 0 -0.26 6 6
Calcineurin A alpha-beta B1/BCL2 -0.069 0.22 -10000 0 -0.54 91 91
FKBP8 0.034 0.009 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.038 0.06 0.26 6 -10000 0 6
KPNB1 0.033 0.009 -10000 0 -10000 0 0
KPNA2 0.059 0.06 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
MAP3K8 -0.04 0.19 -10000 0 -0.54 65 65
NFAT4/CK1 alpha 0.029 0.038 -10000 0 -0.33 1 1
MEF2D/NFAT1/Cbp/p300 0.034 0.1 -10000 0 -0.31 17 17
CABIN1 0.031 0.061 0.26 1 -0.27 7 8
CALM1 0.033 0.008 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
CAMK4 0.035 0.017 -10000 0 -10000 0 0
mol:Ca2+ 0 0.004 -10000 0 -10000 0 0
MAPK3 0.032 0.01 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/AKAP79/PKA 0.053 0.04 -10000 0 -0.4 2 2
YWHAB 0.033 0.008 -10000 0 -10000 0 0
MAPK8 0.032 0.026 -10000 0 -0.54 1 1
MAPK9 0.034 0.009 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
FKBP1A 0.034 0.012 0.18 2 -10000 0 2
NFAT1-c-4/YWHAQ 0.045 0.098 0.32 1 -0.42 6 7
PRKCH 0.029 0.051 -10000 0 -0.54 4 4
CABIN1/Cbp/p300 0.042 0.024 -10000 0 -10000 0 0
CASP3 0.033 0.008 -10000 0 -10000 0 0
PIM1 0.036 0.015 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.022 0.009 -10000 0 -10000 0 0
apoptosis -0.002 0.058 -10000 0 -10000 0 0
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 0.04 0.047 -10000 0 -10000 0 0
PRKCB 0 0 -10000 0 -10000 0 0
PRKCE 0.034 0.004 -10000 0 -10000 0 0
JNK2/NFAT4 0.011 0.063 -10000 0 -10000 0 0
BAD/BCL-XL 0.048 0.013 -10000 0 -10000 0 0
PRKCD 0.035 0.017 -10000 0 -10000 0 0
NUP214 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0.002 -10000 0 -10000 0 0
PRKCA 0.031 0.013 -10000 0 -10000 0 0
PRKCG 0.034 0.006 -10000 0 -10000 0 0
PRKCQ 0.039 0.03 -10000 0 -10000 0 0
FKBP38/BCL2 -0.033 0.17 -10000 0 -0.38 95 95
EP300 0.03 0.015 -10000 0 -10000 0 0
PRKCB1 0 0 -10000 0 -10000 0 0
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
NFATc/JNK1 0.057 0.087 0.34 1 -0.37 6 7
CaM/Ca2+/FKBP38 0.044 0.016 -10000 0 -10000 0 0
FKBP12/FK506 0.025 0.008 0.13 2 -10000 0 2
CSNK1A1 0.016 0.012 -10000 0 -10000 0 0
CaM/Ca2+/CAMK IV 0.044 0.018 -10000 0 -10000 0 0
NFATc/ERK1 0.054 0.086 0.34 1 -0.38 5 6
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV 0.066 0.063 -10000 0 -10000 0 0
NR4A1 0.024 0.14 -10000 0 -0.48 24 24
GSK3B 0.034 0.01 -10000 0 -10000 0 0
positive T cell selection 0.013 0.008 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.007 0.06 -10000 0 -0.27 5 5
RCH1/ KPNB1 0.063 0.047 -10000 0 -10000 0 0
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
AKAP5 0.04 0.051 -10000 0 -0.54 2 2
MEF2D 0.028 0.016 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
NFATc/p38 alpha 0.058 0.086 0.34 1 -0.38 5 6
CREBBP 0.03 0.015 -10000 0 -10000 0 0
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
p38 MAPK signaling pathway

Figure S103.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S103.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TRAF6/ASK1 0.008 0.07 -10000 0 -0.28 26 26
TRAF2/ASK1 0.022 0.087 -10000 0 -0.34 26 26
ATM 0.03 0.012 -10000 0 -10000 0 0
MAP2K3 -0.016 0.14 0.29 1 -0.4 36 37
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 -0.015 0.13 0.28 1 -0.36 42 43
hyperosmotic response 0 0 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
GADD45G 0.036 0.018 -10000 0 -10000 0 0
TXN 0.01 0.006 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
GADD45A 0.025 0.072 -10000 0 -0.54 8 8
GADD45B 0.032 0.037 -10000 0 -0.54 2 2
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
MAP3K6 0.033 0.008 -10000 0 -10000 0 0
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
MAP3K4 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
ASK1/ASK2 0.022 0.1 -10000 0 -0.37 30 30
TAK1/TAB family -0.002 0.021 -10000 0 -0.21 1 1
RAC1/OSM/MEKK3 0.058 0.023 -10000 0 -10000 0 0
TRAF2 0.035 0.012 -10000 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.008 0.12 -10000 0 -0.33 28 28
TRAF6 0.009 0.002 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
CAMK2B 0.039 0.069 -10000 0 -0.54 5 5
CCM2 0.034 0.005 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB 0.047 0.046 -10000 0 -0.34 5 5
MAPK11 0.032 0.009 -10000 0 -10000 0 0
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB/ASK1 0.042 0.094 -10000 0 -0.3 31 31
OSM/MEKK3 0.045 0.018 -10000 0 -10000 0 0
TAOK1 0.017 0.013 -10000 0 -10000 0 0
TAOK2 0.015 0.008 -10000 0 -10000 0 0
TAOK3 0.016 0.007 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.034 0.005 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
MAP3K5 0.003 0.13 -10000 0 -0.54 26 26
MAP3K10 0.033 0.039 -10000 0 -0.54 2 2
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
TRX/ASK1 0.01 0.082 -10000 0 -0.32 28 28
GADD45/MTK1/MTK1 0.067 0.059 -10000 0 -0.29 10 10
Visual signal transduction: Cones

Figure S104.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S104.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.048 0.037 -10000 0 -0.29 3 3
RGS9BP 0.055 0.065 -10000 0 -0.54 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
mol:Na + 0.043 0.042 0.23 1 -0.34 2 3
mol:ADP 0.008 0.019 0.14 1 -0.4 1 2
GNAT2 0.031 0.045 -10000 0 -0.54 3 3
RGS9-1/Gbeta5/R9AP 0.05 0.1 -10000 0 -0.32 28 28
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.041 0.038 -10000 0 -0.34 4 4
GRK7 0.033 0.027 -10000 0 -0.54 1 1
CNGB3 0.033 0.03 -10000 0 -10000 0 0
Cone Metarhodopsin II/X-Arrestin 0.026 0.001 -10000 0 -10000 0 0
mol:Ca2+ 0.056 0.075 0.28 8 -0.31 2 10
Cone PDE6 0.07 0.1 -10000 0 -0.3 21 21
Cone Metarhodopsin II 0.021 0.015 -10000 0 -0.31 1 1
Na + (4 Units) 0.056 0.046 -10000 0 -0.31 2 2
GNAT2/GDP 0.057 0.096 -10000 0 -0.28 30 30
GNB5 0.032 0.026 -10000 0 -0.54 1 1
mol:GMP (4 units) 0.021 0.044 -10000 0 -0.31 5 5
Cone Transducin 0.052 0.04 -10000 0 -0.31 3 3
SLC24A2 0.033 0.01 -10000 0 -10000 0 0
GNB3/GNGT2 0.043 0.02 -10000 0 -10000 0 0
GNB3 0.033 0.011 -10000 0 -10000 0 0
GNAT2/GTP 0.023 0.034 -10000 0 -0.34 4 4
CNGA3 0.043 0.053 0.18 37 -0.54 2 39
ARR3 0.035 0.002 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.044 0.042 0.23 1 -0.34 2 3
mol:Pi 0.049 0.1 -10000 0 -0.32 28 28
Cone CNG Channel 0.064 0.063 -10000 0 -0.29 6 6
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.033 0.01 -10000 0 -10000 0 0
RGS9 0.002 0.13 -10000 0 -0.54 27 27
PDE6C 0.034 0.028 -10000 0 -0.54 1 1
GNGT2 0.031 0.011 -10000 0 -10000 0 0
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H 0.033 0.03 -10000 0 -0.54 1 1
Retinoic acid receptors-mediated signaling

Figure S105.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S105.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC3 0.034 0.006 -10000 0 -10000 0 0
VDR 0.032 0.037 -10000 0 -0.54 2 2
Cbp/p300/PCAF 0.04 0.017 -10000 0 -10000 0 0
EP300 0.033 0.009 -10000 0 -10000 0 0
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.001 0.088 -10000 0 -0.3 17 17
KAT2B 0 0 -10000 0 -10000 0 0
MAPK14 0.034 0.005 -10000 0 -10000 0 0
AKT1 -0.006 0.11 0.26 3 -0.26 52 55
RAR alpha/9cRA/Cyclin H 0.078 0.064 -10000 0 -0.27 3 3
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.002 0.1 -10000 0 -0.24 53 53
CDC2 0 0.003 -10000 0 -10000 0 0
response to UV 0.001 0.004 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.046 0.046 -10000 0 -0.44 1 1
NCOR2 0.034 0.005 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.024 0.027 -10000 0 -0.4 2 2
RXRs/RARs/NRIP1/9cRA 0.024 0.12 0.38 1 -0.51 11 12
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA3 0.032 0.009 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
VDR/VDR/DNA 0.032 0.037 -10000 0 -0.54 2 2
RARG 0.035 0.007 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.046 0.009 -10000 0 -10000 0 0
MAPK3 0.032 0.013 -10000 0 -10000 0 0
MAPK1 0.033 0.009 -10000 0 -10000 0 0
MAPK8 0.033 0.028 -10000 0 -0.54 1 1
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0.069 0.067 -10000 0 -0.36 1 1
RARA 0.022 0.023 0.2 1 -0.23 1 2
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0.001 0.091 -10000 0 -0.34 13 13
PRKCA 0.033 0.019 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC1 0.028 0.13 0.41 4 -0.53 10 14
RXRG 0.021 0.033 -10000 0 -0.32 3 3
RXRA 0.04 0.054 0.22 1 -0.26 4 5
RXRB 0.027 0.019 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.024 0.027 -10000 0 -0.4 2 2
RBP1 0.007 0.13 -10000 0 -0.54 26 26
CRBP1/9-cic-RA 0.005 0.094 -10000 0 -0.4 26 26
RARB -0.052 0.21 -10000 0 -0.54 77 77
PRKCG 0.035 0.015 -10000 0 -10000 0 0
MNAT1 0.034 0.006 -10000 0 -10000 0 0
RAR alpha/RXRs 0.011 0.11 -10000 0 -0.44 5 5
RXRs/RARs/SMRT(N-CoR2)/9cRA 0.029 0.1 -10000 0 -0.41 5 5
proteasomal ubiquitin-dependent protein catabolic process 0.018 0.095 0.25 6 -0.31 10 16
RXRs/RARs/NRIP1/9cRA/HDAC3 0.028 0.13 0.41 4 -0.55 10 14
positive regulation of DNA binding 0.061 0.055 -10000 0 -0.26 3 3
NRIP1 0.02 0.19 0.56 2 -1.1 9 11
RXRs/RARs 0.029 0.12 0.36 4 -0.46 10 14
RXRs/RXRs/DNA/9cRA 0.026 0.056 -10000 0 -0.34 2 2
PRKACA 0.034 0.005 -10000 0 -10000 0 0
CDK7 0.033 0.008 -10000 0 -10000 0 0
TFIIH 0.066 0.018 -10000 0 -10000 0 0
RAR alpha/9cRA 0.08 0.05 -10000 0 -10000 0 0
CCNH 0.033 0.007 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
RAR gamma2/9cRA 0.063 0.023 -10000 0 -10000 0 0
Paxillin-dependent events mediated by a4b1

Figure S106.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S106.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.032 0.009 -9999 0 -10000 0 0
Rac1/GDP 0.03 0.013 -9999 0 -10000 0 0
DOCK1 0.03 0.044 -9999 0 -0.54 3 3
ITGA4 0.04 0.029 -9999 0 -10000 0 0
RAC1 0.034 0.005 -9999 0 -10000 0 0
alpha4/beta7 Integrin 0.054 0.022 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.031 0.01 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.07 0.025 -9999 0 -10000 0 0
alpha4/beta7 Integrin/Paxillin 0.06 0.023 -9999 0 -10000 0 0
lamellipodium assembly -0.031 0.16 -9999 0 -0.44 58 58
PIK3CA 0.033 0.008 -9999 0 -10000 0 0
PI3K 0.005 0.13 -9999 0 -0.4 44 44
ARF6 0.034 0.005 -9999 0 -10000 0 0
TLN1 0.034 0.006 -9999 0 -10000 0 0
PXN 0.017 0.003 -9999 0 -10000 0 0
PIK3R1 -0.02 0.17 -9999 0 -0.54 47 47
ARF6/GTP 0.069 0.032 -9999 0 -10000 0 0
cell adhesion 0.074 0.029 -9999 0 -10000 0 0
CRKL/CBL 0.044 0.019 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin 0.059 0.024 -9999 0 -10000 0 0
ITGB1 0.034 0.006 -9999 0 -10000 0 0
ITGB7 0.034 0.004 -9999 0 -10000 0 0
ARF6/GDP 0.03 0.013 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/VCAM1 0.07 0.064 -9999 0 -0.3 11 11
p130Cas/Crk/Dock1 0.053 0.043 -9999 0 -0.34 3 3
VCAM1 0.024 0.086 -9999 0 -0.54 11 11
alpha4/beta1 Integrin/Paxillin/Talin 0.076 0.03 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.074 0.033 -9999 0 -10000 0 0
BCAR1 0.029 0.013 -9999 0 -10000 0 0
mol:GDP -0.071 0.032 -9999 0 -10000 0 0
CBL 0.031 0.011 -9999 0 -10000 0 0
PRKACA 0.034 0.005 -9999 0 -10000 0 0
GIT1 0.032 0.011 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.076 0.03 -9999 0 -10000 0 0
Rac1/GTP -0.037 0.18 -9999 0 -0.5 57 57
Arf6 trafficking events

Figure S107.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S107.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 -0.25 0.28 -10000 0 -0.54 253 253
CLTC 0.034 0.056 -10000 0 -0.42 3 3
calcium ion-dependent exocytosis 0.016 0.043 -10000 0 -0.37 2 2
Dynamin 2/GTP 0.03 0.013 -10000 0 -10000 0 0
EXOC4 0.034 0.006 -10000 0 -10000 0 0
CD59 0.021 0.044 -10000 0 -0.34 2 2
CPE -0.04 0.13 -10000 0 -0.34 83 83
CTNNB1 0.029 0.052 -10000 0 -0.54 4 4
membrane fusion 0.012 0.035 -10000 0 -0.35 1 1
CTNND1 0.031 0.054 0.37 1 -10000 0 1
DNM2 0.034 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.022 0.046 0.23 2 -0.41 1 3
TSHR 0.015 0.028 -10000 0 -0.34 3 3
INS 0.008 0.099 -10000 0 -0.5 18 18
BIN1 0.034 0.005 -10000 0 -10000 0 0
mol:Choline 0.012 0.035 -10000 0 -0.35 1 1
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.016 0.006 -10000 0 -10000 0 0
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0.034 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0.03 0.012 -10000 0 -10000 0 0
JUP 0.022 0.036 -10000 0 -0.29 2 2
ASAP2/amphiphysin II 0.043 0.009 -10000 0 -10000 0 0
ARF6/GTP 0.025 0.004 -10000 0 -10000 0 0
CDH1 0.008 0.066 -10000 0 -0.38 4 4
clathrin-independent pinocytosis 0.025 0.004 -10000 0 -10000 0 0
MAPK8IP3 0.03 0.038 -10000 0 -0.54 2 2
positive regulation of endocytosis 0.025 0.004 -10000 0 -10000 0 0
EXOC2 0.041 0.033 -10000 0 -10000 0 0
substrate adhesion-dependent cell spreading 0.036 0.053 -10000 0 -0.36 3 3
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0.031 0.011 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.045 0.082 0.36 4 -10000 0 4
positive regulation of phagocytosis 0.017 0.005 -10000 0 -10000 0 0
ARF6/GTP/JIP3 0.041 0.029 -10000 0 -0.34 2 2
ACAP1 0.011 0.035 -10000 0 -0.23 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 0.027 0.04 -10000 0 -0.29 2 2
clathrin heavy chain/ACAP1 0.03 0.069 0.3 3 -0.42 2 5
JIP4/KLC1 0.056 0.025 -10000 0 -10000 0 0
EXOC1 0.034 0.005 -10000 0 -10000 0 0
exocyst 0.036 0.053 -10000 0 -0.36 3 3
RALA/GTP 0.025 0.004 -10000 0 -10000 0 0
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0.041 0.016 -10000 0 -10000 0 0
receptor recycling 0.025 0.004 -10000 0 -10000 0 0
CTNNA1 0.032 0.055 0.37 1 -10000 0 1
NME1 0.016 0.006 -10000 0 -10000 0 0
clathrin coat assembly 0.037 0.065 0.32 1 -0.42 3 4
IL2RA 0.027 0.047 -10000 0 -0.36 3 3
VAMP3 0.017 0.005 -10000 0 -10000 0 0
GLUT4/clathrin heavy chain/ACAP1 -0.1 0.13 -10000 0 -0.35 16 16
EXOC6 0.034 0.027 -10000 0 -0.54 1 1
PLD1 0.005 0.062 -10000 0 -0.3 18 18
PLD2 0.016 0.016 -10000 0 -0.27 1 1
EXOC5 0.034 0.006 -10000 0 -10000 0 0
PIP5K1C 0.019 0.038 0.22 1 -0.42 1 2
SDC1 0.037 0.051 -10000 0 -0.36 3 3
ARF6/GDP 0.028 0.011 -10000 0 -10000 0 0
EXOC7 0.032 0.009 -10000 0 -10000 0 0
E-cadherin/beta catenin 0.047 0.085 -10000 0 -0.4 3 3
mol:Phosphatidic acid 0.012 0.035 -10000 0 -0.35 1 1
endocytosis -0.041 0.009 -10000 0 -10000 0 0
SCAMP2 0.034 0.006 -10000 0 -10000 0 0
ADRB2 -0.11 0.15 -10000 0 -0.42 13 13
EXOC3 0.033 0.008 -10000 0 -10000 0 0
ASAP2 0 0 -10000 0 -10000 0 0
Dynamin 2/GDP 0.037 0.022 -10000 0 -10000 0 0
KLC1 0.034 0.007 -10000 0 -10000 0 0
AVPR2 0.032 0.068 0.29 2 -0.38 4 6
RALA 0.034 0.005 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.04 0.084 0.34 2 -0.38 3 5
Canonical NF-kappaB pathway

Figure S108.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S108.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.035 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.063 0.12 0.34 5 -0.33 11 16
ERC1 0.033 0.013 -10000 0 -10000 0 0
RIP2/NOD2 0.053 0.051 0.26 3 -10000 0 3
NFKBIA 0.016 0.027 -10000 0 -0.32 1 1
BIRC2 0.031 0.011 -10000 0 -10000 0 0
IKBKB 0.029 0.013 -10000 0 -10000 0 0
RIPK2 0.029 0.022 -10000 0 -10000 0 0
IKBKG 0.02 0.13 -10000 0 -0.39 41 41
IKK complex/A20 0.041 0.15 -10000 0 -0.42 21 21
NEMO/A20/RIP2 0.029 0.022 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
NEMO/ATM 0.031 0.15 -10000 0 -0.37 51 51
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
Exportin 1/RanGTP 0.045 0.009 -10000 0 -10000 0 0
IKK complex/ELKS 0.026 0.13 -10000 0 -0.41 21 21
BCL10/MALT1/TRAF6 0.064 0.021 -10000 0 -10000 0 0
NOD2 0.06 0.062 -10000 0 -10000 0 0
NFKB1 0.036 0.007 -10000 0 -10000 0 0
RELA 0.035 0.009 -10000 0 -10000 0 0
MALT1 0.034 0.01 -10000 0 -10000 0 0
cIAP1/UbcH5C 0.045 0.018 -10000 0 -10000 0 0
ATM 0.03 0.012 -10000 0 -10000 0 0
TNF/TNFR1A 0.05 0.021 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
PRKCA 0.031 0.013 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
UBE2D3 0.034 0.005 -10000 0 -10000 0 0
TNF 0.038 0.023 -10000 0 -10000 0 0
NF kappa B1 p50/RelA 0.073 0.025 -10000 0 -10000 0 0
BCL10 0.034 0.007 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.016 0.027 -10000 0 -0.32 1 1
beta TrCP1/SCF ubiquitin ligase complex 0.035 0.008 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
IKK complex 0.033 0.14 -10000 0 -0.41 25 25
CYLD 0.03 0.012 -10000 0 -10000 0 0
IKK complex/PKC alpha 0.036 0.14 -10000 0 -0.41 19 19
Paxillin-independent events mediated by a4b1 and a4b7

Figure S109.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S109.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.027 0.026 -10000 0 -10000 0 0
CRKL 0.032 0.009 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
DOCK1 0.03 0.044 -10000 0 -0.54 3 3
ITGA4 0.04 0.029 -10000 0 -10000 0 0
alpha4/beta7 Integrin/MAdCAM1 0.085 0.033 -10000 0 -10000 0 0
EPO 0.054 0.05 -10000 0 -10000 0 0
alpha4/beta7 Integrin 0.054 0.022 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.01 -10000 0 -10000 0 0
alpha4/beta1 Integrin 0.053 0.023 -10000 0 -10000 0 0
EPO/EPOR (dimer) 0.063 0.037 -10000 0 -10000 0 0
lamellipodium assembly -0.004 0.11 -10000 0 -0.36 21 21
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
ARF6 0.034 0.005 -10000 0 -10000 0 0
JAK2 0.043 0.034 -10000 0 -10000 0 0
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
MADCAM1 0.034 0.013 -10000 0 -10000 0 0
cell adhesion 0.082 0.032 -10000 0 -10000 0 0
CRKL/CBL 0.044 0.019 -10000 0 -10000 0 0
ITGB1 0.034 0.006 -10000 0 -10000 0 0
SRC 0.021 0.064 0.38 2 -0.31 11 13
ITGB7 0.034 0.004 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 0.062 0.067 0.26 4 -0.34 11 15
p130Cas/Crk/Dock1 0.04 0.071 0.37 1 -0.28 14 15
VCAM1 0.024 0.086 -10000 0 -0.54 11 11
RHOA 0.033 0.008 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.082 0.035 -10000 0 -10000 0 0
BCAR1 -0.007 0.061 0.39 2 -0.29 11 13
EPOR 0.034 0.005 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
GIT1 0.032 0.011 -10000 0 -10000 0 0
Rac1/GTP -0.004 0.12 -10000 0 -0.38 20 20
Class I PI3K signaling events

Figure S110.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S110.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.006 0.05 0.24 7 -10000 0 7
DAPP1 0.034 0.11 0.29 6 -0.32 20 26
Src family/SYK family/BLNK-LAT/BTK-ITK 0.044 0.14 0.36 11 -0.48 15 26
mol:DAG 0.042 0.094 0.27 35 -10000 0 35
HRAS 0.036 0.014 -10000 0 -10000 0 0
RAP1A 0.036 0.007 -10000 0 -10000 0 0
ARF5/GDP 0.047 0.078 -10000 0 -0.33 8 8
PLCG2 0.022 0.073 -10000 0 -0.54 8 8
PLCG1 0.033 0.008 -10000 0 -10000 0 0
ARF5 0.034 0.005 -10000 0 -10000 0 0
mol:GTP -0.007 0.049 0.28 7 -10000 0 7
ARF1/GTP 0.002 0.044 0.27 7 -10000 0 7
RHOA 0.033 0.008 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
RAP1A/GTP -0.004 0.051 0.24 8 -10000 0 8
ADAP1 -0.008 0.039 0.22 6 -10000 0 6
ARAP3 -0.007 0.049 0.28 7 -10000 0 7
INPPL1 0.032 0.01 -10000 0 -10000 0 0
PREX1 0.056 0.08 -10000 0 -0.54 4 4
ARHGEF6 0.014 0.11 -10000 0 -0.54 18 18
ARHGEF7 0.031 0.013 -10000 0 -10000 0 0
ARF1 0.028 0.014 -10000 0 -10000 0 0
NRAS 0.037 0.017 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
ARF6 0.034 0.005 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
mol:Ca2+ 0.027 0.064 0.22 22 -10000 0 22
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.035 0.012 -10000 0 -10000 0 0
ZAP70 0.038 0.024 -10000 0 -10000 0 0
mol:IP3 0.03 0.077 0.24 30 -0.17 1 31
LYN 0.03 0.015 -10000 0 -10000 0 0
ARF1/GDP 0.038 0.076 0.42 1 -0.32 8 9
RhoA/GDP 0.05 0.058 0.32 2 -10000 0 2
PDK1/Src/Hsp90 0.059 0.026 -10000 0 -10000 0 0
BLNK 0.039 0.026 -10000 0 -10000 0 0
actin cytoskeleton reorganization 0.037 0.083 0.36 6 -0.35 2 8
SRC 0.033 0.008 -10000 0 -10000 0 0
PLEKHA2 -0.005 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PTEN 0.028 0.044 -10000 0 -0.52 3 3
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
ARF6/GTP -0.006 0.049 0.24 7 -10000 0 7
RhoA/GTP -0.005 0.054 0.32 5 -10000 0 5
Src family/SYK family/BLNK-LAT 0.044 0.091 0.31 11 -0.37 6 17
BLK 0.039 0.044 -10000 0 -10000 0 0
PDPK1 0.032 0.01 -10000 0 -10000 0 0
CYTH1 -0.008 0.039 0.22 6 -10000 0 6
HCK 0.037 0.022 -10000 0 -10000 0 0
CYTH3 -0.008 0.039 0.22 6 -10000 0 6
CYTH2 -0.008 0.039 0.22 6 -10000 0 6
KRAS 0.036 0.019 -10000 0 -10000 0 0
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.014 0.031 0.26 1 -10000 0 1
SGK1 0.016 0.034 0.27 1 -10000 0 1
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.032 0.078 0.44 1 -0.34 8 9
SOS1 0.034 0.004 -10000 0 -10000 0 0
SYK 0.039 0.027 -10000 0 -10000 0 0
ARF6/GDP 0.032 0.061 0.34 6 -10000 0 6
mol:PI-3-4-5-P3 -0.008 0.043 0.25 6 -10000 0 6
ARAP3/RAP1A/GTP -0.004 0.052 0.24 8 -10000 0 8
VAV1 0.038 0.025 -10000 0 -10000 0 0
mol:PI-3-4-P2 0.008 0.003 -10000 0 -10000 0 0
RAS family/GTP/PI3K Class I 0.056 0.044 0.29 2 -10000 0 2
PLEKHA1 -0.008 0.021 -10000 0 -0.34 2 2
Rac1/GDP 0.048 0.078 -10000 0 -0.34 7 7
LAT 0.036 0.025 -10000 0 -10000 0 0
Rac1/GTP 0.028 0.082 -10000 0 -0.31 20 20
ITK -0.003 0.057 0.31 5 -0.29 2 7
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma 0.044 0.11 0.31 30 -0.26 1 31
LCK 0.049 0.044 -10000 0 -10000 0 0
BTK -0.002 0.055 0.31 5 -10000 0 5
PDGFR-beta signaling pathway

Figure S111.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S111.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.04 0.084 0.34 1 -0.34 6 7
PDGFB-D/PDGFRB/SLAP 0.041 0.027 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/APS/CBL 0.041 0.017 -10000 0 -10000 0 0
AKT1 0.027 0.12 0.39 15 -10000 0 15
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.047 0.094 0.35 3 -0.37 8 11
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
FGR 0.01 0.1 -10000 0 -0.45 17 17
mol:Ca2+ 0.037 0.092 0.34 3 -0.39 9 12
MYC 0.049 0.23 0.42 11 -0.78 29 40
SHC1 0.028 0.014 -10000 0 -10000 0 0
HRAS/GDP 0.049 0.046 0.27 1 -10000 0 1
LRP1/PDGFRB/PDGFB 0.065 0.023 -10000 0 -10000 0 0
GRB10 0.03 0.051 -10000 0 -0.54 4 4
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GO:0007205 0.037 0.092 0.34 3 -0.39 9 12
PTEN 0.029 0.045 -10000 0 -0.54 3 3
GRB2 0.034 0.018 -10000 0 -10000 0 0
GRB7 0.029 0.013 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SHP2 0.05 0.01 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB10 0.047 0.041 -10000 0 -0.4 4 4
cell cycle arrest 0.041 0.027 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
HIF1A 0.021 0.12 0.37 15 -0.33 1 16
GAB1 0.04 0.099 0.33 4 -0.4 8 12
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 0.038 0.094 0.38 4 -0.35 6 10
PDGFB-D/PDGFRB 0.061 0.037 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.049 0.018 -10000 0 -10000 0 0
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB 0.031 0.078 -10000 0 -0.39 3 3
positive regulation of MAPKKK cascade 0.05 0.01 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.037 0.093 0.34 3 -0.4 9 12
E5 0 0.001 -10000 0 -10000 0 0
CSK 0.033 0.012 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7 0.043 0.021 -10000 0 -10000 0 0
SHB 0.036 0.018 -10000 0 -10000 0 0
BLK -0.033 0.17 -10000 0 -0.4 72 72
PTPN2 0.034 0.009 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.049 0.013 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
VAV2 0.039 0.11 0.37 3 -0.42 10 13
CBL 0.031 0.011 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.05 0.015 -10000 0 -10000 0 0
LCK 0.025 0.096 -10000 0 -0.49 11 11
PDGFRB 0.035 0.009 -10000 0 -10000 0 0
ACP1 0.034 0.006 -10000 0 -10000 0 0
HCK 0.026 0.071 -10000 0 -0.61 3 3
ABL1 0.033 0.096 0.33 4 -0.39 9 13
PDGFB-D/PDGFRB/CBL 0.035 0.11 0.33 2 -0.43 13 15
PTPN1 0.037 0.03 -10000 0 -10000 0 0
SNX15 0.033 0.007 -10000 0 -10000 0 0
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT1 0.059 0.055 -10000 0 -10000 0 0
cell proliferation 0.052 0.21 0.4 14 -0.68 29 43
SLA 0.029 0.025 -10000 0 -10000 0 0
actin cytoskeleton reorganization 0.051 0.059 0.45 2 -10000 0 2
SRC 0.021 0.06 -10000 0 -0.62 2 2
PI3K -0.011 0.066 -10000 0 -0.27 20 20
PDGFB-D/PDGFRB/GRB7/SHC 0.047 0.034 -10000 0 -10000 0 0
SH2B2 0 0 -10000 0 -10000 0 0
PLCgamma1/SPHK1 0.048 0.096 0.35 3 -0.38 8 11
LYN 0.022 0.056 -10000 0 -0.44 2 2
LRP1 0.034 0.005 -10000 0 -10000 0 0
SOS1 0.034 0.004 -10000 0 -10000 0 0
STAT5B 0.033 0.01 -10000 0 -10000 0 0
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
NCK1-2/p130 Cas 0.076 0.054 -10000 0 -10000 0 0
SPHK1 0.035 0.06 -10000 0 -0.55 4 4
EDG1 0.001 0.003 -10000 0 -10000 0 0
mol:DAG 0.037 0.093 0.34 3 -0.4 9 12
PLCG1 0.037 0.094 0.34 3 -0.41 9 12
NHERF/PDGFRB 0.075 0.05 -10000 0 -10000 0 0
YES1 0.011 0.11 -10000 0 -0.56 13 13
cell migration 0.074 0.05 -10000 0 -10000 0 0
SHC/Grb2/SOS1 0.067 0.056 -10000 0 -10000 0 0
SLC9A3R2 0.033 0.015 -10000 0 -10000 0 0
SLC9A3R1 0.06 0.059 -10000 0 -10000 0 0
NHERF1-2/PDGFRB/PTEN 0.081 0.068 -10000 0 -0.31 3 3
FYN 0.005 0.11 -10000 0 -0.54 9 9
DOK1 0.037 0.051 -10000 0 -10000 0 0
HRAS/GTP 0.025 0.009 -10000 0 -10000 0 0
PDGFB 0.034 0.016 -10000 0 -10000 0 0
RAC1 0.025 0.16 0.38 2 -0.5 28 30
PRKCD 0.038 0.056 0.34 3 -10000 0 3
FER 0.037 0.055 0.38 2 -10000 0 2
MAPKKK cascade 0.048 0.098 0.33 21 -10000 0 21
RASA1 0.037 0.055 0.38 2 -10000 0 2
NCK1 0.034 0.005 -10000 0 -10000 0 0
NCK2 0.035 0.008 -10000 0 -10000 0 0
p62DOK/Csk 0.055 0.045 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SHB 0.05 0.019 -10000 0 -10000 0 0
chemotaxis 0.033 0.095 0.33 4 -0.38 9 13
STAT1-3-5/STAT1-3-5 0.08 0.049 -10000 0 -0.29 1 1
Bovine Papilomavirus E5/PDGFRB 0.026 0.007 -10000 0 -10000 0 0
PTPRJ 0.035 0.017 -10000 0 -10000 0 0
Nephrin/Neph1 signaling in the kidney podocyte

Figure S112.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S112.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity -0.048 0.032 -10000 0 -10000 0 0
KIRREL 0.032 0.018 -10000 0 -10000 0 0
Nephrin/NEPH1Par3/Par6/Atypical PKCs 0.048 0.032 -10000 0 -10000 0 0
PLCG1 0.033 0.008 -10000 0 -10000 0 0
ARRB2 0.031 0.011 -10000 0 -10000 0 0
WASL 0.033 0.026 -10000 0 -0.54 1 1
Nephrin/NEPH1/podocin/CD2AP 0.072 0.047 -10000 0 -10000 0 0
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP 0.032 0.027 -10000 0 -10000 0 0
FYN 0.064 0.094 0.28 67 -0.24 2 69
mol:Ca2+ 0.066 0.047 -10000 0 -10000 0 0
mol:DAG 0.067 0.048 -10000 0 -10000 0 0
NPHS2 0.033 0.017 -10000 0 -10000 0 0
mol:IP3 0.067 0.048 -10000 0 -10000 0 0
regulation of endocytosis 0.054 0.044 -10000 0 -0.22 2 2
Nephrin/NEPH1/podocin/Cholesterol 0.056 0.038 -10000 0 -10000 0 0
establishment of cell polarity 0.048 0.032 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2 0.083 0.053 -10000 0 -10000 0 0
Nephrin/NEPH1/beta Arrestin2 0.056 0.046 -10000 0 -0.23 2 2
NPHS1 0.049 0.031 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin 0.057 0.043 -10000 0 -0.24 2 2
TJP1 0.032 0.027 -10000 0 -0.54 1 1
NCK1 0.034 0.005 -10000 0 -10000 0 0
NCK2 0.035 0.008 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 0.069 0.049 -10000 0 -10000 0 0
CD2AP 0.034 0.009 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/GRB2 0.069 0.05 -10000 0 -10000 0 0
GRB2 0.034 0.018 -10000 0 -10000 0 0
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 0.056 0.11 0.3 63 -0.3 12 75
cytoskeleton organization 0.034 0.056 0.28 10 -10000 0 10
Nephrin/NEPH1 0.04 0.027 -10000 0 -10000 0 0
Nephrin/NEPH1/ZO-1 0.058 0.042 -10000 0 -0.37 1 1
Aurora C signaling

Figure S113.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S113.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.046 0.04 -10000 0 -10000 0 0
Aurora C/Aurora B/INCENP 0.079 0.055 0.24 19 -10000 0 19
metaphase 0 0 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
H3F3B 0.017 0.032 -10000 0 -0.31 4 4
AURKB 0.057 0.058 -10000 0 -10000 0 0
AURKC 0.036 0.019 0.18 8 -10000 0 8
Insulin-mediated glucose transport

Figure S114.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S114.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Insulin responsive Vesicles -0.075 0.14 0.38 1 -0.3 30 31
CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
AKT1 0.035 0.017 -10000 0 -10000 0 0
AKT2 0.034 0.005 -10000 0 -10000 0 0
STXBP4 0.031 0.014 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucose -0.09 0.13 0.41 1 -0.3 46 47
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
TBC1D4 0.006 0.07 -10000 0 -0.4 14 14
mol:Ca2+ 0 0 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
YWHAB 0.033 0.008 -10000 0 -10000 0 0
SNARE/Synip 0.053 0.032 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
ASIP 0 0 -10000 0 -10000 0 0
PRKCI 0.035 0.017 -10000 0 -10000 0 0
AS160/CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
RHOQ 0.033 0.026 -10000 0 -0.54 1 1
GYS1 0.017 0.021 0.26 3 -10000 0 3
PRKCZ 0 0 -10000 0 -10000 0 0
TRIP10 0.033 0.026 -10000 0 -0.54 1 1
TC10/GTP/CIP4/Exocyst 0.044 0.026 -10000 0 -0.34 2 2
AS160/14-3-3 0.025 0.077 -10000 0 -0.37 8 8
VAMP2 0.031 0.011 -10000 0 -10000 0 0
SLC2A4 -0.099 0.14 0.42 1 -0.32 48 49
STX4 0.032 0.01 -10000 0 -10000 0 0
GSK3B 0.028 0.014 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
LNPEP 0.035 0.016 -10000 0 -10000 0 0
YWHAE 0.031 0.01 -10000 0 -10000 0 0
Signaling events mediated by HDAC Class I

Figure S115.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S115.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA 0.077 0.054 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC1 0.009 0.003 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.05 0.064 -10000 0 -0.31 1 1
SUMO1 0.034 0.005 -10000 0 -10000 0 0
ZFPM1 0.029 0.015 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.018 0.02 -10000 0 -10000 0 0
FKBP3 0.034 0.005 -10000 0 -10000 0 0
Histones 0.077 0.047 -10000 0 -10000 0 0
YY1/LSF 0.031 0.056 -10000 0 -0.26 8 8
SMG5 0.03 0.017 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
I kappa B alpha/HDAC3 0.031 0.026 -10000 0 -10000 0 0
I kappa B alpha/HDAC1 0.043 0.042 -10000 0 -10000 0 0
SAP18 0.032 0.009 -10000 0 -10000 0 0
RELA 0.028 0.043 -10000 0 -0.23 8 8
HDAC1/Smad7 0.065 0.019 -10000 0 -10000 0 0
RANGAP1 0.038 0.03 -10000 0 -10000 0 0
HDAC3/TR2 0.045 0.039 -10000 0 -0.29 1 1
NuRD/MBD3 Complex 0.039 0.06 -10000 0 -0.32 5 5
NF kappa B1 p50/RelA 0.042 0.069 0.4 1 -0.33 2 3
EntrezGene:23225 0 0 -10000 0 -10000 0 0
GATA2 0.042 0.033 -10000 0 -10000 0 0
GATA1 0.035 0.003 -10000 0 -10000 0 0
Mad/Max 0.049 0.013 -10000 0 -10000 0 0
NuRD/MBD3 Complex/GATA1/Fog1 0.028 0.093 -10000 0 -0.36 14 14
RBBP7 0.038 0.022 -10000 0 -10000 0 0
NPC 0.02 0.002 -10000 0 -10000 0 0
RBBP4 0.034 0.006 -10000 0 -10000 0 0
MAX 0.033 0.007 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
FBXW11 0.034 0.006 -10000 0 -10000 0 0
NFKBIA 0.028 0.019 -10000 0 -0.27 1 1
KAT2B 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SIN3/HDAC complex 0.028 0.051 -10000 0 -0.3 4 4
SIN3 complex 0.078 0.032 -10000 0 -10000 0 0
SMURF1 0.034 0.005 -10000 0 -10000 0 0
CHD3 0.032 0.016 -10000 0 -10000 0 0
SAP30 0.034 0.009 -10000 0 -10000 0 0
EntrezGene:23636 0 0 -10000 0 -10000 0 0
NCOR1 0.031 0.011 -10000 0 -10000 0 0
YY1/HDAC3 0.032 0.05 -10000 0 -0.36 2 2
YY1/HDAC2 0.034 0.046 -10000 0 -0.23 5 5
YY1/HDAC1 0.034 0.049 -10000 0 -0.24 6 6
NuRD/MBD2 Complex (MeCP1) 0.039 0.056 -10000 0 -0.25 4 4
PPARG -0.21 0.16 -10000 0 -0.31 336 336
HDAC8/hEST1B 0.058 0.029 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.006 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
HDAC3/SMRT (N-CoR2) 0.046 0.037 -10000 0 -10000 0 0
MBD3L2 0.033 0.026 -10000 0 -0.54 1 1
ubiquitin-dependent protein catabolic process 0.064 0.019 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
NuRD/MBD3/MBD3L2 Complex 0.04 0.082 -10000 0 -0.37 7 7
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC3 0.03 0.013 -10000 0 -10000 0 0
HDAC2 0.034 0.017 -10000 0 -10000 0 0
YY1 0.017 0.008 -10000 0 -10000 0 0
HDAC8 0.035 0.002 -10000 0 -10000 0 0
SMAD7 0.033 0.008 -10000 0 -10000 0 0
NCOR2 0.034 0.005 -10000 0 -10000 0 0
MXD1 0.035 0.007 -10000 0 -10000 0 0
STAT3 0.024 0.011 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.034 0.004 -10000 0 -10000 0 0
YY1/LSF/HDAC1 0.049 0.057 -10000 0 -0.25 6 6
YY1/SAP30/HDAC1 0.05 0.053 -10000 0 -0.25 2 2
EP300 0.033 0.009 -10000 0 -10000 0 0
STAT3 (dimer non-phopshorylated) 0.024 0.011 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.028 0.019 -10000 0 -0.27 1 1
histone deacetylation 0.038 0.059 -10000 0 -0.28 5 5
STAT3 (dimer non-phopshorylated)/HDAC3 0.033 0.042 -10000 0 -0.26 1 1
nuclear export -0.058 0.028 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GATAD2B 0.028 0.014 -10000 0 -10000 0 0
GATAD2A 0.037 0.022 -10000 0 -10000 0 0
GATA2/HDAC3 0.051 0.043 -10000 0 -10000 0 0
GATA1/HDAC1 0.05 0.01 -10000 0 -10000 0 0
GATA1/HDAC3 0.046 0.036 -10000 0 -10000 0 0
CHD4 0.033 0.009 -10000 0 -10000 0 0
TNF-alpha/TNFR1A 0.05 0.021 -10000 0 -10000 0 0
SIN3/HDAC complex/Mad/Max 0.029 0.061 -10000 0 -0.44 3 3
NuRD Complex 0.04 0.077 -10000 0 -0.36 4 4
positive regulation of chromatin silencing 0.074 0.045 -10000 0 -10000 0 0
SIN3B 0.035 0.014 -10000 0 -10000 0 0
MTA2 0.034 0.006 -10000 0 -10000 0 0
SIN3A 0.034 0.006 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
SUMO1/HDAC1 0.053 0.05 -10000 0 -0.25 3 3
HDAC complex 0.082 0.031 -10000 0 -10000 0 0
GATA1/Fog1 0.043 0.02 -10000 0 -10000 0 0
FKBP25/HDAC1/HDAC2 0.064 0.023 -10000 0 -10000 0 0
TNF 0.038 0.023 -10000 0 -10000 0 0
negative regulation of cell growth 0.026 0.071 -10000 0 -0.41 7 7
NuRD/MBD2/PRMT5 Complex 0.039 0.056 -10000 0 -0.25 4 4
Ran/GTP/Exportin 1 0.052 0.05 -10000 0 -0.26 3 3
NF kappa B/RelA/I kappa B alpha 0.031 0.049 -10000 0 -0.32 1 1
SIN3/HDAC complex/NCoR1 0.021 0.065 -10000 0 -0.32 10 10
TFCP2 0.032 0.036 -10000 0 -0.54 2 2
NR2C1 0.033 0.026 -10000 0 -0.54 1 1
MBD3 0.033 0.007 -10000 0 -10000 0 0
MBD2 0.034 0.011 -10000 0 -10000 0 0
Atypical NF-kappaB pathway

Figure S116.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S116.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.049 0.015 -10000 0 -10000 0 0
FBXW11 0.034 0.006 -10000 0 -10000 0 0
NF kappa B1 p50/c-Rel 0.033 0.022 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.043 0.052 -10000 0 -0.26 1 1
NFKBIA 0.033 0.037 -10000 0 -0.28 1 1
MAPK14 0.034 0.005 -10000 0 -10000 0 0
NF kappa B1 p105/p50 0.031 0.016 -10000 0 -10000 0 0
ARRB2 0.017 0.006 -10000 0 -10000 0 0
REL 0.038 0.023 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
BCL3/NF kappa B1 p50 0.032 0.018 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
NF kappa B1 p105/RelA 0.031 0.016 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
NF kappa B1 p50 dimer 0.022 0.015 0.26 1 -10000 0 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
NFKB1 0.014 0.007 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
positive regulation of anti-apoptosis 0.039 0.05 -10000 0 -0.22 3 3
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.042 0.057 -10000 0 -0.29 2 2
SRC 0.033 0.008 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
NF kappa B1 p50/RelA 0.039 0.05 -10000 0 -0.22 3 3
IKBKB 0.029 0.013 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.006 -10000 0 -10000 0 0
SYK 0.039 0.027 -10000 0 -10000 0 0
I kappa B alpha/PIK3R1 0.017 0.1 -10000 0 -0.28 37 37
cell death 0.04 0.055 -10000 0 -0.28 2 2
NF kappa B1 p105/c-Rel 0.033 0.022 -10000 0 -10000 0 0
LCK 0.049 0.044 -10000 0 -10000 0 0
BCL3 0.035 0.014 -10000 0 -10000 0 0
IL2 signaling events mediated by STAT5

Figure S117.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S117.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.03 0.013 -10000 0 -10000 0 0
ELF1 0.045 0.029 -10000 0 -10000 0 0
CCNA2 0.082 0.069 -10000 0 -10000 0 0
PIK3CA 0.033 0.009 -10000 0 -10000 0 0
JAK3 0.035 0.006 -10000 0 -10000 0 0
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
JAK1 0.034 0.007 -10000 0 -10000 0 0
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.065 0.11 0.31 8 -0.36 8 16
SHC1 0.028 0.014 -10000 0 -10000 0 0
SP1 0.036 0.048 -10000 0 -0.35 8 8
IL2RA 0.036 0.057 -10000 0 -10000 0 0
IL2RB 0.036 0.022 -10000 0 -10000 0 0
SOS1 0.035 0.004 -10000 0 -10000 0 0
IL2RG 0.044 0.035 -10000 0 -10000 0 0
G1/S transition of mitotic cell cycle 0.048 0.15 0.4 2 -0.84 9 11
PTPN11 0.035 0.004 -10000 0 -10000 0 0
CCND2 0.01 0.1 -10000 0 -0.74 9 9
LCK 0.049 0.044 -10000 0 -10000 0 0
GRB2 0.035 0.018 -10000 0 -10000 0 0
IL2 0.034 0.027 -10000 0 -0.54 1 1
CDK6 0.028 0.063 -10000 0 -0.54 6 6
CCND3 0.066 0.11 0.46 4 -0.45 1 5
Aurora A signaling

Figure S118.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S118.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.047 0.055 -10000 0 -0.29 8 8
BIRC5 0.12 0.075 -10000 0 -10000 0 0
NFKBIA 0.023 0.041 0.27 5 -10000 0 5
CPEB1 0.02 0.092 -10000 0 -0.54 13 13
AKT1 0.023 0.041 0.3 3 -10000 0 3
NDEL1 0.031 0.011 -10000 0 -10000 0 0
Aurora A/BRCA1 0.041 0.034 -10000 0 -10000 0 0
NDEL1/TACC3 0.095 0.067 0.26 2 -10000 0 2
GADD45A 0.025 0.072 -10000 0 -0.54 8 8
GSK3B 0.004 0.027 -10000 0 -10000 0 0
PAK1/Aurora A 0.056 0.049 -10000 0 -10000 0 0
MDM2 0.033 0.01 -10000 0 -10000 0 0
JUB 0 0 -10000 0 -10000 0 0
TPX2 0.11 0.059 -10000 0 -10000 0 0
TP53 0.022 0.058 -10000 0 -10000 0 0
DLG7 0.023 0.032 -10000 0 -10000 0 0
AURKAIP1 0.034 0.013 -10000 0 -10000 0 0
ARHGEF7 0.031 0.013 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.1 0.07 0.27 2 -10000 0 2
G2/M transition of mitotic cell cycle 0.04 0.034 -10000 0 -10000 0 0
AURKA 0.032 0.041 -10000 0 -10000 0 0
AURKB 0.044 0.053 -10000 0 -10000 0 0
CDC25B 0.036 0.046 -10000 0 -10000 0 0
G2/M transition checkpoint 0.016 0.027 -10000 0 -10000 0 0
mRNA polyadenylation 0.031 0.059 -10000 0 -0.28 13 13
Aurora A/CPEB 0.031 0.059 -10000 0 -0.28 13 13
Aurora A/TACC1/TRAP/chTOG 0.054 0.088 -10000 0 -0.28 21 21
BRCA1 0.036 0.022 -10000 0 -10000 0 0
centrosome duplication 0.056 0.049 -10000 0 -10000 0 0
regulation of centrosome cycle 0.092 0.065 0.25 1 -10000 0 1
spindle assembly 0.053 0.086 -10000 0 -0.28 21 21
TDRD7 0.034 0.005 -10000 0 -10000 0 0
Aurora A/RasGAP/Survivin 0.12 0.072 0.28 1 -10000 0 1
CENPA 0.061 0.056 0.16 62 -0.23 1 63
Aurora A/PP2A 0.053 0.036 -10000 0 -10000 0 0
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process 0.029 0.037 0.27 1 -10000 0 1
negative regulation of DNA binding 0.023 0.059 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.044 0.02 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
Ajuba/Aurora A 0.016 0.028 -10000 0 -10000 0 0
mitotic prometaphase 0.006 0.024 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.032 0.041 -10000 0 -10000 0 0
TACC1 0.002 0.12 -10000 0 -0.54 23 23
TACC3 0.096 0.074 -10000 0 -10000 0 0
Aurora A/Antizyme1 0.069 0.037 -10000 0 -10000 0 0
Aurora A/RasGAP 0.052 0.036 -10000 0 -10000 0 0
OAZ1 0.034 0.007 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.004 0.027 -10000 0 -10000 0 0
GIT1 0.032 0.011 -10000 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.059 0.044 -10000 0 -10000 0 0
Importin alpha/Importin beta/TPX2 0.11 0.058 -10000 0 -10000 0 0
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
Aurora A/TPX2 0.11 0.063 0.25 5 -10000 0 5
PAK1 0.044 0.046 -10000 0 -10000 0 0
CKAP5 0.035 0.015 -10000 0 -10000 0 0
Arf6 downstream pathway

Figure S119.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S119.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR 0.098 0.13 0.42 7 -10000 0 7
regulation of axonogenesis -0.022 0.05 0.24 1 -10000 0 1
myoblast fusion -0.066 0.073 -10000 0 -0.24 9 9
mol:GTP 0.048 0.044 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.091 0.066 -10000 0 -10000 0 0
ARF1/GTP 0.053 0.044 -10000 0 -10000 0 0
mol:GM1 0.033 0.039 -10000 0 -10000 0 0
mol:Choline 0.017 0.076 -10000 0 -0.31 20 20
lamellipodium assembly 0.056 0.078 0.25 7 -0.33 1 8
MAPK3 0.071 0.077 -10000 0 -10000 0 0
ARF6/GTP/NME1/Tiam1 0.093 0.067 -10000 0 -10000 0 0
ARF1 0.028 0.014 -10000 0 -10000 0 0
ARF6/GDP 0.066 0.073 0.25 9 -10000 0 9
ARF1/GDP 0.057 0.069 -10000 0 -10000 0 0
ARF6 0.055 0.025 -10000 0 -10000 0 0
RAB11A 0.034 0.007 -10000 0 -10000 0 0
TIAM1 0.04 0.014 -10000 0 -10000 0 0
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.072 0.079 0.22 15 -10000 0 15
actin filament bundle formation -0.076 0.063 -10000 0 -10000 0 0
KALRN 0.042 0.055 -10000 0 -10000 0 0
RAB11FIP3/RAB11A 0.045 0.017 -10000 0 -10000 0 0
RhoA/GDP 0.076 0.064 -10000 0 -10000 0 0
NME1 0.036 0.015 -10000 0 -10000 0 0
Rac1/GDP 0.078 0.063 -10000 0 -10000 0 0
substrate adhesion-dependent cell spreading 0.048 0.044 -10000 0 -10000 0 0
cortical actin cytoskeleton organization 0.056 0.078 0.25 7 -0.33 1 8
RAC1 0.034 0.005 -10000 0 -10000 0 0
liver development 0.048 0.044 -10000 0 -10000 0 0
ARF6/GTP 0.048 0.045 -10000 0 -10000 0 0
RhoA/GTP 0.062 0.041 -10000 0 -10000 0 0
mol:GDP 0.052 0.076 0.22 4 -10000 0 4
ARF6/GTP/RAB11FIP3/RAB11A 0.076 0.044 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
PLD1 0.029 0.086 -10000 0 -0.35 20 20
RAB11FIP3 0.032 0.01 -10000 0 -10000 0 0
tube morphogenesis 0.056 0.078 0.25 7 -0.33 1 8
ruffle organization 0.022 0.05 -10000 0 -0.24 1 1
regulation of epithelial cell migration 0.048 0.044 -10000 0 -10000 0 0
PLD2 0.042 0.045 -10000 0 -0.36 1 1
PIP5K1A 0.022 0.05 -10000 0 -0.24 1 1
mol:Phosphatidic acid 0.017 0.076 -10000 0 -0.31 20 20
Rac1/GTP 0.056 0.078 0.25 7 -0.33 1 8
Effects of Botulinum toxin

Figure S120.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S120.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.012 0.019 -10000 0 -10000 0 0
UniProt:P19321 0 0 -10000 0 -10000 0 0
RIMS1/UNC13B 0.054 0.029 -10000 0 -10000 0 0
STXBP1 0.034 0.005 -10000 0 -10000 0 0
ACh/CHRNA1 0.023 0.031 -10000 0 -0.16 1 1
RAB3GAP2/RIMS1/UNC13B 0.058 0.038 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
UniProt:P30996 0 0 -10000 0 -10000 0 0
UniProt:Q60393 0 0 -10000 0 -10000 0 0
CST086 0 0 -10000 0 -10000 0 0
RIMS1 0.042 0.036 0.18 31 -10000 0 31
mol:ACh 0 0.032 0.097 7 -0.12 11 18
RAB3GAP2 0.028 0.014 -10000 0 -10000 0 0
STX1A/SNAP25/VAMP2 0.041 0.055 -10000 0 -10000 0 0
UniProt:P10844 0 0 -10000 0 -10000 0 0
muscle contraction 0.023 0.031 -10000 0 -0.16 1 1
UNC13B 0.035 0.014 -10000 0 -10000 0 0
CHRNA1 0.035 0.01 -10000 0 -10000 0 0
UniProt:P10845 0 0 -10000 0 -10000 0 0
ACh/Synaptotagmin 1 0.052 0.078 0.18 12 -0.33 9 21
SNAP25 0.007 0.035 -10000 0 -0.3 5 5
VAMP2 0.006 0.002 -10000 0 -10000 0 0
SYT1 0.07 0.1 -10000 0 -0.54 8 8
UniProt:Q00496 0 0 -10000 0 -10000 0 0
STXIA/STXBP1 0.033 0.015 -10000 0 -10000 0 0
STX1A/SNAP25 fragment 1/VAMP2 0.041 0.055 -10000 0 -10000 0 0
LPA4-mediated signaling events

Figure S121.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S121.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 -0.01 0.033 -10000 0 -0.34 5 5
ADCY5 -0.005 0.021 -10000 0 -0.34 1 1
ADCY6 -0.007 0.001 -10000 0 -10000 0 0
ADCY7 -0.003 0.018 -10000 0 -10000 0 0
ADCY1 -0.006 0.009 -10000 0 -10000 0 0
ADCY2 -0.009 0.042 -10000 0 -0.34 7 7
ADCY3 -0.006 0.007 -10000 0 -10000 0 0
ADCY8 -0.003 0.015 -10000 0 -10000 0 0
PRKCE 0.009 0.001 -10000 0 -10000 0 0
ADCY9 -0.004 0.015 -10000 0 -10000 0 0
mol:DAG 0 0 -10000 0 -10000 0 0
cAMP biosynthetic process 0.036 0.07 0.24 15 -10000 0 15
Ephrin A reverse signaling

Figure S122.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S122.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade 0.043 0.022 -9999 0 -0.34 1 1
EFNA5 0.033 0.029 -9999 0 -0.54 1 1
FYN 0.017 0.031 -9999 0 -0.31 3 3
neuron projection morphogenesis 0.043 0.022 -9999 0 -0.34 1 1
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 0.044 0.022 -9999 0 -0.34 1 1
EPHA5 0.034 0.005 -9999 0 -10000 0 0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S123.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S123.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A 0.034 0.004 -10000 0 -10000 0 0
oxygen homeostasis 0 0 -10000 0 -10000 0 0
TCEB2 0.032 0.01 -10000 0 -10000 0 0
TCEB1 0.028 0.014 -10000 0 -10000 0 0
HIF1A/p53 0.045 0.06 -10000 0 -0.27 8 8
HIF1A 0.03 0.05 -10000 0 -0.25 8 8
COPS5 0.029 0.013 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 0.071 0.051 -10000 0 -10000 0 0
FIH (dimer) 0.034 0.005 -10000 0 -10000 0 0
CDKN2A 0.053 0.054 -10000 0 -10000 0 0
ARNT/IPAS 0.04 0.021 -10000 0 -10000 0 0
HIF1AN 0.034 0.005 -10000 0 -10000 0 0
GNB2L1 0.034 0.005 -10000 0 -10000 0 0
HIF1A/ARNT 0.033 0.056 -10000 0 -0.27 8 8
CUL2 0.034 0.009 -10000 0 -10000 0 0
OS9 0.034 0.006 -10000 0 -10000 0 0
RACK1/Elongin B/Elongin C 0.053 0.03 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF1A/Hsp90 0.049 0.059 -10000 0 -0.27 8 8
PHD1-3/OS9 0.076 0.06 -10000 0 -0.32 1 1
HIF1A/RACK1/Elongin B/Elongin C 0.058 0.065 -10000 0 -0.27 6 6
VHL 0.036 0.018 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
HIF1A/JAB1 0.039 0.059 -10000 0 -0.27 7 7
EGLN3 0.06 0.064 -10000 0 -0.54 1 1
EGLN2 0.036 0.017 -10000 0 -10000 0 0
EGLN1 0.028 0.014 -10000 0 -10000 0 0
TP53 0.031 0.015 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.044 0.066 -10000 0 -0.46 7 7
ARNT 0.028 0.014 -10000 0 -10000 0 0
ARD1A 0 0 -10000 0 -10000 0 0
RBX1 0.033 0.009 -10000 0 -10000 0 0
HIF1A/p19ARF 0.06 0.069 0.26 4 -0.26 7 11
Rapid glucocorticoid signaling

Figure S124.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S124.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma 0.053 0.036 -10000 0 -0.29 4 4
MAPK9 0.01 0.005 -10000 0 -10000 0 0
adrenocorticotropin secretion 0.01 0.017 0.14 9 -10000 0 9
GNB1/GNG2 0.044 0.021 -10000 0 -0.34 1 1
GNB1 0.034 0.011 -10000 0 -10000 0 0
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.009 0.001 -10000 0 -10000 0 0
Gs family/GTP 0.019 0.025 -10000 0 -0.31 3 3
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0.001 0.006 0.08 3 -10000 0 3
GNAL 0.03 0.044 -10000 0 -0.54 3 3
GNG2 0.033 0.026 -10000 0 -0.54 1 1
CRH 0.031 0.024 -10000 0 -10000 0 0
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.009 0.016 -10000 0 -0.34 1 1
MAPK11 0.009 0.003 -10000 0 -10000 0 0
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S125.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S125.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 0.033 0.008 -10000 0 -10000 0 0
SMAD2 -0.007 0.05 -10000 0 -0.33 2 2
SMAD3 0.028 0.045 0.29 2 -10000 0 2
SMAD3/SMAD4 0.058 0.065 -10000 0 -0.46 3 3
SMAD4/Ubc9/PIASy 0.059 0.031 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4 0.066 0.073 -10000 0 -0.32 1 1
PPM1A 0.034 0.006 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
SMAD2/SMAD4 0.01 0.055 -10000 0 -0.3 3 3
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
TRAP-1/SMAD4 0.048 0.019 -10000 0 -0.17 2 2
MAPK3 0.032 0.01 -10000 0 -10000 0 0
MAPK1 0.033 0.009 -10000 0 -10000 0 0
NUP214 0.034 0.005 -10000 0 -10000 0 0
CTDSP1 0.034 0.005 -10000 0 -10000 0 0
CTDSP2 0.034 0.006 -10000 0 -10000 0 0
CTDSPL 0.031 0.036 -10000 0 -0.54 2 2
KPNB1 0.033 0.009 -10000 0 -10000 0 0
TGFBRAP1 0.034 0.004 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
NUP153 0.034 0.006 -10000 0 -10000 0 0
KPNA2 0.059 0.06 -10000 0 -10000 0 0
PIAS4 0.035 0.016 -10000 0 -10000 0 0
BARD1 signaling events

Figure S126.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S126.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 0.048 0.023 -10000 0 -10000 0 0
ATM 0.03 0.012 -10000 0 -10000 0 0
UBE2D3 0.034 0.005 -10000 0 -10000 0 0
PRKDC 0.031 0.019 -10000 0 -10000 0 0
ATR 0.034 0.006 -10000 0 -10000 0 0
UBE2L3 0.032 0.009 -10000 0 -10000 0 0
FANCD2 0.025 0.015 -10000 0 -10000 0 0
protein ubiquitination 0.089 0.059 -10000 0 -10000 0 0
XRCC5 0.034 0.005 -10000 0 -10000 0 0
XRCC6 0.032 0.009 -10000 0 -10000 0 0
M/R/N Complex 0.049 0.033 -10000 0 -10000 0 0
MRE11A 0.031 0.011 -10000 0 -10000 0 0
DNA-PK 0.057 0.031 -10000 0 -10000 0 0
FA complex/FANCD2/Ubiquitin 0.026 0.11 -10000 0 -0.46 12 12
FANCF 0.034 0.006 -10000 0 -10000 0 0
BRCA1 0.036 0.022 -10000 0 -10000 0 0
CCNE1 0.059 0.056 -10000 0 -10000 0 0
CDK2/Cyclin E1 0.068 0.047 0.26 8 -10000 0 8
FANCG 0.034 0.009 -10000 0 -10000 0 0
BRCA1/BACH1/BARD1 0.053 0.025 -10000 0 -10000 0 0
FANCE 0.033 0.027 -10000 0 -0.54 1 1
FANCC 0.036 0.016 -10000 0 -10000 0 0
NBN 0.028 0.016 -10000 0 -10000 0 0
FANCA 0.061 0.065 -10000 0 -10000 0 0
DNA repair 0.075 0.1 0.36 5 -0.38 3 8
BRCA1/BARD1/ubiquitin 0.053 0.025 -10000 0 -10000 0 0
BARD1/DNA-PK 0.073 0.04 -10000 0 -10000 0 0
FANCL 0.034 0.004 -10000 0 -10000 0 0
mRNA polyadenylation -0.048 0.022 -10000 0 -10000 0 0
BRCA1/BARD1/CTIP/M/R/N Complex 0.024 0.074 -10000 0 -0.31 3 3
BRCA1/BACH1/BARD1/TopBP1 0.069 0.029 -10000 0 -10000 0 0
BRCA1/BARD1/P53 0.078 0.039 -10000 0 -10000 0 0
BARD1/CSTF1/BRCA1 0.064 0.032 -10000 0 -10000 0 0
BRCA1/BACH1 0.036 0.022 -10000 0 -10000 0 0
BARD1 0.037 0.023 -10000 0 -10000 0 0
PCNA 0.038 0.027 -10000 0 -10000 0 0
BRCA1/BARD1/UbcH5C 0.069 0.027 -10000 0 -10000 0 0
BRCA1/BARD1/UbcH7 0.066 0.03 -10000 0 -10000 0 0
BRCA1/BARD1/RAD51/PCNA 0.12 0.071 0.35 2 -10000 0 2
BARD1/DNA-PK/P53 0.078 0.051 -10000 0 -10000 0 0
BRCA1/BARD1/Ubiquitin 0.053 0.025 -10000 0 -10000 0 0
BRCA1/BARD1/CTIP 0.048 0.039 -10000 0 -0.31 2 2
FA complex 0.043 0.054 -10000 0 -0.3 2 2
BARD1/EWS 0.05 0.02 -10000 0 -10000 0 0
RBBP8 0.013 0.028 -10000 0 -0.4 2 2
TP53 0.031 0.015 -10000 0 -10000 0 0
TOPBP1 0.035 0.012 -10000 0 -10000 0 0
G1/S transition of mitotic cell cycle -0.075 0.038 -10000 0 -10000 0 0
BRCA1/BARD1 0.097 0.064 -10000 0 -10000 0 0
CSTF1 0.032 0.01 -10000 0 -10000 0 0
BARD1/EWS-Fli1 0.028 0.016 -10000 0 -10000 0 0
CDK2 0.038 0.021 -10000 0 -10000 0 0
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.11 0.074 -10000 0 -10000 0 0
RAD50 0.034 0.006 -10000 0 -10000 0 0
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme 0.053 0.025 -10000 0 -10000 0 0
EWSR1 0.033 0.009 -10000 0 -10000 0 0
a4b1 and a4b7 Integrin signaling

Figure S127.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S127.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.034 0.006 -9999 0 -9999 0 0
ITGB7 0.034 0.004 -9999 0 -9999 0 0
ITGA4 0.04 0.029 -9999 0 -9999 0 0
alpha4/beta7 Integrin 0.054 0.022 -9999 0 -9999 0 0
alpha4/beta1 Integrin 0.053 0.023 -9999 0 -9999 0 0
Glypican 2 network

Figure S128.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S128.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK 0.044 0.038 -9999 0 -9999 0 0
GPC2 0 0 -9999 0 -9999 0 0
GPC2/Midkine 0.032 0.026 -9999 0 -9999 0 0
neuron projection morphogenesis 0.032 0.026 -9999 0 -9999 0 0
Sumoylation by RanBP2 regulates transcriptional repression

Figure S129.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S129.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.006 0.013 -10000 0 -10000 0 0
MDM2/SUMO1 0.049 0.052 -10000 0 -0.25 3 3
HDAC4 0.034 0.007 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC1 0.006 0.014 -10000 0 -10000 0 0
SUMO1 0.034 0.005 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1 0.016 0.026 -10000 0 -0.29 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
XPO1 0.007 0.034 -10000 0 -0.27 3 3
EntrezGene:23636 0 0 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.034 0.004 -10000 0 -10000 0 0
SUMO1/HDAC4 0.051 0.051 -10000 0 -0.25 3 3
SUMO1/HDAC1 0.053 0.05 -10000 0 -0.25 3 3
RANGAP1 0.038 0.03 -10000 0 -10000 0 0
MDM2/SUMO1/SUMO1 0.078 0.031 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1/RanBP2/Ubc9 0.018 0.02 -10000 0 -10000 0 0
Ran/GTP 0.036 0.046 -10000 0 -0.26 3 3
EntrezGene:23225 0 0 -10000 0 -10000 0 0
MDM2 0.033 0.01 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.035 0.05 0.26 2 -0.26 3 5
NPC 0.02 0.002 -10000 0 -10000 0 0
PIAS2 0.033 0.007 -10000 0 -10000 0 0
PIAS1 0.033 0.007 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
Arf1 pathway

Figure S130.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S130.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
coatomer protein complex 0.016 0.037 -10000 0 -10000 0 0
EntrezGene:79658 0 0 -10000 0 -10000 0 0
ARF1/GDP/Membrin/GBF1/p115/Brefeldin A 0.035 0.051 -10000 0 -0.19 2 2
AP2 0.049 0.017 0.26 1 -10000 0 1
mol:DAG 0 0 -10000 0 -10000 0 0
Arfaptin 2/Rac/GTP 0.044 0.015 -10000 0 -10000 0 0
CLTB 0.034 0.007 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ER cargo protein 0.018 0.019 -10000 0 -0.16 3 3
CD4 0.032 0.009 -10000 0 -10000 0 0
CLTA 0.034 0.006 -10000 0 -10000 0 0
mol:GTP -0.001 0.003 -10000 0 -10000 0 0
ARFGAP1 0.009 0.008 0.14 2 -10000 0 2
mol:PI-4-5-P2 0.009 0.02 -10000 0 -0.19 1 1
ARF1/GTP 0.015 0.014 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1/ER cargo protein 0.012 0.022 0.18 5 -10000 0 5
mol:Choline 0.008 0.02 -10000 0 -0.2 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
ARF1 0.029 0.015 -10000 0 -10000 0 0
DDEF1 0.007 0.02 -10000 0 -0.2 1 1
ARF1/GDP 0.001 0.024 -10000 0 -0.15 1 1
AP2M1 0.034 0.009 -10000 0 -10000 0 0
EntrezGene:1313 0 0 -10000 0 -10000 0 0
actin filament polymerization 0.013 0.008 -10000 0 -10000 0 0
Rac/GTP 0.029 0.007 -10000 0 -10000 0 0
ARF1/GTP/GGA3/ARF-GAP1 0.034 0.025 -10000 0 -10000 0 0
ARFIP2 0.021 0.026 -10000 0 -10000 0 0
COPA 0.028 0.014 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
ARF1/GTP/coatomer protein complex 0.017 0.032 -10000 0 -0.2 3 3
ARF1/GTP/ARHGAP10 0.018 0.01 -10000 0 -10000 0 0
GGA3 0.032 0.009 -10000 0 -10000 0 0
ARF1/GTP/Membrin 0.017 0.039 -10000 0 -0.26 5 5
AP2A1 0.035 0.013 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1 0.011 0.032 -10000 0 -0.23 5 5
ARF1/GDP/Membrin 0.019 0.048 -10000 0 -0.25 11 11
Arfaptin 2/Rac/GDP 0.041 0.016 -10000 0 -10000 0 0
CYTH2 -0.001 0.003 -10000 0 -10000 0 0
ARF1/GTP/GGA3 0.034 0.021 -10000 0 -10000 0 0
mol:ATP 0 0 -10000 0 -10000 0 0
Rac/GDP 0.025 0.004 -10000 0 -10000 0 0
mol:Brefeldin A 0 0 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex/Coatomer protein complex/ARF1/GTP 0.025 0.033 -10000 0 -10000 0 0
PLD2 0.008 0.02 -10000 0 -0.2 1 1
ARF-GAP1/v-SNARE 0.009 0.008 0.14 2 -10000 0 2
PIP5K1A 0.009 0.02 -10000 0 -0.19 1 1
ARF1/GTP/Membrin/GBF1/p115 0.016 0.024 -10000 0 -10000 0 0
mol:Phosphatic acid 0 0 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.008 0.02 -10000 0 -0.2 1 1
KDEL Receptor/Ligand/ARF-GAP1 0.009 0.008 0.14 2 -10000 0 2
GOSR2 0.013 0.018 -10000 0 -0.26 1 1
USO1 0.012 0.024 -10000 0 -0.31 2 2
GBF1 0.014 0.02 -10000 0 -0.31 1 1
ARF1/GTP/Arfaptin 2 0.036 0.022 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex 0.062 0.026 -10000 0 -10000 0 0
Alternative NF-kappaB pathway

Figure S131.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S131.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.048 0.015 -10000 0 -9999 0 0
FBXW11 0.034 0.006 -10000 0 -9999 0 0
proteasomal ubiquitin-dependent protein catabolic process 0 0 -10000 0 -9999 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.006 -10000 0 -9999 0 0
CHUK 0.034 0.005 -10000 0 -9999 0 0
NF kappa B2 p100/RelB 0.096 0.035 -10000 0 -9999 0 0
NFKB1 0.034 0.005 -10000 0 -9999 0 0
MAP3K14 0.033 0.007 -10000 0 -9999 0 0
NF kappa B1 p50/RelB 0.052 0.017 -10000 0 -9999 0 0
RELB 0.037 0.02 -10000 0 -9999 0 0
NFKB2 0.035 0.012 -10000 0 -9999 0 0
NF kappa B2 p52/RelB 0.048 0.018 0.23 1 -9999 0 1
regulation of B cell activation 0.047 0.017 0.23 1 -9999 0 1
Inferred Pathway Levels Matrix

Table 3.  Get Full Table First 10 out of 7202 rows and 4 out of 513 columns in the PARADIGM inferred pathway levels matrix.

pid_entity TCGA.E2.A1BD TCGA.E2.A1BC TCGA.E2.A1B6 TCGA.E2.A1B5
109_MAP3K5 0.04 0.04 0.094 0.094
47_PPARGC1A 0.035 0.035 0.035 0.18
105_BMP4 0.035 0.035 0.035 0.035
105_BMP6 0.035 0.035 0.035 0.035
105_BMP7 0.035 0.035 0.035 0.035
105_BMP2 0.035 0.035 0.035 0.035
131_RELN/VLDLR 0.09 0.09 -0.31 0.18
30_TGFB1/TGF beta receptor Type II 0.034 0.034 0.034 0.034
84_STAT5B -0.21 -0.0029 -0.029 -0.21
84_STAT5A -0.21 -0.0029 -0.029 -0.21
Methods & Data
Input

  • Expression Data Normalization = Normal controls were used to median center the expression data used in this analysis.

  • mRNA Expression File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_MergeDataFilesPipeline/BRCA-TP/11446322/GDAC_MergeDataFiles_3799172/BRCA-TP.transcriptome__agilentg4502a_07_3__unc_edu__Level_3__unc_lowess_normalization_gene_level__data.data.txt

  • Copy Number File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Gistic2/BRCA-TP/11541490/Gistic2_Analysis_11541873/all_data_by_genes.txt

Data Sets and Pathway Interactions

Both copy number and expression data are incorporated into PARADIGM's inference. Whenever normal tissue controls are available for analysis in the expression data, each patient's gene-value is normalized by subtracting the gene's median level observed in the normal control. Copy number data is also normalized to reflect the difference in copy number between a gene's levels detected in tumor versus control (e.g. blood normal). The collection of pathways used by PARADIGM includes those from NCI-PID on September 15, 2009 containing 131 pathways, 11,563 interactions, and 7,204 entities. All gene identifiers were translated into HUGO standard identifiers wherever possible. We refer to molecular entities as "concepts," which include gene products such as proteins and miRNAs, small molecules, protein complexes, and abstract concepts. Each concept is represented as "node" in PARADIGM's graphical model. The abstract concepts correspond to general cellular processes (such as "apoptosis" or "DNA damage response") and families of genes that share functional activity such as the RAS family of signal transducers. Various types of concept-concept interactions are included in the pathways including protein-protein interactions, transcriptional regulatory interactions, and protein modifications such as phosphorylation and ubiquitinylation interactions.

Pathway Inference Method

The PARADIGM algorithm (described in PMID: 20529912) assigns an integrated pathway level (IPL) reflecting the activity of a concept determined through a belief propagation strategy. The belief propagation is given the copy number and gene expression measurements of all of the genes and iteratively updates hidden states reflecting the activities of all of the genes in a pathway so as to maximize the likelihood of the observed data given the interactions in the pathway. In the end, the inferred level of a concept reflects both the data observed for the concept and the neighborhood of activity surrounding the concept.

Determining significantly altered levels

The significance of the IPL obtained for each concept in each patient sample is assessed using a permutation analysis. Importantly, the permutation analysis preserves data tuples so as to preserve any implicit correlations between the different data modalities. For example, genes that are deleted have concomitantly lower expression levels. Preserving the copy number and expression pairs therefore retains this data property. The simulation therefore makes "null samples" by permuting data tuples across all of the genes in the genome so that each gene in a null sample is associated with a random tuple of another gene with equal probability. This approach has the added benefit of preserving the pathway structure so that every observed IPL can be compared to a distribution of random IPLs derived from exactly the same interaction context. PARADIGM inferences are then obtained for 1000 "null" patients and serve as a background distribution to contrast the observed IPLs against. Pathway concepts are excluded from further analysis if they did not obtain a minimum IPL of 0.5 in any patient sample both observed or simulated.

An IPL I(i,j) for concept i in sample j, is considered to be deviated if its absolute level is two standard deviations from the average level observed for concept i in the 1000 null samples. The degree to which a concept has significantly altered levels across a patient cohort is summarized in the proportion of deviated samples (PDS) score. For example, a protein with a PDS of 0.10 reflects that the protein's level of activity was inferred to be significantly higher or lower in tumors compared to normal in 10% of the patient samples. An average PDS for a pathway is also reported by computing the mean PDS over all concepts in the pathway.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[2] Charles J. Vaske, Stephen C. Benz, J. Zachary Sanborn, Dent Earl, Christopher Szeto, Jingchun Zhu, David Haussler, and Joshua M. Stuart, Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, Bioinformatics 12(26):237-245 (2010)
Copyright © 2015 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle